8/0//8
‫התשס"ט‬/'‫א‬
‫רשומות‬
ISRAEL STATE RECORDS
‫ב' בטבת התשס"ט‬
December 29, 2008
‫יומן הפטנטים והמדגמים‬
PATENTS AND DESIGNS JOURNAL
PATENTS
Applications filed
Applications accepted
Patents granted
Patents renewed
Patents not in force
Patents renewed for 20 years
Extension orders renewed
Patents expired
Notices
Corrigendum
Changes in particulars entered
in register
Country codes
Indices of applications accepted
DESIGNS
Designs registered
Designs renewed
Designs void
‫עמוד‬
Page
2682
2112
2216
2213
2221
2222
2222
2223
2223
2223
‫פטנטים‬
2221
i
‫בקשות שהוגשו‬
‫בקשות שקובלו‬
‫פטנטים שניתנו‬
‫פטנטים שחודשו‬
‫פטנטים שתוקפם פקעו‬
‫פטנטים שחודשו לעשרים שנה‬
‫צווי הארכה שחודשו‬
‫פטנטים שפג תוקפם‬
‫הודעות‬
‫תיקון טעות‬
‫שינויים בפרטים רשומים‬
‫בפנקס‬
‫קודים למדינות‬
‫מפתחות לבקשות שקובלו‬
2222
2233
2233
‫מדגמים‬
‫מדגמים שנרשמו‬
‫מדגמים שחודשו‬
‫מדגמים שבוטלו‬
2223
‫ידיעות כלליות‬
:‫ וכו' בענייני פטנטים ומדגמים יש לשלוח אל‬,‫ מסמכים‬,‫מכתבים‬
‫ ירושלים‬,4 ‫ רח' הסדנא‬,‫רשם הפטנטים והמדגמים‬
‫ ירושלים והיא פתוחה לציבור בימי חול‬,‫ תלפיות‬,4 ‫לשכת הפטנטים נמצאת ברח' הסדנא‬
.00::/ -‫ ו‬8::/ ‫שאינם ערבי שבת או מועד בין השעות‬
‫ שקלים בעד כל‬0../ ‫לשכת הפטנטים מספקת תצלומים של פירוטים ושרטוטים במחיר של‬
.‫עמוד או חלק ממנו‬
'‫אגרות לל שכת הפטנטים מתקבלות אך ורק על ידי תשלום לחשבון הלשכה בבנק הדואר מס‬
‫ יש להציג קבלת בנק הדואר ללשכה יחד עם הבקשה לפעולה שעבורה האגרה‬. /-0404.-0
.‫שולמה‬
GENERAL INFORMATION
Letters, documents, etc. concerning Patents and Designs should be addressed to:
The Commissioner of Patents and Designs, 4 Hasadnah St., Jerusalem
The Patent Office is located at 4 Hasadnah St., Talpiot, Jerusalem and is open to the public on
weekdays, except on Fridays or on the eves of holydays, from 08:30 to 12:30 hrs.
The Patent Office supplies photocopies of specifications and drawings at the rate of NIS 2.50
per page or part thereof.
Fees to the Patent Office can be accepted only by payment to the Postal Bank Account of the
Office, No. 0-24145-2. The receipt of the Postal Bank must be presented to the office together
with the application for the action for which the fee has been paid.
Copyright by the State of Israel. No
Extracts may be published except with the
permission of the Patent Office.
‫זכות היוצרים בתקצירים אלה שמורה‬
‫ אין להעתיק מת‬,‫למדינת ישראל‬
‫קצירים‬
.‫אלה אלא ברשות לשכת הפטנטים‬
Price per single issue (incl. VAT) : NIS 38.
.₪ 69 ).‫מ‬.‫ע‬.‫ לכל חוברת בודדת (כולל מ‬:‫מחיר‬
Annual subscription (incl. VAT):
NIS 15132.
Available at the Distribution Service of
Government Publications, 29 B-Street,
Hakirya, Tel-Aviv.
December 29, 2008
– ‫ב' בטבת התשס"ט‬
.₪ 0,0.0 ).‫מ‬.‫ע‬.‫דמי חתימה לשנה (כולל מ‬
:‫אפשר להשיג אצל‬
'‫ רחוב ב‬,‫שרות ההפצה של פרסומי הממשלה‬
.‫אביב‬-‫ תל‬,‫ הקריה‬,06 '‫מס‬
2860
NOTICE UNDER SECTION 16 OF THE
PATENTS LAW, 5727-1967
In the following there are listed new
Applications complying with the
Provisions of rule 32(a) of the Patent
Regulations, 5728-1968
Particulars of the applications are
given in the following order:
Number and date of application
And the first four symbols of the
International Classification
Title of invention
(as proposed by applicant)
‫ לחוק הפטנטים‬09 ‫הודעה לפי סעיף‬
0697 - ‫תשכ"ז‬
‫להלן רשימת בקשות חדשות‬
‫הממלאות אחר הדרישות שנקבעו‬
,‫(א) לתקנות הפטנטים‬:0 ‫בתקנה‬
:0698–‫תשכ"ח‬
‫פרטי הבקשות מובאים לפי‬
:‫סדר זה‬
‫מספר הבקשה – ותאריך הגשתה‬
‫וארבעה הסמנים הראשונים של‬
‫הסיווג הבינלאומי‬
‫שם האמצאה (כפי שהוצע ע"י‬
)‫המבקש‬
‫המבקש‬
Applicant
Priority right: Convention country –
Number and date of
Foreign application
– ‫ מדינת האיגוד‬:‫דין קדימה‬
‫תאריך ומספר‬
‫בקשת החוץ‬
International Application Number
‫מספר בקשה בינלאומית‬
International Publication Number
‫מס' פרסום בינלאומי‬
2861
December 29, 2008
– ‫ב' בטבת התשס"ט‬
1091/90110
181804
METHOD AND KIT FOR MODIFYING
THE COLORATION OF KERATINOUS
FIBRES
LES PRODUITS VERNICO LTEE
CA
2481140
09/09/2004
PCT/CA/2005/001339
WO/2006/026851
0091/90111
‫שיטה וערכה לשינוי הצבע של סיבים‬
‫קרניים‬
182049
COOLING DEVICE HAVING A
PLURALITY OF CONTROLLABLE
COOLING ELEMENTS TO PROVIDE A
PREDETERMINED COOLING
PROFILE
ZELTIQ AESTHETICS, INC.
US
11/528225
26/09/2006
PCT/US/2007/064018
WO/2008/039557
0091/90111
COOLING DEVICES WITH FLEXIBLE
SENSORS
ZELTIQ AESTHETICS, INC.
US
11/528189
26/09/2006
PCT/US/2007/064017
WO/2008/039556
182456
CABLE TERMINAL WITH FLEXIBLE
CONTACTS
PRECISION INTERCONNECT, INC.
US
10/965425
13/10/2004
PCT/US/2005/035291
WO/2006/044167
December 29, 2008
– ‫ב' בטבת התשס"ט‬
F02C
‫התקן קירור עם מספר גופי קירור‬
‫מבוקרים למתן פרופיל קירור קבוע מראש‬
182050
/191/90110
A61K
G01L
‫התקנים לקירור עם חיישנים גמישים‬
H04L
‫מסוף כבל עם נקודות מגע גמישות‬
2862
0/90190110
182546
‫תרכובות אימונוגניות של אנטיגנים‬
‫פוליפפטידיים של סטפילוקוקוס‬
‫אפידרמידיס‬
IMMUNOGENIC COMPOSITIONS OF
STAPHYLOCOCCUS EPIDERMIDIS
POLYPEPTIDE ANTIGENS
WYETH
US
60/620788
PCT/US/2005/037746
WO/2007/001423
1090090110
G01N
21/10/2004
183816
SCREENING METHOD (METABOLITE
GRID) FOR NOVEL THERAPEUTIC
EXTRACTS AND MOLECULES FOR
DIABETES
AVESTHAGEN LIMITED
G01N
‫שיטת סריקה (רשת מטבוליטית) למיצויים‬
‫רפואיים ומולקולות לטיפול בסכרת‬
PCT/IB/2004/004077
WO/2006/061676
0090090110
183824
OXYGEN-IMPERVIOUS PACKAGING
AND METHODS FOR STORING
THYROID HORMONE
KING PHARMACEUTICALS
RESEARCH & DEVELOPMENT, INC.
US
60/639328
27/12/2004
832823233
2021222333
US
PCT/US/2005/047011
WO/2006/071844
2863
A61K
‫אריזה בלתי חדירה לחמצן ושיטות אחסון‬
‫להורמון התירואיד‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
0090090110
183859
USE OF A 5-HT6 AGONIST FOR THE
TREATMENT AND PREVENTION OF
NEURODEGENERATIVE DISORDERS
WYETH
US
60/635766
14/12/2004
PCT/US/2005/044820
WO/2006/065710
0090090110
183929
USE OF INERFERON - ? IN THE
PREPARATION OF A MEDICAMENT
LABORATORIES SERONO S.A.
EP
04106652.3 16/12/2004
832820603
2321222333
US
PCT/EP/2005/056793
WO/2006/064026
0190090110
183939
ANTI - IL - 12 ANTIBODIES,
EPITOPES, COMPOSITIONS,
METHODS AND USES
CENTOCOR, INC.
US
60/637819
21/12/2004
PCT/US/2005/046063
WO/2006/069036
December 29, 2008
– ‫ב' בטבת התשס"ט‬
A61K
‫ לטיפול ומניעה‬HT6–. ‫שימוש באגוניסט‬
‫של הפרעות נוירודגנרטיביות‬
A61K
‫שימוש באינטרפרון ? בייצור תרופה‬
C07K
,‫ אפיטופים‬,IL – ANTI – 00 –‫נוגדנים ל‬
‫ שיטות ושימושים‬,‫הרכבים‬
2864
0090090110
183963
1 - AMINOCYCLOHEXANE DERIVATIVES FOR THE TREATMENT
OF MULTIPLE SCLEROSIS,
EMOTIONAL LIABILITY AND
PSEUDOBULBAR AFFECT
MERZ PHARMA GMBH & CO. KGAA
US
60/638423
22/12/2004
PCT/US/2005/046733
WO/2006/069294
0191090112
‫ ציקלוהקסאנים‬0 – ‫ אמינו‬0 – ‫תולדות‬
‫ נטיה ריגשית‬,)MS( ‫לטיפול בטרשת נפוצה‬
)PBA( ‫ואפקט פסבדו– בולבר‬
183973
SPM 927 FOR ADD -ON THERAPY OF
SCHIZOPHRENIA
SCHWARZ PHARMA AG
EP
05001843.1 28/01/2005
832830313
2623122333
US
PCT/EP/2006/000722
WO/2006/079547
0290090110
A61K
‫ לטיפול מוסף בסכיזופרניה‬SPM 607
183985
METHODS FOR TREATING
AUTOIMMUNE DISORDERS
GENENTECH, INC.
US
60/636846
16/12/2004
832036280
3821222333
US
PCT/US/2005/045603
WO/2006/066088
2865
A61K
C07K
‫שיטות לטיפול באי–סדרים הנובעים‬
‫מחיסון עצמי‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
0091090112
184024
IRTA-5 ANTIBODIES AND THEIR
USES
MEDAREX, INC.
US
60/643689
12/01/2005
832883213
2323222333
US
PCT/US/2006/001444
WO/2006/076691
0191090112
‫ ושימושיהן‬IRTA–. ‫נוגדני‬
184025
SUBSTITUTED CYCLOPENTANES OR
CYCLOPENTANONES FOR THE
TREATMENT OF OCULAR
HYPERTENSIVE CONDITIONS
ALLERGAN, INC.
US
60/644069
14/01/2005
PCT/US/2006/000831
WO/2006/076370
0091290111
USE OF TAA PEPTIDES AND
ANTIBODIES IN THE DETECTION OF
CANCER
LAB DISCOVERIES LTD
December 29, 2008
– ‫ב' בטבת התשס"ט‬
C07K
‫ ובנוגדנים לגילוי‬TAA ‫שימוש בפפטידים‬
‫סרטן‬
‫לאב דיסקובריז בע"מ‬
184029
BIOMARKERS FOR IDENTIFYING
EFFICACY OF TEGASEROD IN
PATIENTS WITH CHRONIC
CONSTIPATION
NOVARTIS AG
US
60/641238
04/01/2005
PCT/US/2006/000022
WO/2006/074127
C07K
‫ציקלופנטאנונים או ציקלופנטאנים‬
‫מותמרים לטיפול בתופעות שלציתר דם‬
‫עיני‬
184026
1/91090112
C07K
C12Q
‫סמנים ביולוגים ל זיהוי יעילות של טגסרוד‬
‫בחולים עם עצירות כרונית‬
2866
0191090112
184037
COMBINATION THERAPY WITH
GLATIRAMER ACETATE AND
RASAGILINE FOR THE TREATMENT
OF MULTIPLE SCLEROSIS
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
60/654012
17/02/2005
PCT/US/2006/005741
WO/2006/089164
0190090110
‫טבע תעשיות פרמצבטיות בע"מ‬
C07K
‫תכשירים לרפוי פצעים‬
184047
METHODS AND COMPOSITIONS FOR
TREATING AMYLOID-RELATED
DISEASES
NEUROCHEM (INTERNATIONAL)
LIMITED
US
60/638636
22/12/2004
PCT/IB/2005/004166
WO/2006/085149
2867
‫טיפול קומבינציה עם גלטירמר אצטט‬
‫ורסג'ילין לטיפול בטרשת נפוצה‬
184045
COMPOSITIONS FOR WOUND
HEALING
MUSC FOUNDATION FOR RESEARCH
DEVELOPMENT
US
60/638366
21/12/2004
832801038
1323322333
US
PCT/US/2005/046442
WO/2006/069181
0090090110
A61K
C07C
‫שיטות ותכשירים לטיפול במחלות‬
‫הקשורות לאמילואיד‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
0090090110
184113
‫תולדות אינדול בעלות פעילות אנטי‬
‫סרטנית‬
INDOLE DERIVATIVES WITH
ANTITUMOR ACTIVITY
CELL THERAPEUTICS EUROPE S.R.L.
IT
MI2004A002476 23/12/2004
PCT/EP/2005/013886
WO/2006/066923
1090090110
184123
QUINOLINE DERIVATIVES FOR THE
TREATMENT OF LATENT
TUBERCULOSIS
JANSSEN PHARMACEUTICA N.V.
EP
04078529.7 24/12/2004
3313333658
3623822333
EP
PCT/EP/2005/056594
WO/2006/067048
/090090110
PROCESS FOR THE MANUFACTURE
OF TAURINE
MAGD AHMED KOTB ABDALLA
ES
2005010013 05/01/2005
PCT/EG/2005/000044
WO/2006/072259
December 29, 2008
– ‫ב' בטבת התשס"ט‬
C07C
‫תהליך להכנת טארין‬
184239
USE OF INHIBITORS OF SOLUBLE
EPOXIDE HYDROLASE TO
SYNERGIZE ACTIVITY OF COX AND
5-LOX INHIBITORS
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA
US
60/643028
10/01/2005
PCT/US/2006/000914
WO/2006/086108
A61K
‫תולדות קווינולין לטיפול בשחפת כמוסה‬
184221
0191090112
A61K
A61K
‫שימוש במעכבי אפוקסיד הידרולאז מסיס‬
–.–‫ ו‬COX ‫לחיזוק פעילותם של מעכבי‬
‫ בפעולה משותפת‬LOX
2868
0/90090110
184273
METHODS TO ELICIT, ENHANCE
AND SUSTAIN IMMUNE RESPONSES
AGAINST MHC CLASS I-RESTRICTED
EPITOPES, FOR PROPHYLACTIC OR
THERAPEUTIC PURPOSES
MANNKIND CORPORATION
US
60/640402
29/12/2004
PCT/US/2005/047440
WO/2006/071989
1091090112
‫ להגברת ולהחזקת‬,‫שיטות לגרימת‬
–‫תגובות חיסוניות נגד אפיטופים מוגבלים‬
‫ למטרות מניעה או ריפוי‬I ‫ מסוג‬MHC
184283
HSP60, HSP60 PEPTIDES AND T CELL
VACCINES FOR
IMMUNOMODULATION
YEDA RESEARCH AND
DEVELOPMENT CO. LTD
US
60/641075
04/01/2005
832803830
1123322333
US
PCT/IL/2006/000014
WO/2006/072946
0/91/90110
C12N
CELL –‫ ו‬HSP60 ‫ פפטידים של‬HSP 9/
,‫ המבוססים עליהם‬VACCINES T
‫לשימוש באימונומודולציה‬
‫ידע חברה למחקר ופיתוח בע"מ‬
184378
PAIR OF INTERVERTERBRAL
PROSTHESES
CERVITECH, INC.
EP
05000841.6 17/01/2005
PCT/EP/2005/010082
WO/2006/074710
2869
A61K
A61F
‫זוג תותבות בין חוליתיות‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
0091090112
184406
CONSTRUCTS BINDING TO
PHOSPHATIDYLSERINE AND THEIR
USE IN DISEASE TREATMENT
THE BOARD OF REGENTS OF THE
UNIVERSITY OF TEXAS SYSTEM
US
60/646333
24/01/2005
PCT/US/2006/002964
WO/2006/079120
1091090112
‫קישור מבנים לפוספאטידיל סרין ושימוש‬
‫בהם לטיפול במחלה‬
184415
CONJUGATES FOR DUAL IMAGING
AND RADIOCHEMOTHERAPY:
COMPOSITION, MANUFACTURING,
AN APPLICATIONS
BOARD OF REGENTS, THE
UNIVERSITY OF TEXAS SYSTEM
US
60/641559
05/01/2005
PCT/US/2006/000269
WO/2006/074272
/191090112
184423
HOMOGENEOUS PREPARATIONS OF
IL-31
ZYMOGENETICS INC.
US
60/648189
28/01/2005
PCT/US/2006/003318
WO/2006/081573
December 29, 2008
– ‫ב' בטבת התשס"ט‬
C07K
A61K
:‫צמודים להדמיה דואלית ורדיוכימותרפיה‬
‫ ייצור ושימושים‬,‫תכשיר‬
C07K
LI– :0 ‫הרכבים הומוגניים של‬
2870
1/91090112
184424
CXCR4 ANTAGONISTS FOR THE
TREATMENT OF HIV INFECTION
EMORY UNIVERSITY
US
60/642374
07/01/2005
832832203
3023122333
US
832862833
1623322333
US
PCT/US/2006/000600
WO/2006/074426
0/91090112
‫ לטיפול בזיהום‬CXCR4 ‫אנטגוניסטים של‬
HIV
184438
MACROLIDES WITH ANTIINFLAMMATORY ACTIVITY
GLAXOSMITHKLINE ISTRAZIVACKI
CENTAR ZAGREB D.O.O.
US
60/643841
13/01/2005
832013626
3323322333
US
PCT/IB/2006/001238
WO/2006/087644
1291090112
C07H
‫מקרולידים עם פעילות אנטי–דלקתית‬
184445
COMPOUNDS FOR INFLAMMATION
AND IMMUNE RELATED USES
SYNTA PHARMACEUTICALS CORP.
US
60/642179
07/01/2005
832030633
1223622333
US
PCT/US/2006/000296
WO/2006/083477
2871
A61K
C07D
‫תרכובות לשימושים במקרי דלקת ומקרים‬
‫הקשורים בחיסון‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
1091090112
184452
RIGIDIFIED COMPOUNDS FOR
MODULATING HEPARANASE
ACTIVITY
INSIGHT BIOPHARMACEUTICALS
LTD.
US
60/641444
06/01/2005
832861382
1023322333
US
PCT/IL/2006/000023
WO/2006/072953
1091090112
184453
COMPOSITIONS AND METHODS FOR
REGULATING APOPTOSIS
YEDA RESEARCH AND
DEVELOPMENT CO. LTD
US
60/641424
06/01/2005
PCT/IL/2006/000021
WO/2006/072951
1091090112
184467
CRIPTO BINDING MOLECULES
Biogen Idec MA Inc.
US
60/641691
05/01/2005
PCT/US/2006/000502
WO/2006/074397
0191090111
184474
A STORAGE DEVICE COUPLED TO
AN ALIMENT
BEN SHOAN RAZ
US
60/799354
11/05/2006
PCT/IL/2007/000571
WO/2007/132448
December 29, 2008
– ‫ב' בטבת התשס"ט‬
C07D
‫חומרים בעלי מבנה כימי מקובע לוויסות‬
‫פעילות של האנזים הפאראנאז‬
‫אינסייט ביופרמצבטיקה בע"מ‬
A61K
‫חומרים ושיטות לבקרת אפופטוזיס‬
‫ידע חברה למחקר ופיתוח בע"מ‬
C07K
CRIPTO ‫מולקולות קושרות‬
A23G
‫מתקן אכסון מחובר לפריט מזון‬
‫בן שואן רז‬
2872
1091190111
184478
COMPOSITIONS, METHODS AND
KITS FOR THE DIAGNOSIS
CARRIERS OF MUTATION IN THE
BRCA1 AND BRCA2 GENES AND
EARLY DIAGNOSIS OF CANCEROUS
DISORDERS ASSOCIATED WITH
MUTATIONS IN BRCA1 AND BRCA2
GENS
HADASIT MEDICAL RESEARCH
SERVICES & DEVELOPMENT LTD.
0091090112
‫ שיטות וערכות לזיהוי נשאים‬,‫תכשירים‬
‫של מוטציות בגנים‬
‫ ולזיהוי מוקדם של‬BRCA 0–‫ ו‬BRCA0
‫מחלות סרטניות הקשורות במוטציות‬
‫בגנים אלה‬
‫הדסית שרותי מחקר רפואי ופיתוח בע"מ‬
184523
A METHOD OF MODULATING T
CELL FUNCTIONING
THE BOARD OF TRUSTEES OF THE
LELAND STANFORD JUNIOR
UNIVERSITY
US
60/644502
14/01/2005
PCT/US/2006/001241
WO/2006/076580
0091190111
INTERACTION BETWEEN DYNEIN
HEAVY
CHAIN (DHC) AND A PROCASPASE
YEDA RESEARCH AND
DEVELOPMENT CO. LTD
2873
C12N
A61K
T ‫שיטה לווסת תפקוד תאי‬
184536
C12N
‫אינטראקציה בין שרשרת כבדה של דיניין‬
‫ ) ופרוקאספאז‬DHC(
‫ידע חברה למחקר ופיתוח בע"מ‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
1091090112
184544
METHOD FOR TREATING FUNGOID
GROWTH OF RHIZOCTIONIA,
RYTHIUM AND PHYTOPHTHORA
COPIER ADVIESBUREAU B.V
NL
1027964
06/01/2005
PCT/NL/2006/050004
WO/2006/085768
0091090112
‫שיטה לטיפול בגידולים פטרייתיים מסוג‬
‫ ריתיום ופיטופתורה‬,‫ריזוקטוניה‬
184554
PHARMACEUTICAL COMPOSITION
FOR THE TREATMENT OR
PREVENTION OF DISEASES
INVOLVING OBESITY, DIABETES,
METABOLIC SYNDROME, NEURODEGENERATIVE DISEASES AND
MITOCHONDRIA DYSFUNCTION
DISEASES
MD BIOALPHA CO. LTD.
10-2005KR
16/02/2005
0012625
PCT/KR/2006/000531
WO/2006/088315
1/91090112
December 29, 2008
– ‫ב' בטבת התשס"ט‬
A61K
‫תכשירי רוקחות לטיפול או מניעה של‬
,‫ סוכרת‬,‫מחלות הכוללות השמנת יתר‬
‫ מחלות ניוון עיצבי‬,‫הפרעה מטבולית‬
‫ותפקוד מיטוכונדריות לקוי‬
184564
INHIBITING HER2 SHEDDING WITH
MATRIX METALLOPROTEASE
ANTAGONISTS
GENENTECH, INC.
US
60/651348
09/02/2005
PCT/US/2006/004926
WO/2006/086730
A01N
C12N
‫ באמצעות‬HER2 ‫עיכוב הפצה של‬
‫אנטגוניסטים של מטריקס מתאלופרוטאז‬
2874
1091090112
184567
ANTI-IL-20, ANTI-IL-22 AND ANTI-IL22RA ANTIBODIES AND BINDING
PARTNERS AND METHODS OF
USING IN INFLAMMATION
ZYMOGENETICS INC.
US
60/650830
08/02/2005
PCT/US/2006/004311
WO/2006/086396
0/91090112
RA22–IL–‫ ו‬IL, 22 –IL –0/ ‫נוגדנים נוגדי‬
‫וחומרים נקשרים ושיטות לשימוש בדלקות‬
184585
184611
RIPHON PHARMA LTD
184627
AGENTS FOR DIAGNOSING AND
MODULATING METASTASIS AND
FIBROSIS AS WELL AS
INFLAMMATION IN A MAMMALIAN
TISSUE
TECHNION RESEARCH AND
DEVELOPMENT FOUNDATION LTD.
2875
A61K
‫טיפול במחלות על ידי פפטידים‬
‫אנטימיקרוביאלים או ע"י עיכובם של אותם‬
‫פפטידים‬
‫ריפאון פארמה בע"מ‬
DISEASE TREATMENT VIA
ANTIMICROBIAL PEPTIDES OR
THEIR INHIBITORS
0091190111
A61K
‫מניעה וטיפול באי סדרים של תסחיף‬
‫פקיקי‬
PREVENTION AND TREATMENT OF
THROMBOEMBOLIC DISORDERS
BAYER HEALTHCARE AG
EP
05001893.6 31/01/2005
PCT/EP/2006/000431
WO/2006/079474
0091190111
C07K
A61K
‫תרכובות לאבחון ומודולציה של גרורות‬
‫פיברוזה ודלקת ברקמה של יונקים‬
‫מוסד הטכניון למחקר ופתוח בע"מ‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
0191190111
184671
SUBSTANCES DIRECTED TO
HEPARANASE C-TERMINAL
DOMAIN-OR SUBSTANCE DERIVED
THEREFROM AND USES THEREOF
AS MODULATORS OF HEPARANAS
BIOLOGICAL ACTIVITIES
HADASIT MEDICAL RESEARCH
SERVICES & DEVELOPMENT LTD.
0090090110
0/91090112
‫הדסית שרותי מחקר רפואי ופיתוח בע"מ‬
0091090112
– ‫ב' בטבת התשס"ט‬
A61K
‫תכשירים בצורת טבלית למתן דרך הפה‬
‫ בעל זמינות ביולוגית‬CCI – 776 ‫המכילים‬
184723
METHOD OF IMPROVING
NEMATODE TOLERANT OR
RESISTANT PLANT GROWTH
SYNGENTA PARTICIPATIONS AG
US
60/656042
24/02/2005
PCT/EP/2006/001615
WO/2006/089733
F41H
‫גוף מגן הנוצר מחומרים מרוכבים גמישים‬
‫עם עמידות לדקירות סכין‬
184716
ORALLY BIOAVAILABLE CCI-779
TABLET FORMULATIONS
WYETH
US
60/652889
15/02/2005
PCT/US/2006/006991
WO/2006/089312
December 29, 2008
‫חומרים הנקשרים למתחם הקרבוקסי‬
‫טרמינלי של הפרנאז או חומרים הנגזרים‬
‫ממנו ושימושיהם כמודולטורים של‬
‫פעילויות ביולוגיות של הפרנאז‬
184693
BODY ARMOR WITH IMPROVED
KNIFE-STAB RESISTANCE FORMED
FROM FLEXIBLE COMPOSITES
JHRG, LLC
US
11/037680
18/01/2005
PCT/US/2005/046714
WO/2007/084104
A61K
A01N
‫שיטה לשיפור התנגדות או עמידות גדילת‬
‫צמח לנמטודה‬
2876
1091090112
184791
METHOD FOR TREATING GEFITINIB
RESISTANT CANCER
WYETH
US
60/649483
03/02/2005
832801363
1323322333
US
PCT/US/2006/003717
WO/2006/084058
/091190111
‫שיטה ומתקן ליצירת תשייתית של ביומסה‬
‫של מיקרואורגניזמים פוטוסינטזיים במיחר‬
,‫ וביומסה פיגמנט שלהם‬,‫הלובטריה‬
‫במיחד בקטריורודופסין‬
‫סלבין ולדימיר‬
C12N
‫ שיטות ומערכת לתגובה ביולוגית‬,‫התקנים‬
‫בעל צפיפות גבוהה‬
185004
NUTRITIONAL PRODUCTS FOR
AMELIORATING SYMPTOMS OF
RHEUMATOID ARTHRISTIS
ABBOTT LABORATORIES
US
60/658931
04/03/2005
PCT/US/2006/007787
WO/2006/096579
2877
C12N
184971
HIGH DENSITY BIOREACTOR
SYSTEM, DEVICES AND METHODS
BRIGHTSOURCE ENERGY, INC.
US
60/821074
01/08/2006
1291/90112
‫שיטה לטיפול בסרטן העמיד בגפיטיניב‬
184941
METHOD AND DEVICE FOR
PRODUCING BIOMASS OF
PHOTOSYNTHESIZING
MICROORGANISMS MAINLY
HALOBACTERIA HALOBACTERIUM
AS WELL AS BIOMASS OF THE SAID
MICROORGANISMS PIGMENTS
BACTERIORHODOPSIN IN
PARTICULAR
SLAVIN VLADIMIR
1091090111
A61K
A61K
‫מוצרי תזונה המשפרים סימפטומים של‬
‫דלקת מפרקים שגרונית‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
1291090110
185041
A61N
NON-THERMAL ACOUSTIC TISSUE
MODIFICATION
ULTRASHAPE INC.
‫שינוי רקמה באופן אקוסטי לא–תרמי‬
PCT/IL/2005/000148
WO/2006/082573
1291090111
185053
CARBON BLACK, METHOD OF
PRODUCING CARBON BLACK, AND
DEVICE FOR IMPLEMENTING THE
METHOD
DEGUSSA GMBH
DE
102006037079.1 07/08/2006
1191090112
185136
ORAL COMPOSITIONS FOR THE
PREVENTION OF UV DAMAGES
KANEBO COSMETICS INC.
2005JP
10/02/2005
035234
PCT/EP/2006/001048
WO/2006/084658
1091/90112
185180
METHODS AND COMPOSITIONS FOR
MODULATING TWEAK AND FN14
ACTIVITY
GENENTECH, INC.
US
60/659339
07/03/2005
PCT/US/2006/007547
WO/2006/096487
December 29, 2008
– ‫ב' בטבת התשס"ט‬
C06B
‫ שיטה לייצור פחם שחור‬,‫פחם שחור‬
‫והתקן ליישום השיטה‬
A61K
‫תכשירים אוראלים למניעת נזקי קרינה‬
‫אולטרה סגולית‬
A61P
04 ‫שיטות ותכשירים לאפנון פעילות של‬
TWEAK–‫ ו‬FN
2878
0/91/90112
185215
2-CYANOBENZENESULFONAMIDE
COMPOUNDS FOR SEED
TREATMENT
BASF SE
US
60/664771
24/03/2005
PCT/EP/2006/060988
WO/2006/100288
0/91090112
‫–ציאנו בנזן סולפונאמיד לטיפול‬0 ‫תרכובות‬
‫בזרעים‬
185257
SYSTEM AND DEVICES FOR
COMPENSATING A LOCAL
DEFORMATION OF THE CORNEA OF
EYE
KARIN TOMALLA
DE
102005009259.4 25/02/2005
PCT/EP/2006/060199
WO/2006/089922
1/91/90112
A61F
‫מערכת והתקן לשיפוי עיוות מקומי‬
‫בקרנית העין‬
185299
COMPOSITIONS AND METHODS FOR
TOPICAL APPLICATION AND
TRANSDERMAL DELIVERY OF
BOTULINUM TOXINS
REVANCE THERAPEUTICS, INC.
US
60/658434
03/03/2005
PCT/FR/2006/007830
WO/2006/094263
2879
A01N
A61P
‫הרכבים ושיטות למתן טופיקלי והעברה‬
‫טרנסדרמלית של רעלני בוטולינום‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
0191090112
185372
ACTIVE SUBSTANCE COMPOSITION
COMPRISING AT LEAST ONE
NITROGEN ATOM-CONTAINING
HYPERBRANCHED POLYMER
BASF SE
DE
102005007844.3 21/02/2005
PCT/EP/2006/001515
WO/2006/087227
0/91090110
185412
PLANT EXTRACTS AND METHODS
AND USES THEREFORE
AVESTHAGEN LIMITED
A61K
‫תכשיר של חומר פעיל המכיל פולימר‬
‫מסועף המכיל לפחות אטום חנקן אחד‬
A61K
‫מיצויי צמחים ושיטות ושימושים שלהם‬
PCT/IB/2005/000474
WO/2006/090198
0091090112
185446
REFLECTIVE ELECTROACTIVE
PARTICLES
BAE SYSTEMS LAND &
ARMAMENTS L.P.
US
11/063226
22/02/2005
PCT/US/2006/005270
WO/2007/094778
December 29, 2008
– ‫ב' בטבת התשס"ט‬
B32B
‫חלקיקים אלקטרואקטיבים רפלקטיבים‬
2880
0191/90112
185713
A RECOMBINANT FUNGUS THAT
PRODUCES A CAROTENOID AND A
METHOD FOR PRODUCING
CAROTENOIDS UTILIZING THE
SAME
MICROBIA PRECISION
ENGINEERING INC.
US
60/663621
18/03/2005
PCT/US/2006/010271
WO/2006/102342
1091090112
‫פטרייה רקומביננטית המיצרת קרוטנואיד‬
‫ושיטה להכנת קרוטנואידים המשתמשת‬
‫בה‬
185830
DETECTOR AND OPTICAL SYSTEM
PYRONIX LIMITED
US
60/660221
10/03/2005
333333853
1323222333
GB
333333353
1123222333
GB
332238253
3221122333
GB
PCT/GB/2006/000325
WO/2006/095122
1/91/90112
C12P
G08B
‫גלאי ומערכת אופטית‬
185831
B60R
‫סופית לכבל גרירה‬
TOW CABLE TERMINATION
SELEX SENSORS AND AIRBORNE
SYSTEMS LIMITED
GB
0504842.6
09/03/2005
3323132350
3323222333
EP
PCT/GB/2006/050046
WO/2006/095206
2881
December 29, 2008
– ‫ב' בטבת התשס"ט‬
0191/90112
185832
PLASTIC PRODUCT WITH
STIFFENING PROVISIONS, AND
METHOD FOR MANUFACTURING
SAME
ECIM TECHNOLOGIES B.V.
NL
1028510
10/03/2005
PCT/NL/2006/000126
WO/2006/096057
1/90090110
185835
METHODS AND SYSTEMS UTILIZING
TRUE AIRSPEED TO IMPROVE
VERTICAL VELOCITY ACCURACY
HONEYWELL INTERNATIONAL INC.
US
11/075171
08/03/2005
PCT/US/2005/044631
WO/2006/096226
1/91/90112
185836
AN APPARATUS AND METHOD OF
BODY CONTOURING AND SKIN
CONDITIONING
RONALD ALLAN GREENBERG
AU
2005901111 09/03/2005
PCT/AU/2006/000305
WO/2006/094348
1091/90112
185838
RECOMBINANT E-SELECTIN MADE
IN INSECT CELLS
NOVAVAX, INC
US
60/660258
10/03/2005
112283066
3023222338
US
PCT/US/2006/008340
WO/2006/099006
December 29, 2008
– ‫ב' בטבת התשס"ט‬
B29C
‫מוצר פלסטיק עם אמצעי חיזוק ושיטת‬
‫יצור שלו‬
G01C
‫שיטות ומערכות מהירות אוויר אמיתית‬
‫לשיפור דיוק מהירות אנכית‬
A61H
‫מכשיר ושיטה לחיטוב גוף והתניית עור‬
C07K
‫–סלקטין רקומביננטי שנעשה בתאי‬E
‫חרקים‬
2882
0091/90112
ANTIBACTERIAL AMIDEMACROCYCLES V
AICURIS GMBH & CO.KG
DE
102005014245.1
PCT/EP/2006/002617
WO/2006/103015
0191/90112
185899
‫ אנטי‬V ‫מאקרוציקליים אמידיים‬
‫בקטריאלים‬
30/03/2005
185957
G06F
‫מכפיל מערך נתונים בעל הספק נמוך‬
LOW POWER ARRAY MULTIPLIER
QUALCOMM INCORPORATED
US
11/083698
17/03/2005
PCT/US/2006/009706
WO/2006/102076
0/91/90111
C07K
186076
C06B
‫לאוקואנטוציאנינים של סויה‬
‫דניאל חיות‬
SOY LEUCOANTHOCYANINS
DANIEL CHAJUSS
0090190111
186933
USE OF RHIZOPUS STOLONIFER
(EHRENBERG)VUILLEMIN IN METHODS
FOR TREATING INDUSTRIAL
WASTEWATERS CONTAINING DYES
UNIVERSITA DEGLI STUDI DI TORINO
IT
TO2006A000808 13/11/2006
0090190111
2883
C02F
)‫שימוש בריזופוס סטולוניפר (ארנברג‬
‫וויילמין בשיטות לטיפול במי שפכים‬
‫תעשייתיים המכילים צבעים‬
186934
December 29, 2008
C02F
– ‫ב' בטבת התשס"ט‬
USE OF RHIZOMUCOR PUSILLUS
(LINDT) SCHIPPER IN METHODS FOR
TREATING INDUSTRIAL
WASTEWATERS CONTAINING DYES
UNIVERSITA DEGLI STUDI DI TORINO
IT
TO2006A000810 13/11/2006
0/90190111
)‫שימוש בריזומוקור פוסילוס (לינדט‬
‫שיפר בשיטות לטיפול במי שופכין‬
‫תעשייתיים המכילים צבעים‬
186978
C07J
‫תכשירי ציקלופרופן‬
CYCLOPROPENE COMPOSITIONS
ROHM AND HAAS COMPANY
US
60/858253
09/11/2006
0/90190111
186979
A PROCESS FOR THE PREPARATION OF
PYRIDINE-METHYLSULFINYL
COMPOUNDS
DIPHARMA FRANCIS S.R.L.
IT
MI2006A002086 30/10/2006
1323822330
IT
MI2007A1208
/190190111
187047
A LIQUID COMPOSITION SUITABLE
FOR USE AS A CORRSION INHIBITOR
AND A METHOD FOR ITS
PREPARATION
BROMINE COMPOUNDS LTD.
1090090111
187069
METHOD AND DEVICE FOR
CATHODIC PROTECTION OF
METALS
JOSEPH RISKIN 75%
1290090111
December 29, 2008
–‫תהליך להכנת תרכובות פירידין‬
‫מתילסולפיניל‬
C23F
‫הרכב נוזלי המתאים לשימוש כמעכב‬
‫קורוזיה ושיטה להכנתו‬
‫תרכובות ברום בע"מ‬
C21D
‫שיטה והתקן להגנה כתודית של מתכות‬
‫יוסף דיסקין‬
187200
– ‫ב' בטבת התשס"ט‬
C07D
C08J
2884
PROCESSES FOR THE SEPARATION
OF SOLUTES FROM SOLUTIONS
TATE & LYLE INGREDIENTS
AMERICAS, INC.
1090090111
‫תהליכים להפרדת מומסים מתמיסות‬
187245
SYNTHETIC SPHINGOLIPID
ANALOGS
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM
1090090111
‫אנלוגים סינתטיים של ספינגוליפיד‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים‬
187247
NOVEL SYNTHETIC ANALOGS OF
SPHINGOLIPIDS
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM
0090090111
C07C
C07C
‫אנלוגים סינתטיים חדשים של‬
‫ספינגוליפידים‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים‬
187285
C11C
‫נוזל יוניפאוואר‬
‫הזימה נדים‬
UNIPOWER LIQUID
NADIM HAZIME
1/90090111
187829
PREPARATION OF A POTASSIUM
PHOSPHATE BASED COMPOSITION
ROTEM AMFERT NEGEV LTD.
1090090111
2885
C01D
‫הכנת תכשיר המבוסס על אשלגן זרחתי‬
‫רותם אמפרט נגב בע"מ‬
187875
C01D
December 29, 2008
– ‫ב' בטבת התשס"ט‬
COMPOSITIONS OF POLYMERIC
CONCRETE
NICOLAS FERNANDO TEJADA
JUAREZ
1090090111
‫תכשירים המכילים בטאון פולומרי‬
187913
COMPOSITION FOR IMPROVING
PLANT GROWTH AND YIELD AND
METHOD FOR USING SAME
BENJAMIN BOGOMOLNY
‫תכשיר לשפר גידול ויבול של צמחים‬
‫ושיטה להשתמש בו‬
‫בנימין בוגומולני‬
1290090111
187927
METHOD FOR THE CONTINUOUS
MIXING AND MELTING OF INORGANIC
SALTS AS WELL AS FURNACE
INSTALLATION FOR REALIZING SAID
METHOD
DURFERRIT GMBH
DE
102007014230.9 24/03/2007
1290090111
BETA GLYCOLIPIDS FOR THE
TREATMENT OF CALCIFICATION
RELATED DEGENERATIVE
DISORDERS
HADASIT MEDICAL RESEARCH
SERVICES AND DEVELOPMENT LTD
December 29, 2008
A61K
‫בטא–גליקוליפידים לטיפול במחלות‬
‫ניווניות הקשורות בהסתיידות‬
‫הדסית שירותי מחקר רפואי ופיתוח בע"מ‬
187990
– ‫ב' בטבת התשס"ט‬
C01D
‫שיטה לערבוב והמסה רציפים של‬
‫מלחים אנאורגניים וכן התקנת תנור‬
‫למימוש השיטה‬
187959
1/90090111
A01H
A61J
2886
AN IMPROVED DEVICE FOR
COLLECTION AND EJECTION OF
BIOLOGICAL FLUIDS
ADED MEDICAL
NANOTECHNOLOGIES LTD
0190090111
‫מתקן משופר לאיסוף והזרקה של נוזלים‬
‫ביולוגיים‬
‫אדאו מדיקל ננו טכנולוג'יס בע"מ‬
188033
METHOD AND SYSTEM FOR
DETECTION OF PRE-FAINTING
CONDITIONS
HADASIT MEDICAL RESEARCH
SERVICES & DEVELOPMENT LTD.
0090090111
‫שיטה ומערכת לזיהוי תנאים טרם עילפון‬
‫הדסית שרותי מחקר רפואי ופיתוח בע"מ‬
188048
WESTE TREATMENT PROCESS
SAVVAS SEIMANIDIS
GR
20060100679 15/12/2006
0090090111
C02F
‫תהליך לטיפול בשפכים‬
188058
PUMP SET AND PUMP WITH
ELECTROMAGNETIC RADIATION
OPERATED INTERLOCK
COVIDIEN AG
US
11/609234
11/12/2006
0090090111
A61B
A61M
‫מערכת שאיבה ומשאבה המופעלת‬
‫בשילוב עם קרינה אלקטרומגנטית‬
188060
C07C
‫תחליבים מרוכזים‬
EMULSIFIABLE CONCENTRATES
SUMITOMO CHEMICAL COMPANY,
LIMITED
2006JP
20/12/2006
342396
0090090111
2887
188067
A61C
December 29, 2008
– ‫ב' בטבת התשס"ט‬
DEVICE AND METHOD FOR
FRAGMENTING AND REMOVING
CONCRETIONS FROM BODY DUCTS
AND CAVITIES
LITHOTECH MEDICAL LTD.
0090090111
‫התקן ושיטה לשבירה לרסיסים והסרת‬
‫גושים מצינורות וחללים בגוף‬
‫ליתוטק מדיקל בע"מ‬
188077
CYCLIC CHEMICAL VAPOR
DEPOSITION OF METAL-SILICON
CONTAINING FILMS
AIR PRODUCTS AND CHEMICALS,
INC.
US
60/874653
13/12/2006
112333686
3321222330
US
0090090111
‫שיקוע כימי באמצעות קיטור מחזורי של‬
‫פילמים המכילים מתכת–סיליקון‬
188097
METHOD AND DEVICE FOR THE
MANUFACTURE OF A SPUNBONDED
FABRIC OF CELLULOSIC
FILAMENTS
REIFENHAUSER GMBH & CO. KG
MASCHINENFABRIK
EP
06026730.9 22/12/2006
0/90090111
0290090111
December 29, 2008
– ‫ב' בטבת התשס"ט‬
A43B
‫נעל קפיצית לטיפול בבעיות הליכה ויציבה‬
‫ דרוקמן ניהול בע"מ‬.‫ד‬.‫א‬
188169
HIGH RESOLUTION ENDOSCOPE
VISIONSENSE LTD.
B05C
‫שיטה והתקן ליצור אריג טווי–הדבקה‬
‫מחוטים תאיים‬
188117
SPRING-MOTION SHOE FOR
A.D. DRUKMAN MANAGEMENT LTD.
C23G
A61B
‫אנדוסקופ בעל רזולוציה גבוהה‬
‫ויז'נסנס בע"מ‬
2888
US
60/875673
18/12/2006
0190090111
188195
HYDROGEN GENERATING
APPARATUS AND FUEL CELL
POWER GENERATION SYSTEM
CONTROLLING AMOUNT OF
HYDROGEN GENERATION
SAMSUNG ELECTRO-MECHANICS
CO. LTD.
KR10-2007KR
21/02/2007
0017343
KR10-2007- 2223622330
KR
0085142
0190090111
‫התקן ייצור מימן ומערכת לבקרת כמות‬
‫ייצור מימן‬
188197
HYDROGEN GENERATING
APPARATUS AND FUEL CELL
POWER GENERATION SYSTEM
CONTROLLING AMOUNT OF
HYDROGEN GENERATION
SAMSUNG ELECTRO-MECHANICS
CO. LTD.
KR10-2007KR
16/03/2007
0025872
KR10-2007- 2223622330
KR
0085131
0090090111
C01B
C01B
‫התקן ייצור מימן ומערכת לבקרת כמות‬
‫ייצור מימן‬
188215
A NEW COMPOSITION FOR SKIN
WHITENING
OR-LE-OR LTD.
0090090111
A PROCESS FOR THE PREPARATION
OF ENTACAPONE
DIPHARMA FRANCIS S.R.L.
2889
A61K
‫תכשיר חדש להלבנת עור‬
‫עור בע"מ‬-‫ל‬-‫חברת אור‬
188218
C07C
‫תהליך להכנת אנטאקאפון‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
IT
MI2006A2450
19/12/2006
0090090111
188219
CRYSTALLINE FORM RABEPRAZOLE
SODIUM
DIPHARMA FRANCIS S.R.L.
IT
MI2006A002449 19/12/2006
0/90090111
‫צורה גבישית של רבפראזול נתרני‬
188262
SYSTEM AND METHOD FOR
SUPERIMPOSING A
REPRESENTATION OF THE TIP OF A
CATHETER ON AN IMAGE
ACQUIRED BY A MOVING IMAGER
MEDIGUIDE LTD.
US
60/879672
10/01/2007
0190090111
A61C
‫שיטה ומערכת להצגה חופפת של קצה‬
‫של קתטר על תמונה הנרכשת על ידי‬
‫מכשיר הדמייה נע‬
‫מדיגייד בע"מ‬
188300
188302
APPARATUS AND METHOD FOR
DESERT ENVIRONMENTAL CONTROL
AND FOR PROMOTING DESERT PLANTS
GROWTH
WAN YOU BAO
CN
200610155407.7 22/12/2006
112322328
3121122330
US
0/90090111
December 29, 2008
188338
– ‫ב' בטבת התשס"ט‬
A61B
‫מוצר לבקרת הפרשה‬
‫סנס בע"מ‬-‫קומון‬
SECRETION-MONITORING ARTICLE
COMMON SENSE LTD.
0190090111
C07D
A01G
‫התקן ושיטה לשליטה סביבתית‬
‫במדבר ולקידום גידול צמחי מדבר‬
A61K
2890
CHOLINESTERASE ACTIVITIES
PREDICT THE INFLAMMATORY
RESPONSE AND OUTCOME IN
PATIENTS WITH ACUTE ISCHEMIC
STROKE
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM
0291190112
‫פעילות כולינאסטראז כצפי לתגובה‬
‫דלקתית ותוצאה קלינית בחולי שבץ אקוטי‬
‫איסכמי‬
‫קרן מחקרים ופיתוח תשתיות שליד המרכז‬
‫הרפואי תל אביב ע"ש סוראסקי‬
188412
METHOD FOR AFFINITY
CHROMATOGRAPHY OF
ANTITHROMBIN III
AVENTIS PHARMA S.A.
FR
0507986
27/07/2005
PCT/FR/2006/001820
WO/2007/012754
0/91290112
‫שיטה לכרומטוגרפיית אפיניות של‬
III ‫אנטיטרומבין‬
188419
REPAIR OF TYMPANIC MEMBRANE
USING PLACENTA DERIVED
COLLAGEN BIOFABRIC
ANTHROGENESIS CORPORATION
US
60/696167
30/06/2005
PCT/US/2006/025938
WO/2007/005807
/090090111
2891
A61L
‫תיקון עור התוף באמצעות שימוש באריג‬
‫ביולוגי של קולגן המופק משיליה‬
188507
PHASED ARRAY ANTENNA HAVING
INTEGRAL CALIBRATION NETWORK
AND METHOD FOR MEASURING
CALIBRATION RATIO THEREOF
ELTA SYSTEMS LTD.
1191090110
B01D
H01Q
‫מערך פאזי של אנטנות הכולל רשת כיול‬
‫אינטגראלית ושיטה למדידת יחס כיולי‬
‫שלה‬
‫אלתא מערכות בע"מ‬
188628
A61K
December 29, 2008
– ‫ב' בטבת התשס"ט‬
USE OF SOLUBLE LDL-R FOR VIRAL
HEPATITIS
YEDA RESEARCH AND
DEVELOPMENT CO. LTD
1291190112
‫ מסיס בצהבת ויראלית‬R–LDL ‫שימוש של‬
‫ידע חברה למחקר ופיתוח בע"מ‬
188657
NOVEL USE OF ACTIVATORS AND
STIMULATORS OF SOLUBLE
GUANYLATE CYCLASE FOR THE
PREVENTION OR TREATMENT OF
RENAL DISORDERS
BAYER HEALTHCARE AG
EP
05015522.5 18/07/2005
PCT/EP/2006/006601
WO/2007/009607
1/91090110
‫שימוש חדש במפעילים וממריצים של‬
‫גוואנילאט ציקלאז מסיס למניעה או טיפול‬
‫באי סדרים כליתיים‬
188681
PHARMACEUTICAL COMPOSITIONS
AND METHODS UTILIZING A DAMINO ACID
AMINO ACID SOLUTIONS INC.
0091190112
188685
USE OF 4-(3,4-DICHLORO-PHENYL)1,2,3,4-TETRAHYDRO-NAPHTALEN-1YLAMINE FOR TREATING CANCER
ANCERIS
FR
0507480
PCT/EP/2006/064155
WO/2007/006797
A61K
‫תכשירי רוקחות ושיטות המשתמשות‬
D ‫בחומצת אמינו‬
C07C
–4,:,0,0–)‫–דיכלורו–פניל‬4,:(–4 ‫שימוש ב‬
–0–‫טטראהידרו–נפתלן‬
‫איל אמין לטיפול בסרטן‬
12/07/2005
0091190112
December 29, 2008
A61K
188734
– ‫ב' בטבת התשס"ט‬
A61K
2892
JNK INHIBITORS AND
ENDOMETRIOSIS
LABORATOIRES SERONO SA
US
60/699658
15/07/2005
3313333052
1121322333
EP
PCT/US/2006/027455
WO/2007/011762
0091190112
188735
USE OF GLEPP-1 INHIBITOR FOR THE
MENUFACTURE OF A MEDICAMENT
FOR TREAMENT OF AN
AUTOIMMUNE AND/OR
INFLAMATORY DISORDER
LABORATOIRES SERONO SA
EP
05106547.2 15/07/2005
832038283
3623622333
US
PCT/EP/2006/064288
WO/2007/009959
0/91090110
‫ ואנדומטריוסיס‬JNK ‫מעכבי‬
A61K
‫ בייצור של‬GLEPP–0 ‫שימוש במעכב של‬
‫או‬/‫תרופה לטיפול במחלות אוטאימוניות ו‬
‫דלקתיות‬
188740
A61K
COMPOSITE MATERIAL AND
PROCESS FOR THE PREPARATION
THEREOF
MANISTON ENTERPRISES LTD.
0091190112
‫חומר מרוכב ותהליך להכנתו‬
188744
HIGH DRUG LOAD FORMULATIONS
AND DOSAGE FORMS
MYRIAD GENETICS, INC.
US
60/701710
22/07/2005
832038233
3623622333
US
PCT/US/2006/028602
WO/2007/014124
0/91190112
2893
A61K
‫תצורות תרופתיות ופורמולציות בעלות‬
‫כושר נשיאה גבוהה של תרופות‬
188751
December 29, 2008
A61K
– ‫ב' בטבת התשס"ט‬
‫אמצעי מניעה למתן פומי המכיל‬
‫טרימגסטון‬
ORAL CONTRACEPTION WITH
TRIMEGESTONE
GRUNENTHAL GMBH
DE
102005034498.4 20/07/2005
112236333
3823222338
US
PCT/EP/2006/007103
WO/2007/009769
0091190112
188789
FORMULATION AND METHOD FOR
ADMINISTRATION OF
OPHTHALMOLOGICALLY ACTIVE
AGENTS
CHAKSHU RESEARCH INC.
US
11/182998
15/07/2005
112162303
1323022333
US
PCT/US/2006/027685
WO/2007/011874
0291090110
‫פורמולציה ושיטה למתן של גורמים‬
‫פעילים תורת העיניים‬
188817
NOVEL COMPOSITIONS FOR
CONTROL OF MALICIOUS MARINE
ANEMONES
RED SEA FISH PHARM LTD.
0/91190112
‫רד סי פיש פארם בע"מ‬
LPA2 RECEPTOR AGONIST
INHIBITORS OF CFTR
UNIVERSITY OF TENNESSEE
RESEARCH FOUNDATION
US
60/700489
19/07/2005
PCT/US/2006/027765
WO/2007/011905
December 29, 2008
188823
– ‫ב' בטבת התשס"ט‬
A61K
–‫תרכובות כימיות חדשות לבקרה שושנות‬
‫ים טורדניות‬
188820
0191190112
A61K
A61K
LPA0 ‫אגוניסטים של רצפטור של‬
CFTR ‫המעכבים‬
A61K
2894
COMBINATION OF A LONG-ACTING
HYPNOTIC AGENT AND A SHORTACTING HYPNOTIC AGENT AND
THERAPEUTIC USE OF SAME
SANOFI-AVENTIS
FR
0508643
19/08/2005
PCT/FR/2006/001830
WO/2007/020337
0091090110
188909
‫מכתשים מפעלים כימיים בע"מ‬
188983
IMPROVED FLAME RETARDATION
OF TEXTILES
BROMINE COMPOUNDS LTD.
0091090110
2895
D06H
‫עיכוב בעירה משופר בבדים‬
‫תרכובות ברום בע"מ‬
189000
FUSION PEPTIDES BASED ON
INFLUENZA HEMAGGLUTININ
POLYPEPTIDES
ABIC BIOLOGICAL LABORATORIES
TEVA LTD.
0/91090110
A01N
‫נגזרות חדשות של דיפנילאוראה להדברת‬
‫חרקים‬
NEW INSECTICIDAL
DIPHENYLUREA DERIVATIVES
MAKTHESHIM CHEMICAL WORKS
LTD.
0/91090110
‫צירוף של חומר היפנוטי ארוך–טווח וחומר‬
‫היפנוטי קצר–טווח ושימוש רפואי שלו‬
C12N
‫חלבוני איחוי המבוססים על פוליפפטידים‬
‫של המגלוטינינים ממקור וירוס השפעת‬
‫אביק מעבדות ביולוגיות טבע בע"מ‬
189117
A61B
December 29, 2008
– ‫ב' בטבת התשס"ט‬
CORRELATION OF ULTRASOUND
IMAGES AND GATED POSITION
MEASUREMENTS
BIOSENSE WEBSTER, INC.
US
11/669620
31/01/2007
0/91090110
‫התאמה של תמונות אלטרסאונד ומדידות‬
‫מיקום במצב מקובע‬
189119
A LIQUID COMPOSITION SUITABLE
FOR USE AS A CORROSION
INHIBITOR AND A METHOD FOR ITS
PREPARATION
BROMINE COMPOUNDS LTD.
1/91090110
‫הרכב נוזלי המתאים לשימוש כמעכב‬
‫קורוזיה ושיטה להכנתו‬
‫תרכובות ברום בע"מ‬
189176
189184
DELIVERY VECTORS INVOLVING
ADENOSINE RECEPTORS
LEA MADI
1091090110
‫לאה מדי‬
METHOD FOR IDENTIFYING
ELECTROPHILES AND
NUCLEOPHILES IN A SAMPLE
TECHNION RESEARCH AND
DEVELOPMENT FOUNDATION LTD.
December 29, 2008
C07H
‫שיטה לזיהוי אלקטרופילים ונוקלאופילים‬
‫בדגימה‬
189316
– ‫ב' בטבת התשס"ט‬
C12N
‫וקטורים להושטה באמצעות קולטני אדנוזין‬
189253
1291090110
D06F
‫שיטה ומערכת כביסה‬
‫לב גורביץ‬
LAUNDERING METHOD SYSTEM
LEV GUREVICH
1/91090110
C23F
‫מוסד הטכניון למחקר ופתוח בע"מ‬
E21C
2896
POLYMERIC SPACTHEL MADE FROM
QUARRY WASTE
MASURY NEHMIA
0191090110
‫ידע חברה למחקר ופיתוח בע"מ‬
189459
2897
‫נגזרות טריאזוליות חדשות כליגנדים‬
‫אנלוגיים לגרלין של קולטנים לגרוי‬
‫הפרשה של הורמון גדילה‬
A61F
‫התקן להשתלת עדשה תוך עינית‬
‫ניולנס בע"מ‬
189538
C07K
‫מפריד חלבונים‬
‫רד סי פיש פארם בע"מ‬
PROTEIN SKIMMER
RED SEA FISH PHARM LTD.
0091090110
C07D
189537
INTRAOCULAR LENS
IMPLANTATION DEVICE
NULENS LTD.
0091090110
A61K
0 ‫עיצוב של סיווה‬
NOVEL TRIAZOLE DERIVATIVES AS
GHRELIN ANALOGUE LIGANDS OF
GROWTH HORMONE
SECRETAGOGUE RECEPTORS
UNIVERSITY OF MONTPELLIER II
US
60/707941
15/08/2005
3331002256
1823622333
EP
832060332
2123222338
US
PCT/EP/2006/007945
WO/2007/020013
0091090110
‫מסורי נחמיה‬
189405
STABILIZATION OF SIVA2
YEDA RESEARCH AND
DEVELOPMENT CO. LTD
0091090112
‫ייצור שליכט פולימרי מפסולת מחצבה‬
189539
A61K
December 29, 2008
– ‫ב' בטבת התשס"ט‬
DRUG DETOXIFICATION PROTOCOL
USING MICRODOSING
SCOTT M. CONNORS
US
11/675560
15/02/2007
0191090110
‫פרוטוקול גמילה מסמים בעזרת מינון נמוך‬
189552
METHOD AND APPARATUS FOR
PRODUCING FIBERS AND FABRICS
INCLUDING MULTIPLE POLYMER
COMPONENTS IN A CLOSED
SYSTEM
REIFENHAUSER GMBH & CO. KG
MASCHINENFABRIK
EP
07003306.3 16/02/2007
0091090110
‫שיטה ומערכת לייצור סיבים ובדים‬
‫הכוללים רכיבים פולימריים רבים במערכת‬
‫סגורה‬
189576
CHEMICALLY SENSITIVE FIELD
EFFECT TRANSISTORS FOR
EXPLOSIVE DETECTION
TECHNION RESEARCH AND
DEVELOPMENT FOUNDATION LTD.
0091090110
189655
METHOD AND DEVICE FOR A GAME
AND FOR DRAWING WITH THE
AIDOT MAGNETS
YAIR MENASHE
US
60/902743
23/02/2007
0091090110
189691
FABRIC ARTICLES AND METHODS
OF MAKING SUCH ARTICLES
December 29, 2008
– ‫ב' בטבת התשס"ט‬
B05D
H01L
‫טרנזיסטור תוצא – שדה בעל רגישות‬
‫לחומרים כימיים לגילוי של חומרי נפץ‬
‫מוסד הטכניון למחקר ופתוח בע"מ‬
A63B
‫שיטה והתקן למשחק ולציור בעזרת‬
‫מגנטים‬
‫עוזי עזרא חבושה‬
B05C
‫פריטי בד ושיטה לייצור פריטי בד‬
2898
BRIGHT TECHNOLOGIES CORP. INC.
US
60/903313
26/02/2007
0091090110
189699
A PROCESS FOR THE RECOVERY OF
HCL FROM A DILUTE SOLUTION
THEREOF
HCL CLEANTECH LTD.
0091090110
‫תהליך להפקת חומצה הידרוכלורית‬
‫מתמיסה מדוללת שלה‬
‫אייץ' ס' אל קלינטג בע"מ‬
189700
189731
PACKAGED CONCENTRATE FOR
PREPARING A BOUILLON, SOUP,
SAUCE, GRAVY OR FOR USE AS
SEASONING, THE CONCENTRATE
COMPRISING XANTHAN AND TARA
GUM
UNILEVER PLC
EP
07110027
12/06/2007
0091090110
2899
A61N
.‫לב מלאכותי חשמלי‬
‫ד"ר חיים עמרם בן שמחון‬
ELECTRICAL ARTIFICIAL HEART.
DR. HAIM AMRAM BEN-SIMHON
0091090110
C01B
A47G
,‫ תבלין‬,‫ מרק‬,‫תרכיז ארוז להכנת מרק צח‬
‫ התרכיז מכיל‬,‫רוטב או לשימוש כתבלין‬
‫קסנטאן ושרף טרה‬
189732
C01B
December 29, 2008
– ‫ב' בטבת התשס"ט‬
PACKAGED CONCENTRATE FOR
PREPARING A BOUILLON, SOUP,
SAUCE, GRAVY OR FOR USE AS A
SEASONING, THE CONCENTRATED
COMPRISING XANTHAN AND GUAR
GUM
UNILEVER PLC
EP
07110024
12/06/2007
0091090110
189733
PACKAGED CONCENTRATE FOR
PREPARING A BOUILLON, SOUP,
SAUCE, GRAVY OF THE USE AS A
SEASONING, THE CONCENTRATE
COMPRISING XANTHAN AND
CASSIA GUM
UNILEVER PLC
EP
07110025.9 12/06/2007
0091090110
0091090110
C01B
,‫ תבלין‬,‫ מרק‬,‫תרכיז ארוז להכנת מרק צח‬
‫ התרכיז מכיל‬,‫רוטב או לשימוש כתבלין‬
‫עמילן ששונה‬
189735
– ‫ב' בטבת התשס"ט‬
C01B
,‫ תבלין‬,‫ מרק‬,‫תרכיז ארוז להכנת מרק צח‬
‫ התרכיז מכיל‬,‫רוטב או לשימוש כתבלין‬
‫קסנטאן ושרף קסיה‬
189734
PACKAGED CONCENTRATE FOR
PREPARING A BOUILLON, SOUP,
SAUCE, GRAVY OR FOR USE AS A
SEASONING THE CONCENTRATE
COMPRISING, MODIFIED STARCH
UNILEVER PLC
EP
07110028.3 12/06/2007
December 29, 2008
,‫ תבלין‬,‫ מרק‬,‫תרכיז ארוז להכנת מרק צח‬
‫ התרכיז מכיל‬,‫רוטב או לשימוש כתבלין‬
‫קסנטאן ושרף גואר‬
C01B
2900
PACKAGED CONCENTRATE FOR
PREPARING A BOUILLON, SOUP,
SAUCE, GRAVY OR FOR USE AS
SEASONING, THE CONCENTRATE
COMPRISING KONJAC MANNAN
UNILEVER PLC
EP
07110026.7 12/06/2007
0091090110
,‫ תבלין‬,‫ מרק‬,‫תרכיז ארוז להכנת מרק צח‬
‫ התרכיז מכיל‬,‫רוטב או לשימוש כתבלין‬
MANNAN–KONJAC
189740
MATERIAL FOR POLLUTED SOIL
RECLAMATION AND METHOD OF
ITS PRODUCTION
MORDEHAI HASSAN
0091/90112
‫חומרים לניקוי וחידוש קרקעות מזוהמות‬
‫ושיטות ליצורם‬
‫מורדכי חסן‬
189751
COMBINATION DRUG CONTAINING
PROBUCOL AND A
TETRAZOLYALKOXYDIHYDROCARBOSTYRIL
DERIVATIVE WITH SUPEROXIDE
SUPRESSANT EFFECTS
OTSUKA PHARMACEUTICAL CO.,
LTD.
US
60/716954
15/09/2005
832081003
2323122338
US
PCT/JP/2006/318675
WO/2007/032557
0091/90112
2901
A01B
C07D
‫שילוב תרופתי המכיל תולדת פרובוקול‬
‫וטטרהזוליאלקוקסי–דיהידרוקארבוסטריל‬
‫עם השפעות סופראוקסיד מדכאות‬
189755
A61K
December 29, 2008
– ‫ב' בטבת התשס"ט‬
ASSOCIATION OF ?3 RECEPTOR
AGONIST AND MONOAMINE
REUPTAKE INHIBITORS,
PHARMACEUTICAL COMPOSITION
CONTAINING SAME AND
THERAPEUTIC USE THEREOF
SANOFI-AVENTIS
FR
0509528
19/09/2005
PCT/FR/2006/002125
WO/2007/034056
0291090110
:–‫איחוד של אגוניסט של רצפטורי ביתא‬
,‫עם מעכבי ספיגה חוזרת של מונואמינים‬
‫תרכובות פרמצבטיות המכילות אותו‬
‫ושימושיו הרפואיים‬
189764
‫מתודה לדיאגנוזה של תחילת הלידה‬
‫האמיתית‬
‫אלכסנדר גולברג‬
METHOD FOR DIAGNOSIS OF AN
ONSET OF TRUE LABOR
ALEX GOLBERG
0191090110
189805
189813
GARMENT FOR RELIEVING BACK
DISCOMFORT
YURI BABKIN
0091090110
‫יורי בבקין‬
METHOD AND APPARATUS FOR
MAKING A SPUNBOND WEB
REIFENHAUSER GMBH & CO. KG
MASCHINENFABRIK
EP
07004747/7 08/03/2007
189839
BLAST ATTENUATION BARRIER
December 29, 2008
– ‫ב' בטבת התשס"ט‬
A61C
‫מלבוש להקלת אי–נוחות בגב‬
189823
0091090110
A01G
‫התקן הלבשה לניגוב שטיפה והברקה‬
‫אליהו יצחקי‬
WIPING AND WAXING DIVICE
ELIYAHU YITSCHAKI
0091090110
A61B
B65H
‫שיטה ומערכת להכנת אריג בטכניקת‬
SPUNBOND
B64D
‫מחסום המעטת הדף‬
2902
‫אורטק מערכות מיגון בע"מ‬
ORTECH DEFENCE SYSTEMS LTD.
0091/90112
NEW FORMULATION
NOVARTIS AG
US
60/722624
PCT/US/2006/037198
WO/2007/041053
0091090110
189856
‫תכשיר חדש‬
29/09/2005
189863
LENS DELIVERY SYSTEM
CARTRIDGE
ALCON MANUFACTURING, LTD.
US
11/684337
09/03/2007
0091090110
2903
A61F
‫מחסנית למערכת להחדרת עדשות‬
189864
LENS DELIVERY SYSTEM
ALCON MANUFACTURING, LTD.
US
11/682622
06/03/2007
/191090112
A61K
A61F
‫מערכת להחדרת עדשות‬
189869
A61K
December 29, 2008
– ‫ב' בטבת התשס"ט‬
POTENTIATION OF THE
THERAPEUTIC ACTION OF AN
OPIOID RECEPTOR AGONIST
AND/OR INHIBITION OR REVERSAL
OF TOLERANCE TO AN OPIOID
RECEPTOR AGONISTS USING AN
ULTRALOW DOSE OF AN ALPHA-2
RECEPTOR ANTAGONIST
QUEEN'S UNIVERSITY AT KINGSTON
US
60/712545
30/08/2005
832032336
2221222333
US
PCT/CA/2006/001441
WO/2007/025383
0091090110
‫הגברת הפעילות הרפואית של אגוניסט‬
‫או עיכוב או היפוך‬/‫לרצפטור לאופיאויד ו‬
‫הסובלנות לאגוניסטים לרצפטור‬
‫לאופיאויד תוך שימוש במינון אולטרא–נמוך‬
0–‫של אנטגוניסט לרצפטור אלפא‬
189870
LENS DELIVERY SYSTEM
CARTRIDGE AND METHOD OF
MANUFACTURING
ALCON, INC.
US
11/734084
11/04/2007
1091/90110
‫מחסנית למערכת להחדרת עדשות ושיטה‬
‫לייצור‬
189888
A63H
‫צעצוע‬
‫עירית מילוא‬
TOY
IRIT MILO
1/91/90110
189891
METHOD FOR BROADCASTING
/MULTICASTING TRANSMISSIONS IN
WIRELESS NETWORKS
ALVARION LTD.
1/91/90110
189892
H04L
‫הפצה של תשדורות‬/ ‫שיטה לשידור‬
‫ברשתות אלחוטיות‬
‫אלווריון בע"מ‬
H01R
‫שקע‬
A SOCKET
December 29, 2008
A61F
– ‫ב' בטבת התשס"ט‬
2904
‫סופקו אינטרנשיונל בע"מ‬
SUPCO INTERNATIONAL LTD
1091/90110
189913
FETAL MOVEMENT REPLICATION
APPARATUS
BIOPAD LTD
1091/90110
‫התקן לשכפול תנועות עובר‬
‫ביופאד בע"מ‬
189951
A RAPID INJECTION DEVICE
ADST TECHNOLOGIES LTD.
US
60/893159
06/03/2007
1291/90110
A61B
A61C
‫התקן להזרקה מהירה‬
‫איי די אס טי טכנולוגיות בע"מ‬
189978
A61F
‫עדשה תוך–עינית‬
INTRAOCULAR LENS
ALCON MANUFACTURING, LTD.
US
11/862244
27/09/2007
1291/90110
189979
LENS INJECTOR LUMEN TIP FOR
WOUND ASSISTED DELIVERY
ALCON, INC.
US
11/761457
12/06/2007
1291/90110
2905
A61F
‫מכשיר להזרקת עדשות בעל חוד חלול‬
‫לסיוע בהחדרה לפגיעה‬
189988
A61K
December 29, 2008
– ‫ב' בטבת התשס"ט‬
BETA GLYCOLIPIDS FOR THE
TREATMENT OF
NEURODEGENERATIVE DISORDERS
HADASIT MEDICAL RESEARCH
SERVICES & DEVELOPMENT LTD.
1291/90110
‫בתא גליקוליפידים לטיפול במחלות נווניות‬
‫של מערכת העצבים‬
‫הדסית שרותי מחקר רפואי ופיתוח בע"מ‬
189993
‫פריטי סיליקון קרביד המיוצרים באמצעות‬
‫שקיעה כימית של אדים‬
CHEMICAL VAPOR DEPOSITED
SILICON CARBIDE ARTICLES
ROHM AND HAAS ELECTRONIC
MATERIALS, LLC
US
60/905952
09/03/2007
1091290112
C01B
190045
C07J
–‫– אלפא‬C– 10 C 17 :–‫שימוש ב‬
‫–דהידרוקורטקסולון‬00 ,6 ‫אסטרים של‬
‫כגורמים אנטי–גונדוטרופים‬
USE OF C3-C10 17 ALFA-ESTERS OF
9,11-DEHYDROCORTEXOLONE AS
ANTI-GONADOTROPHIC AGENTS
COSMO BIO-TECHNOLOGIES SRL
IT
MI2005A001695 14/09/2005
PCT/EP/2006/062995
WO/2007/031349
0191/90110
190046
A SOCK HAVING AN ORTHOPAEDIC
AND SUPPORTING STRUCTURE AT
THE SOLE
CHEN MIMON
0191/90110
December 29, 2008
‫גרב בעלת מבנה אורטופדי תומך בסוליה‬
190048
THE SPOUTCH
– ‫ב' בטבת התשס"ט‬
A61F
‫חן מימון‬
B65D
‫צינור מתחבר‬
2906
‫שמואל יוסף בורנשטיין‬
YOHANAN ZVI HELLER
0191/90110
190049
G07B
‫מערכת לחניה סלולארית‬
‫דורון ניאגו‬
CELLULAR PARKING SYSTEM
DORON NIEGO
0191/90110
190050
A23L
ACIDIFY PREVENTION OF MOIST
DATES
AHARON CHAZUT
0191/90110
‫מניעת החמצה בתמרים לחים‬
‫אהרון חזות‬
190051
TAMPON WITH ANOTHER STRING
THAT USE FOR INDICATION FOR
REPLACMENT
EFRAT MADAR
0191/90110
‫טמפון עם חוט נוסף המשמש ראינדיקטור‬
‫להחלפה‬
‫אפרת מדר‬
190056
COLLISION SAFETY DEVICE BEING
APPLICABLE TO INFANT SEATS
JANE, S.A.
ES
ES200700827U 23/04/2007
0191/90110
2907
A61F
B60N
‫מתקן בטיחות להתנגשות המותאם‬
‫למושבי תינוקות‬
190058
G09C
December 29, 2008
– ‫ב' בטבת התשס"ט‬
METHOD AND SYSTEM FOR
MANAGING DATA AT DISTRIBUTED
POINTS OF SALE
360 MESH LTD
0191/90110
‫שיטה ומערכת לניהול נתונים בנקודות‬
‫מכירה מבוזרות‬
‫ מאיש בע"מ‬:9/
190059
‫שיטה לשימוש באסטרטגיה קבוצתית‬
‫במשחקי קלפים‬
‫שחר אדיב‬
A METHOD FOR PLAYING CARD
GAMES USING TEAM STRATEGY
SHACHAR ADIV
0091/90112
190060
ALCANOIC ACID AMIDES
SUBSTITUTED BY SATURATED OHETEROCYCLES
SPEEDEL EXPERIMENTA AG
CH
01518/05
17/09/2005
PCT/EP/2006/066368
WO/2007/031557
0091/90110
CIRCUIT-COVER ASSEMBLY
HAVING AN APERTURE
ENDWAVE CORPORATION
US
11/692129
27/03/2007
December 29, 2008
190067
– ‫ב' בטבת התשס"ט‬
C07D
‫אמידי חומצה אלקנואית מותמרים על ידי‬
‫–הטרוציקלים רוויים‬O
190066
0291/90112
A63F
A47J
‫מכלול מכסה מעגלי הכולל חור‬
C07C
2908
PHARMACEUTICAL COMPOSITIONS
CONTAINING AN ACTIVE VITAMIN
D COMPOUND FOR
GASTROINTESTINAL DISORDERS
NOVACEA, INC.
US
60/719988
26/09/2005
PCT/US/2006/037246
WO/2007/038428
0091090112
190080
METHODS FOR TREATMENT AND
PREVENTION OF OTITIS MEDIA
USING CHEMICAL PENETRATION
ENHANCERS TO FACILITATE
TRASMEMBRANE DRUG DELIVERY
INTO THE MIDDLE EAR
PIEDMONT PHARMACEUTICALS,
LLC
US
60/720535
26/09/2005
PCT/US/2006/033346
WO/2007/037874
0091/90110
2909
‫שיטות לטיפול ומניעה של תווך דלקתי‬
‫באוזן באמצעות שימוש בחומרים פעילי‬
‫שטח להקלת העברת תרופה דרך‬
‫הממברנה לאוזן התיכונה‬
B32B
‫מתקן למריחת משחה‬
‫יוסף רחום‬
190087
AN APPARATUS FOR PREPARING A
BEVERAGE
ORA MASHEAH
0091/90110
A61K
190086
PASTE APPLICATOR
YOSEF RAHUM
0091/90110
‫ פעיל‬D ‫תכשירי רוקחות המכילים ויטמין‬
‫עבור אי סדרים של מערכת העיכול‬
A47J
‫מכשיר להכנת משקה‬
‫מאיר גיטליס‬
190098
A47F
December 29, 2008
– ‫ב' בטבת התשס"ט‬
‫מדף נעליים‬
SHOE RACK
CHU, LI-CHI
0091/90110
190100
CUTTER TOOL AND CUTTER INSERT
THEREFOR
NO SCREW LTD
IL
183721
06/06/2007
163331
2323822330
IL
163032
1323022330
IL
0091/90112
‫כלי לחיתוך ותוספת חיתוך בתוכו‬
‫בלי בורג בע"מ‬
190110
CYCLOPROPYL AMINES AS
MODULATORS OF THE HISTAMINE
H3 RECEPTOR
JANSSEN PHARMACEUTICA N.V.
US
60/717659
16/09/2005
PCT/US/2006/035877
WO/2007/035425
0091/90110
0091/90110
December 29, 2008
A63B
‫שיטה ומערכת לייצוג נתוני משחק בצורה‬
‫גנרית‬
‫ממורייז בע"מ‬
190115
– ‫ב' בטבת התשס"ט‬
C07C
‫אמינים ציקלופרופילים כמודולטורים‬
H: ‫לרצפטור להיסטמין‬
190111
METHOD AND SYSTEM FOR
REPRESENTING GAME DATA IN A
GENERIC FORM
MEMORAZE LTD.
B23B
G07B
2910
SYSTEM AND METHOD FOR
PROCESSING APPLICATIONS FOR
JOINING AND TRANSFERRING
PROVIDENT FUNDS
TMURA INSURANCE AGENCY (1987)
LTD
0091/90110
‫מערכת ושיטה לניהול בקשות הצטרפות‬
‫לקופות גמל ובקשות להעברת כספי‬
‫עמיתים בין קופות גמל‬
190127
RAZOR BLADE SHARPENEER AND
METHOD OF SHARPENING
SAHAR ZEIDI
0/91/90110
‫סהר זיידי‬
190140
2911
‫בדיקת ראש מלטש עם בסיס נייד‬
B60L
‫ מקורות טעינה למכונית חשמלית‬4
‫אלבז גבריאל‬
190156
G08C
‫התקנים ושיטות לבקרה אופטית של‬
‫אותות‬
‫אוניברסיטת בר אילן‬
DEVICES AND METHODS FOR
OPTICAL SIGNAL CONTROL
BAR ILAN UNIVERSITY
0/91/90110
B24B
190147
4 SOURCES TO RECHARGE
ELECTRIC CAR
ELBAZ GAVRIEL
0/91/90110
B26B
‫מחדד סכיני גילוח ושיטת חידוד‬
POLISHING HEAD TESTING WITH
MOVABLE PEDESTAL
APPLIED MATERIALS, INC.
US
11/686868
15/03/2007
0/91/90110
‫ ) בע"מ‬0687(‫תמורה סוכנות לביטוח‬
190168
A43B
December 29, 2008
– ‫ב' בטבת התשס"ט‬
‫נעל אורתופדית‬
‫ד"ר גד שמואלי‬
ORTHOPEDIC SHOE
DR. GAD SHMUELI
0191/90110
190203
A SYSTEM FOR ELECTRONICALLY
ALIGNING THE POLARISATION OF AN
ANTENNA
SPACE ENGINEERING S.P.A.
IT
RM2007A000144 20/03/2007
0191/90110
‫מערכת לכיול קיטוב של אנטנה‬
190208
AN ELECTRONIC DEVICE FOR
AIDING HEART PATIENTS BEFORE
AND WHILE AN HEART ATTACK
ZILBERMAN AVRAHAM
0191/90110
‫כהן סער דוד‬
190232
0091/90110
December 29, 2008
G08C
‫חצי‬/ ‫מערכת ושיטה למיון נכנסים אוטומטי‬
‫אוטומטי‬
‫ בע"מ‬00 ‫אף אס טי‬
190256
– ‫ב' בטבת התשס"ט‬
A63B
‫גמישונית‬
‫מיכאל קיל‬
SHOULDER EXERCISER
MICHAEL KIEL
SYSTEM AND METHOD FOR
AUTOMATED/SEMI-AUTOMATED
ENTRY FILTERING
FST21 LTD
A61M
‫מכשיר אלקטרוני המסייע לחולי לב לפני‬
‫או בזמן התקפי לב‬/‫ו‬
190209
0191/90110
G08C
B65D
2912
PACKAGE INTEGRITY INDICATING
CLOSURE
KRAFT FOODS HOLDINGS, INC.
US
11/693751
30/03/2007
0091/90110
190386
TREATMENT ELEMENT CONNECTED
AND SEPARATE IN DENTAL FLOSS,
THAT REMAIN IN THE GAP
BETWEEN THE TEETH AN THE
GUMS
YEHOSHOUA TABOR
0091/90110
2913
‫יהושע תבור‬
B67B
‫ייצור מוצרי אריזה‬-066/ ‫ימ"א‬
190412
G06F
‫שיטת קריפטוגרפיה על בסיס לימוד של‬
‫רשתות נירונים‬
‫לאוניד שניידר‬
190419
A LASER AIMING AND MARKING
DEVICE
OPTIGO SYSTEMS LTD
0091/90110
‫אלמנט טיפולי מחובר ומתנתק לחוט‬
‫ שנשאר ברווח בין השיניים‬,‫דנטאלי‬
‫לחניכיים‬
‫כיסוי למשטח טובין‬
METHOD OF CRYPTOGRAPHY ON
THE BASIS OF THE NEURAL
NETWORK TRAINING
LEONID SHNA
0091/90110
A61C
190407
PALLET LID
IMA 1990-PACKAGING PRODUCTS
MANUFACTURE
0091/90110
‫סוגר המעיד על שלמות אריזה‬
H01S
‫התקן לייזר לכיוון וסימון‬
‫אלתא מערכות בע"מ‬
190425
G08B
December 29, 2008
– ‫ב' בטבת התשס"ט‬
SYSTEM AND METHOD FOR
LOCATION DETECTION OF MOBILE
COMMUNICATION DEVICES
INTUCELL LTD
0091/90110
‫מערכת ושיטה לאיתור מכשיר קשר נייד‬
‫אינטיוסל בע"מ‬
190432
ASSEMBLY SYSTEM FOR FLOOR
AND/OR WALL TILES
PROMOCIONES BRIAL, S.L.
ES
P200701309 14/03/2007
ES
P200700831 2323222330
ES
P200701779 3823822330
ES
P200701920 3323022330
ES
P200703428 2321222330
ES
P200800072 1123122336
0091/90110
‫או קיר‬/‫מערכת הרכבה למרצפות רצפה ו‬
190433
SYSTEM AND METHOD OF
MODIFYING DATA PACKET TAGS
MARVELL ISRAEL (M.I.S.L) LTD
US
60/897000
26/03/2007
832313308
3223322330
US
0290190112
190436
TRIAZOLE DERIVATIVES AS
INHIBITORS OF 11-BETAHYDROXYSTEROID
DEHYDROGENASE-1
MERCK & CO., INC.
US
60/728723
20/10/2005
PCT/US/2006/040459
WO/2007/047625
0091/90110
December 29, 2008
190438
– ‫ב' בטבת התשס"ט‬
E04F
G06F
‫מערכת ושיטה להתאמת תוויות חבילת‬
‫מידע‬
‫אל) בע"מ‬.‫אס‬.‫איי‬.‫מארוול ישראל (אמ‬
C07D
–‫–בטא‬00 ‫נגזרות טריאזול כמעכבים‬
0–‫הידרוקסיסטרויד דהידרוגנאז‬
A61B
2914
A METHOD OF SETTING A DRILL
FOR DRILLING A HOLE IN A BONE
COAXIAL TO THE HOLE IN THE NAIL
AND AIMING DEVICE FOR
REALIZING THIS METHOD
K.M.B.Y. LTD
0291/90110
‫שיטה להכוונת מקדח לצורך קידוח חור‬
‫בתוך העצם בהתאמה לחור אשר במסמר‬
‫ומכשיר להכוונת פעולה זו‬
‫ בע"מ‬.‫י‬.‫ב‬.‫מ‬.‫ק‬
190439
METHOD, SYSTEM & COMPONENT
ELEMENTS FOR FUELING VEHICLE
ON DEMAND
ZVI LUBINSKI
0291/90110
‫ מערכת ורכיבים לתדלוק רכב על פי‬,‫שיטה‬
‫דרישה‬
‫צבי לובנסקי‬
190458
HEATING DEVICE
A.H.T. ADVANCED HEATING
TECHNOLOGIES LTD.
0191/90112
2915
G02B
‫טלסקופי עבור תחום ספקטרה‬
‫אינפראדום‬
TELEOPTICS FOR THE INFRARED
SPECTRAL RANGE
DIEHL BGT DEFENCE GMBH & CO. KG
DE
102007015896.5 02/04/2007
0191/90110
B60S
190469
A47J
‫התקן חימום‬
‫ אדוונסד היטינג טכנולוג'יז בע"מ‬.‫טי‬.'‫איצ‬.‫אי‬
190486
A61K
December 29, 2008
– ‫ב' בטבת התשס"ט‬
GELLING HYDROPHOBIC
INJECTABLE POLYMER
COMPOSITIONS
EFRAT BIOPOLYMERS LTD.
US
60/720840
27/09/2005
PCT/IB/2006/003540
WO/2007/110694
0191/90110
‫גליצה של פולימרים הידרופוביים‬
‫אפרת ביופולימרים בע"מ‬
190493
‫רדאר עבור‬/‫אומדן תנועה מבוסס לייזר‬
‫ניווט‬
LADAR-BASED MOTION
ESTIMATION FOR NAVIGATION
HONEYWELL INTERNATIONAL INC.
US
11/692651
28/03/2007
/191/90110
G08G
190505
PRE-LUBRICATED AND ENVELOPED
CATHATER
DR. HAIM AMRAM BEN-SIMHON
/191/90110
‫קטטר סטרילי משומן וארוז‬
‫ד"ר חיים עמרם בן שמחון‬
190512
PORTABLE APPARATUS FOR
RESCUE FROM ELEVATED
LOCATIONS
RES-Q RESCUE TECHNOLOGIES LTD.
1190090112
December 29, 2008
A62B
‫התקן לירידה מבוקרת ממיקום גבוה‬
‫קיו טכנולוגיות חילוץ בע"מ‬-‫רס‬
190524
– ‫ב' בטבת התשס"ט‬
A61B
C07D
2916
PHARMACEUTICAL SALTS AND POLYMORPHS
OF N-(5-CHLORO-2-PYRIDINYL)-2-[[-4[(DIMETHYLAMINO)IMINOMETHYL]BENZOYL]
AMINO]-5-METHOXY-BENZAMIDE, A FACTOR
XA INHIBITOR
MILLENNIUM PHARMACEUTICALS, INC.
US
60/735224
08/11/2005
PCT/US/2006/043635
WO/2007/056517
/091/90110
–N–(5 ‫מלחים רוקחיים ופולימורפים של‬
–4[[–0–)‫–פירידיניל‬0–‫כלורו‬
–]‫(דימתילאמינו)אימינומתיל]בנזואיל]אמינו‬
XA ‫ מעכב פקטור‬,‫–מתוקסי–בנזאמיד‬.
190525
B65D
‫אריזה לטבליות‬
BLISTER PACKAGING
DIVIDELLA AG.
/091/90110
190526
METHOD FOR IDENTIFYING
PATIENTS
BENJAMIN BEN AMI
/091/90110
‫שיטה לאיתור מטופלים‬
‫בנימין בן עמי‬
190527
AUTOMATIC SEALING FOR
SQUEEZE BOTTLES
DEGANI & CO
/091/90110
‫דגני ושות' עורכי דין‬
190534
A47C
‫משענת למושב של רכב מתקפלת‬
‫איתמר מרום‬
190556
MAGNETICALLY OPERATED GAME
2917
B67B
‫סגירה אוטומטית לשפופרות לחיצות‬
FOLDABLE HEAD SUPPORT OF
VEHICLE
ITAMAR MAROM
1091090110
A61B
A63H
‫משחק הפועל באמצעות מגנטים‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
YAIR MENASHE
US
60/921231
‫ עו"ד‬,‫עוזי חבושה‬
02/04/2007
1091090110
190557
‫מתקן לבקבוק ולמזיגת למשקאות‬/‫מעמד‬
‫מנקין פתחיה‬
A BOTTLE STAND/POURING DEVICE
PTAHYA MENKIN
1091090110
190560
PROJECTILE WITH A PENETRATION
CAPABILITY
JUNGHANS MICROTEC GMBH
DE
102007016488.4 05/04/2007
23233633213358
1323222336
DE
1091090110
190567
NECK-TIE WITH MEANS TO ATTACH
THE TIE TO THE SHIRT
UNDERNEATH (TO THE BUTTON OR
BUTTONS ETC)
DR. HAIM AMRAM BEN-SIMHON
1091090110
190571
APPARATUS FOR WASTE-WATER
FILTRATION
CEQUESTA WATER LTD.
1091090110
December 29, 2008
– ‫ב' בטבת התשס"ט‬
F41H
‫קליע עם יכולת חדירה‬
A41F
‫עניבה עם אמצעים להדוקה לחולצה‬
‫שמתחתיה (לכפתור או לכפתורים‬
.)‫וכדומה‬
‫ד"ר חיים עמרם בן שמחון‬
B30B
‫התקן לסינון מי שפכין‬
‫סאקווסטה ווטאר בע"מ‬
190572
SHOWER APPARATUS
AMOS TAIB
A47J
A47L
‫מיתקן למקלחת‬
‫עמוס טייב‬
2918
1091090110
190575
B67C
‫מנפק נוזלים‬
‫שאול חליף‬
A LIQUID DISPENSER
SHAUL HALIF
1091090110
190577
CARTRIDGE FOR STORING AN IOL
AND FORCEPS FOR USE THEREWITH
NULENS LTD.
1091090110
A61F
‫מחסנית לאחסון עדשה בין עינית‬
‫ומלקחיים לשימוש איתה‬
‫ניולנס בע"מ‬
190579
A63F
‫משחק לטיני‬
‫מרדכי לנדו‬
A LATIN GAME
MORDECHAI LANDO
1091090110
190584
‫תמרון ע"י אובייקט תוכן‬
‫טי בע"מ‬.‫וי‬.‫אי‬
OBJECT CONTENT NAVIGATION
EVT TECHNOLOGIES LTD.
1091090110
190589
LEVEL-RESTORED SUPPLYREGULATED PLL
MARVELL ISRAEL (M.I.S.L) LTD
US
60/909804
03/04/2007
122381202
3223322336
US
1/91090110
NOVEL ULTRA LOW POWER
VITERBI DECODER CIRCUIT
2919
H04N
H03L
‫אל וסת–אספקה‬.‫אל‬.‫משוחזר–במאוזן פי‬
‫אל) בע"מ‬.‫אס‬.‫איי‬.‫מארוול ישראל (אמ‬
190590
H03M
‫ בצריכת זרם‬VITERBI ‫מפענח מסוג‬
‫נמוכה ביותר‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
‫ אדבנסד‬-.‫ אס‬.‫ פי‬.‫ אם‬.‫חברת איי‬
‫מיקרופאואר סמיקונדקטורס בע"מ‬
A.M.P.S-ADVANCED MICRO POWER
SEMI-CONDUCTORS LTD
1/91090110
190591
ULTRA LOW POWER FULLY
DIFFERENTIAL CURRENT MODE
VITERBI DECODER SUBSYSTEM
A.M.P.S-ADVANCED MICRO POWER
SEMI-CONDUCTORS L.T.D
1/91090110
‫ הפועל‬VITERBI ‫מפענח דיפרניצאלי מסוג‬
‫זרם בצריכת זרם נמוכה ביותר‬
‫אדבנסד מיקרופאואר‬-‫אס‬.‫פי‬.‫אם‬.‫איי‬
‫סמיקונדקטורס בע"מ‬
190592
COMPLETE CURRENT MODE MICRO
POWER MULTIPLIER WITH
FLOATING GATE OFFSET
CANCELLATION
A.M.P.S-ADVANCED MICRO POWER
SEMI-CONDUCTORS L.T.D
1/91090110
‫אדבנסד מיקרופאואר‬-‫אס‬.‫פי‬.‫אם‬.‫איי‬
‫סמיקונדקטורס בע"מ‬
COMPLETE CURRT MODE MICRO
POWER DIVIDER CIRCUIT WITH
FLOATING GATE OFFSET
CANCELLATION
A.M.P.S-ADVANCED MICRO POWER
SEMI-CONDUCTORS L.T.D
December 29, 2008
– ‫ב' בטבת התשס"ט‬
H02N
‫מחלק הפועל באופן זרם עם טרנזיסטור‬
‫בעל שער צף לקיזוז שער היסט‬
‫אדבנסד מיקרופאואר‬-‫אס‬.‫פי‬.‫אם‬.‫איי‬
‫סמיקונדקטורס בע"מ‬
190594
ULTRA LOW POWER (ULP) CARRIER
FREQUENCY CORRECTION FOR
OFDM RECEIVERS
H02N
‫מכפל מושלם הפועל באופן זרם עם‬
‫טרנזיסטור בעל שער צף לקיזוז שער‬
‫היסט‬
190593
1/91090110
H03M
H03F
,‫ בצריכת הספק נמוכה ביותר‬,‫מעגל תיקון‬
‫לתדר גל הנושא של האינפורמציה‬
OFDM ‫הנקלטת במקלט‬
2920
‫אדבנסד מיקרופאואר‬-‫אס‬.‫פי‬.‫אם‬.‫איי‬
‫סמיקונדקטורס בע"מ‬
A.M.P.S-ADVANCED MICRO POWER
SEMI-CONDUCTORS L.T.D
1/91090110
190595
ULTRA LOW POWER (ULP) TIMING
SYNCHRONIZATION METHOD FOR
WIRED AND WIRELESS RECEIVERS
A.M.P.S-ADVANCED MICRO POWER
SEMI-CONDUCTORS LTD
0/91/90112
‫ בצריכת הספק‬,"‫מעגל "מעגל סנכרון תדר‬
‫או אלחוטי‬/‫ למקלט חוטי ו‬,‫נמוכה ביותר‬
‫ אדבנסד‬-.‫ אס‬.‫ פי‬.‫ אם‬.‫חברת איי‬
‫מיקרופאואר סמיקונדקטורס בע"מ‬
190619
1291090110
06/10/2005
190624
190625
BLANKET-COVER WITH OPENNING
IN THE FAR CORNERS OF THE
COVER TO FACILTATE FITTING OF
THE COVER TO THE BLANKET.
2921
H04J
‫שפופרת טלפון אלחוטית‬
‫יורם אהרונוביץ‬
WIRELESS HANDSET
YORAM AHARONOVITCH
1291090110
C07D
‫שימוש מפעילי גוואנילאט ציקלאז‬
‫מסיס לטיפול במחלות ריאה חריפות‬
‫וכרוניות‬
USE OF SOLUBLE GUANYLATE
CYCLASE ACTIVATORS FOR TREATING
ACUTE AND CHRONIC LUNG DISEASES
BAYER HEALTHCARE AG
DE
102005047946.4
PCT/EP/2006/009264
WO/2007/039155
H03F
A47F
‫כסוי שמיכה עם פתחים בפנות המרוחקות‬
‫של כסוי השמיכה להקלת ההתאמה של‬
.‫השמיכה לכיסוי‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
‫ד"ר חיים עמרם בן שמחון‬
DR. HAIM AMRAM BEN-SIMHON
1291090110
190626
TELESCOPIC HANGER FOR
TOWELLS ETC.
DR. HAIM AMRAM BEN-SIMHON
1291090110
.'‫מתלה טלסקופי למגבות וכד‬
‫ד"ר חיים עמרם בן שמחון‬
190627
TABLET WITH DEEP GROOVING TO
ENABLE EASY CUTTING OF THE
TABLET INTO TWO HALVES AND/OR
FOUR QUARTERS.
DR. HAIM AMRAM BEN-SIMHON
1291090110
‫ד"ר חיים עמרם בן שמחון‬
OPTICAL DEVICE INCLUDING AT
LEAST TWO SENSORS, AND
CORRESPONDING METHOD OF
IMPLEMENTATION
SAGEM DEFENSE SECURITE
FR
0754364
06/04/2007
190640
METHOD AND APPARATUS FOR
PROTECTING FLASH MEMORY
HARRIS CORPORATION
US
11/714987
07/03/2007
– ‫ב' בטבת התשס"ט‬
H02G
‫חיבור זוויתי עבור תעלה לחיווט חשמלי בו‬
‫הזווית ניתנת לשינוי‬
‫דנטק פלסט בע"מ‬
VARIABLE ANGLE ELECTRICAL
CABLE DUCT
DANTEC PLAST LTD
December 29, 2008
G02B
,‫התקן אופטי הכולל לפחות שני חיישנים‬
‫ושיטת יישום תואמת‬
190637
1291090110
A61K
‫טבליה עם חרוץ עמוק להקל את חתוכה‬
.‫או לרבעים‬/‫לחצאים ו‬
190633
1291090110
A47K
G06F
‫שיטה ומערכת להגנה על זיכרון הבזק‬
2922
1090190112
190644
FLOATING-POINT PROCESSOR WITH
SELECTABLE SUBPRECISION
QUALCOMM INCORPORATED
US
11/244492
05/10/2005
PCT/US/2006/039063
WO/2007/044493
0190190112
‫מעבד נקודה צפה עם תת דיוק בר בחירה‬
190646
MULTI-FUNCTIONAL IONIC LIQUID
COMPOSITIONS FOR OVERCOMING
POLYMORPHISM AND IMPARTING
IMPROVED PROPERTIES FOR
ACTIVE PHARMACEUTICAL,
BIOLOGICAL, NUTRITIONAL, AND
ENERGETIC INGREDIENTS
THE UNIVERSITY OF ALABAMA
US
60/724604
07/10/2005
832023833
3021322333
US
832083633
3223222338
US
PCT/US/2006/039454
WO/2007/044693
1191090110
DEVICE FOR GROWING PLANTS
VERTIALLY
HOCHBERG MORDECHI
2923
A61K
‫תערובות יוניות נוזליות רב תכליתיות‬
‫להתגברות על פולימורפיזם ולהענקת‬
,‫תכונות משופרות לרכיבים תרופתיים‬
‫ ואנרגטיים פעילים‬,‫ביולוגיים תזונתיים‬
190647
REPLACING DISCHARGED
BATTERIES IN ELECTRIC VEHICLES
JECHESKEL DAVIDOVITCH
1191090110
G06F
B60L
‫ בכלי‬,‫החלפת מצברים ריקים בטעונים‬
‫רכב חשמליים‬
‫יחזקאל דודוביץ‬
190650
A01G
‫מתקן לגידול צמחים לגובה‬
‫הוכברג מרדכי‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
1290190112
190652
NOVEL PHARMACEUTICAL
COMBINATIONS FOR THE
TREATMENT OF RESPIRATORY
DISORDERS
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
EP
05109374.8 10/10/2005
PCT/EP/2006/067122
WO/2007/042467
1191090110
‫צירופי רוקחות חדשים לטיפול באי–סדרים‬
‫נשימתיים‬
190659
WIRELESS COMMUNICATION
NETWORK WITH RELAY STATIONS
ALVARION LTD.
1191090110
A METHOD FOR MAKING A
MUSICAL CREATION
AMIR ZIV-AV
‫אב‬-‫אמיר זיו‬
TOOL FOR MANUFACTURING
CERAMIC CASTING CORES FOR
TURBOMACHINE BLADES
SNECMA
FR
0702640
11/04/2007
December 29, 2008
– ‫ב' בטבת התשס"ט‬
B22C
‫כלי ליצור ליבת יציקה קרמית עבור להבי‬
‫מנועי טורבו‬
190674
VEHICLE AWARENESS SYSTEM
JANUS INTERFACE LTD
G09B
‫שיטה להכנת יצירה מוזיקלית‬
190667
1191090110
H04L
‫רשת תקשורת אלחוטית הכוללת תחנות‬
‫ממסר‬
‫אלווריון בע"מ‬
190660
1191090110
C07D
G08G
‫מערכת להגברת הערנות בכלי רכב‬
‫ג'אנוס אינטרפייס בע"מ‬
2924
0/90190112
190696
CHITOSAN AND HEPARIN
NANOPARTICLES
ADVANCED IN VITRO CELL
TECHNOLOGIES, S.L.
EP
05380228.6 14/10/2005
PCT/EP/2006/067389
WO/2007/042572
1091090110
‫הולהלה פיתוח שעשועים בע"מ‬
190700
B64C
.)'‫מדחף שרשרת (ימי וכו‬
‫ד"ר חיים עמרם בן שמחון‬
190727
METHOD OF INHIBITING FLT3
KINASE
JANSSEN PHARMACEUTICA N.V.
US
60/727687
18/10/2005
PCT/US/2006/060028
WO/2007/048088
1091090110
B32B
‫שטיח [או בד ארוג] המשנה את צבעיו‬
CHAIN PROPELLER (MARINE ETC.).
DR. HAIM AMRAM BEN-SIMHON
0190190112
‫ננוחלקיקים של צ'יטוסאן והפארין‬
190699
A CARPET [OR A CLOTH] THAT
CHANGES ITS COLOR
HULLALA FUN DEVELOPMENTS
LTD.
1091090110
A61K
C07D
FLT: ‫שיטה לעיכוב קינאז מסוג‬
190734
B23C
‫מנגנון כוונון‬
‫ישקר בע"מ‬
ADJUSTMENT MECHANISM
ISCAR LTD.
2925
December 29, 2008
– ‫ב' בטבת התשס"ט‬
1/91090110
190735
G07F
‫מכירה במסירון‬
‫אסקר מחרובלישוילי‬
S.M.S SHOP
OSKAR MAHAROBLISHVILI
1/91090110
190736
A47K
SPONGE CONTAINING DEAD SEA
MUD AND MINERALS, PRODUCTION
METHOD AND SET-UP
ISRAEL TSABARI
0191/90112
‫ספוג המכיל בוץ ומינרלים מים המלח‬
‫ושיטה ומערכת ייצור‬
‫ישראל צברי‬
190745
MICROANGIOPATHY TREATMENT AND
PREVENTION
BAYER HEALTHCARE AG
DE
102005048824.2 10/10/2005
PCT/EP/2006/009373
WO/2007/042146
0091090112
1/91090110
– ‫ב' בטבת התשס"ט‬
A61K
‫מנה רוקחית למתן פומי בצורת חלקיקים‬
‫זעירים למניעת שימוש שאינו נכון‬
190763
VACUUM TABLE AND A METHOD
FOR SUPPORTING AN OBJECT
CAMTEK LTD.
US
60/911892
15/04/2008
December 29, 2008
‫טיפול ומניעה של מחלת כלי דם קטנים‬
190749
ANTI-MISUSE MICROPARTICULATE
ORAL PHARMACEUTICAL FORM
FLAMEL TECHNOLOGIES
FR
0553437
10/11/2005
PCT/EP/2006/062627
WO/2007/054378
C07D
A47B
‫שולחן וואקום ושיטה לתמיכה באובייקט‬
‫קמטק בע"מ‬
2926
1/91090110
190764
METHOD AND SYSTEM FOR SECURE
TRANSACTION
POSTALGUARD LTD.
0191090110
‫שיטה ומערכת להעברה בטוחה‬
‫פוסטלגארד בע"מ‬
190772
190776
A METHOD AND A SYSTEM FOR
FALSE ALARM REDUCTION IN
MOTION DETECTION BY SCANNING
CAMERAS
PRO TRACK LTD
0191090110
‫שיטה ומערכת להפחתת אזעקת שווא‬
‫באבחון תנועה באמצעות מצלמות סריקה‬
‫פרו טראק בע"מ‬
A61K
–‫ציפוי עבור מכשיר רפואי בעל מצמד אנטי‬
‫תרומבוטי‬
190799
TREATMENT OF STRESS URINARY
INCONTINENCE AND MIXED
URINARY INCONTINENCE
UROGENE
FR
05/10649
19/10/2005
832020623
1321322333
US
PCT/IB/2006/003682
2927
G08G
190791
A COATING FOR A MEDICAL DEVICE
HAVING AN ANTI-THROMBOTIC
CONJUGATE
CORDIS CORPORATION
US
11/741997
30/04/2007
0091090112
B62D
‫התקן לספיגת הלם ריסוק‬
‫עה בע"מ‬-‫מאג‬
CRASH SHOCK ABSORBING DEVICE
MAG-EH LTD.
0191090110
G07F
C07D
‫טיפול באי שליטה במתן שתן בעקבות‬
‫לחץ ובעקבות שילוב של לחץ ודחף‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
WO/2007/046003
0091090112
190800
TREATMENT OF THE SYMPTOMS OF
BLADDER IRRITATION
UROGENE
FR
05/10650
19/10/2005
832020623
1321322333
US
PCT/IB/2006/003691
WO/2007/046004
0190190112
190803
COMPOUNDS
GLAXO GROUP LIMITED
US
60/728975
21/10/2005
832628333
2223322338
US
PCT/US/2006/060023
WO/2007/081597
0/91090110
190808
CHAIN / PROPELLER AND A
SHIP/BOAT, THAT FITS CHAIN
PROPELLER (S).
DR. HAIM AMRAM BEN-SIMHON
0/91090110
‫תרכובות‬
B64C
F42D
‫מערכת ושיטה לחסימת טיל‬
‫ראובן ברמן‬
190814
– ‫ב' בטבת התשס"ט‬
C07D
‫ד"ר חיים עמרם בן שמחון‬
AN SYSTEM AND METHOD FOR
BLOCKING A ROCKET
REUBEN BERMAN
December 29, 2008
‫טיפול בסימפטומים של גירוי שלפוחית‬
‫ סירה המתאימה‬/ ‫מדחף שרשרת ואוניה‬
.‫למדחף(י) שרשרת‬
190811
0/91090110
C07D
B62B
2928
WHEELCHAIR, ABLE TO CLIMB AND
DESCEND STAIRS
OLGA LAPATIN
0/91090110
‫עגלת נכים בעלת יכולת לעלות ולרדת‬
‫במדרגות‬
‫יפים לפטין‬
190818
LIGHT TRAPPING FILM FOR
INCREASING PHOTOVOLTAIC
EFFICIENCY AND METHOD FOR
MANUFACTURING THE SAME
G01J
‫שכבה לוכדת אור להגדלת יעילות‬
‫פוטוואלטאית ושיטה לייצורה‬
‫אירידיאנס בע"מ‬
IRIDIANCE LTD
1/90190112
190825
FAULT PROTECTION SYSTEM AND
METHOD FOR AN ELECTRICAL
POWER DISTRIBUTION SYSTEM
S & C ELECTRIC COMPANY
US
60/731571
28/10/2005
832022303
3221122333
US
PCT/US/2006/038470
WO/2007/050240
/090190112
‫מערכת הגנת ליקויים ושיטה למערכת‬
‫הפצת הספק חשמלי‬
190826
A PROBE FOR TESTING ELECTRICAL
PROPERTIES OF A TEST SAMPLE
CAPRES A/S
EP
05388093.6 31/10/2005
PCT/DK/2006/000603
WO/2007/051471
2929
H02H
G01R
‫מכשיר בדיקה לבחינת מאפיינים‬
‫אלקטרוניים של דוגמיות ניסוי‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
0/90190112
190827
SOLID ORAL PHARMACEUTICAL
COMPOSITIONS FOR ONCE DAILY
DOSING CONTAINING PREGABALIN,
A MATRIX FORMING AGENT AND A
SWELLING AGENT
PFIZER PRODUCTS INC.
US
60/732589
02/11/2005
PCT/IB/2006/003063
WO/2007/052125
0/91090110
0/90190112
B25B
‫מכלול הידוק ושיטה יעילה במיוחד להידוק‬
‫רכיב בעל פרופיל חלול במלחצת‬
)CLAMP(
190829
BALLOON CATHETER
ANGIOSLIDE LTD
US
60/726160
112300612
US
PCT/IB/2006/002955
WO/2007/042935
‫דקורה נהריה בע"מ‬
A61M
‫צנתר בלון‬
‫אנג'יוסלייד בע"מ‬
14/10/2005
2323822338
0290190112
190830
STABLE PHARMACEUTICAL
FORMULAIONS CONTAINING
ESCITALOPRAM AND BUPROPION
H. LUNDBECK A/S
US
60/727055
14/10/2005
PCT/US/2006/060010
WO/2007/048080
December 29, 2008
‫הרכב ריקחי למניעת התמכרות לניקוטין‬
‫ולטיפול בהתמכרות לניקוטין ביונק‬
190828
CLAMPED ASSEMBLY AND METHOD
PARTICULARLY USEFUL FOR
CLAMPING A HOLLOW PROFILE
MEMBER TO A MOUNTING MEMBER
DEKORA NAHARIA LTD
A61K
– ‫ב' בטבת התשס"ט‬
C07D
‫תכשירים רוקחיים יציבים המכילים‬
‫אציטלופראם ובופרופיון‬
2930
0290190112
190831
METHODS OF TREATING CENTRAL
NERVOUS SYSTEM DISORDERS
WITH A LOW DOSE COMBINATION
OF ESCITALOPRAM AND
BUPROPION
H. LUNDBECK A/S
US
60/727276
14/10/2005
832613662
3223822338
US
832633368
3823822338
US
PCT/US/2006/060006
WO/2007/053796
0091090110
C07D
‫שיטות לטיפול בהפרעות במערכת‬
‫העצבים התיכונה עם מינון נמוך של‬
‫תערובת של אציטלופראם ובופרופיון‬
190833
G02B
‫מחזיר חד–מוקדי‬
‫אורי נטע‬
CONFOCAL REFLECTOR
URI NETA
0091090110
190834
A61F
‫שיפורים לתחבושות‬
‫פרסיס מדיקל בע"מ‬
IMPROVEMENTS TO BANDAGES
PERSYS MEDICAL LTD.
0091090110
190839
METHOD AND SYSTEM FOR
MONETARY BILLING FOR THE USE
OF CONTENT SERVICES IN
INTERNET SITES, BY SENDING SMS
MESSAGES FROM CELLULAR
PHONES
ARI ELIAZ
US
60/911902
15/04/2007
2931
G07F
‫שיטה ומערכת לחיוב כספי על שימוש‬
‫בשירותי תוכן באתרי אינטרנט על ידי‬
‫שליחת מסרונים מטלפונים סלולריים‬
‫אורי אליעז‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
0091090110
190856
A DEVICE FOR LOCKING AND
UNLOCKING THE FOLDED AND
UNFOLDED POSITIONS OF AN INFANT
PUSHCHAIR
JANE, S.A.
ES
ES200701159U 31/05/2007
0091090110
0091090110
190864
0091090110
190881
COMPACT IMAGING LENS IN A
SUBSTRATE
LUMUS LTD
0091090110
G02B
A47J
‫מכשיר ושיטה ליצוב כלי‬
‫יפתח סגל‬
190890
– ‫ב' בטבת התשס"ט‬
G01B
‫לומוס בע"מ‬
INSTRUMENT AND METHOD FOR
STABILIZING A TOOL
IFTACH SEGAL
TECHNIQUE FOR DETECTION OF
OPTICAL DATA SIGNALS
ECI TELECOM LTD.
‫התקן מעצור לעגלת תינוק‬
‫רכיב אופטי קומפקטי במצע מוליך‬
190889
0091090110
B62C
‫פונקציה מרובת מפתחות‬
POLY-KEYED FUNCTIONS
NDS LIMITED
December 29, 2008
‫מתקן עבור נעילת ופתיחת עגלת‬
‫תינוקות במצבי קיפול ופתיחה‬
190857
A BRAKE DEVICE FOR PRAMS
JANE, S.A.
ES
ES200701130U 29/05/2007
B62B
H04B
‫שיטה לגילוי אותות אופטיים של נתונים‬
‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
2932
0291090110
190910
‫מנגנון עזר להרמה‬
LIFT ASSISTING MECHANISM
AMINACH BEDDING & FURNITURE
MANUFACTURING LTD.
‫עמינח תעשית רהיטים ומזרונים בע"מ‬
0/90190112
190919
SOLAR POWER SYSTEM WITH A
NUMBER OF PHOTOVOLTAIC
MODULES
SYSTAIC AG
DE
102005050883.9 21/10/2005
13233333366350
2121322333
DE
PCT/EP/2006/067681
WO/2007/045695
0191090110
190925
COMPACT CORRUGATED
CARDBOARD CONTAINERS WITH
HANDLE
2933
A47D
‫דלת מודולרית‬
‫דור אל דלתות מקבוצת דלויה בע"מ‬
190928
MEANS AND METHOD FOR
ADMINISTERING MEDICAMENTS TO
INFANTS
SHAHAF DANIEL
0191090110
H01L
‫מערכת כוח סולארי עם מספר יחידות‬
‫פוטו–ואלטאיות‬
MODULAR DOOR
DOOR-AL DLATOT MIKVUSAT
DELOUYA LTD.
0191090110
A47C
A61J
‫אמצעים ושיטה למתן תרופה לילדים‬
‫דניאל שחף‬
190929
B65D
‫מיכלים קומפקטים מקרטון גלי בעלי ידית‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
THE CENTRAL BOTTLING COMPANY
LTD
1290090112
‫קרגל בע"מ‬
190937
USE OF PYRACLOSTROBIN AS
SAFENER FOR TRITICONAZOLE FOR
CONTROLLING HARMFUL FUNGI
BASF SE
US
60/735195
10/11/2005
PCT/EP/2006/068103
WO/2007/054471
/090190112
‫שימוש בפיראכלוסטרובין כמגן‬
‫לטריטיקונאזול לבקרה על פטריות מזיקות‬
190938
STRONTIUM TITANIUM OXIDES AND
ABRADABLE COATINGS MADE
THEREFROM
H.C. STARCK INC.
US
11/264868
02/11/2005
PCT/US/2006/042400
WO/2007/120194
0191090110
190941
FRONT SIDE ETCHING PROCESS FOR
MICRONEEDLES
NANOPASS TECHNOLOGIES LTD.
0191090110
190942
ENDODONTIC POST AND METHOD
OF USE THEREOF
ZEV MIKLER
December 29, 2008
– ‫ב' בטבת התשס"ט‬
A01N
C09D
‫אוקסידים של סטרונטיום טיטאניום‬
‫וציפויים הניתנים לגירוד שמכינים מהם‬
B81C
‫תהליך עיכול קדמי למיקרו–מחטים‬
A61C
‫יתד אנדודונטי ושיטת שימוש בו‬
‫זאב מיקלר‬
2934
0090190112
190946
CONDITIONALLY IMMORTALIZED
LONG-TERM STEM CELLS AND
METHODS OF MAKING AND USING
SUCH CELLS
REGENTS OF THE UNIVERSITY OF
COLORADO
US
60/728131
18/10/2005
832083332
3823222338
US
PCT/US/2006/040379
WO/2007/047583
/190190112
2935
C07D
‫פירולונים מותמרים המשמשים‬
‫כמודולטורים אלוסטרים של גלוקוקינאז‬
190963
NOVEL PROCESSES FOR THE
PREPARATION OF PIPERAZINLY
AND DIAZAPANYL BENZAMIDE
DERIVATIVES
JANSSEN PHARMACEUTICA N.V.
US
60/731941
31/10/2005
PCT/US/2006/041859
WO/2007/053427
/090190112
‫תאי גזע בעלי זמן חיים ארוך על תנאי‬
‫ושיטות להכנתם ושימוש בהם‬
190962
SUBSTITUTED PYRROLONES AS
ALLOSTERIC MODULATORS OF
GLUCOKINASE
JANSSEN PHARMACEUTICA N.V.
US
60/732369
01/11/2005
PCT/US/2006/042588
WO/2007/053657
0290190112
A01N
C07D
‫תהליכים חדשים להכנת נגזרות של‬
‫פיפרזיניל ודיאזפניל בנזמיד‬
190964
G01N
December 29, 2008
– ‫ב' בטבת התשס"ט‬
METHODS AND COMPOSITIONS FOR
DIAGNOSING ANKYLOSING
SPONDYLITIS USING BIOMARKERS
‫שיטות ותכשירים לאבחון דלקת חוליות‬
,‫עמוד השדרה הנגרמת כתוצאה מקשחת‬
‫ע"י שימוש בסמנים ביולוגיים‬
ABBOTT BIOTECHNOLOGY LTD.
US
60/732444
01/11/2005
PCT/US/2006/042564
WO/2007/089303
0290190112
190965
PROCESSES FOR THE PREPARATION
OF CYCLOPROPYL-AMIDE
DERIVATIVES
JANSSEN PHARMACEUTICA N.V.
US
60/731725
31/10/2005
PCT/US/2006/041590
WO/2007/053386
/190190112
–‫תהליכים להכנת נגזרות של ציקלופרופיל‬
‫אמיד‬
190966
SUBSTITUTED
DIHYDROISOINDOLONES AS
ALLOSTERIC MODULATORS OF
GLUCOKINASE
JANSSEN PHARMACEUTICA N.V.
US
60/732370
01/11/2005
PCT/US/2006/042188
WO/2007/053503
/190190112
December 29, 2008
190967
– ‫ב' בטבת התשס"ט‬
C07D
C07D
‫דיהידרואיזואינדולונים מותמרים‬
‫המשמשים כמודולטורים אלוסטרים של‬
‫גלוקוקינאז‬
C07D
2936
DIHYDROISOINDOLONES AS
ALLOSTERIC MODULATORS OF
GLUCOKINASE
JANSSEN PHARMACEUTICA N.V.
US
60/732412
01/11/2005
832002230
1323222338
US
112333322
2321322338
US
PCT/US/2006/042602
WO/2007/053662
0/90190112
‫דיהידרואיזואינדולונים המשמשים‬
‫כמודולטורים אלוסטרים של גלוקוקינאז‬
190969
PYRAZOLES USEFUL IN THE
TREATMENT OF INFLAMMATION
BIOLIPOX AB
US
60/728300
20/10/2005
PCT/GB/2006/003876
WO/2007/045868
0090190112
UPDATING MULTIPLE LEVELS OF
TRANSLATION LOOKASIDE
BUFFERS (TLBS) FIELD
2937
‫פיראזולים היעילים בטיפול בדלקת‬
190971
METHOD AND COMPOUNDS FOR
PREPARING CC-1065 ANALOGS
MEDAREX, INC.
US
60/730804
26/10/2005
PCT/US/2006/060050
WO/2007/051081
0190190112
C07D
C07D
‫ אנלוגי‬CC–0/9. ‫שיטה ותרכובות להכנת‬
190972
G06F
‫עדכון רב שלבי של שדות מחיצות תרגום‬
)TLBS( ‫צידיות‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
QUALCOMM INCORPORATED
US
11/254898
20/10/2005
PCT/US/2006/060134
WO/2007/048134
0190190112
190973
TUNE-AWAY PROTOCOLS FOR
WIRELESS SYSTEMS
QUALCOMM INCORPORATED
US
11/261803
27/10/2005
PCT/US/2006/060330
WO/2007/051184
0190190112
‫פרוטוקל כוון נמשך למערכות אלחוטיות‬
190974
RESOURCE ALLOCATION DURING
TUNE-AWAY
QUALCOMM INCORPORATED
US
11/260925
27/10/2005
PCT/US/2006/042057
WO/2007/050923
0190190112
0190190112
December 29, 2008
– ‫ב' בטבת התשס"ט‬
H04Q
‫מגוון ערוצי איתות לחיבור אחורי במערכת‬
‫תקשורת אלחוטית‬
190977
CACHING MEMORY ATTRIBUTE
INDICATORS WITH CACHED
MEMORY DATA
H04Q
‫מקור הקצבה במהלך כוון נמשך‬
190975
VARIED SIGNALING CHANNELS FOR
A REVERSE LINK IN A WIRELESS
COMMUNICATION SYSTEM
QUALCOMM INCORPORATED
US
11/261806
27/10/2005
PCT/US/2006/060333
WO/2007/051187
H04Q
G06F
‫אינדיקטורים מאפייני זיכרון מוטען עם‬
‫מידע זיכרון מוטמן‬
2938
QUALCOMM INCORPORATED
US
11/254873
20/10/2005
PCT/US/2006/060135
WO/2007/048135
0190190112
190978
METHOD AND APPARATUS FOR
SAVING POWER IN A RADIO
COMMUNICATION SYSTEM
QUALCOMM INCORPORATED
US
11/260928
27/10/2005
PCT/US/2006/060334
WO/2007/051188
0190190112
‫מחיצת תמיכת אחסון למנוע שמירת‬
‫הרישום של תיקיית רישום נערם‬
C09K
‫חומר פוטולומיניסנטי‬
190984
LONG AFTER-GLOW
PHOTOLUMINESCENT MATERIAL
VISIONGLOW IP PTY LTD
AU
2005905975 28/10/2005
PCT/AU/2006/001608
2939
G06F
190982
PHOTOLUMINESCENT MATERIAL
VISIONGLOW IP PTY LTD
AU
2005905974 28/10/2005
PCT/AU/2006/001609
WO/2007/048201
0190190112
‫שיטה ומערכת לשמירת כוח במערכות‬
‫תקשורת רדיו‬
190979
BACKING STORE BUFFER FOR THE
REGISTER SAVE ENGINE OF A
STACKED REGISTER FILE
QUALCOMM INCORPORATED
US
11/254320
20/10/2005
PCT/US/2006/060128
WO/2007/048128
0190190112
H04Q
C09K
‫חומר פוטולומיניסנטי ממושך זהירה‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
WO/2007/048200
0090090112
190985
PROGENITOR ENDOTHELIAL CELL
CAPTURING WITH A DRUG ELUTING
IMPLANTABLE MEDICAL DEVICE
ORBUSNEICH MEDICAL, INC.
US
60/736920
15/11/2005
832622301
1323622338
US
832622331
1323622338
US
832622383
1323622338
US
PCT/US/2006/044423
WO/2007/059253
0191090110
190987
FOLDABLE EYEGLASES WITH
LOCKING MEANS
DAVID TAIEB
0190090112
NOVEL HIGHLY FUNCTIONAL
ENZYME HAVING MODIFIED
SUBSTRATE-SPECIFICITY
TOKYO METROPOLITAN
ORGANIZATION FOR MEDICAL
RESEARCH
2005JP
18/11/2005
333660
PCT/JP/2006/323509
WO/2007/058381
December 29, 2008
190989
– ‫ב' בטבת התשס"ט‬
‫לכידת תאי אנדותל קדמונים עם תרופה‬
‫המשוחררת ממכשיר רפואי מושתל‬
A45C
‫משקפיים מתקפלים עם אמצעי נעילה‬
190988
0290190112
A61F
C12N
‫אנזים חדש פונקציונלי ביותר בעל‬
‫ספציפיות–סובסטרט מותאמת‬
C07D
2940
THIAZOLO [4,5-C]PYRIDINE
DERIVATIVES
F. HOFFMANN-LA ROCHE AG
EP
05110461.0 08/11/2005
PCT/EP/2006/067794
WO/2007/054436
0091090112
190990
METHOD FOR MAKING THREEDIMENSIONAL FIBROUS ANNULAR
STRUCTURES
MESSIER-BUGATTI
FR
0510811
24/10/2005
PCT/FR/2006/050812
WO/2007/048946
0190190112
VEHICLE SLIDING WINDOW
CANEL OTOMOTIV SANAYI VE
TICARET ANONIM SIRKETI
2941
D04H
‫שיטה להכנת מבנים טבעתיים סיביים‬
‫תלת מימדיים‬
190991
AGENTS FOR TREATING
CARDIOPATHY
CHUGAI SEIYAKU KABUSHIKI
KAISHA
2005JP
21/10/2005
307349
PCT/JP/2006/320905
WO/2007/046489
0190190112
‫]פירידין‬C–4,5[‫תולדות תיאזולו‬
A61K
‫גורמים לטיפול במחלת שריר הלב‬
190992
B60J
‫חלון נפתח של מכונית‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
TR
2005/04194
PCT/TR/2006/000049
WO/2007/046779
19/10/2005
0/90190112
190993
CEILING-ONLY DRY SPRINKLER
SYSTEMS AND METHODS FOR
ADDRESSING A STORAGE
OCCUPANCY FIRE
TYCO FIRE PRODUCTS LP
US
60/728734
21/10/2005
832033833
2123222338
US
832616212
3323022338
US
PCT/US/2006/060170
WO/2007/048144
0090190112
0090190112
– ‫ב' בטבת התשס"ט‬
C12Q
‫שיטות וערכה לאבחון חומר גנטי של עובר‬
190996
STERILISED NUTRITIONAL
BEVERAGE
UNILEVER PLC
EP
05077588.1 14/11/2005
3330036353
1321122333
EP
December 29, 2008
‫מערכות תקרתיות להתזה יבשה ושיטות‬
‫להתייחסות לאחסון אמצעי כיבוי שריפה‬
190994
METHODS AND KITS FOR
ANALYZING GENETIC MATERIAL OF
A FETUS
MONALIZA MEDICAL LTD.
US
60/728799
21/10/2005
PCT/IL/2006/001212
WO/2007/046108
A62C
‫מונהליזה מדיקל בע"מ‬
A23L
‫משקה תזונתי מעוקר‬
2942
3830338353
EP
PCT/EP/2006/010321
WO/2007/054207
3123222338
0/90190112
190997
NEW HIGHLY STABLE AQUEOUS
SOLUTION, ELECTRODE WITH
NANOCOATING FOR PREPARING THE
SOLUTION AND METHOD FOR MAKING
THIS ELECTRODE
AKUATECH S.R.L
IT
PN2005A000079 28/10/2005
IT
MI2006A001252 2623822338
PCT/EP/2006/067676
WO/2007/048772
0091/90112
METHODS AND DEVICES FOR
TERMINATION
GUIDED DELIVERY SYSTEMS, INC.
2943
‫תמיסה מימית חדשה היציבה במידה‬
‫ אלקטרודה עם ציפוי ננו חלקיקי‬,‫רבה‬
‫להכנת התמיסה ושיטה להכנת‬
‫האלקטרודה‬
190998
METHOD AND APPARATUS FOR
RETRANSMISSION MANAGEMENT
FOR RELIABLE HYBRID ARQ
PROCESS
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/729286
21/10/2005
832623333
1223322338
US
PCT/US/2006/038269
WO/2007/050231
1090090112
C02F
H04L
‫שיטה והתקן לפיקוח על העברה מחדש‬
‫ מוכלא ואמין‬ARQ ‫עבור תהליך‬
190999
A61B
‫שיטות והתקנים לסיום‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
US
11/270034
PCT/US/2006/043597
WO/2007/056502
08/11/2005
0191090110
191029
LINEAR TRAVEL, SELF ALIGNING,
ROTATING, RETENTION CLAMP
HARRIS CORPORATION
US
11/799056
30/04/2007
0191090110
191036
FLOOR CLOTH WHICH DOES NOT
SLIDES AND DOES NOT FALLS OFF
THE FLOOR WIPER
ITAMAR MAROM
0191090110
‫עפרי מדיוני‬
191038
B67B
‫מכלול למכסה של מיכל ושיטת הרכבה‬
‫עבורו‬
‫יוסף בן ברק‬
191041
CUTTING TOOL INSERT INCLUDING
BORON NITRIDE
– ‫ב' בטבת התשס"ט‬
B65H
‫מערכת למעיכת מיכלים‬
A TANK LID ASSEMBLY AND
MOUNTING ,METHOD THEREFOR
JOSEF BEN BARAK
December 29, 2008
A47L
‫איתמר מרום‬
CANISTER COMPRESSION
APPARATUS
OFRI MEDIONI
0191090110
‫ תנועה‬,‫מלחציים בעלי יכולת סיבובית‬
‫לינארית והיערכות עצמית‬
‫סחבת רצפה שלא מחליקה ולא נופלת‬
‫ממגב לשטיפת רצפה‬
191037
0191090110
B23B
C04B
‫תותבת עבור מכשיר חיתוך המכיל בור‬
‫ניטריד‬
2944
SANDVIK INTELLECTUAL
PROPERTY AB
SE
0701028-3
27/04/2007
1/90090112
191043
AMINOPYRIMIDINE DERIVATIVES
AND PHARMACEUTICAL
COMPOSITIONS CONTAINING THE
SAME
VERTEX PHARMACEUTICALS
INCORPORATED
US
60/732951
03/11/2005
832022330
3321122333
US
PCT/US/2006/042994
WO/2007/056164
1/90090112
C07D
‫תולדות אמינופירימידין ותכשירי רוקחות‬
‫המכילים אותן‬
191045
SPINAL MOTION PRESERVATION
ASSEMBLIES
TRANS1 INC.
US
11/256810
24/10/2005
112233813
2321322333
US
2945
‫תולדות אמינופירימידין ותכשירי רוקחות‬
‫המכילים אותן‬
191044
AMINOPYRIMIDINE DERIVATIVES
AND PHARMACEUTICAL
COMPOSITIONS CONTAINING THE
SAME
VERTEX PHARMACEUTICALS
INCORPORATED
US
60/732951
03/11/2005
832022330
3321122333
US
PCT/US/2006/042993
WO/2007/056163
0090190112
A01N
A61B
‫מבנים לשימור תנועת חוט השדרה‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
PCT/US/2006/041535
WO/2007/050640
0090190112
191046
METHODS AND TOOLS FOR
DELIVERY OF SPINAL MOTION
PRESERVATION ASSEMBLIES
TRANS1 INC.
US
11/256810
24/10/2005
112233813
2321322333
US
PCT/US/2006/041522
WO/2007/050629
/190190112
191047
ADAPTIVE CODING AND
MODULATION FOR BROADBAND
DATA TRANSMISSION
VIASAT, INC.
US
60/731122
28/10/2005
PCT/US/2006/043258
WO/2007/051079
0191090110
191048
EDGE DETECTION IN ULTRASOUND
IMAGES
BIOSENSE WEBSTER, INC.
US
60/915152
01/05/2007
122326213
3623222336
US
December 29, 2008
– ‫ב' בטבת התשס"ט‬
A61B
‫שיטות וכלי עבודה להעברת מבנים‬
‫לשימור תנועה של חוט השדרה‬
H04L
‫מודולציה וקידוד הניתנים להתאמה‬
‫להעברת מידע בפס רחב‬
A61B
‫איתור קצוות בדימות אולטראסאונד‬
2946
0190190112
191049
C07D
: ‫נגזרות של טרופאן מונומותמר בעמדה‬
‫המשמשות כליגנדים לרצפטור של‬
‫נוסיספטין‬
3-MONOSUBSTITUTED TROPANE
DERIVATIVES AS NOCICEPTIN
RECEPTOR LIGANDS
SCHERING CORPORATION
US
60/731703
31/10/2005
PCT/US/2006/041925
WO/2007/053435
0191090110
191050
COHERENT SIGNAL REJECTION IN
ECG
BIOSENSE WEBSTER, INC.
US
11/743195
02/05/2007
/090190112
‫דחיית אות קוהרנטית באלקטרוקרדיוגרם‬
)ECG(
191051
METHOD FOR MANUFACTURE OF
SANITISED ORGANIC SLUDGE
AGRONOVA AS
NO
20055066
31/10/2005
PCT/NO/2006/000387
WO/2007/053033
0190190112
C05F
‫שיטה לייצור בוצה אורגנית מחוטאת‬
191052
PROCESS FOR THE PREPARATION
OF TAMSULOSIN AND RELATED
COMPOUNDS
MEDICHEM, S.A.
US
60/730865
28/10/2005
PCT/IB/2006/004231
WO/2007/119110
2947
A61B
C07C
‫תהליך להכנת טמסולוסין ותרכובות‬
‫קשורות‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
0190190112
191053
DEVICES AND METHODS FOR SAMPLE
COLLECTION AND ANALYSIS
INVERNESS MEDICAL SWITZERLAND
GMBH
CN
200520131943.4 25/10/2005
112233023
2821322333
US
PCT/GB/2006/003909
WO/2007/049009
0090090112
1/90090112
– ‫ב' בטבת התשס"ט‬
C07D
–H1(–.[–)‫–יל‬4–‫]נון‬:.:.0[‫–אזא–ביציקלו‬0(
‫–יל)–הטרואריל]אמינים כליגנדים‬.–‫אינדול‬
‫ לטיפול‬ACHR–N –‫כולינרגיים של ה‬
‫בהפרעות פסיכוטיות ונוירודגנרטיביות‬
191055
HERBICIDAL COMPOSITION
COMPRISING AMINOPHOSPHATE OR
AMINOPHOSPHONATE POTASSIUM
SALT
December 29, 2008
‫התקנים ושיטות לאיסוף וניתוח דגימה‬
191054
(1-AZA-BICYCLO[3.3.1]NON-4-YL)-[5(1H-INDOL-5-YL)HETEROARYL]AMINES AS
CHOLINERGIC LIGANDS OF THE NACHR FOR THE TREATMENT OF
PSYCHOTIC AND
NEURODEGENERATIVE DISORDERS
NOVARTIS AG
GB
0525673.0
16/12/2005
PCT/EP/2006/012022
WO/2007/068475
G01N
A01N
‫תרכובת קוטלת צמחים המכילה מלח‬
‫אשלגן אמינופוספאט או אמינופוספונאט‬
2948
RHODIA OPERATIONS
US
60/736061
PCT/EP/2006/068297
WO/2007/054540
0/90090112
10/11/2005
191056
PROCESS FOR PREPARING BETA(FLUOROPHENYL)-PROPANOATE
ESTER DERIVATIVES
ASTRAZENECA AB
SE
0502515-0
16/11/2005
PCT/GB/2006/004205
WO/2007/057643
0/90090112
C07D
‫–אמינו–הטרוציקלים חדשים השימושיים‬0
ABETA–‫בטיפול בפתולוגיות הקשורות ל‬
191059
PYRAZINE DERIVATIVES AS
SODIUM CHANNEL MODULATORS
FOR THE TREATMENT OF PAIN
PFIZER LIMITED
US
60/733662
04/11/2005
PCT/IB/2006/003055
WO/2007/052123
2949
–‫תהליך להכנת תולדות בטא‬
‫(פלואורופניל)–פרופאנואט אסטר‬
191057
NOVEL 2-AMINO-HETEROCYCLES
USEFUL IN THE TREATMENT OF
ABETA-RELATED PATHOLOGIES
ASTRAZENECA AB
US
60/737327
15/11/2005
PCT/SE/2006/001283
WO/2007/058583
0/90190112
C07C
C07D
‫תולדות פיראזין כמאפננים של תעלות‬
‫נתרן לטיפול בכאב‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
0190190112
191061
TRIAZOLE COMPOUNDS AS
LIPOXYGENASE INHIBITORS
BIOLIPOX AB
US
60/731481
31/10/2005
PCT/GB/2006/004010
WO/2007/051982
1090090112
‫תרכובות טריאזול כמעכבי ליפואוקסיגנאז‬
191063
DEVICE TO COVER AND
TRANSPORT A PORTABLE
COMPUTER
FASHIONTECH
FR
0511194
03/11/2005
3838663
2023022338
FR
PCT/EP/2006/068038
WO/2007/051822
0190190112
0190190112
December 29, 2008
– ‫ב' בטבת התשס"ט‬
C12Q
‫זיהוי בזמן אמת בגוף החי של חומצת גרעין‬
‫תוך שימוש בהשלמת חלבון‬
191065
ACTIVATED SPLIT-POLYPEPTIDES
AND METHODS FOR THEIR
PRODUCTION AND USE
THE TRUSTEES OF BOSTON
UNIVERSITY
US
60/730752
27/10/2005
PCT/US/2006/042299
WO/2007/051002
A45C
‫מכשיר לכיסוי ומשלוח של מחשב נייד‬
191064
REAL TIME NUCLEIC ACID
DETECTION IN VIVO USING
PROTEIN COMPLEMENTATION
THE TRUSTEES OF BOSTON
UNIVERSITY
US
60/730746
27/10/2005
PCT/US/2006/042210
WO/2007/050979
C07D
C12Q
‫פוליפפטידים מפוצלים משופעלים ושיטות‬
‫לייצורם ושימושם‬
2950
0190190112
191066
C02F
METHOD AND APPARATUS FOR
WATER TREATMENT TO ELIMINATE
AQUATIC ORGANISMS
RESOURCE BALLAST
TECHNOLOGIES (PROPRIETARY)
LIMITED
ZA
2005/10473 28/10/2005
PCT/IB/2006/003022
WO/2007/049139
0290190112
‫שיטה והתקן לטיפול במים למניעת‬
‫אורגניזם מימיים‬
191067
MICRONISED AZODICARBONAMIDE,
THE PREPARATION AND USE
THEREOF
H-PHAR
EP
05110022.0 26/10/2005
PCT/EP/2006/067805
WO/2007/048820
1/91090112
‫מזעור אזודיקרבונמיד הכנתו והשימוש בו‬
191068
APPARATUS FOR TREATING
NEUROLOGICAL DISORDERS BY
MEANS OF CHRONIC ADAPTIVE BRAIN
STIMULATION AS A FUNCTION OF
LOCAL BIOPOTENTIALS
UNIVERSITA DEGLI STUDI DI MILANO
IT
MI2005A002061 28/10/2005
PCT/IB/2006/002184
WO/2007/049105
2951
A61K
A61N
‫מתקן לטיפול בבעיות נוירולוגיות על ידי‬
‫גירוי מוח כרוני הסתגלותי כפונקציה‬
‫של ביופוטנציאליים מקומיים‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
0090190112
191069
AMINOACID DERIVATIVES
CONTAINING A DISULFANYL
GROUP IN THE FORM OF MIXED
DISULFANYL AND
AMINOPEPTIDASE N INHIBITORS
PHARMALEADS
FR
05/10862
25/10/2005
38233323
3323322338
FR
PCT/EP/2006/067711
WO/2007/048787
0/90190112
‫תולדות של חומצה אמינית המכילות‬
‫קבוצת דיסולפניל בצורת מעכבי מעורבים‬
N ‫של דיסולפניל ואמינופפטידאז‬
191070
DESKTOR ORGANIZER
SCHULMAN, CARL H.
US
60/730214
112333002
US
PCT/US/2006/060166
WO/2007/100383
B42F
‫קופסה לארגון לשולחן עבודה‬
25/10/2005
1621322338
0190190112
191071
DEVICE FOR DETECTING ANALYTES IN
FLUID SAMPLES
INVERNESS MEDICAL SWITZERLAND
GMBH
CN
200510113977.5 25/10/2005
112283338
2821322333
US
PCT/GB/2006/003910
WO/2007/049010
December 29, 2008
C07D
– ‫ב' בטבת התשס"ט‬
G01N
‫התקן לגילוי חומרים נבדקים בדגימות‬
‫נוזלים‬
2952
0090190112
191072
THERAPEUTIC COMPOSITIONS AND
METHODS
THE REGENTS OF THE UNIVERSITY
OF MICHIGAN
US
60/730711
26/10/2005
PCT/US/2006/041446
WO/2007/050587
1/90190112
‫תכשירים רפואיים ושיטות‬
191073
REDUNDANT ULTRAFILTRATION
DEVICES
NEPHROS, INC.
US
60/734006
03/11/2005
112333823
1323822338
US
PCT/US/2006/038984
WO/2007/055842
0290190112
‫מכשירי סינון – על חליפיים‬
A61K
‫שיטה להכנת ליפוזומים והשימושים בהם‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים‬
191075
PROCESS AND SYSTEM FOR
GASIFICATION WITH IN-SITU TAR
REMOVAL
TAYLOR BIOMASS ENERGY, LLC
US
60/728989
21/10/2005
PCT/US/2006/041435
WO/2007/048058
2953
C02F
191074
A METHOD FOR PREPARING
LIPOSOMES AND USES THEREOF
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM
US
60/730045
26/10/2005
PCT/IL/2006/001229
WO/2007/049278
0/90190112
A01N
C01B
‫תהליך ומערכת להפיכה לגז בעזרת‬
‫הרחקת עטרן הקיים באתר‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
0090090112
191076
A BLISTER PACK DEVICE AND A
METHOD OF EJECTING A UNIT
DOSAGE FROM A BLISTER PACK
USING THE DEVICE
ASTRAZENECA AB
SE
0502514-3
15/11/2005
PCT/SE/2006/001289
WO/2007/058586
0190190112
191079
SELF-PROPELLABLE ENDOSCOPIC
APPARATUS AND METHOD
SOFTSCOPE MEDICAL
TECHNOLOGIES, INC.
US
11/260342
27/10/2005
PCT/US/2006/040617
WO/2007/050370
0090190112
191082
METHOD AND SYSTEM FOR
COMPRESSION OF DATA FOR
BLOCK MODE ACCESS STORAGE
STOREWIZ INC.
US
11/258379
26/10/2005
112333261
1323322338
US
PCT/IB/2006/002827
WO/2007/049108
December 29, 2008
– ‫ב' בטבת התשס"ט‬
B65D
‫אביזר לאריזת בועות ושיטה להוצאת‬
‫יחידת מינון מאריזת בועות על ידי שימוש‬
‫באביזר‬
A61B
‫התקן אנדוסקופי הנדחף מעצמו ושיטה‬
‫הקשורה לכך‬
H03M
‫שיטה ומערכת לדחיסה של נתונים עבור‬
‫אחסון בלוק עם מוד גישה‬
2954
0090190112
191083
METHOD AND SYSTEM FOR
COMPRESSION OF LOGICAL DATA
OBJECTS FOR STORAGE
STOREWIZ INC.
US
11/258379
26/10/2005
112223061
3323122338
US
PCT/IB/2006/002836
WO/2007/049109
1290190112
H03M
‫שיטה ומערכת לדחיסה של אובייקטי מידע‬
‫לוגי עבור אחסון‬
191088
A61B
SYSTEM AND METHOD FOR
PREDICTION OF COGNITIVE
DECLIINE
NEW YORK UNIVERSITY
US
11/262906
31/10/2005
PCT/US/2006/039314
WO/2007/053263
0290190112
‫מערכת ושיטה לחיזוי ירידת כישורים‬
‫קוגניטיביים‬
191090
A METHOD FOR PRODUCTION OF A
COATED ENDOVASCULAR DEVICE
I.B.S. INTERNATIONAL BIOMEDICAL
SYSTEMS S.P.A.
IT
MO2005A000283 28/10/2005
PCT/EP/2006/067825
WO/2007/048825
2955
A61L
‫שיטה לייצור מתקן אנדווסקולרי‬
‫מצופה‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
0090190112
191091
IMPROVED LEAD-FREE INSULATION
COMPOSITIONS CONTAINING
METALLOCENE POLYMERS
GENERAL CABLE TECHNOLOGIES
CORPORATION
US
60/729735
25/10/2005
PCT/US/2006/041637
WO/2007/050688
0190190112
191092
SHARED SIGNALING CHANNEL
QUALCOMM INCORPORATED
US
11/261158
27/10/2005
PCT/US/2006/060292
WO/2007/051159
0190190112
191093
PILOT SIGNAL TRANSMISSION FOR
AN ORTHOGONAL FREQUENCY
DIVISION WIRELESS
COMMUNICATION SYSTEM
QUALCOMM INCORPORATED
US
11/261361
27/10/2005
PCT/US/2006/060336
WO/2007/051190
0090190112
191115
POLY(VINYL BUTYRAL)PELLETS
SOLUTIA INC.
US
11/264510
01/11/2005
PCT/US/2006/060143
WO/2007/076168
December 29, 2008
– ‫ב' בטבת התשס"ט‬
C08K
‫תרכובות מבודדות נטולות–עופרת‬
‫המכילות פולימרים‬
H04Q
‫ערוץ איתות משותף‬
H04L
‫שידור איתות ניסיוני עבור מערכת‬
‫תקשורת אלחוטית מחולקת תדר‬
‫אורתוגונאלי‬
C08K
)‫טבליות של פולי (ויניל בוטיראל‬
2956
0091090110
191116
A BRACE-LOCKING DEVICE FOR AN
AIRCRAFT UNDERCARRIAGE
MESSIER-DOWTY SA
FR
0703175
03/05/2007
1090090112
CD 4/ –‫שימושים של נוגדים אנטי‬
A61K
‫שיטה לטיפול בנזק למפרק‬
191119
2-(BENZIMIDAZOL-1-YL)ACETAMIDE BIARYL DERIVATIVES
AND THEIR USE AS INHIBITORS OF
THE TRPV1 RECEPTOR
N.V. ORGANON
EP
05110422.0 08/11/2005
PCT/EP/2006/068125
WO/2007/054480
2957
C07K
191118
METHOD FOR TREATING JOINT
DAMAGE
GENENTECH, INC.
US
60/737291
15/11/2005
832683382
3821122338
US
PCT/US/2006/044290
WO/2007/059188
1290090112
‫התקן נעילה עבור תושבת מטוס‬
191117
USES OF ANTI-CD40 ANTIBODIES
XOMA TECHNOLOGY LTD.
US
60/732580
01/11/2005
PCT/US/2006/042601
WO/2007/053661
0090090112
B64C
C07D
‫–איל)אצטאמיד‬0–‫–(בנזימידאזול‬0 ‫תולדות‬
‫ביאריל והשימוש בהן כמעכבי קולטן‬
TRPV0
December 29, 2008
– ‫ב' בטבת התשס"ט‬
0091090110
191120
SYSTEMS AND METHODS FOR
IMPROVED TRACKING FOR
TACTICAL IMAGING
HARRIS CORPORATION
US
11/745170
07/05/2007
0/90090112
191121
TAMPER EVIDENT CLOSURE
BAYER CONSUMER CARE AG.
EP
05292423.0 15/11/2005
PCT/EP/2006/010841
WO/2007/057133
1190090112
191122
ENHANCED CLASSIFICATION FOR
POWER OVER ETHERNET
MICROSEMI CORP - ANALOG MIXED
SIGNAL GROUP LTD
US
60/735253
10/11/2005
PCT/IL/2006/001282
WO/2007/054930
0091090110
191124
APPARATUS AND METHOD FOR
BIOLOGICAL TREATMENT OF
WASTEWATER
BIOTOPE PLUS LTD
0190090112
December 29, 2008
‫מערכות ושיטות לעיקוב משופר אחר‬
‫מטרה עבור הדמיה טקטית‬
B65D
‫פקק עם סוגר נראה‬
H04L
‫סיווג משופר לאספקת מתח על גבי‬
‫תשתית אטרנט‬
‫ אנאלוג מיקסד סינגל‬- ‫מיקרוסמי קורפ‬
‫גרופ בע"מ‬
B01B
‫מכשיר ושיטה לטיפול ביולוגי של מי‬
‫שופכין‬
‫ביוטופ פלוס בע"מ‬
191125
– ‫ב' בטבת התשס"ט‬
G01S
C07D
2958
PROCESS FOR PRODUCTION OF
CINNAMIDE DERIVATIVE
EISAI R&D MANAGEMENT CO., LTD.
2005JP
18/11/2005
334286
PCT/JP/2006/322982
WO/2007/058305
/190190112
‫תהליך ליצור תולדת סינאמיד‬
191127
‫חיפוש מצלמת מהירות גבוהה בשימוש‬
‫במפתח קידוד מאוכסן‬
HIGH SPEED CAM LOOKUP USING
STORED ENCODED KEY
QUALCOMM INCORPORATED
US
11/262063
28/10/2005
PCT/US/2006/060371
WO/2007/051205
/190190112
G11C
191128
G11C
‫מעגל ושיטה לתת–חלוקת בנק‬
‫ על ידי שליטה בקרקע‬CAMRAM
‫וירטואלית‬
CIRCUIT AND METHOD FOR
SUBDIVIDING A CAMRAM BANK BY
CONTROLLING A VIRTUAL GROUND
QUALCOMM INCORPORATED
US
11/262062
28/10/2005
PCT/US/2006/060370
WO/2007/051204
0/91090110
191130
REMINDER COSMETIC STICKER FOR
THE ORAL REGION
OLEG GELMAN
0290190112
2959
A61C
‫מדבקות קוסמטיות לתזכורת על אזור הפה‬
‫גלמן אולג‬
191132
A23B
December 29, 2008
– ‫ב' בטבת התשס"ט‬
ADSORPTION OF VOLATILE
ORGANIC COMPOUNDS DERIVED
FROM ORGANIC MATTER
JOHNSON MATTHEY PLC
GB
0522229.4
01/11/2005
PCT/GB/2006/050354
WO/2007/052074
0/90090112
‫ספיחה של תרכובות אורגניות נדיפות‬
‫הנגזרות מחומר אורגאני‬
191133
USE OF A COMPOSITION FOR
PRESERVING ORGANS AND MEMBERS
NOVALIQ GMBH
DE
102005055811.9 23/11/2005
PCT/EP/2006/011247
WO/2007/059968
0190090112
‫שימוש בתכשיר לשימור איברים‬
191134
EFFICIENT LOCATION AND
TRACKING OF MOBILE
SUBSCRIBERS
TOM TOM INTERNATIONAL B.V
GB
0523513.0
18/11/2005
PCT/GB/2006/004310
WO/2007/057694
0091090111
December 29, 2008
– ‫ב' בטבת התשס"ט‬
H04Q
‫איתור ומעקב יעילים אחר מנויים ניידים‬
191135
METHOD FOR STORING THE
POSITION OF A PARKED VEHICLE
AND NAVIGATION DEVICE
ARRANGED FOR THAT
TOM TOM INTERNATIONAL B.V
NL
1030943
18/01/2006
PCT/NL/2007/050012
WO/2007/083997
A01N
G01C
‫שיטה לאחסון עמדה של רכב חונה והתקן‬
‫ניווט המאורגן לכך‬
2960
0190090112
191136
A NAVIGATION DEVICE
DISPLAYING TRAFFIC
INFORMATION
TOM TOM INTERNATIONAL B.V
GB
0523512.2
18/11/2005
PCT/GB/2006/004314
WO/2007/057696
/090190112
A61K
‫ תכשירים‬,‫קומפלקסים רבי קטיון–רבי אניון‬
‫ושיטות לשימוש בהם‬
191138
PYRAZOLOISOQUINOLINE
DERIVATIVES
PALAU PHARMA S.A.
EP
05381056.0 25/11/2005
PCT/EP/2006/068815
WO/2007/060198
2961
‫התקן ניווט המציג מידע על תנועה‬
191137
POLYCATION-POLYANION
COMPLEXES, COMPOSITIONS AND
METHODS OF USE THEREOF
AERIS THERAPEUTICS, INC.
US
60/732987
02/11/2005
PCT/US/2006/042338
WO/2007/055950
0/90090112
G01C
C07D
‫תולדות פיראזולואיזו קווינוליניות‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
0190090112
191139
NOVEL PYRIDOPYRAZINES AND
THEIR USE AS MODULATORS OF
KINASES
AETERNA ZENTARIS GMBH
US
60/735698
11/11/2005
3332383252
1121122333
EP
832633081
3821322338
US
PCT/EP/2006/068322
WO/2007/054556
1/90090112
‫פירידופיראזינים חדשים ושימושם כמאפנני‬
‫קינאזות‬
191140
AMINOPYRIMIDINE DERIVATIVES
AND PHARMACEUTICAL
COMPOSITIONS CONTAINING THE
SAME
VERTEX PHARMACEUTICALS
INCORPORATED
US
60/732951
03/11/2005
832022330
3321122333
US
PCT/US/2006/043096
WO/2007/056221
1090090112
191141
HETEROCYCLIC COMPOUNDS AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
VERTEX PHARMACEUTICALS
INCORPORATED
US
60/734506
08/11/2005
832033368
2021222333
US
832632336
2223322338
US
December 29, 2008
– ‫ב' בטבת התשס"ט‬
C07D
C07D
‫תולדות אמינופירימידין ותכשירי רוקחות‬
‫המכילים אותן‬
C07D
‫תרכובות הטרוציקליות ותכשירי רוקחות‬
‫המכילים אותן‬
2962
PCT/US/2006/043289
WO/2007/056341
0290090112
191142
AN ISOLATED NUCLEIC ACID
WHICH ENCODES A LIGAND
BINDING FLUORESCENT
INDICATOR, MULTIMERIC
BIOSENSORS AND METHODS OF
USING THE SAME
CARNEGIE INSTITUTION OF
WASHINGTON
US
60/736878
16/11/2005
PCT/US/2006/044633
WO/2007/059297
1190090112
‫חומצת גרעין מבודדת המקודדת אינדקטור‬
‫ חיישן מן‬,‫פלואורסצנציה של קישור ליגנדי‬
‫החי מולטימרי ושיטות להשתמש בו‬
191143
A POLYMERIC FIRE-RETARDANT
COATING COMPOSITION AND
METHODS FOR APPLYING THE
SAME
LAXMI, C. GUPTA
US
60/734960
08/11/2005
832632021
1123322338
US
PCT/US/2006/043369
WO/2007/056382
0/91090110
2963
C09D
‫תכשיר ציפוי פולימרי המעכב שריפה‬
‫ושיטות להנחתו‬
191144
AN ENHANCED PIANO ACTION,
PARTICULARLY FOR UPRIGHT
PIANO
GIDEON SHAMIR
0/91090110
C12Q
G10C
‫ במיוחד עבור‬.‫מנגנון משופר לפסנתר‬
‫פסנתר ניצב‬
‫גדעון שמיר‬
191145
B65H
December 29, 2008
– ‫ב' בטבת התשס"ט‬
‫תיק–מגבת‬
‫רבקה שיין דייויס‬
BAG-TOWEL
YITZHAK SHAHAR
1290090112
191146
DISEASE RESISTENT CUCUMBER
PLANTS
DE RUITER SEEDS R & D B.V.
EP
05077528.7 04/11/2005
PCT/NL/2006/000553
WO/2007/053015
1/90090112
191147
PEPTIDE-DICER SUBSTRATE RNA
CONJUGATES AS DELIVERY
VEHICLES FOR SIRNA
MDRNA, INC.
US
60/733665
04/11/2005
832622638
1623622338
US
PCT/US/2006/042978
WO/2007/056153
/090190112
191148
OPTICAL DEVICES AND METHODS
FOR SELECTIVE AND
CONVENTIONAL
PHOTOCOAGULATION OF THE
RETINAL PIGMENT EPITHELIUM
THE GENERAL HOSPITAL
CORPORATION
US
11/263677
31/10/2005
PCT/US/2006/042696
WO/2007/053701
December 29, 2008
– ‫ב' בטבת התשס"ט‬
C12Q
‫צמחי מלפפון עם עמידות למחלות‬
A61K
‫ כנשאי‬RNA–‫קוניוגטים של פפטיד ו‬
SIRNA ‫החדרה של‬
A61B
‫אמצעים אופטיים ושיטות להקרשה ע"י‬
‫אור נבחרות וקונבנציונאליות של אפיתל‬
‫פיגמנט הרשתית‬
2964
1090090112
191149
‫מערכת השקיה בטפטוף‬
‫ אגודה שיתופית‬- ‫דן ג'יין השקייה‬-‫נענ‬
‫חקלאית בע"מ‬
DRIP IRRIGATION APPARATUS
NAANDAN JAIN IRRIGATION C.S.
LTD.
US
60/732611
01/11/2005
PCT/IL/2006/001265
WO/2007/052272
1090090112
191150
CYTOTOXIC ANTIBODIES
TARGETING ANTIBODIES
INHIBITING FACTOR VIII
LFB BIOTECHNOLOGIES
FR
0511146
02/11/2005
PCT/FR/2006/002452
WO/2007/051926
/190190112
‫נוגדנים ציטוטוקסיים המכוונים כנגד‬
8 ‫נוגדנים המעכבים פקטור‬
A61F
‫אמצעי קישור ושחרור ושיטות להרכבתם‬
‫ושימושם‬
191152
POLYPEPTIDE FILMS AND METHODS
2965
A61K
191151
COUPLING AND RELEASE DEVICES
AND METHODS FOR THEIR
ASSEMBLY AND USE
THE BIOMERIX CORPORATION
US
11/264402
31/10/2005
PCT/US/2006/042357
WO/2007/053568
0/90090112
B05D
A61K
‫שכבות דקות של פוליפפטידים ושיטות‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
LOUISIANA TECH UNIVERSITY
FOUNDATION
US
60/736723
14/11/2005
PCT/US/2006/043986
WO/2008/013558
/090190112
191153
MODIFIED COLORANTS AND INKJET
INK COMPOSITIONS COMPRISING
MODIFIED COLORANTS
CABOT CORPORATION
US
60/731721
31/10/2005
832613233
2123822338
US
832613220
2123822338
US
832613228
2123822338
US
PCT/US/2006/042347
WO/2007/053563
0/91090110
191154
PHOTON COUNTING X-RAY
DETECTOR WITH OVERRANGE
LOGIC CONTROL
GENERAL ELECTRIC COMPANY
US
11/744292
04/05/2007
0/91090110
December 29, 2008
191156
– ‫ב' בטבת התשס"ט‬
C09B
‫צובענים ששונו והרכבי דיו להזרקת דיו‬
‫המכילים צובענים ששונו‬
H05G
‫גלאי רנטגן הסופר פוטונים עם שליטה‬
‫לוגית בטווח–על‬
H01P
2966
GIGA-HZ SURFACE ACOUSTIC
WAVES WAVE-GUIDES
TELEMATICS-WIRELESS LTD.
0/91090110
‫מוליכי–גל אקוסטי משטחי בתדרי גיגהרץ‬
‫וויירלס בע"מ‬-‫טלמטיקס‬
191157
‫עיבוד אות בינשכבתי על–ידי התקן גל‬
‫אקוסטי משטחי‬
‫וויירלס בע"מ‬-‫טלמטיקס‬
SIGNAL INTRA-PROCESSING BY A
SURFACE ACOUSTIC WAVE DEVICE
TELEMATICS-WIRELESS LTD.
1090090112
191158
CONCURRENT CHEMOTHERAPY
AND IMMUNOTHERAPY
UNIVERSITY OF TEXAS
M.D.ANDERSON CANCER CENTER
US
60/732741
02/11/2005
PCT/US/2006/042812
WO/2007/056061
0090090112
2967
A61K
‫שילוב של כימותרפיה ואימונותרפיה‬
191159
IMPROVED VARIANTS OF PIGMENT
EPITHELIUM DERIVED FACTOR AND
USES THEREOF
YEDA RESEARCH AND
DEVELOPMENT CO. LTD
US
60/735875
14/11/2005
PCT/IL/2006/001314
WO/2007/054949
0190090112
H01P
A61K
‫וריאנטים משופרים של הפקטור שמקורו‬
‫מהאפיתל הפיגמנטלי ושימושים בהם‬
‫ידע חברה למחקר ופיתוח בע"מ‬
191160
C07D
December 29, 2008
– ‫ב' בטבת התשס"ט‬
PYRIDOPYRAZINE DERIVATIVES
AND USE THEREOF
AETERNA ZENTARIS GMBH
EP
05024692.5 11/11/2005
832023030
1121122333
US
PCT/EP/2006/068323
WO/2007/079999
0/90190112
‫תולדות פירידופיראזין ושימוש בהן‬
191161
METHOD OF PRODUCING AN
IMPECT-RESISTANT
THERMOPLASTIC RESIN
OMYA DEVELOPMENT AG
FR
0511274
04/11/2005
PCT/IB/2006/003054
WO/2007/052122
/190190112
‫שיטה לייצור שרף תרמופלסטי העמיד‬
‫בפני פגיעה‬
191162
PROCESS FOR PREPARING
SUBSTITUTED DIMETHYL (3ARYLBUTYL)AMINE COMPOUNDS BY
MEANS OF HOMOGENEOUS
CATALYSIS
GRUNENTHAL GMBH
DE
102005052588.1 02/11/2005
PCT/EP/2006/010407
WO/2007/051576
0090090112
191163
INDANYL-AND
TETRAHYDRONAPHTYL-AMINOTHIOUREA COMPOUNDS FOR
COMBATING ANIMAL PESTS
BASF SE
US
60/739729
25/11/2005
PCT/EP/2006/068480
WO/2007/060120
December 29, 2008
C08F
– ‫ב' בטבת התשס"ט‬
C07C
–:( ‫תהליך להכנת תרכובות דימתיל‬
‫ארילבוטיל)אמין מותמרות באמצעות‬
‫קטליזה הומוגנית‬
C07C
–‫תרכובות אינדאניל–וטטראהידרונפתיל‬
‫אמינו–תיאואוריאה לבקרה על מזיקים‬
2968
/090190112
191166
MODIFIED COLORANTS AND INKJET
INK COMPOSITIONS COMPRISING
MODIFIED COLORANTS
CABOT CORPORATION
US
60/731721
31/10/2005
832613233
2123822338
US
832613220
2123822338
US
832613228
2123822338
US
PCT/US/2006/042348
WO/2007/053564
0290190112
2969
C07D
–‫מעכבי קינאזים מסוג בי–אריל מטה‬
‫פירימידין‬
191168
COMPOSITIONS AND METHODS FOR
TREATING CNS DISORDERS
EPIX PHARMACEUTICALS, INC.
US
11/271019
10/11/2005
PCT/US/2006/043140
WO/2007/058805
/191090110
‫צובענים ששונו והרכבי דיו להזרקת דיו‬
‫המכילים צובענים ששונו‬
191167
BI-ARYL META-PYRIMIDINE
INHIBITORS OF KINASES
TARGEGEN, INC.
US
60/732629
01/11/2005
832626332
1323622338
US
PCT/US/2006/042044
WO/2007/053452
1290090112
C09B
A61K
‫תרכובות ושיטות לטיפול בהפרעות‬
‫במערכת העצבים המרכזית‬
191171
A47J
December 29, 2008
– ‫ב' בטבת התשס"ט‬
IMPROVEMENT OF DISPOSABLE
CROCKERY
SHYREL GABAY
0190090112
‫שיפוד לכלים חד פעמיים‬
191172
DEPOSITION OF DISCRETE
NANOPARTICLES ON AN IMPLANT
SURFACE
BIOMET 3i, LLC
US
60/736269
14/11/2005
832030613
3323322338
US
PCT/US/2006/044000
WO/2007/059038
0190090112
‫ריבוץ של ננו–חלקיקים בדידים על משטח‬
‫של שתל‬
191173
POWDER DISPENSING AND SENSING
APPARATUS AND METHODS
MANNKIND CORPORATION
US
60/738474
21/11/2005
PCT/US/2006/044972
WO/2007/061987
/191090110
MEDICATION REMINDER AND
CONSULTING SYSTEM
SPINA ENRICO
US
11/829195
27/07/2007
191176
WHEELS SUSPENSION SYSTEM FOR
VEHICLES
AFIKIM ELECTRIC VEHICLES
December 29, 2008
– ‫ב' בטבת התשס"ט‬
B65B
‫התקן ושיטות לחלוקה ותחושה של אבקה‬
191174
/191090110
A61L
A61J
‫מערכת תזכורת וייעוץ לתרופות‬
‫ספינא אנריקו‬
B60G
‫מערכת מתלים לכלי רכב‬
‫אפיקים רכב חשמלי‬
2970
1091090110
191188
CIRCUITS AND METHODS FOR
OPERATING DISCHARGE LAMPS
ELTAM EIN HASHOFET
1091090110
H05B
‫מעגלים ושיטות להפעלת נורת פריקה‬
‫אלתם עין השופט‬
191231
A47B
‫אביזר להחזקה והצמדה של פתקיות‬
‫תזכורת‬
‫ישראל בלזברג‬
AN ACCESSORY FOR HOLDING AND
ATTACHING MEMO NOTES
ISRAEK BLAZBERG MIRKIN
1091090110
191242
FISH POND WITH MEANS TO HEAT
THE POND AND MEANS TO
OXIGENATE THE POND'S WATER AT
THE SAME TIME.
DR. HAIM AMRAM BEN-SIMHON
1091090110
‫בריכת דגים עם אמצעים לחמום סולרי‬
.‫וחמצון הבריכה בו זמנית‬
‫ד"ר חיים עמרם בן שמחון‬
191251
METHOD PROVIDING A
FUNCTIONAL ASSEMBLY AND
ELEMENTS
TECHITRIX LTD
1091090110
B67B
‫שיטה לאספקת הרכב תפקודי וגורמים‬
‫טקיטריקס בע"מ‬
191257
IR JAMMING SYSTEM FOR DEFENCE
AGAINST MISSILES WITH IR-SENSITIVE
HOMING HEADS
EADS DEUTSCHLAND GMBH
2971
A01K
F41B
‫ להגנה כנגד טילים‬IR ‫מערכת דחיסת‬
‫ רגישים מתבייתים‬IR ‫עם ראשי‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
DE
102007022820.315
15/05/2007
0/90090110
191287
‫פורמולציה של אטורבסטטין‬
ATORVASTATIN FORMULATION
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
60/738828
21/11/2005
PCT/US/2005/042789
WO/2007/058664
1191090110
‫טבע תעשיות פרמצבטיות בע"מ‬
191305
METHOD OF EYESIGHT
REHABILITATION
BEKERMAN JOSEF
0090090112
‫בקרמן יוסף‬
ORAL PHARMACEUTICAL DOSAGE
FORM COMPRISING AS ACTIVE
INGREDIENTS A PROTON PUMP
INHIBITOR TOGETHER WITH
ACETYL SALICYCLIC ACID
ASTRAZENECA AB
US
60/740981
30/11/2005
832616668
3823022338
US
PCT/SE/2006/001349
WO/2007/064274
December 29, 2008
A61K
‫צורת מינון של תכשיר רוקחות למתן פומי‬
‫המכיל כמרכיבים פעילים מעכב משאבת‬
‫פרוטונים יחד עם חומצת אצטיל‬
‫סליציקלית‬
191317
– ‫ב' בטבת התשס"ט‬
A61B
‫שיטה לשיפור הראייה‬
191312
1/90090112
A61K
A61K
2972
IMMUNOMODULATORY
PROPERTIES OF MULTIPOTENT
ADULT PROGENITOR CELLS AND
USES THEREOF
OREGON HEALTH AND SCIENCE
UNIVERSITY
US
11/269736
09/11/2005
PCT/US/2006/043804
WO/2007/056578
0091090110
‫תכונות אפנן חיסוני של תאי אב בוגרים‬
‫רבי עוצמה ושימושיהם‬
191330
A MILLING TOOL ASSEMBLY
HAVING A REPLACEABLE CUTTER
KENNAMETAL INC.
0091090110
‫מכלול כלי טחינה בעל להב מתחלף‬
191350
GASTRIC BAND WITH POSITION
SENSING
BIOSENSE WEBSTER, INC.
US
11/749387
16/05/2007
0091090110
191352
G09F
‫פרסומת המוצגת באתרי אינטרנט‬
191368
METHOD FOR RECYCLING OF
SYNTHETIC MATERIAL
CONTAINING WASTE
DIPL.-ING. JOST-ULRICH KUGLER
EP
07009927.0 18/05/2007
2973
A61F
‫פאוץ' עם חישת מיקום לשימוש גסטרי‬
INTERNET BANNERS
ATOMYNET INC.
0091090110
A47J
B09B
‫שיטה למיחזור של פסולת המכילה חומר‬
‫סינטטי‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
0091090110
191377
MODULAR TRANSPORTABLE
VEHICLE PARKING ASSEMBLY
MILIK BERG
0/91090110
‫מכלל מודולרי נייד לחניית רכבים‬
‫מיליק ברג‬
191396
A DEVICE FOR PROTECTING THE
ENGAGEABLE ELEMENTS OF A
CONNECTOR
SAGEM DEFENSE SECURITE
FR
07/03834
30/05/2007
0/91090110
191399
METHOD AND SYSTEM FOR
PREVENTING UNDESIRED GROWTH
OF PLANT ROOTS
DOV ABRAHAM
0/91090110
191404
COATED CUTTING TOOL INSERT
SANDVIK INTELLECTUAL
PROPERTY AB
SE
0701320-4
01/06/2007
3031333-1
1323822330
SE
3031336-3
2023822330
SE
3031083-1
2223022330
SE
0/91090110
December 29, 2008
191405
– ‫ב' בטבת התשס"ט‬
E04H
A47G
‫התקן להגנה על חלקים מתחברים של‬
‫מחבר‬
A01G
‫שיטה ומערכת למניעת גידול בלתי רצוי‬
‫של שורשי צמח‬
‫דב אברהם‬
C23C
‫תותבת מצופה עבור מכשיר חיתוך‬
C23C
2974
CUTTING TOOL INSERT FOR
TURNING HEAT RESISTANT ALLOYS
AND STAINLESS STEEL
SANDVIK INTELLECTUAL
PROPERTY AB
SE
0701320-4
01/06/2007
3031333-1
1323822330
SE
3031336-3
2023822330
SE
3031081-3
2223022330
SE
0/91090110
191407
191409
A NONINVANSIVELY DEVICE FOR
DETECTION OF MYOCARDIAL
ISCHEMIC
EUROTECH COMMUNICATION LTD.
0/91090110
CUTTING TOOL AND CUTTING
INSERT THEREFOR
ISCAR LTD.
2975
A61B
‫מערכת לגילוי מוקדם של איסקמיה של‬
‫שריר הלב‬
‫יורוטק קומיוניקיישן בע"מ‬
191414
SATELLITE POSITIONING METHOD
AND SYSTEM
ASTRIUM SAS
FR
07/03562
18/05/2007
0/91090110
A01F
‫מפוח דו דרגתי למייבש שער‬
0/// ‫אפיליידי‬
TWO STAGES FAN FOR DRIER
EPILADY 200 LLC
0/91090110
‫תותבות עבור מכשיר חיתוך לחריטת‬
‫סגסגות חסיני חום ופלדה‬
G01C
‫שיטה ומערכת למיקום לוויין‬
191415
B23C
‫כלי חיתוך ושימת חיתוך עבורו‬
‫ישקר בע"מ‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
0091090110
191434
‫משחק לוחמי האצבע‬
‫חן‬-‫משה בר‬
A THIMBLE WARRIOR GAME
MOSHE BAR-HEN
0190090112
A63B
191435
PROTECTIVE SLEEVE FOR
ENDOSCOPIC TOOL
A61B
‫שרוול מגן לכלי אנדוסקופי‬
‫ בע"מ‬.‫ אי‬.‫סטריקר ג'י‬
US
60/738001
PCT/IL/2006/001219
WO/2007/057880
17/11/2005
1090090112
191436
PROTECTIVE COVER FOR
ENDOSCOPIC TOOL
A61B
‫כיסוי מגן לכלי אנדוסקופי‬
‫ בע"מ‬.‫ אי‬.‫סטריקר ג'י‬
US
60/738002
PCT/IL/2006/001272
WO/2007/057881
17/11/2005
0091090110
191437
‫מערכת ושיטה לטיפול בצמיגים‬
‫פנאומטיים‬
‫משה גיבירץ‬
SYSTEM AND METHOD FOR
PNEUMATIC TIRE TREATMENT
MOSHE GEWERTZ
0091090110
191443
A GUIDE FOR PLACEMENT OF
CATHETER INTO BRAIN AND A
METHOD OF UTILIZING THE SAME
December 29, 2008
– ‫ב' בטבת התשס"ט‬
B60S
A61B
‫מכשיר ושיטה להנחיית והחדרת צנתר‬
‫לחדר במוח‬
2976
ARNON AGMON
US
60/917683
‫ארנון אגמון‬
14/05/2007
0091090110
191458
A COATED CEMENTED CARBIDE
CUTTING TOOL INSERT
SANDVIK INTELLECTUAL
PROPERTY AB
SE
0701321-2
01/06/2007
0091090110
C23C
‫תותבת מקארביד מודבק מצופה עבור‬
‫מכשיר חיתוך‬
191465
A47J
‫פותחן שקיות חלב‬
‫דניאל דבדה‬
MILK BAG CUTTER
DANEIL DAVDA
0091090110
191515
A METHOD TO ENABLE OPTIMIZING
TOWARDS GOALS
CLICKSOFTWARE TECHNOLOGIES
LTD
US
12/046480
12/03/2008
0091090110
DEVICE FOR SECURING A WATCH
STRAP TO A WATCH CASING
2977
‫שיטה המאפשרת תיעול אל יעדים‬
‫קליקסופטוור טכנולוגיות בע"מ‬
191517
METHOD FOR CONTROLLING AN
ELECTRONIC DEVICE USING
INFRARED DETECTION AND A
DEVICE CONTROLLED BY SUCH A
METHOD
EVERSPRING INDUSTRY CO., LTD
0091090110
G09B
H04B
‫שיטה לבקרה של התקן אלקטרוני‬
‫באמצעות קרינת אינפרא–אדום והתקן‬
‫המבוקר באמצעותה‬
191518
A44C
‫התקן לחיבור רצוע לבית שעון‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
‫אופטו ליין בע"מ‬-‫אחים סגל‬
SEGAL BROS.-OPTO LINE LTD
0091090110
191520
CUTTING TOOL AND CUTTING
INSERT THEREFOR
ISCAR LTD.
0/90090112
‫כלי חיתוך ושימת חיתוך עבורו‬
‫ישקר בע"מ‬
191522
METHOD AND APPARATUS
UTILIZING ANIMALS FOR
DETECTING TARGET SUBSTANCES
BIO EXPLORERS LTD
US
60/597249
18/11/2005
PCT/IL/2006/001328
WO/2007/057901
0190090110
B23D
A61K
‫שיטה ומתקן העושים שימוש בבעלי חיים‬
‫לזיהוי חומרי מטרה‬
191523
LANSOPRAZOLE ORALLY
DISINTEGRATING TABLETS
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
‫ביו אקספלוררס בע"מ‬
A61K
‫טבליות לנזופרזול מתפוררות בפה‬
‫טבע תעשיות פרמצבטיות בע"מ‬
PCT/US/2005/046296
WO/2007/078271
0091090112
191524
AQUEOUS DISPERSIONS AND
SOLUTIONS OF DIFFICULT TO
DISSOLVE COMPOUNDS AND
METHODS OF THEIR PREPARATION
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
60/749244
09/12/2005
PCT/US/2006/018550
WO/2007/067208
December 29, 2008
– ‫ב' בטבת התשס"ט‬
A61K
‫תמיסות ודיספרסיה מימית של תרכובות‬
‫קשות תמס ודרכים להכנתן‬
‫טבע תעשיות פרמצבטיות בע"מ‬
2978
0091090111
191525
PROCESS FOR THE PREPARATION
OF (S)-(-)-N,N-DIMETHYL-3-(2THIENYL)- 3HYDROXYPROPANAMINE, A
DULOXETINE INTERMEDIATE
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
60/775593
21/02/2006
832031132
1323322338
US
832032612
1023322338
US
PCT/US/2007/004632
WO/2007/098250
0190090112
–:–‫–דימתיל‬S)–(–)–N, N( ‫תהליך להכנת‬
‫ חומר‬,‫–הידרוקסיפרופאנאמין‬:–)‫–תיאניל‬0(
‫ביניים של דולוקסטין‬
G06F
‫מערכות ושיטות לשימוש במידע תכנוני‬
‫ביחד עם מידע של בדיקה‬
191528
METHODS AND SYSTEMS FOR
UTILIZING DESIGN DATA IN
COMBINATION WITH INSPECTION
DATA
KLA-TENCOR TECHNOLOGIES
CORPORATION
US
60/737947
18/11/2005
2979
‫טבע תעשיות פרמצבטיות בע"מ‬
191527
METHODS AND SYSTEMS FOR
UTILIZING DESIGN DATA IN
COMBINATION WITH INSPECTION
DATA
KLA-TENCOR TECHNOLOGIES
CORPORATION
US
60/737947
18/11/2005
832026233
1621122333
US
112381833
2321122338
US
112381023
2321122338
US
PCT/US/2006/061113
WO/2007/120280
0190090112
C07D
G06F
‫מערכות ושיטות לשימוש במידע תכנוני‬
‫ביחד עם מידע של בדיקה‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
832026233
US
112381833
US
112381023
US
PCT/US/2006/061112
WO/2007/120279
1621122333
2321122338
2321122338
/191090112
191529
VIDEO COMPRESSION ENCODER
AVOCENT CORPORATION
US
11/282688
21/11/2005
PCT/US/2006/021182
WO/2007/097773
/190090110
191531
ORALLY ABSORBED
PHARMACEUTICAL FORMULATION
GENEREX PHARMACEUTICALS INC
H04N
‫מקודד וידיאו דחוס‬
A61K
‫פורמולציה רוקחית הנספגת דרך הפה‬
PCT/CA/2005/001816
WO/2007/062494
0090090112
191532
FUSED BICYCLIC mTOR INHIBITORS
OSI PHARMACEUTICALS, INC.
US
60/737581
17/11/2005
832633230
2321322338
US
PCT/US/2006/044461
WO/2007/061737
0090090112
December 29, 2008
191533
– ‫ב' בטבת התשס"ט‬
C07D
mTOR ‫מעכבים מאוחים ביציקליים של‬
C12N
2980
EXTRACELLULAR MATRIX
COMPONENTS FOR EXPANSION OR
DIFFERENTIATION OF HEPATIC
PROGENITORS
THE UNIVERSITY OF NORTH
CAROLINA AT CHAPEL HILL
US
60/736873
16/11/2005
PCT/US/2006/060904
WO/2007/059501
0090090112
‫רכיבי מטריצה חוץ–תאיים להרחבה או‬
‫הבחנה של מולידי תאי כבד‬
191535
ARTICLE PROCESSING APPARATUS
AND RELATED METHOD
BIODEFENSE CORPORATION
US
11/281921
18/11/2005
PCT/US/2006/044246
WO/2007/089312
/191/90111
‫מערכת לעיבוד פריטים ושיטה קשורה‬
191536
MODULAR MULTIFUNCTIONAL
SOLAR STRUCTURE (MMSS)
AMILCAR LUIS JERONIMO LOPES
PT
103479
12/05/2006
PCT/IB/2007/051158
WO/2007/132363
0090090112
2981
F24J
‫מבנה סולרי מודולרי רב–פונקציות‬
191537
METHODS AND COMPOSITIONS FOR
THE TREATMENT OF
GASTROINTESTINAL DISORDERS
IRONWOOD PHARMACEUTICALS,
INC.
US
60/739491
23/11/2005
PCT/US/2006/045289
WO/2007/062168
0090090112
A61L
C07H
‫שיטות ותכשירים לטיפול באי–סדרים של‬
‫הקיבה והמעיים‬
191538
C12Q
December 29, 2008
– ‫ב' בטבת התשס"ט‬
METHOD FOR DIAGNOSING,
PROGNOSING AND TREATING
GLIOMA
GENENTECH, INC.
US
60/750944
16/12/2005
PCT/US/2006/061869
WO/2007/111733
0190090112
‫ חיזוי וטיפול בדיבקומת‬,‫שיטה לאבחון‬
191539
SYSTEM FOR WIRELESS
COMMUNICATIONS AMONG
PLURAL ELECTRICAL
DISTRIBUTION DEVICES OF AN
ELECTRICAL DISTRIBUTION
ENCLOSURE
EATON CORPORATION
US
11/312024
20/12/2005
PCT/IB/2006/003730
WO/2007/072194
0090090112
H02J
‫מערכת עבור תקשורת אלחוטית בין‬
‫התקני הפצה חשמליים רבים של מתקן‬
‫הפצה חשמלי‬
191540
NOVEL THIOPHENE DERIVATIVES
ACTELION PHARMACEUTICALS LTD.
GB
PCT/IB05/053882 23/11/2005
PCT/IB/2006/054388
WO/2007/060626
0090090112
December 29, 2008
191541
– ‫ב' בטבת התשס"ט‬
C07D
‫תולדות תיאופן חדשות‬
B23C
2982
CUTTNIG TOOL
TAEGUTEC LTD.
KR
1020050111220
PCT/KR/2006/004895
WO/2007/058513
1090090112
‫כלי חיתוך‬
21/11/2005
191544
DIARYLETHER DERIVATIVES AS
ANTITUMOR AGENTS
OTSUKA PHARMACEUTICAL CO.,
LTD.
2005JP
05/12/2005
351255
PCT/JP/2006/324610
WO/2007/066784
1290090112
‫תולדות דיארילאתר כחומרים נוגדי גידול‬
191545
METHODS FOR PREPARING
CRYSTALLINE RAPAMYCIN AND
FOR MEASURING CRYSTALLINITY
OF RAPAMYCIN COMPOUNDS USING
DIFFERENTIAL SCANNING
CALORIMETRY
WYETH
US
60/748005
07/12/2005
PCT/US/2006/046445
WO/2007/067566
1290090112
G01N
‫שיטות להכנת ראפאמיצין קריסטלי‬
‫ולמדידת הקריסטליות של תרכובות‬
‫ראפאמיצין תוך שימוש בסריקה‬
‫דיפרנציאלית קלורימטרית‬
191546
PROCESS FOR THE PREPARATION
OF PURIFIED CRYSTALLINE CCI-779
WYETH
US
60/748006
07/12/2005
PCT/US/2006/046444
WO/2007/067565
2983
B23C
C07D
– 776 ‫תהליך להכנת קריסטל מטוהר של‬
CCI
December 29, 2008
– ‫ב' בטבת התשס"ט‬
1090090112
191547
NEW PROCESS FOR THE
PREPARATION OF ESOMEPRAZOLE
NON-SALT FORM
ASTRAZENECA AB
US
60/742296
05/12/2005
PCT/SE/2006/001381
WO/2007/067128
0090090112
‫תהליך חדש להכנת אסומפראזול בצורה‬
‫שאינה מלח‬
191548
191549
191550
SCALABLE PROCESS FOR THE
PREPARATION OF A RAPAMYCIN 42ESTER FROM A RAPAMYCIN 42ESTER BORONATE
WYETH
US
60/748143
07/12/2005
PCT/US/2006/046434
WO/2007/067560
0090090112
December 29, 2008
C07D
–40 ‫תהליך בר מדידה להכנת ראפאמיצין‬
‫–אסטר בורונאט‬40 ‫אסטר מראפאמיצין‬
191553
– ‫ב' בטבת התשס"ט‬
C07D
–‫תולדות תיאדיאזול כחומרים אנטי‬
‫סוכרתיים‬
THIADIAZOLE DERIVATIVES AS
ANTIDIABETIC AGENTS
NOVARTIS AG
US
60/748573
08/12/2005
PCT/US/2006/046545
WO/2007/067615
1290090112
C05D
‫או בקשר להתפתחות סוכר‬/‫שיפורים ב‬
‫ענבים‬
IMPROVEMENTS IN OR RELATING
TO GRAPE SUGAR DEVELOPMENT
SYNGENTA PARTICIPATIONS AG
GB
0525565.8
15/12/2005
PCT/EP/2006/011402
WO/2007/068347
1290090112
C07D
B01D
2984
METHOD AND APPARATUS FOR
COLLECTING AND/OR REMOVING
SLUDGE
ULTRA AQUATIC TECHNOLOGY PTY
LTD
AU
2005906471 22/11/2005
PCT/AU/2006/001749
WO/2007/059562
1090090112
‫או סילוק‬/‫שיטה ומתקן עבור איסוף ו‬
‫אשפה‬
191554
‫תרכובות לאקטם ושיטות לשימוש של‬
‫הנ"ל‬
LACTAM COMPOUNDS AND
METHODS OF USING THE SAME
INCYTE CORPORATION
US
60/742353
05/12/2005
832636806
2823322338
US
PCT/US/2006/046309
WO/2007/067504
0090090112
191555
PYRIMIDINE DERIVATIVES FOR THE
TREATMENT OF ABNORMAL CELL
GROWTH
PFIZER PRODUCTS INC.
US
60/752708
21/12/2005
PCT/IB/2006/003655
WO/2007/072158
0190090112
2985
C07D
C07D
‫נגזרות של פירימידין לטיפול בגידול תאים‬
‫לא–תקינים‬
191556
H01L
December 29, 2008
– ‫ב' בטבת התשס"ט‬
SOLAR SYSTEM AND METHOD FOR
THE OPERATION THEREOF
DR.HANA FRAUENKNECHT
EP
05405676.7 29/11/2005
PCT/CH/2006/000661
WO/2007/062537
0191090110
‫מערכת סולרית ושיטת שימוש בה‬
191557
PARKING SYSTEM EMPLOYING
REMOTE ASSET MANAGEMENT
TECHNIQUES
INNOVAPARK, LLC
US
11/802244
21/05/2007
0191090110
‫מערכת חניה המשתמשת בטכניקות ניהול‬
‫נכסים מרוחק‬
191558
SCOOTER HAVING RESILIENT
BOARD
TOYMONSTER INTELLECTUAL
PROPERTY LIMITED
1290190112
FIRE SUPPRESSION DEVICE
GOODRICH CORPORATION
US
60/756374
05/01/2006
112310032
3623322338
US
PCT/US/2006/039298
WO/2007/081415
191560
3,4-DIHYDROBENZOXAZINE
DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
JAPAN TOBACCO INC.
December 29, 2008
– ‫ב' בטבת התשס"ט‬
B62C
‫קורקינט עם לוח קפיצי‬
191559
0090090112
G07F
A62C
‫מתקן לדיכוי שריפה‬
C07D
‫–דיהידרובנזאקסאזין ותכשירי‬4,: ‫תולדות‬
‫רוקחות המכילים אותן‬
2986
2005377754
832038238
US
PCT/JP/2006/326314
WO/2007/074916
JP
28/12/2005
3323122338
0191090110
191561
THE PLANNING AND DISPERSING
THE MANPOWER HOURS ON TIME
AXIS FOR MANUFACTURING,
PRODUCTION SERIES, PROVIDING
HEAVY INDUSTRIAL SERVICES,
AND HIGH TECH ENVIRONMENTS
ELIAHOO DAYAN
0090090112
‫תכנון והפצת שעות כח אדם על פני ציר‬
,‫ ייצור סידרתי‬,‫הזמן למפעלי ייצור חלקים‬
‫מתן שירותי מוסכים לתעשיה כבדה‬
‫בסביבות תעשיות והיי–טק‬
‫אליהו דיין‬
191562
A METHOD AND APPARATUS FOR
MANAGING COMMUNICATIONS
WITHIN A DISTRIBUTED NETWORK
VIRTUAL EXTENSION LTD
US
60/738025
21/11/2005
112263832
2321122333
US
PCT/IL/2006/001339
WO/2007/057910
0191090110
INCREASING THE VIABILITY AND
STRESS TOLERANCE OF VIABLE
BIOLOGICAL MATERIAL
2987
H04J
‫שיטה והתקן לניהול תקשורת בתוך‬
‫מערכת תקשורת מבוזרת‬
VIRTUAL EXTENSION LTD
191564
MULTIPLE CONFIGURATION
ELECTRONIC THERMOMETER
COVIDIEN AG
US
11/752155
22/05/2007
0090090112
G09F
G01K
‫מד–חום אלקטרוני בעל תצורה כפולה‬
191565
A01N
‫הגדלת יכולת הקיום והטולרנטיות של‬
‫חומר ביולוגי בר–קיימא‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
SEMPRE LTD
HU
P0501079
PCT/IB/2006/054358
WO/2007/060608
22/11/2005
0/90090112
191566
‫סמנים לסרטן השד‬
MARKERS FOR BREAST CANCER
PERLEGEN SCIENCES, INC.
US
60/740971
29/11/2005
832061362
1323222338
US
PCT/US/2006/045812
WO/2007/064776
0/90090112
191567
CLEAR AND THICKENING AQUEOUS
COMPOSITIONS, THE USE THEREOF
IN ACIDIC AQUEOUS
FORMULATIONS, AND THE
RESULTING FORMULATIONS
COATEX S.A.S.
FR
05/12929
20/12/2005
PCT/IB/2006/003645
WO/2007/072152
0190090112
0090090112
December 29, 2008
C07D
–.,4[‫–תיאזולו‬H:–‫–אמינו‬. ‫תהליך להכנת‬
‫–און‬0–‫]פירימידין‬d
191569
– ‫ב' בטבת התשס"ט‬
C08G
,‫תכשירים מימיים צלולים וסמיכים‬
,‫שימושם בהרכבים מימיים חומציים‬
‫וההרכבים המתקבלים‬
191568
NOVEL PROCESS FOR THE
PREPARATION OF 5-AMINO-3HTHIAZOLO[4,5-D]PYRIMIDIN-2-ONE
ANADYS PHARMACEUTICALS, INC.
US
60/738055
21/11/2005
PCT/US/2006/061111
WO/2007/062355
C12Q
C22C
2988
STEEL FOR HOT TOOLING AND
PART PRODUCED FROM SAID STEEL,
METHOD FOR THE PRODUCTION
THEREOF AND USES OF THE SAME
AUBERT & DUVAL
FR
0512091
29/11/2005
PCT/FR/2006/002607
WO/2007/063210
0190090112
‫פלדה להכנת כלים בחום וחלק המיוצר‬
‫ שיטה להכנתם ושימוש בהם‬,‫מפלדה זו‬
191570
C07J
‫מטרימי תרופות סולפאמואיל‬
‫סולפונאטים‬
SULFAMOYL SULFONATE PRODRUGS
BAYER SCHERING PHARMA AG
DE
102005057408.4 30/11/2005
PCT/EP/2006/011726
WO/2007/062874
0090090112
191571
METHOD FOR PRODUCING PLANAR
METALLISED TEXTILE STRUCTURES,
PLANAR METALLISED TEXTILE
STRUCTURE AND USE OF THE THUS
PRODUCED PLANAR METALLISED
TEXTILE STRUCTURE
BASF SE
DE
102005062028.0 22/12/2005
PCT/EP/2006/069799
WO/2007/074090
0090090112
2989
D06M
‫שיטה ליצור מבנים טקסטיליים‬
‫ מבנים‬,‫מישוריים המכילים מתכת‬
‫טקסטיליים מישוריים המכילים מתכת‬
‫ושימוש במבנים המיוצרים הללו‬
191572
C07D
December 29, 2008
– ‫ב' בטבת התשס"ט‬
‫תכשיר קוטל רמשים‬
PESTCIDAL COMPOSITIONS
BASF SE
US
60/753367
22/12/2005
PCT/EP/2006/069525
WO/2007/071585
0090090110
191573
A61C
‫מוצא מיקום חודי‬
APICAL POSITION LOCATOR
LEVY, JACOB
PCT/IL/2005/001228
WO/2007/057878
0/90090112
191574
A HERMETICALLY CLOSED FLUID
BAG WITH AN INTEGRALLY
WELDED DRINKING SPOUT OR
DISPENSING SPOUT
BELCAP SWITZERLAND AG
CH
1880/05
25/11/2005
PCT/CH/2006/000657
WO/2007/059643
0090090112
‫נאד סגור הרמטי לאיחסון נוזלים עם ספל‬
‫מחובר קבע או חד פעמי‬
191575
OBJECT DENSITY ESTIMATION IN
VIDEO
OBJECTVIDEO INC.
US
60/739013
23/11/2005
PCT/US/2006/045068
WO/2007/062044
0090090112
191577
PROCESS FOR THE PRODUCTION OF
A JACKETED PENETRATOR
December 29, 2008
– ‫ב' בטבת התשס"ט‬
B65D
G06K
‫הערכת צפיפות אובייקטים ווידאו‬
F42B
‫תהליך לייצורו של חודרן עטוף‬
2990
NEDERLANDSE ORGANISATIE VOOR
TOEGEPASTNATUURWETENSCHAPPELIJK
ONDERZOEK TNO
EP
05077635.0 21/11/2005
PCT/NL/2006/000587
WO/2007/058531
0/90090112
191578
‫טבליה מטריצה של נרמקסאן בעלת‬
‫שחרור מושהה‬
NERAMEXANE MODIFIED RELEASE
MATRIX TABLET
MERZ PHARMA GMBH & CO. KGAA
US
60/740975
30/11/2005
PCT/EP/2006/011438
WO/2007/062815
0/90090112
191579
BIFUNCTIONAL METAL CHELATING
CONJUGATES
MALLINCKRODT INC.
US
60/740395
29/11/2005
832033033
3223122338
US
PCT/US/2006/045604
WO/2007/064661
1091090111
INDOLE DERIVATIVES AND THEIR
USE AS INTERMEDIATES IN THE
PREPARATION OF QUINAZOLINE
DERIVATIVES
2991
A61K
A61K
‫מצמדי מתכת קלאטים ביפונקציונליים‬
191580
C07D
‫נגזרות אינדול והשימוש בהן כחומרי ביניים‬
‫להכנת נגזרות קווינאזולין‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
ASTRAZENECA AB
EP
99400305.1
PCT/GB/2000/000373
WO/2000/047212
10/02/1999
1091090111
191581
PHARMACEUTICAL COMPOSITIONS
CONTAINING QUINAZOLINE
DERIVATIVES, USE THEREOF IN THE
PREPARATION OF MEDICAMENTS
FOR PRODUCING ANTIANGIOGENIC
AND/OR VASCULAR PERMEABILITY
REDUCING EFFECTS, SOME SUCH
NOVEL QUINAZOLINE DERIVATIVES
AND PROCESSES FOR THEIR
PREPARATION
ASTRAZENECA AB
EP
99400305.1 10/02/1999
PCT/GB/2000/000373
WO/2000/047212
0/91190///
December 29, 2008
0–‫שילוב של אנטגוניסט של אנגיופויטין‬
FLT0 ‫או‬/‫ ו‬A–VEGF, KDR ‫ואנטגוניסט של‬
‫לטיפול בסרטן‬
191582
POLYMORPH OF A
PHARMACEUTICAL
ABBOTT LABORATORIES
US
09/119345
20/07/1998
332228332
3323821333
US
PCT/US/1999/016334
WO/2000/004016
– ‫ב' בטבת התשס"ט‬
A61K
C07D
‫פולימורף של תכשיר רוקחי‬
2992
0190090112
191583
APPARATUS AND METHOD FOR
ENSURING ROTATION OF A
CONTAINER DURING INSPECTION
OWENS-BROCKWAY GLASS
CONTAINER INC
US
11/287331
23/11/2005
PCT/US/2006/044698
WO/2007/061855
0290090112
‫מכשיר ושיטה להבטחת סיבוב של מיכל‬
‫במהלך בדיקה‬
191584
HOMO AND HETEROCYCLIC
COMPOUNDS SUITABLE AS CETP
INHIBITORS
BRISTOL-MYERS SQUIBB COMPANY
US
60/739374
23/11/2005
112336303
1221122338
US
PCT/US/2006/060958
WO/2007/062308
0190090112
HETEROCYCLE-SUBSTITUTED 3ALKYL AZETIDINE DERIVATIVES
MERCK & CO., INC.
2993
C07C
‫תרכובות הומו והטרו–ציקליות המתאימות‬
CETP–‫כמעכבים ל‬
191585
SUBSTITUTED 5-HETEROARYL-1PHENYL-PYRAZOLE CANNABINOID
MODULATORS
JANSSEN PHARMACEUTICA N.V.
US
60/739129
23/11/2005
PCT/US/2006/044890
WO/2007/061948
0090090112
G01N
C07D
–‫–פניל‬0–‫–הטרואריל‬. ‫מודולטורים של‬
‫פירזול–קנאבינויד מותמר‬
191586
C07D
‫–אלקיל אזטידין המותמרות‬: ‫נגזרות‬
‫בטבעת הטרוציקלית‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
US
60/740183
PCT/US/2006/045328
WO/2007/062193
28/11/2005
/190090112
191587
MONOCLONAL ANTIBODIES
AGAINST AMYLOID BETA PROTEIN
AND USES THEREOF
ABBOTT LABORATORIES
US
60/740866
30/11/2005
832006333
3223222338
US
PCT/US/2006/046148
WO/2007/064972
/190090112
191588
ANTI -A? GLOBULOMER
ANTIBODIES, ANTIGEN-BINDING
MOIETIES THEREOF,
CORRESPONDING HYBRIDOMAS,
NUCLEIC ACIDS, VECTORS, HOST
CELLS, METHODS OF PRODUCING
SAID ANTIBODIES, COMPOSITIONS
COMPRISING SAID ANTIBODIES,
USES OF SAID ANTIBODIES AND
METHODS OF USING SAID
ANTIBODIES
ABBOTT LABORATORIES
US
60/740866
30/11/2005
832003101
3223222338
US
832060281
2323222338
US
832632333
3323322338
US
PCT/EP/2006/011530
WO/2007/062852
0090090112
191589
POSITIONING SYSTEM AND
METHOD
RAYTHEON UTD INC
US
60/750787
16/12/2005
PCT/US/2006/048219
WO/2007/075553
December 29, 2008
– ‫ב' בטבת התשס"ט‬
C07K
‫נוגדנים מונוקלונאלים נגד חלבון‬
‫ ושימושים שלהם‬AMYLOID–BETA
C07K
‫ קבוצות‬,‫–ביטא גלובולומר‬A–‫נוגדני אנטי‬
‫ היברידומות‬,‫קושרות אנטיגן שלהם‬
,‫ וקטורים‬,‫ חומצות נוקלאיות‬,‫מתאימות‬
‫ שיטות לייצור הנוגדנים‬,‫תאים פונדקאים‬
‫ תכשירים המכילים את הנוגדנים‬,‫הללו‬
‫ שימושים בנוגדנים הללו ושיטות‬,‫הללו‬
‫לשימוש בנוגדנים הללו‬
G06F
‫שיטה ומערכת כיוונון‬
2994
0091090110
191590
PARKING BOX THAT ALLOWS
FRONTWARD MANUORES FOR
PARKING A VEHICLE.
‫מלבן חניה המאפשר תמרון לחניה‬
.‫קדומנית‬
‫ד"ר חיים עמרם בן שמחון‬
DR. HAIM AMRAM BEN-SIMHON
0091090110
E04H
191591
A23L
‫מכונה למלואי אורז‬
‫אריה סולומון‬
RICE FILLING MACHINE
ARIEH SOLOMON
0091090110
191592
A23L
‫מכונה למלואי אורז‬
‫אריה סולומון‬
RICE FILLING MACHINE
ARIEH SOLOMON
0090090112
191595
STABILIZING FORMULATIONS FOR
RECOMBINANT VIRUSES
SANOFI PASTEUR LIMITED
US
60/597280
21/11/2005
PCT/CA/2006/001855
WO/2007/056847
0090090112
ACTIVIN-ACTRIIA ANTAGONISTS
AND USES FOR PROMOTING BONE
GROWTH
ACCELERON PHARMA INC
2995
C12N
‫ניסוחים מייצבים לוירוסים רקומביננטיים‬
191596
C07K
ACTRIIA–ACTIVIN ‫אנטגוניסטים של‬
‫ושימושים לקידום גדילת עצמות‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
US
60/739462
832062222
US
832633633
US
PCT/US/2006/045322
WO/2007/062188
23/11/2005
1023222338
1323322338
1090090112
191600
IL–9–‫מולקולות נוגדנים בעלות בררנות ל‬
‫ממקור אנושי‬
ANTIBODY MOLECULES HAVING
SPECIFICITY FOR HUMAN IL-6
UCB PHARMA S.A.
US
60/748926
09/12/2005
PCT/GB/2006/004518
WO/2007/066082
0/90090112
191601
NEW PHENANTHRIDINE
DERIVATIVES AS BRADYKININ
ANTAGONISTS
RICHTER GEDEON NYRT.
HU
P0501169
20/12/2005
PCT/HU/2006/000120
WO/2007/072092
0191090111
C07D
‫תולדות פנאנטרידין חדשות כאנטגוניסטים‬
‫של ברדיקינין‬
191604
PHARMACEUTICAL COMPOSITIONS
CONTAINING MIXTURES OF
POLYMERS AND ACTIVE AGENTS
POORLY SOLUBLE IN WATER
EVONIK ROHM GMBH
DE
102006005485.7 03/02/2006
PCT/EP/2007/050465
December 29, 2008
C07K
– ‫ב' בטבת התשס"ט‬
A61K
‫תכשירי רוקחות המכילים תערובות של‬
‫פולימרים וגורמים פעילים המתמוססים‬
‫במים באופן גרוע‬
2996
WO/2007/090721
/190090112
191605
POLYPEPTIDE MARKER FOR THE
DIAGNOSIS AND EVALUATION OF
VASCULAR DISEASES
MOSAIQUES DIAGNOSTICS AND
THERAPEUTICS AG
DE
102005057382.7 30/11/2005
3812360353
1323322338
EP
PCT/EP/2006/069096
WO/2007/063089
0/90090112
‫סמן פוליפפטידי לאבחון והערכה של‬
‫מחלות כלי דם‬
191606
F41A
‫התקן להעמסת מערכת כלי נשק של‬
‫שלדת כלי רכב‬
DEVICE FOR MOUNTING A WEAPON
SYSTEM ON A VEHICLE CHASIS
NEXTER SYSTEMS
FR
0511826
21/11/2005
PCT/FR/2006/002509
WO/2007/057550
0/90090112
191607
ABSORBER FOR THE CONVERSION OF
SOLAR RAYS INTO THERMAL ENERGY
GERALD GOEBEL
DE
102005055858.5 23/11/2005
PCT/EP/2006/011251
WO/2007/059972
2997
G01N
F24J
‫מבלע עבור המרת קרני שמש לאנרגיה‬
‫תרמית‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
0090090112
191608
ELECTROCHEMICAL METHOD OF
DETECTING AN ANALYTE
AGENCY FOR SCIENCE,
TECHNOLOGY AND RESEARCH
US
60/740675
30/11/2005
PCT/SG/2006/000365
WO/2007/064300
/190090112
‫שיטה אלקטרוכימית לגילוי אנליט‬
191609
NANOPARTICLE AND METHODS
THEREFOR
AGENCY FOR SCIENCE,
TECHNOLOGY AND RESEARCH
US
60/740676
30/11/2005
PCT/SG/2006/000368
WO/2007/064301
1090090112
0091090110
December 29, 2008
– ‫ב' בטבת התשס"ט‬
C07K
–0–‫נוגדנים מונוקלונלים אנושיים לפוקוזיל‬
‫ ושיטות לשימוש בנוגדנים נגד‬GM0
GM0–‫פוקוזיל‬
191611
NIGHT VISION GOGGLE MOUNT
WITH RETRACTABLE STOPS
ITT MANUFACTURING
ENTERPRISES, INC.
US
11/944951
26/11/2007
B82B
‫ננו–חלקיק ושיטות לזה‬
191610
HUMAN MONOCLONAL
ANTIBODIES TO FUCOSYL-GM1 AND
METHODS FOR USING ANTIFUCOSYL-GM1
MEDAREX, INC.
US
60/748915
08/12/2005
PCT/US/2006/061817
WO/2007/067992
G01N
G02B
‫מרכב אמצעי ראיית לילה עם עצירות‬
‫ניתנות לחזרה‬
2998
0091090110
191612
HELMET MOUNT FOR NIGHT VISION
GOGGLES
ITT MANUFACTURING
ENTERPRISES, INC.
US
11/944942
26/11/2007
0190190112
G02B
‫מרכב קסדה לאמצעי ראיות לילה‬
191614
F42B
MCD ‫מעטפת‬
MCD SHELL
BAE SYSTEMS BOFORS AB
SE
0502564-8
23/11/2005
PCT/SE/2006/001144
WO/2007/061350
0290090112
191618
N-HYDROXYAMIDE DERIVATIVES,
THEIR PREPARATION AND USE
LABORATORIES SERONO S.A.
EP
05111228.2 24/11/2005
832033211
2621122333
US
PCT/EP/2006/068574
WO/2007/060132
1290090112
‫ הכנתן והשימוש‬,‫–הידרוקסיאמיד‬N ‫תולדות‬
‫בהן‬
191619
METHOD FOR PURIFYING FSH OR A
FSH MUTANT
ARES TRADING S.A.
EP
05111915.4 09/12/2005
3311131053
3321222333
EP
832623033
3323622338
US
PCT/EP/2006/069396
WO/2007/065918
2999
C07D
C07K
FSH ‫ או מוטנט של‬FSH ‫שיטה לניקוי של‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
/190090112
191623
FUSED HETEROCYCLIC
COMPOUNDS AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
VERTEX PHARMACEUTICALS
INCORPORATED
US
60/740737
30/11/2005
832033031
2321122333
US
832033633
2321122333
US
PCT/US/2006/045847
WO/2007/064797
0091090110
191624
191625
191627
BETA GLYCOLIPIDS AS IMMUNOMODULATORS
ENZO BIOCHEM INC.
IL
172175
24/11/2005
December 29, 2008
– ‫ב' בטבת התשס"ט‬
A45D
B25C
‫פטיש אוחז מסמרים‬
‫בנימין עטיה‬
HAMMER HOLDS NAILS
BENYAMIN ATIYA
0/90190112
‫תרכובות הטרוציקליות מותכות ותכשירי‬
‫רוקחות המכילים אותן‬
‫אוחז מסמרים‬
‫בנימין עטיה‬
HOLDS NAILS
BENYAMIN ATIYA
0091090110
C07D
A61P
‫בטא גליקוליפידים כאימונו–מודולטורים‬
3000
PCT/IL/2006/001217
WO/2007/060652
0090090112
ALKYLSULPHONAMIDE
QUINOLINES
ASTRAZENECA AB
US
60/749431
832621318
US
PCT/SE/2006/001408
WO/2007/069977
0/90090112
191628
‫קווינולינים אלקילסולפונאמידים‬
12/12/2005
3123622338
191629
TRICYCLIC AMIDE DERIVATIVES
USEFUL FOR TREATING OBESITY
F. HOFFMANN-LA ROCHE AG
EP
05111879.2 09/12/2005
PCT/EP/2006/069040
WO/2007/065820
0091090110
3001
C07D
‫תולדות אמיד טריציקליות היעילות לטיפול‬
‫בהשמנת יתר‬
191631
A METHOD AND SYSTEM FOR
FINANCIAL AND ENVIRONMENTAL
EDUCATION OF CHILDREN AND
ADOLESCENTS
CHOY LTD
1190090112
C07D
G09B
‫שיטה ומערכת לחינוך פיננסי וסביבתי של‬
‫ילדים ומתבגרים‬
‫צ'וי בע"מ‬
191632
A61K
December 29, 2008
– ‫ב' בטבת התשס"ט‬
FILM-COATED AND/OR
GRANULATED CALCIUMCONTAINING COMPOUNDS AND USE
THEREOF IN PHARMACEUTICAL
COMPOSITIONS
NYCOMED PHARMA AS
DK
PA200501736 07/12/2005
DK
PA200601203 1323322338
832633123
3821322338
US
PCT/DK/2006/000696
WO/2007/065441
0190090112
‫תרכובות המכילות סידן מצופות פילם‬
‫או מגורענות ושימושן בתכשירים‬/‫ו‬
‫רפואיים‬
191633
VECTOR FOR EFFICIENT SELECTION
AND/OR MATURATION OF AN
ANTIBODY AND USES THEREOF
TECNOGEN S.P.A
EP
05028501.4 27/12/2005
PCT/IT/2006/000876
WO/2007/074496
0090090112
0190090112
– ‫ב' בטבת התשס"ט‬
C05D
‫שיפורים באיכות תפוחי אדמה או הקשורים‬
‫לאיכותם‬
191636
NEUROPEPTIDE-2 RECEPTORAGONISTS
F. HOFFMANN-LA ROCHE AG
US
60/748071
07/12/2005
832633233
2321322338
US
PCT/EP/2006/068924
WO/2007/065808
December 29, 2008
‫או הבשלה של‬/‫וקטור לסלקציה יעילה ו‬
‫נוגדן ושימושים שלו‬
191634
IMPROVEMENTS IN OR RELATING
TO POTATO QUALITY
SYNGENTA PARTICIPATIONS AG
GB
0525564.1
15/12/2005
PCT/EP/2006/011403
WO/2007/068348
C12N
A61P
0–‫אגוניסטים של הרצפטור לניורופפטיד‬
3002
0/90090112
191637
COMPOUNDS FOR THE TREATMENT
OF INFLAMMATORY DISORDERS
AND MICROBIAL DISEASES
SCHERING CORPORATION
US
60/741264
01/12/2005
PCT/US/2006/045739
WO/2007/064732
/190090112
‫תרכובות לטיפול בהפרעות זיהומיות‬
‫ובמחלות מיקרוביאליות‬
191639
A METHOD AND APPARATUS FOR
VERIFYING A PERSON'S IDENTITY
OR ENTITLEMENT USING ONE-TIME
TRANSACTION CODES
GRIDLOCKTS LIMITED
GB
0524414.0
01/12/2005
383131352
2123122338
GB
832003223
1023222338
US
381262356
1223022338
GB
381333253
2023022338
GB
PCT/GB/2006/050422
WO/2007/063346
0091090110
‫שיטה ומכשיר לאימות זהותו של אדם או‬
‫הרשאתו לביצוע פעולה על ידי שימוש‬
‫בקודי העברה חד פעמיים‬
H01T
‫שקעים שימושיים עם ניתוב של פינוי חרום‬
‫המשתנה באופן דינאמי‬
191642
UTILITY OUTLETS AS REMOTE
CONTROL REPEATERS
OPTIMAL INNOVATIONS, INC.
US
60/940015
24/05/2007
3003
G07F
191640
UTILITY OUTLETS HAVING
DYNAMICALLY CHANGING
EMERGENCY EVACUATION
ROUTING
OPTIMAL INNOVATIONS, INC.
US
60/939946
24/05/2007
0091090110
C07D
H01R
‫שקעים שימושיים היכולים להיות משיבים‬
‫לשליטה מרחוק‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
0090090110
191643
COMMUNICATION METHOD,
COMMUNICATION SYSTEM AND
COMMUNICATION DEVICE
ZEBIC GREGOR
H04L
‫ מערכת תקשורת ומכשיר‬,‫שיטת תקשורת‬
‫תקשורת‬
PCT/EP/2005/012633
WO/2007/059788
0190090112
191646
ACTIVE INGREDIENTS FOR
INCREASING A PLANT'S DEFENCE IN
RELATION TO ABIOTIC STRESS, AND
METHODS FOR DETECTING SAID
ACTIVE INGREDIENTS
BAYER CROPSCIENCE AG
DE
102005057250.2 29/11/2005
PCT/EP/2006/010796
WO/2007/062737
0/90090112
191647
BUSHING FOR RECEIVING A
DROPPER NECK, AND
CORRESPONDING PACKAGE AND
KIT
SANOFI-AVENTIS
FR
0511943
25/11/2005
PCT/EP/2006/068806
WO/2007/060193
1090090110
191648
ENDOSCOPIC BITE BLOCK
ORIDION MEDICAL 1987 LTD.
A01H
‫מרכיבים פעילים להעלאת ההגנה של‬
‫צמח ביחס ללחץ אביוטי ושיטות לזיהוי‬
‫אותם מרכיבים פעילים‬
A61J
‫ ואריזה‬,‫תותב לאכסון צוואר טפטפת‬
‫תואמת וערכה‬
A61G
‫מנשך אנדוסקופי‬
‫ בע"מ‬0687 ‫אורידיון מדיקל‬
PCT/IL/2005/001291
WO/2007/063532
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3004
0090090112
191649
A COMPRESSIBLE DEVICE
FEMEDA LTD
GB
0523917.3
24/11/2005
PCT/EP/2006/011286
WO/2007/059988
0090090112
A61N
‫מכשיר הניתן לדחיסה‬
191651
A61N
‫אלקטרודות דחיסות‬
COMPRESSIBLE ELECTRODES
FEMEDA LTD
GB
0523916.5
24/11/2005
PCT/EP/2006/011288
WO/2007/059990
0/90090112
191652
LOW CALORIE FAT SUBSTITUTE
CARGILL INCORPORATED
EP
05257437.3 02/12/2005
PCT/EP/2006/069082
WO/2007/063084
0/90090112
3005
‫תחליף שומן דל קלוריות‬
191654
SYSTEM AND METHOD OF
MANAGING DATA PROTECTION
RESOURCES
CONTINUITY SOFTWARE LTD
US
60/739416
25/11/2005
PCT/IL/2006/001353
WO/2007/060664
0090090112
A23L
G06F
‫מערכת ושיטה לניהול מקורות הגנה‬
‫לנתונים‬
‫קונטיניואיטי סופטוור בע"מ‬
191655
C07C
December 29, 2008
– ‫ב' בטבת התשס"ט‬
NOVEL COMPOUNDS, THEIR
PREPARATION AND USE
TRANSTECH PHARMA, INC.
EP
05112758.7 22/12/2005
3811382151
1323822338
EP
PCT/EP/2006/070096
WO/2007/071766
0091090110
191656
NIGHT VISION BINOCULARS
SAGEM DEFENSE SECURITE
FR
0755304
29/05/2007
0090090112
191657
SYSTEMS AND METHODS FOR
ELECTRICITY METERING
QUADLOGIC CONTROLS
CORPORATION
US
60/739375
23/11/2005
832612331
1323822338
US
PCT/US/2006/045457
WO/2007/062232
0091090110
191658
SUBMERSIBLE LOUDSPEAKER
ASSEMBLY
HARRIS CORPORATION
US
11/807549
29/05/2007
0291090111
December 29, 2008
191659
– ‫ב' בטבת התשס"ט‬
‫ הכנתן ושימוש‬,‫תרכובות חדשות‬
G02B
‫משקפת לראיית לילה‬
G06F
‫מערכות ושיטות למדידת חשמל‬
H04R
‫מכלול רמקולים ברי–טבילה במים‬
A61F
3006
A DISPOSABLE PANT-LIKE
ABSORBENT UNDERGARMENT
THAT PROVIDES CLOSE TO THE
BODY FIT
KIMBERLY-CLARK WORLDWIDE,
INC.
US
11/367220
03/03/2006
PCT/IB/2007/050613
WO/2007/099493
1091/90111
191660
A DISPOSABLE PANT-LIKE
ABSORBENT UNDERGARMENT
CLOSELY RESEMBLING CLOTH
UNDERWEAR
KIMBERLY-CLARK WORLDWIDE,
INC.
US
11/367219
03/03/2006
PCT/IB/2007/050673
WO/2007/099510
0/90090112
A61F
‫לבוש תחתון חד פעמי סופג דמוי חיתול‬
‫הדומה בקירוב ללבוש תחתון מבגד‬
191661
MULTILAYER TUBE FOR
TRANSPORTING WATER OR GAS
ARKEMA FRANCE
FR
0511906
24/11/2005
832063236
3623222338
US
PCT/FR/2006/051219
WO/2007/060367
0190090112
‫לבוש תחתון חד פעמי סופג דמוי חיתול‬
‫הניתן להתאמה צמודה לגוף‬
B32B
‫צינור רב–שכבתי להעברת מים או גז‬
191662
B32B
‫חומר מגן‬
FRAG SHIELD
HONEYWELL INTERNATIONAL INC.
US
11/285817
23/11/2005
3007
December 29, 2008
– ‫ב' בטבת התשס"ט‬
PCT/US/2006/044831
WO/2007/089317
0090090112
191663
HOMOPOLYMER PVC RESIN
FORMULATION
E. M. A. T. LTD
US
60/738613
22/11/2005
PCT/IL/2006/001346
WO/2007/060660
0/90090112
191664
METHOD AND SYSTEM FOR
REGIONAL ASSESSMENT OF LUNG
PHYSIOLOGY
DEEPBREEZE LTD
US
60/739415
25/11/2005
PCT/IL/2006/001352
WO/2007/060663
0091090110
191666
C08J
‫ הומופולימרי‬PVC ‫פורמולציות של שרף‬
‫ בע"מ‬.‫ טי‬.‫איי‬.‫ אם‬.‫אי‬
A61B
‫שיטה ומערכת להערכת תפקוד ריאות‬
‫דיפבריז בע"מ‬
B60S
‫מכשיר לשטיפת רכיבים בעל כיור הניתן‬
‫להזזה‬
MOVABLE SINK PARTS WASHER
SAFETY-KLEEN SYSTEMS, INC.
US
11/767299
22/06/2007
0090090112
191667
SYSTEM AND METHOD FOR
PRODUCING A SOLAR CELL ARRAY
ISRAEL AIRCRAFT INDUSTRIES
LIMITED
US
60/739868
25/11/2005
PCT/IL/2006/001340
WO/2007/060657
December 29, 2008
– ‫ב' בטבת התשס"ט‬
H01L
‫מערכת ושיטה ליצירת מערך של תאים‬
‫סולריים‬
‫התעשיה האווירית לישראל בע"מ‬
3008
0090090112
191668
AMPLIFIER OF ACCELERATION
SIGNAL-AUTO PILOT, FOR NEW
TECHNOLOGY CARS
PANAGOPOULOS DIMITRIOS
GR
20050100600 09/12/2005
PCT/GR/2006/000065
WO/2007/066155
0/90090112
,‫מגבר לאור האצה – טייס אוטומטי‬
‫למכוניות בעלות טכנולוגיה חדשה‬
191669
METHODS OF IMPROVING STEM
CELL HOMING AND ENGRAFTMENT
GAMIDA-CELL LTD.
US
11/289004
29/11/2005
PCT/IL/2006/001381
WO/2007/063545
0090090112
191670
C07K
‫תרכובות לעיכוב מוות תאי מתוכנן‬
)‫(אפופטוזיס‬
191671
CONCRETE SAFETY BARRIER
ELEMENT
DELTA BLOC EUROPA GMBH
AT
A1905/2005 24/11/2005
PCT/AT/2006/000437
WO/2007/059542
3009
C12N
‫שיטות לשיפור התבייתות וריבוי של שתלי‬
‫תאי גזע‬
‫סל בע"מ‬-‫גמידה‬
COMPOUNDS FOR THE INHIBITION
OF APOPTOSIS
LABORATORIOS SALVAT, S.A.
ES
P200502890 23/11/2005
PCT/IB/2006/003312
WO/2007/060524
0090190112
B60K
E01F
‫אלמנט מחסום ביטחון מבטון‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
/190090112
191672
CLEANING COMPOSITIONS AND
METHODS
COLGATE-PALMOLIVE COMPANY
US
60/740885
30/11/2005
PCT/US/2006/061403
WO/2007/065127
1290090112
191673
SULFUR-CONTAINING OLIGOMERS
AND HIGH INDEX POLYURETHANES
PREPARED THEREFROM
C11D
‫הרכבים ושיטות ניקוי‬
C08G
‫אוליגומרים שכוללים גופרית‬
‫ופוליאוריתנים בעלי מקדם שבירה גבוה‬
‫שהוכנו מהם‬
PPG INDUSTRIES OHIO, INC.
US
11/303707
16/12/2005
PCT/US/2006/046639
WO/2007/078550
0/90090112
191678
SPRAY NOZZLES
BETE FOG NOZZLE, INC.
US
60/741022
29/11/2005
PCT/US/2006/046247
WO/2007/065001
/190090112
191679
IN VITRO METHODS FOR
DIAGNOSING INFLAMMATORY
BOWEL DISEASE
PROMETHEUS LABORATORIES INC.
US
11/293616
01/12/2005
PCT/US/2006/046136
WO/2007/064964
December 29, 2008
– ‫ב' בטבת התשס"ט‬
B05B
‫זרבוביות ריסוס‬
C12Q
‫שיטה לאבחון מחוץ לגוף של מחלת‬
‫דלקתית של המעיים‬
3010
/190090112
191683
HIGH-FREQUENCY MEASURING HALL
FOR MEASURING LARGE TEST
OBJECTS
ASTRIUM GMBH
DE
102005057403.3 30/11/2005
13233833833653
2321122338
DE
PCT/EP/2006/011493
WO/2007/062839
0090090112
‫אולם למדידה בתדר גבוה עבור מדידת‬
‫עצמים גדולים‬
191684
SUB-PIXEL RENDERING OF A
MULTIPRIMARY IMAGE
GENOA COLOR TECHNOLOGIES
LTD.
US
60/739935
28/11/2005
PCT/IL/2006/001368
WO/2007/060672
1090090112
‫גנואה טכנולוגיות צבע בע"מ‬
191685
H04K
‫שיטה ומערכת לשימוש בחסימה של‬
‫הצפנת צופן‬
191686
VARIABLE LENGTH DATA
ENCAPSULATION AND ENCODING
VIASAT, INC.
US
11/292693
02/12/2005
PCT/US/2006/045797
WO/2007/064764
3011
H04N
‫יצירת תמונה רב–צבעית מתת–פיקסלים‬
METHOD AND SYSTEM FOR USAGE
OF BLOCK CIPHER ENCRYPTION
NDS LIMITED
IL
172578
14/12/2005
102682
2123222338
IL
103632
2123322338
IL
PCT/IL/2006/001394
WO/2007/069236
0/90090112
G01R
H03M
‫אנקפסולציה וקידוד של נתונים באורך‬
‫משתנה‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
0190090110
191688
APPARATUS AND METHOD FOR
SYNTHESIZING THREE OUTPUT
CHANNELS USING TWO INPUT CHANNELS
FRAUNHOFER-GESELLSCHAFT ZUR
FORDERUNG DER ANGEWANDTEN
FORSCHUNG E.V.
WO
PCT/EP/2005/013738 20/12/2005
PCT/EP/2005/013738
WO/2007/071270
0090090112
191691
MODIFIED AND PULSATILE
RELEASE PHARMACEUTICAL
FORMULATIONS OF ESCITALOPRAM
H. LUNDBECK A/S
US
60/750841
14/12/2005
PCT/US/2006/062064
WO/2007/070840
1090090112
December 29, 2008
– ‫ב' בטבת התשס"ט‬
‫התקן ושיטה לסינתוז שלושה‬
‫ערוצי פלט בשימוש שני ערוצי קלט‬
A61K
‫תכשירים רוקחיים של אציטלופרם בעלי‬
‫שחרור משופר ובמקצבים‬
191692
POLYMORPHS OF ANDROGEN
RECEPTOR MODULATOR-(N-3HIMIDAZO[4,5-B]PYRIDIN-2-YLMETHYL)-2-FLUORO-4-METHYL-3OXO-4-AZA-ANDROST-1-EN-17
BETA-CARBOXAMIDE
MERCK & CO, INC.
H04S
C07J
‫פולימורפים של מודולטור לרצפטור‬
–0–‫] פירימידין‬B–5,4[‫–אימידזו‬N(–‫אנדרוגן‬
–‫–אוקסו‬:–‫–מתיל‬4–‫–פלוארו‬0–)‫איל–מתיל‬
–‫ ביתא‬EN–17–0–‫–אזא–אנדרוסט‬4
‫קרבוקסאמיד‬
3012
US
60/748028
PCT/US/2006/046263
WO/2007/067490
1090090112
07/12/2005
191694
METHOD OF USING IL6
ANTAGONISTS WITH PROTEASOME
INHIBITORS
CENTOCOR, INC.
US
60/749152
09/12/2005
PCT/US/2006/061786
WO/2007/067976
0090090112
‫ עם‬IL9 ‫שיטה לשימוש באנטגוניסטים של‬
‫מעכבי פרוטזומים‬
191698
N-(6-MEMBERED AROMATIC RING)AMIDO ANTI-VIRAL COMPOUNDS
GENELABS TECHNOLOGIES, INC.
US
60/749771
12/12/2005
PCT/US/2006/047503
WO/2007/070556
0290090112
C07D
–)‫–(טבעת ארומטית משושה‬N ‫תרכובות‬
‫אמידו אנטי–ויראליות‬
191700
SUSTAINING A FLEET OF
CONFIGURATION-CONTROLLED
ASSETS
THE BOEING COMPANY
US
60/740351
29/11/2005
112333332
1321122338
US
PCT/US/2006/044850
WO/2007/064509
3013
A61K
G05B
‫תמיכה בצי נכסים עם קונפיגורציה‬
‫מבוקרת‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
1090090112
191701
AUDIO CHANNEL EXTRACTION
USING INTER-CHANNEL
AMPLITUDE SPECTRA
DTS, INC.
US
11/296730
06/12/2005
PCT/US/2006/046017
WO/2007/067429
0090090112
‫הוצאת ערוץ שמע ע"י שימוש‬
‫באמפליטודת ספקטרום בין–ערוצית‬
191702
AEROSOL CANISTER EMPLOYING A
POLYMERIC FILM HAVING
IMPROVED MOISTURE BARRIER
PROPERTIES
GLAXO GROUP LIMITED
US
60/752679
21/12/2005
PCT/US/2006/062218
WO/2007/076315
0090090112
December 29, 2008
191711
– ‫ב' בטבת התשס"ט‬
A61K
‫תכשירי חיסון המכילים ספונין כחומר‬
‫מסייע‬
VACCINE COMPOSITIONS
COMPRISING A SAPONIN ADJUVANT
GLAXOSMITHKLINE BIOLOGICALS
S.A.
GB
0525321.6
13/12/2005
383333252
1623322338
GB
382322856
1221322338
GB
382322058
1221322338
GB
PCT/GB/2006/004634
WO/2007/068907
1-ORTHOFLUOROPHENYL
SUBSTITUTED 1,2,5THIAZOLIDINEDIONE DERIVATIVES
AS PTP-AS INHIBITORS
A61K
‫מיכל תרסיס המשתמש בשכבה פולימרית‬
‫בעלת תכונות חסימת לחות משופרות‬
191703
1290090112
G06F
C07D
–0–‫–תיאזולידינדיון מותמרות ב‬.,0,0 ‫תולדות‬
AS–PTP ‫אורתופלואורופניל כמעכבי‬
3014
NOVARTIS AG
US
60/748492
PCT/US/2006/046542
WO/2007/067612
0090190112
08/12/2005
191712
NEURODEGENERATIVE DISEASE
DETECTION METHOD, DETECTING
PROGRAM, AND DETECTOR
NIHON MEDI-PHYSICS CO., LTD.
2005JP
30/11/2005
346190
PCT/JP/2006/321138
WO/2007/063656
0090090112
‫ תוכנת‬,‫שיטה לזיהוי מחלה נוירודגנרטיבית‬
‫זיהוי וגלאי‬
191716
ACTUATED SUPPORT PLATFORM
FOR VIDEO SYSTEM
D-BOX TECHNOLOGIES INC
US
11/289352
30/11/2005
PCT/CA/2006/001902
WO/2007/062507
/190090112
A47C
‫תמיכה מונעת למערכת וידאו‬
191717
ANION-EXCHANGE DISPLACEMENT
CHROMATOGRAPHY PROCESS AND
ANIONIC ORGANIC COMPOUNDS
FOR USE AS DISPLACER
COMPOUNDS IN ANION-EXCHANGE
DISPLACEMENT
CHROMATOGRAPHY PROCESS
SACHEM INC.
3015
G01T
C07C
‫תרכובות אורגניות אניוניות ושיטות‬
‫לכרומטוגרפיה באמצעות חילופי אניונים‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
US
60/741863
PCT/US/2006/045872
WO/2007/064809
02/12/2005
0090090112
191720
DEWPOINT COOLING DEVICE
OPTIMAIR HOLDING B.V.I.O.
NL
1030538
28/11/2005
PCT/NL/2006/000595
WO/2007/061298
0/90090112
191721
SYSTEM FOR POSITIONING SLIDING
DOORS
HARDOOR MECHANISM
PRODUCTIONS LTD.
US
60/740245
25/11/2005
PCT/IL/2006/001377
WO/2007/063541
0191190112
191722
METHOD, APPARATUS AND
COMPUTER PROGRAM FOR ACCRSS
CONTROL
IBM CORPORATION
GB
0524111.2
26/11/2005
PCT/EP/2006/064332
WO/2007/060030
December 29, 2008
– ‫ב' בטבת התשס"ט‬
F24F
‫מכשיר קירור ליצירת תנאי נקודת הטל‬
E06B
‫שיטה לייצוב דלתות הזזה‬
‫עמוס חלפון‬
H04L
‫ מערכת ותוכנת מחשב לבקרת‬,‫שיטה‬
‫גישה‬
3016
0090090112
191723
PROCESS FOR PRODUCING A
HYDROCARBON COMPONENT
NESTE OIL OYJ
FI
20055666
12/12/2005
832033328
1221222333
US
PCT/FI/2006/050548
WO/2007/068795
0090090112
BASE OIL
NESTE OIL OYJ
FI
20055662
832033320
US
PCT/FI/2006/050552
WO/2007/068799
3017
C10M
‫הליך עבור ייצור מרכיב פחמימני מתפצל‬
191725
PROCESS FOR PRODUCING A
BRANCHED HYDROCARBON
COMPONENT
NESTE OIL OYJ
FI
20055665
12/12/2005
832033323
1221222333
US
PCT/FI/2006/050550
WO/2007/068797
0090090112
‫הליך עבור ייצור מרכיב פחמימני‬
191724
PROCESS FOR PRODUCING A
BRANCHED HYDROCARBON
COMPONENT
NESTE OIL OYJ
FI
20055663
12/12/2005
832033323
1221222333
US
PCT/FI/2006/050549
WO/2007/068796
0090090112
C10G
C10M
‫הליך עבור ייצור מרכיב פחמימני מתפצל‬
191726
C10M
‫שמן בסיס‬
12/12/2005
1221222333
December 29, 2008
– ‫ב' בטבת התשס"ט‬
1290090112
191729
ASSESSMENT OF ELECTRODE
COUPLING FOR TISSUE ABLATION
ST. JUDE MEDICAL, ATRIAL
FIBRILLATION DIVISION, INC.
US
60/748234
06/12/2005
PCT/US/2006/046565
WO/2007/067628
1290090112
191730
ASSESSMENT OF ELECTRODE
COUPLING FOR TISSUE ABLATION
ST. JUDE MEDICAL, ATRIAL
FIBRILLATION DIVISION, INC.
US
60/748234
06/12/2005
PCT/US/2006/061714
WO/2007/067941
0/90090112
191731
METHOD OF AND EQUIPMENT FOR
MEASURING IONIC MOBILITY
ENVIRONICS OY
FI
20051223
30/11/2005
PCT/FI/2006/000395
WO/2007/063167
0090090112
191732
DEVICE AND METHOD FOR
DRILLING A PIPELINE PROVIDED
WITH A DERIVATION PLATE
GAZ DE FRANCE
FR
0512184
30/11/2005
3830281
1023622338
FR
PCT/FR/2006/002587
WO/2007/063203
December 29, 2008
– ‫ב' בטבת התשס"ט‬
A61N
‫הערכת צימוד אלקטרודות עבור כריתת‬
‫רקמות‬
A61B
‫הערכת צימוד אלקטרודות עבור כריתת‬
‫רקמות‬
G01N
‫שיטה וציוד למדידת ניידות יונית‬
F16L
‫התקן ושיטה לקידוח קו לצינורות עם‬
‫משטח גזירה‬
3018
1290090112
191733
METHOD FOR DISPLAYING
CATHETER ELECTRODE-TISSUE
CONTACT IN ELECTRO-ANATOMIC
MAPPING AND NAVIGATION
SYSTEM
ST. JUDE MEDICAL, ATRIAL
FIBRILLATION DIVISION, INC.
US
60/748234
06/12/2005
PCT/US/2006/061711
WO/2007/067938
1090090112
‫שיטה להצגת מגע בין צנתר אלקטרודה‬
–‫לרקמה במערכת מיפוי וניווט אלקטרו‬
‫אנטומית‬
191734
METHOD FOR ASSIGNING LARGE
SETS OF CHARACTERS IN
DIFFERENT MODES TO KEYS OF A
NUMBER KEYPAD FOR LOW
KEYPRESS-DATA-ENTRY RATIO
ODED VOLOVITZ
3019
A61K
‫נאנו אמולסיות המכילות בוטלניום‬
BOTULINUM NANOEMULSIONS
UNIVERSITY OF MASSACHUSETTS
LOWELL
US
60/741139
01/12/2005
PCT/US/2006/046236
WO/2008/045107
0090090110
A61N
191737
G06F
‫שיטה להקצאת קבוצות גדולות של תווים‬
‫במצבים שונים לכפתורים של מקלדות‬
‫נומריות לשם השגת יחס נמוך של‬
‫הקלדות לתווים מוקלדים‬
‫עודד וולוביץ‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
US
11/000843
PCT/IB/2005/003567
WO/2006/059199
01/12/2004
0090190112
191738
‫התקן לנעילת חיבור צינורות‬
PIPE JOINT LOCKING DEVICE
FUJIKIN INCORPORATED
2005JP
07/12/2005
352883
PCT/JP/2006/320253
WO/2007/066452
/091090111
191739
JOINT BETWEEN TWO SUB-ELEMENTS
OF A ROTARY TOOL SYSTEM
KOMET GROUP HOLDING GMBH
DE
102006028373.2 19/06/2006
PCT/EP/2007/055328
WO/2007/147711
0090090112
191745
HETEROCYCLIC GABA-B
MODULATORS
ASTRAZENECA AB
SE
0502907-9
23/12/2005
PCT/SE/2006/001460
WO/2007/073296
December 29, 2008
– ‫ב' בטבת התשס"ט‬
F16L
B23B
‫חיבור בין שני רכיבים של מערכת‬
‫הכוללת כלי מסתובב‬
C07D
‫ הטרוציקליים‬B–GABA ‫מאפננים‬
3020
1090090112
191746
METHODS FOR IDENTIFYING AND
TARGETING TUMOR STEM CELLS
BASED ON NUCLEAR MORPHOLOGY
MASSACHUSETTS INSTITUTE OF
TECHNOLOGY
US
60/748951
09/12/2005
PCT/US/2006/047136
WO/2007/067795
0090090112
FORMULATION
SYNGENTA LIMITED
GB
0526416.3
PCT/GB/2006/004902
WO/2007/072046
0/91090111
‫שיטות לזיהוי ולטיפול ממוקד בגידול תאי‬
‫אב המבוססות על מורפולוגיה גרעינית‬
191747
23/12/2005
191748
C07D
,‫–אונים‬8–‫]פירמידין‬D–3,4[‫–פירידו‬H–7
‫ייצורם ושימושם כמעכבי פרוטאין קינאז‬
191749
PROPIONAMIDE COMPOUNDS AS
ANTIINFLAMMATORY AGENTS
F. HOFFMANN-LA ROCHE AG
US
60/748799
09/12/2005
PCT/EP/2006/069041
WO/2007/065821
3021
A01N
‫פורמולציה‬
7H-PYRIDO[3,4-D]PYRIMIDIN-8ONES, THEIR MANUFACTURE AND
USE AS PROTEIN KINASE
INHIBITORS
F. HOFFMANN-LA ROCHE AG
EP
06001915.5 31/01/2006
PCT/EP/2007/000725
WO/2007/088014
0/90090112
C12N
C07C
‫תרכובות של פרופיאונאמיד כחומרים‬
‫אנטי–דלקתיים‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
0090090112
191750
IMIDAZOLE DERIVATIVES FOR THE
TREATMENT OF
GASTROINTESTINAL DISORDERS
ASTRAZENECA AB
SE
0502906-1
23/12/2005
PCT/SE/2006/001462
WO/2007/073298
1090090112
‫תולדות אימידאזול לטיפול בהפרעות קיבה‬
‫ומעיים‬
191751
PYRROLO[2,3-C]PYRIDINE
DERIVATIVES
F. HOFFMANN-LA ROCHE AG
EP
05112186.1 15/12/2005
PCT/EP/2006/069289
WO/2007/068620
0090090112
0090090112
December 29, 2008
C07D
‫תולדות בנזימידאזול חדשות כמעכבים של‬
)VRL( ‫ לואניללואיד‬0 ‫רצפטור‬
191754
FORMULATION
SYNGENTA LIMITED
GB
0526416.3
PCT/GB/2006/004912
WO/2007/072052
C07D
‫]פירידין‬C–2,3[ ‫נגזרות של פירולו‬
191753
NOVEL BENZIMIDAZOLE
DERIVATIVES AS VANILLOID
RECEPTOR 1 (VRL) INHIBITORS
ASTRAZENECA AB
US
60/753604
23/12/2005
PCT/SE/2006/001467
WO/2007/073303
C07D
A01N
‫פורמולציה‬
23/12/2005
– ‫ב' בטבת התשס"ט‬
3022
0090090112
191756
PROCESS FOR MANUFACTURING
MICROMECHANICAL DEVICES
CONTAINING A GETTER MATERIAL
AND DEVICES SO MANUFACTURED
SAES GETTERS S.P.A.
IT
MI2005A002343 06/12/2005
PCT/IT/2006/000824
WO/2007/066370
/190090112
‫תהליך לייצור התקנים מיקרומכניים‬
‫המכילים חומר גטר וההתקנים‬
‫המיוצרים בהתאם‬
191757
NOVEL DISTRIBUTED BASE
STATION ARCHITECTURE
BARZILAI, ZOHAR, ZEEV
US
60/740992
30/11/2005
PCT/IL/2006/001383
WO/2007/063546
0/90090112
‫ארכיטקטורה מבוזרת של תחנות בסיס‬
‫ זוהר זאב‬,‫ברזילאי‬
A61K
‫תרכובת עם שחרור מושהה של המרכיב‬
‫ תהליך להכנתה והשימוש בה‬,‫הפעיל‬
191759
GANAXOLONE FORMULATIONS
AND METHODS FOR THE MAKING
AND USE THEREOF
MARINUS PHARMACEUTICALS
US
60/740174
28/11/2005
832033236
2621122333
US
3023
H04J
191758
COMPOSITION WITH SUSTAINED
RELEASE OF THE ACTIVE
INGREDIENT, PROCESS FOR THE
PREPARATION THEREOF AND USE
THEREOF
PIERRE FABRE MEDICAMENT
FR
0512189
01/12/2005
PCT/FR/2006/002577
WO/2007/063200
0090090112
B81C
A61K
‫תכשירי גנקסון ושיטות להכנתם‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
832036101
US
PCT/US/2006/045626
WO/2007/062266
1123122338
0090090112
191760
PROCESS FOR THE PREPARATION
OF AMINES
SYNGENTA PARTICIPATIONS AG
EP
05027072.7 12/12/2005
3833623653
2123322338
EP
PCT/EP/2006/011885
WO/2007/068417
0090090112
0090090112
– ‫ב' בטבת התשס"ט‬
C07D
‫–(פלואורו–פיראזיניל)–פנילסולפונאמידים‬N
‫חדשים כמאפננים של הרצפטור לכימוקין‬
CCR4
191762
SUBSTITUTED CINNOLINE
DERIVATIVES AS GABAARECEPTOR MODULATORS AND
METHOD FOR THEIR SYNTHESIS
ASTRAZENECA AB
US
60/752137
20/12/2005
December 29, 2008
‫תהליך לייצור אמינים‬
191761
NOVEL N-(FLUORO-PYRAZINYL)PHENYLSULFONAMIDES AS
MODULATORS OF CHEMOKINE
RECEPTOR CCR4
ASTRAZENECA AB
SE
0502733-9
12/12/2005
PCT/SE/2006/001409
WO/2007/069978
C07C
C07D
‫תולדות צינוליין מותמרות כמאפננים של‬
‫גאבא–רצפטור ושיטה להכנתן‬
3024
832622832
US
PCT/SE/2006/001433
WO/2007/073283
1290090112
2623622338
191763
PYRROLO [2,3-B]PYRIDINE
DERIVATIVES AS H3 RECEPTOR
MODULATORS
F. HOFFMANN-LA ROCHE AG
EP
05112317.2 16/12/2005
PCT/EP/2006/069390
WO/2007/068641
0090090112
‫]פירידין כמאפננים‬B–:,0[‫תולדות פיררולו‬
H:–‫של הרצפטור ל‬
191765
PYRAZOLES FOR THE TREATMENT
OF GERD AND IBS
ASTRAZENECA AB
SE
0502908-7
23/12/2005
PCT/SE/2006/001461
WO/2007/073297
0090090112
C07D
IBS–‫ ו‬GERD–‫פיראזולים לטיפול ב‬
191766
GABA-B RECEPTOR MODULATORS
ASTRAZENECA AB
SE
0502904-6
23/12/2005
PCT/SE/2006/001464
WO/2007/073300
3025
C07D
C07D
B–‫מודולטורים של רצפטור גאבא‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
0090090112
191767
‫אימידאזולים כמודולטורים של רצפטור‬
B–‫גאבא‬
IMIDAZOLES AS GABA-B RECEPTOR
MODULATORS
ASTRAZENECA AB
SE
0502905-3
23/12/2005
PCT/SE/2006/001463
WO/2007/073299
1090090112
191768
NOVEL FUSED PYRROLE
DERIVATIVES
F. HOFFMANN-LA ROCHE AG
EP
05112210.9 15/12/2005
PCT/EP/2006/069292
WO/2007/068621
0/90090112
0090090112
December 29, 2008
– ‫ב' בטבת התשס"ט‬
C07D
–0[–4–‫–בנזואיל‬0 ‫צורות קריסטליניות של‬
–‫–טריאזול‬H1–4,2–‫–מתיל‬:(–7–‫–מתוקסי‬4[
–H1–]‫–[(פוספונואוקסי)מתיל‬0–)‫–איל‬0
–0,0–]‫–איל‬:–‫]פירידין‬C–:,0[‫פירולו‬
‫דיאוקסואתיל]–פיפרזין‬
191770
CO-CULTURE OF PLACENTAL STEM
CELLS AND STEM CELLS FROM A
SECOND SOURCE
ANTHROGENESIS CORPORATION
US
60/754692
29/12/2005
PCT/US/2006/049492
C07D
‫נגזרות חדשות של פירול מאוחה‬
191769
CRYSTALLINE FORMS OF 1BENZOYL-4-[2-[4-METHOXY-7-(3METHYL-1H-1,2,4-TRIAZOL-1-YL)-1[(PHOSPHONOOXY)METHYL]-1HPYRROLO[2,3-C]PYRIDIN-3-YL]-1,2DIOXOETHYL]-PIPERAZINE
BRISTOL-MYERS SQUIBB COMPANY
US
60/750247
14/12/2005
PCT/US/2006/047571
WO/2007/070589
C07D
C12N
‫תרביות משותפות של תאי גזע משיליה‬
‫ותאי גזע ממקור שני‬
3026
WO/2007/079184
0090090110
191771
IMPROVED COMPOSITION FOR
COLLECTING AND PRESERVING
PLACENTAL STEM CELLS AND
METHODS OF USING THE
COMPOSITION
ANTHROGENESIS CORPORATION
US
60/754969
29/12/2005
PCT/US/2006/049493
WO/2007/079185
0/90090112
‫תכשיר משופר לאיסוף ושימור תאי גזע‬
‫משיליה ושיטות לשימוש בתכשיר‬
191772
COMPOUNDS FOR THE TREATMENT
OF INFLAMMATORY DISORDERS
AND MICROBIAL DISEASES
SCHERING CORPORATION
US
11/291595
01/12/2005
PCT/US/2006/045773
WO/2007/064749
0090090112
C12N
C07D
‫תרכובות לטיפול בהפרעות זיהומיות‬
‫ובמחלות מיקרוביאליות‬
191774
A61K
‫תכשיר מוצק‬
SOLID PREPARATION
TAKEDA PHARMACEUTICAL
COMPANY LIMITED
2005JP
22/12/2005
370375
PCT/JP/2006/326169
3027
December 29, 2008
– ‫ב' בטבת התשס"ט‬
WO/2007/072992
0090090112
191775
THROMBIN-FREE BIOLOGICAL
ADHESIVE AND USE THEREOF AS A
MEDICAMENT
LABORATOIRE FRANCAIS DU
FRACTIONNEMENT ET DES
BIOTECHNOLOGIES SOCIETE
ANONYME
FR
0512817
16/12/2005
PCT/FR/2006/002747
WO/2007/080276
0090090112
191776
CARBONYLAMINO
PYRROLOPYRAZOLES, POTENT
KINASE INHIBITORS
PFIZER PRODUCTS INC.
US
60/753349
21/12/2005
832683322
3621122338
US
PCT/IB/2006/003646
WO/2007/072153
1290090112
191777
HIGH IMPACT POLY (UPETHANE
UREA) POLYSULFIDES
PPG INDUSTRIES OHIO, INC.
US
11/360011
22/02/2006
PCT/US/2006/046649
December 29, 2008
– ‫ב' בטבת התשס"ט‬
A61K
‫דבק ביולוגי ללא תרומבין ושימוש בו‬
‫כתרופה‬
C07D
‫ מעכבי‬,‫קרבונילאמינו פירולופיראזולים‬
‫קינאז פוטנטיים‬
C08G
‫פוליאורטן–אוראה–פוליסולפידים בעלי‬
‫עמידות גבוהה לפגיעות‬
3028
WO/2007/097798
0191090111
191778
INTERVENTIONAL DEPLOYMENT
AND IMAGING SYSTEM
GYNESONICS, INC.
US
60/758881
12/01/2006
PCT/US/2007/060306
WO/2007/149595
1190090112
IMPLANT CONNECTOR
HEARTWARE, INC.
US
11/298410
PCT/US/2006/047133
WO/2007/067792
1290090112
3029
‫פריסה מתערבת ומערכת דימות‬
191779
HIGH PERFORMANCE ADSL LINE
CONDITIONER SYSTEM AND
METHOD
PHYLOGY, INC.
US
11/316781
23/12/2005
PCT/US/2006/046772
WO/2007/078570
1090090112
A61B
H04M
‫ עם‬ADSL ‫שיטה ומערכת ייצוב לקו‬
‫ביצועים גבוהים‬
191780
H01R
‫מחבר שתל‬
08/12/2005
191781
C08G
December 29, 2008
– ‫ב' בטבת התשס"ט‬
POLYURETHANES,
POLYURETHANE(UREAS)
POLYURETHANES AND SULFERCONTAINING POLYURETHANE
(UREAS) AND METHODS OF
PREPARATION
PPG INDUSTRIES OHIO, INC.
US
11/303671
16/12/2005
112232632
1821222333
US
PCT/US/2006/046634
WO/2007/078549
1190090112
,‫ פוליאורטן–אוראות‬,‫פוליאורטנים‬
–‫פוליאורטנים הכוללים גופרית ופוליאורטן‬
‫אוראות הכוללות גופרית ושיטות להכנתם‬
191782
METHOD FOR GENERATING
DENDRITIC CELLS EMPLOYING
DECREASED TEMPERATURE
DANDRIT BIOTECH A/S
DK
PA200501742 08/12/2005
PCT/DK/2006/000694
WO/2007/065439
1090090112
1290090112
– ‫ב' בטבת התשס"ט‬
C07D
,‫פירימידיל ופירימידיל הידרזונים מאוחדים‬
‫הכנתם ותכשירי רוקחות המכילים אותם‬
191784
PROCESS FOR PREPARING COATING
SLIPS FEATURING ENHANCED
WATER RETENTION AND
ENHANCED BROOKFIELD TM
VISCOSITY, USING A COMB
POLYMER HAVING AT LEAST ONE
GRAFTED POLYALKYLENE OXIDE
FUNCTION
December 29, 2008
‫שיטה לייצור תאים דנדריטיים על ידי‬
‫שימוש בטמפרטורה נמוכה‬
191783
PYRIMIDYL AND FUSED PYRIMIDYL
HYDRAZONES, THEIR PREPARATION
AND PHARMACEUTICAL
COMPOSITIONS CONTAINING THEM
LABORATOIRES SERONO SA
US
60/748575
08/12/2005
3811130153
1323222338
EP
PCT/EP/2006/069460
WO/2007/065940
C12N
D21H
‫תהליך לייצור ציפויי נייר עם יכולת שימור‬
‫משופרת במים ודביקות‬
‫ באמצעות שימוש‬BROOKFIELDTM
‫ בעל לפחות יחידה אחת‬COMB ‫בפולימר‬
‫מושתלת של פוליאלקילן אוקסיד‬
3030
COATEX S.A.S.
FR
05/12797
PCT/IB/2006/003575
WO/2007/069037
1090090112
16/12/2005
191785
FRACTAL MONOPOLE ANTENNA
ELTA SYSTEMS LTD.
US
11/293369
05/12/2005
PCT/IL/2006/001396
WO/2007/066327
1090090112
A61K
‫תכשיר רוקחות המכיל פניטיאון נתרני‬
‫ומגנזיום סטארט‬
191787
CABINET MONITORING AND
REPORTING APPARATUS AND
SYSTEM
JAROTH, INC.
US
60/741679
01/12/2005
PCT/US/2006/045804
WO/2007/064770
3031
‫אנטנה חד–קוטבית פרקטלית‬
‫אלתא מערכות בע"מ‬
191786
PHARMACEUTICAL FORMULATION
CONTAINING PHENYTOIN SODIUM
AND MAGNESIUM STEARATE
TARO PHARMACEUTICALS U.S.A.
INC.
US
60/742319
05/12/2005
PCT/US/2006/046323
WO/2007/067508
/190090112
H01Q
G06F
‫משגוח על אחסון והתקן ומערכת לדיווח‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
0190090112
191789
‫הרכבים המכילים טיגציקלין למתן דרך‬
‫הפה‬
ORAL FORMULATIONS COMPRISING
TIGECYCLINE
WYETH
US
60/753035
22/12/2005
PCT/US/2006/048621
WO/2007/075794
0091090110
191790
XANTHINE DERIVATIVES,
PRODUCTION AND USE THEREOF
AS A MEDICAMENT
BOEHRINGER INGELHEIM PHARMA
GMBH & CO. KG
DE
10109021.8 24/02/2001
1311063253
1323322331
DE
1313323352
1023622331
DE
1323236853
2323122332
DE
PCT/EP/2002/001820
WO/2002/068420
1090090112
HCV PRODRUG FORMULATION
F. HOFFMANN-LA ROCHE AG
US
60/750146
14/12/2005
832623333
1223022338
US
PCT/EP/2006/069262
WO/2007/068615
191792
OPTICAL PROJECTION SYSTEM AND
METHOD FOR A COOLED LIGHT
SOURCE
OPTIGO SYSTEMS LTD
IL
172240
29/11/2005
PCT/IL/2006/001378
WO/2007/063542
December 29, 2008
– ‫ב' בטבת התשס"ט‬
C07D
‫ ייצורן והשימוש בהן בתור‬,‫תולדות קסנטין‬
‫תרופה‬
191791
0/90090112
A61K
A61K
HCV–‫הרכב של מטרים תרופה ל‬
H01S
‫מערכת הקרנה אופטית ושיטה לקירור‬
‫מקור אור‬
‫אלתא מערכות בע"מ‬
3032
1290090112
191793
WOUND EXUDATE REMOVAL AND
ISOLATION SYSTEM
KCI LICENSING, INC.
US
60/742755
06/12/2005
PCT/US/2006/046667
WO/2007/067685
0/90090112
A61P
‫ ופמטרקסד‬ZD9474 ‫שילוב של‬
191797
COMBINATION OF AZD2171 AND
PEMETREXED
ASTRAZENECA AB
GB
0526132.6
22/12/2005
381303653
2123322338
GB
PCT/GB/2006/004768
WO/2007/071970
3033
‫מערכת להסרה ובידוד תפליטי פצעים‬
191796
COMBINATION OF ZD6474 AND
PEMETREXED
ASTRAZENECA AB
GB
0526121.9
22/12/2005
381303853
2123322338
GB
PCT/GB/2006/004750
WO/2007/071958
0/90090112
A61F
A61P
‫ ופמטרקסד‬AZD0070 ‫שילוב של‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
0090090112
191801
INCORPORATION OF PARTICULATE
ADDITIVES INTO METAL WORKING
SURFACES
FRICSO LTD.
US
11/287306
28/11/2005
PCT/IL/2006/001369
WO/2007/060673
1090090112
‫הכללת תוספים פרטיקולרים לתוך‬
‫משטחי עבודה מתכתיים‬
‫פריקסו בע"מ‬
191802
HIGH DENSITY NANOWIRE ARRAYS
IN A GLASSY MATRIX AND MEHODS
FOR DRAWINGS THE SAME
ZT3 TECHNOLOGIES, INC.
US
11/301285
09/12/2005
112233262
3321222333
US
PCT/US/2006/046500
WO/2007/070299
0090090112
0090090112
December 29, 2008
– ‫ב' בטבת התשס"ט‬
A61K
‫חומרים הקושרים קולטנים תוך גרעיניים‬
191804
SOLID DISPERSION CONTAINING
AN ACTIVE INGREDIENT AND
TABLETS FOR ORAL
ADMINISTRATION CONTAINING
THE SAME
HANMI PHARM. CO., LTD.
10-2005KR
16/12/2005
0124386
PCT/KR/2006/005526
H01L
‫מערכים צפופים של סיבי ננו במטריצת‬
‫זכוכית ושיטות להכנתם‬
191803
NUCLEAR RECEPTOR BINDING
AGENTS
GTX, INC.
US
60/739898
28/11/2005
PCT/US/2006/045451
WO/2007/062230
B24B
A61K
‫תפזורת מוצקה המכילה חומר פעיל‬
‫וטבליות למתן דרך הפה המכילות אותה‬
3034
WO/2007/069874
0190090112
191805
METHOD AND APPARATUS FOR
TREATING LIMESCALE DEPOSITS IN
WATER HEATERS IN BEVERAGE
DISPENSING MACHINES
RHEA VENDORS S.P.A.
EP
05028307.6 23/12/2005
PCT/IB/2006/003699
WO/2007/072181
0290190112
3035
‫שיטה והתקן לטיפול במשקעי אבנית‬
‫בהתקני חמום מים במכונות להספקת‬
‫משקאות‬
191806
METHOD AND DEVICE FOR
CLEANING COMPONENTS OF A
POWER STATION BY INJECTION OF
A MEDIUM AND MEASURING
DEVICE FOR MEASURING THE
DEGREE OF PURITY OF THE
MEDIUM
SIEMENS AKTIENGESELLSCHAFT
EP
05027687.2 16/12/2005
PCT/EP/2006/067791
WO/2007/071478
0/90090112
F24H
B08B
‫שיטה והתקן לניקוי רכיבים של תחנת כח‬
‫ע"י הזרקת מדיום והתקן מדידת למדידת‬
‫דרגת הניקיון של המדיום‬
191808
A61K
December 29, 2008
– ‫ב' בטבת התשס"ט‬
TARGETING OF SALL4 FOR THE
TREATMENT AND DIAGNOSIS OF
PROLIFERATIVE DISORDERS
ASSOCIATED WITH
MYELODYSPLASTIC SYNDROME
NEVADA CANCER INSTITUTE
US
60/741015
29/11/2005
PCT/US/2006/045672
WO/2007/064696
0090090112
‫ וטיפול ואיבחון של אי‬SALL4 ‫ייעוד של‬
‫סדרים הנובעים משגשוג יתר הקשור עם‬
‫סינדרום דיספלזיה של חוט השדרה‬
191809
POWDER COMPOSITIONS FOR
INHALATION
JAGOTEC AG
GB
0525254.9
12/12/2005
PCT/EP/2006/011941
WO/2007/068443
0190090112
191811
EMISSION GAS TREATING
APPARATUS
TAIYO NIPPON SANSO
CORPORATION
2006JP
11/01/2006
003554
PCT/JP/2006/322969
WO/2007/080706
0090090112
191812
TURBINE FOR FLUID METER,
PARTICULARLY WATER METER
ACTARIS S.A.S
FR
0553973
20/12/2005
PCT/FR/2006/051351
December 29, 2008
– ‫ב' בטבת התשס"ט‬
A61K
‫תכשירים אבקתיים לאינהלציה‬
B01D
‫מערכת לטיפול בפליטת גז‬
G01F
‫ בפרט מד–מים‬,‫טורבינה למדידת נוזל‬
3036
WO/2007/074270
0190090112
191814
DETECTING REPEATING CONTENT
IN BROADCAST MEDIA
GOOGLE INC.
US
60/740760
29/11/2005
832622661
2323622338
US
PCT/US/2006/045549
WO/2007/064640
0090090112
‫גילוי תוכן חוזר במדית שידור‬
191815
COMPOUNDS WITH MEDICINAL
EFFECTS DUE TO INTERACTION
WITH THE GLUCOCORTICOID
RECEPTOR
PHARMACOPEIA, INC.
US
60/752526
21/12/2005
PCT/EP/2006/069814
WO/2007/071638
0090090112
191816
G01S
‫שיטה ומערכת לאיתור פולט לא מוכר‬
‫אלתא מערכות בע"מ‬
191818
METHOD FOR ACTIVATING
PRETHROMBIN-1
ZYMOGENETICS INC.
US
60/753914
22/12/2005
PCT/US/2006/049076
3037
C07C
‫תרכובות בעלות השפעה רפואית עקב‬
‫אינטראקציה עם קולטן גלוקוקורטיקואיד‬
A METHOD AND SYSTEM FOR
LOCATING AN UNKNOWN EMITTER
ELTA SYSTEMS LTD.
IL
172267
30/11/2005
PCT/IL/2006/001370
WO/2007/063537
0090090112
H04H
C12N
0–‫שיטה לשפעול פוטרומבין‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
WO/2007/076033
0090090112
191819
INHIBITORS OF FATTY ACID AMIDE
HYDROLASE
N.V. ORGANON
US
60/755035
29/12/2005
832622600
1623622338
US
832622308
2123622338
US
832623660
3023322338
US
832620681
3221322338
US
832626032
3321322338
US
832688386
2321122338
US
112381003
2321122338
US
PCT/US/2006/049485
WO/2007/079180
0090090112
191820
ANTI-OX40L ANTIBODIES AND
METHODS USING SAME
GENENTECH, INC.
US
60/751377
16/12/2005
PCT/US/2006/062173
WO/2007/133290
1290090112
December 29, 2008
191821
– ‫ב' בטבת התשס"ט‬
C08K
‫מעכבי אמיד הידרולאז של חומצות‬
‫שומניות‬
C07K
‫ ושיטות לשימוש‬L40OX–‫נוגדנים אנטי‬
‫בהם‬
G02B
3038
TRANSPARENT SUBSTRATE
PROVIDED WITH AN
ANTIREFLECTIVE COATING
SAINT-GOBAIN GLASS FRANCE
FR
0554064
23/12/2005
PCT/FR/2006/051288
WO/2007/077373
1090090112
191823
REDUCED TRANSMITTANCE
PHOTOVOLTAIC CONVERSION
DEVICE FOR HIGH SPECTRAL
IRRADIANCE
THALES
FR
0553698
02/12/2005
PCT/FR/2006/051270
WO/2007/063261
/190090112
H01L
‫התקן המרה פוטו–וולטאי בעל העברת‬
‫שידור נמוכה עבור קרינה ספקטרלית‬
‫גבוהה‬
191824
COMPOSITIONS AND METHODS FOR
THE TREATMENT OF DISEASES AND
DISORDERS ASSOCIATED WITH
CYTOKINE SIGNALING
GENENTECH, INC.
US
60/741640
02/12/2005
832622330
1823622338
US
PCT/US/2006/061418
WO/2007/126439
0190090112
‫סובסטראט שקוף המכיל ציפוי נוגד‬
‫החזרת אור‬
C07K
‫תכשירים ושיטות לטיפול במחלות ואי‬
‫סדרים הקשורים לאיתות ציטוקיני‬
191825
F16L
‫מבנה מתאם‬
FITTING STRUCTURE
IHARA SCIENCE CORPORATION
3039
December 29, 2008
– ‫ב' בטבת התשס"ט‬
2005344460
2338-113626
JP
PCT/JP/2006/322936
WO/2007/063717
JP
29/11/2005
1223322338
0090090112
191826
METHOD FOR PRODUCING PURIFIED
FORMYLCYCLOPROPANE
COMPOUND AND INTERMEDIATE OF
SUCH FORMYLCYCLOPROPANE
COMPOUND
SUMITOMO CHEMICAL COMPANY,
LIMITED
2005JP
13/12/2005
358631
PCT/JP/2006/325141
WO/2007/069759
0090090112
191827
METHOD FOR PRODUCING OLEFIN
COMPOUND
SUMITOMO CHEMICAL COMPANY,
LIMITED
2005JP
13/12/2005
358632
PCT/JP/2006/325143
WO/2007/069761
/190090112
191830
PRINTED MULTILAYER SOLENOID
DELAY LINE
December 29, 2008
– ‫ב' בטבת התשס"ט‬
C07C
‫שיטה וייצור תרכובת מטוהרת של‬
‫פורמיציקלופרופאן ושלב הביניים של‬
‫תרכובת פורמיציקלופרופאן כזו‬
C07C
‫שיטה לייצור תרכובת אולפין‬
F16H
‫קו עיכוב סולונוידים רב–שכבתי מודפס‬
3040
AVOCENT CORPORATION
US
60/740637
30/11/2005
112833232
2321122338
US
PCT/US/2006/045775
WO/2007/064751
1190090112
191832
PYRIDIAZINONE DERIVATIVES FOR
THE TREATMENT OF TUMOURS
MERCK PATENT GMBH
DE
102005057924.8 05/12/2005
PCT/EP/2006/010668
WO/2007/065518
1090090112
A61K
–‫וירוסים כימריים בעלי שטח חלבונים לא‬
‫טבעי ושימושים שלהם‬
191837
METHOD FOR DEMETHYLATING
THE 3'-DIMETHYLAMINO GROUP OF
ERYTHROMYCIN COMPOUNDS
PFIZER INC.
US
60/748981
08/12/2005
3041
‫תולדות פירידיאזינון לטיפול בגידולים‬
191835
CHIMERIC VIRUSES PRESENTING
NON-NATIVE SURFACE PROTEINS
AND USES THEREOF
THE MOUNT SINAI SCHOOL OF
MEDICINE OF NEW YORK
UNIVERSITY
US
60/741833
02/12/2005
832632683
2223322338
US
PCT/US/2006/045859
WO/2007/064802
1090090112
C07D
C07H
–:–‫שיטה לדה–מתיליזציה של קבוצת ה‬
‫דימתילאמינו של תרכובות אריתרומיצין‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
832036636
US
112318313
US
PCT/US/2006/042796
WO/2007/067281
3621222333
3223322338
0090090112
191838
AN INTEGRATED SEGMENTATION
AND CLASSIFICATION APPROACH
APPLIED TO MEDICAL
APPLICATIONS ANALYSIS
YEDA RESEARCH AND
DEVELOPMENT CO. LTD
US
60/755393
30/12/2005
PCT/US/2006/049536
WO/2007/079207
0090090112
‫שיטה משולבת מקטעים וארגון המופעלת‬
‫על אפליקציות ניתוח רפואיות‬
191840
PREPARATION OF GAMMA-AMINO
ACIDS HAVING AFFINITY FOR THE
ALPHA-2-DELTA PROTEIN
PFIZER PRODUCTS INC.
US
60/752839
21/12/2005
PCT/IB/2006/003656
WO/2007/072159
0090090112
December 29, 2008
191841
– ‫ב' בטבת התשס"ט‬
G06K
‫ידע חברה למחקר ופיתוח בע"מ‬
C07C
‫הכנת חומצות גאמא–אמינו בעלות זיקה‬
‫–דלתא‬0–‫לחלבון אלפא‬
C07D
3042
[(1H-INDOL-5-YL)HETEROARYLOXY]-(1-AZABICYCLO[3.3.1])NONANES AS
CHOLINERGIC LIGANDS OF THE NACHR FOR THE TREATMENT OF
PSYCHOTIC AND
NEURODEGENERATIVE DISORDERS
NOVARTIS AG
GB
0525672.2
16/12/2005
PCT/EP/2006/012023
WO/2007/068476
0190090112
–0(–]‫–יל)–הטרוארילוקסי‬.–‫ –אינדול‬H 1([
‫])נונאנים כליגנדים‬0.:.:[‫אזא–ביציקלו‬
‫ לטיפול‬ACHR–N ‫כולינרגיים של‬
‫בהפרעות פסיכוטיות ונוירודגנרטיביות‬
191842
A61K
SUSTAINED RELEASE
FORMULATION COMPRISING
OCTREOTIDE AND TWO OR MORE
POLYLACTIDE-CO-GLYCOLIDE
POLYMERS
NOVARTIS AG
GB
0526247.2
22/12/2005
3811336853
1023622338
EP
PCT/EP/2006/012313
WO/2007/071395
0090090112
‫תכשיר שחרור מושהה המכיל‬
‫אוקטראוטייד ושניים או יותר פולימרי‬
‫פולילאקטיד–קו–גליקוליד‬
191843
‫מכשיר לגירוי שריר‬
MUSCLE STIMULATION APPARATUS
TREMO-TEC GMBH
DE
102005062432.4 23/12/2005
PCT/EP/2006/011316
WO/2007/079823
1090090112
3043
A63B
191844
C07D
December 29, 2008
– ‫ב' בטבת התשס"ט‬
BIS-HETEROCYCLIC IMIDAZOLYL
COMPOUNDS
SPEEDEL EXPERIMENTA AG
EP
05111907.1 09/12/2005
PCT/EP/2006/069462
WO/2007/065942
1090090112
‫תרכובות אימידאזוליל ביס–הטרוציקליות‬
191845
FOAM WAFER CONTAINING A
POLYVINYL ALCOHOLPOLYETHYLENEGLYCOL-GRAFT
COPOLYMER
LTS LOHMANN THERAPIE-SYSTEME
AG
DE
102005058569.8 08/12/2005
PCT/EP/2006/011610
WO/2007/065619
0090090112
191846
SUBSTITUTED IMIDAZOQUINOLINES
IMIDAZONAPHTHYRIDINES, AND
IMIDAZOPYRIDINES,
COMPOSITIONS, AND METHODS
COLEY PHARMACEUTICAL GROUP,
INC.
US
60/751392
16/12/2005
PCT/US/2006/048017
WO/2007/075468
December 29, 2008
– ‫ב' בטבת התשס"ט‬
A61K
–‫קצף מים המכיל פוליויניל אלכוהול‬
‫פוליאתילנגליקול–גראפט קופולימר‬
A61P
‫אימידאזוקווינולינים‬
,‫אימידאזונאפתאירידינים מותמרים‬
‫ תרכובות ושיטות‬,‫ואימידאזופירידינים‬
3044
/190090112
191847
SUBSTITUTED PHENETHYLAMINES
WITH SEROTONINERGIC AND/OR
NOREPINEPHRINERGIC ACTIVITY
AUSPEX PHARMACEUTICALS, INC.
US
60/741315
01/12/2005
832631288
2323622338
US
PCT/US/2006/045673
WO/2007/064697
1090090112
A61K
‫כוון לקוניוגטים של נשא–פוספוליפיד‬
191852
ANTIBODIES DIRECTED TO HER-3
AND USES THEREOF
U3 PHARMA AG
US
60/755103
30/12/2005
PCT/EP/2006/012632
WO/2007/077028
0091090111
‫פנתילאמינים מותמרים עם פעילות‬
‫או נורפינפרינרגית‬/‫סרוטונינרגית ו‬
191850
TARGETING VECTORPHOSPHOLIPID CONJUGATES
BRACCO INTERNATIONAL B.V.
US
60/749240
09/12/2005
832622232
2323022338
US
PCT/US/2006/061793
WO/2007/067979
0/90090112
C07C
C07K
‫ ושימושיהם‬HER–:–‫נוגדנים מכוונים ל‬
191853
A63B
‫התקן לאימון נשימה‬
BREATH TRAINING DEVICE
YAKOV ABRAMMEROVICH
GOLDSHTEIN
3045
December 29, 2008
– ‫ב' בטבת התשס"ט‬
RU
2006101896
PCT/RU/2007/000008
WO/2007/091918
24/01/2006
1090090112
191858
AMPLIFIER WITH COMPENSATED
GATE BIAS
NEDERLANDSE ORGANISATIE VOOR
TOEGEPASTNATUURWETENSCHAPPELIJK
ONDERZOEK TNO
EP
05077761.4 02/12/2005
PCT/NL/2006/000608
WO/2007/064201
1290090112
0/90090112
1090090112
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים‬
C12N
‫אינטגראציה של איחסון דוגמה וטיפול בה‬
‫לשימוש במדעי החיים‬
191865
– ‫ב' בטבת התשס"ט‬
C12M
‫מערכות ושיטות לאנליזה וטיפול בדגימות‬
‫ביולוגיות‬
191863
INTEGRATION OF SAMPLE STORAGE
AND SAMPLE MANAGEMENT FOR
LIFE SCIENCE
BIOMATRICA, INC.
US
11/291267
01/12/2005
PCT/US/2006/045661
WO/2007/075253
December 29, 2008
‫מגבר עם שער מפוצה מוטה‬
191862
SYSTEMS AND METHODS FOR
ANALYZING AND MANIPULATING
BIOLOGICAL SAMPLES
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM
US
60/751296
19/12/2005
PCT/IL/2006/001279
WO/2007/072472
H03F
A61K
3046
SUBSTITUTED 4-AMINOPYRROLOTRIAZINE DERIVATIVES
USEFUL FOR TREATING HYPERPROLIFERATIVE DISORDERS AND
DISEASES ASSOCIATED WITH
ANGIOGENESIS
BAYER HEALTHCARE LLC
US
60/741691
02/12/2005
PCT/US/2006/046081
WO/2007/064931
1090090112
‫–אמינו–פירולוטריאזין מותמרות‬4 ‫תולדות‬
‫המשמשות לטיפול באי–סדרים של‬
‫התרבות יתר ומחלות הקשורות להיווצרות‬
‫כלי–דם חדשים‬
191867
AUTONOMOUS AND AUTOMATIC
LANDING SYSTEM FOR DRONES
THALES
FR
0512257
02/12/2005
PCT/EP/2006/069198
WO/2007/063126
1090090112
3047
‫מערכת נחיתה אוטומטית ועצמאית‬
‫למטוס ללא טייס‬
191868
BIOLOGICAL MATERIALS AND USES
THEREOF
BIOINVENT INTERNATIONAL AB
GB
0525214.3
12/12/2005
PCT/EP/2006/012065
WO/2007/068485
/190090110
G05D
C07K
‫חומרים ביולוגיים ושימושיהם‬
191870
G02B
December 29, 2008
– ‫ב' בטבת התשס"ט‬
COMPOSITE MATERIAL STRUCTURE
HAVING AN EMBEDDED OPTICAL
FIBRE IN ONE OF THE SURFACE
LAYERS THEREOF AND METHOD
FOR CONNECTING AND REPAIRING
SAME
AIRBUS ESPANA, S.L.
‫מבנה חומרי מורכב בעל סיב אופטי‬
‫משובץ באחד משכבות המשטח שלו‬
‫ושיטה לחיבור ותיקון כזה‬
PCT/ES/2005/070167
WO/2007/063146
/190090110
191871
COMPOSITE MATERIAL STRUCTURE
WITH EMBEDDED OPTICAL FIBRE
AND METHOD FOR REPAIRING
SAME
AIRBUS ESPANA, S.L.
G02B
‫מבנה חומרי מורכב עם סיב אופטי משובץ‬
‫ושיטה להכנת כזה‬
PCT/ES/2005/070166
WO/2007/063145
0090090112
191872
PYRIDAZINE COMPOUND AND USE
THEREOF
SUMITOMO CHEMICAL COMPANY,
LIMITED
2005JP
07/12/2005
353177
2338-333332 2223222338
JP
PCT/JP/2006/324132
WO/2007/066601
December 29, 2008
– ‫ב' בטבת התשס"ט‬
C07D
‫תרכובת פירידאזין והשימוש מזה‬
3048
/190090112
191873
CHARGING MEMBER FOR AN IMAGE
FORMING APPARATUS
HEWLETT-PACKARD
DEVELOPMENT COMPANY, L.P.
US
11/291379
01/12/2005
PCT/US/2006/046156
WO/2007/064975
0190090112
‫טעינת איבר עבור עיצוב מתקן תדמית‬
191874
SELF-FOAMING LIQUID CULINARY
AIDS AND PROCESSES
NESTEC S.A.
EP
05027202
13/12/2005
PCT/EP/2006/068606
WO/2007/068553
0190090112
3049
A23L
‫עזרי נוזל הקצפה קולינריים ותהליכים‬
191878
GAS-PHASE PROCESS AND
APPARATUS FOR THE
POLYMERIZATION OF OLEFINS
BASELL POLIOLEFINE ITALIA S.R.L
EP
05112964.1 23/12/2005
PCT/EP/2006/068935
WO/2007/071527
0191090111
G03G
B01J
‫התקן ותהליך בפאזה גאזית לפולימריזציה‬
‫של אולפינים‬
191879
A61B
December 29, 2008
– ‫ב' בטבת התשס"ט‬
DEVICE, SYSTEM AND METHOD FOR
MIXING
BAXTER INTERNATIONAL INC.
US
60/759695
17/01/2006
PCT/US/2007/060639
WO/2007/084919
0090090112
191880
COMPOUNDS HAVING CYTOKINE
MODULATING PROPERTIES
VITAL HEALTH SCIENCES PTY LTD.
AU
2005907306 23/12/2005
2338331103
3623222338
AU
PCT/AU/2006/001997
WO/2007/070981
0090090112
191884
1290090112
C07D
‫נגזרות פירזינקרבוקסאמיד וחומרים מעכבי‬
‫מחלות צמחים המכילים אותן‬
191886
A GERMINATING UNIT AS WELL AS A
SEED TAPE INCLUDING SEVERAL OF
SUCH GERMINATING UNITS
SUCCESSIVELY ARRANGED
BENTLE PRODUCTS AG
DK
PA200501727 06/12/2005
PCT/DK/2006/000691
– ‫ב' בטבת התשס"ט‬
A61P
‫תרכובות בעלות תכונות לאפנון ציטוקיניות‬
PYRAZINECARBOXAMIDE
DERIVATIVES AND PLANT DISEASE
CONTROLLING AGENTS
CONTAINING THE SAME
NIHON NOHYAKU CO., LTD.
2005JP
22/12/2005
370863
2338-333386 2323222338
JP
2338-208831 1321322338
JP
PCT/JP/2006/326180
WO/2007/072999
December 29, 2008
‫ מערכת ושיטה לערבוב‬,‫התקן‬
A01C
‫יחידה הנבטה ובנוסף רצועת זרעים‬
‫הכוללת מספר יחידות הנבטה כאלה‬
‫מסודרות ברצף‬
3050
WO/2007/065436
0/90090112
191887
METHOD FOR THE DIAGNOSIS AND
TREATMENT OF CARDIOVASCULAR
DISEASES
SANOFI AVENTIS
EP
05026569.3 06/12/2005
PCT/EP/2006/011220
WO/2007/065562
1190090112
–‫שיטה לאבחון וטיפול במחלות קרדיו‬
‫וסקולאריות‬
191889
191891
CELL PENETRATING PEPTIDE
CONJUGATES FOR DELIVERING
NUCLEIC ACIDS INTO CELLS
DIATOS S.A.
EP
05292722.5 16/12/2005
832033332
3223122338
US
PCT/IB/2006/003642
WO/2007/069068
3051
C07D
‫תרכובות בי–ציקליות בעלות פעילות של‬
‫עיכוב קינאזות‬
BICYCLIC COMPOUNDS WITH
KINASE INHIBITORY ACTIVITY
MILLENNIUM PHARMACEUTICALS,
INC.
US
60/748369
08/12/2005
PCT/US/2006/046097
WO/2007/067444
0090090112
C12Q
A61K
‫קוניוגטים פפטידיים חודרי תאים להעברת‬
‫חומצות גרעין לתוך התא‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
1091090111
191892
2-CARBAMIDE-4-PHENYLTHIAZOLE
DERIVATIVES, PREPARATION
THEREOF AND THERAPEUTIC USE
THEREOF
SANOFI-AVENTIS
FR
0600117
06/01/2006
PCT/FR/2007/000007
WO/2007/077394
1090090112
191893
ALIGNMENT UNIT FOR
DIRECTIONAL RADIOS, IN
PARTICULAR DIRECTIONAL RADIO
ANTENNAS
HUBER-SUHNER AG
CH
1980/05
14/12/2005
PCT/CH/2006/000615
WO/2007/068131
0190090112
191894
PROCESS FOR PREPARATION OF
WATER-SOLUBLE AZOLE
PRODRUGS
EISAI R&D MANAGEMENT CO., LTD.
2005JP
20/12/2005
366862
2338-322312 3323222338
JP
PCT/JP/2006/325352
WO/2007/072851
December 29, 2008
– ‫ב' בטבת התשס"ט‬
C07D
,‫–פנילתיאזול‬4–‫–קרבאמיד‬0 ‫נגזרות של‬
‫הכנתן ושימושיהן הרפואיים‬
H01Q
‫ במיוחד אנטנות‬,‫יחידת מערך לרדיו כיווני‬
‫רדיו כיווני‬
C07F
‫תהליך להכנה פרקורסור לתרופה מסוג‬
‫אזול מסיס במים‬
3052
1090090112
PROBE CARD
NHK SPRING CO. LTD.
2005JP
351305
PCT/JP/2006/324184
WO/2007/066623
0/90090112
191896
‫כרטיס גישוש‬
05/12/2005
191897
METHOD AND SYSTEM FOR REALTIME ANALYSIS OF BIOSENSOR
DATA
UT-BATTELLE, LLC
US
11/302844
14/12/2005
PCT/US/2006/062009
WO/2007/070828
0/90190110
C12Q
‫שיטה ומערכת לאנאליזה בזמן אמת של‬
‫מידע מביוסנסור‬
191899
TRANSGENIC PLANT CELL,PLANT.
SEED AND EXPLANT AND METHOD
FOR PRODUCING A POLYPEPTIDE
THEREFROM
VERDIA, INC.
US
60/244385
30/10/2000
PCT/US/2001/046227
WO/2002/036782
3053
G01R
C12N
‫ זרע ואקספלנט טרנסגניים‬,‫ צמח‬,‫תא צמח‬
‫ושיטה להכנת פוליפפטיד מהם‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
1290090112
191900
SYSTEMS AND TECHNIQUES FOR
MINIMALLY INVASIVE
GASTROINTESTINAL PROCEDURES
CREIGHTON UNIVERSITY
US
60/742826
06/12/2005
832030833
1323122338
US
112330332
1223022338
US
PCT/US/2006/061665
WO/2007/067919
0191090111
‫מערכות וטכניקות עבור תהליכים‬
‫פולשניים מינימליים של הקיבה והמעיים‬
191902
AZAINDOLE DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
VERTEX PHARMACEUTICALS
INCORPORATED
US
60/759367
17/01/2006
832632301
3823322338
US
PCT/US/2007/001225
WO/2007/084557
1290090112
December 29, 2008
– ‫ב' בטבת התשס"ט‬
C07D
‫תולדות אזאאינדול ותכשירי רוקחות‬
‫המכילים אותן‬
191903
NUCLEAR REPROGRAMMING
FACTOR FOR A SOMATIC CELL AND
METHOD UTILIZING THE SAME
KYOTO UNIVERSITY
2005JP
13/12/2005
359537
PCT/JP/2006/324881
WO/2007/069666
A61B
C12N
‫גורם לתכנות גרעיני מחדש של תא סומטי‬
‫ושיטות המשתמשות בו‬
3054
/190090//0
191904
PHARMACEUTICAL AND
COMPOSITIONS CONTAINING A?
FRAGMENTS
NEURALAB LIMITED
US
60/067740
01/12/1997
832363303
3023321336
US
PCT/US/1998/025386
WO/1999/027944
0190190//1
C07K
‫מעכבי פרוטאיזי סירין במיוחד פרוטאיז‬
‫ תכשירי רוקחות‬,C ‫ של צהבת‬NS3 ‫ויראלי‬
‫המכילים אותם ושימוש בהם‬
191906
DECORATIVE EFFECT COATING
COMPOSITIONS AND METHODS OF
MAKING AND APPLYING SAME
UNITED STATES GYPSUM COMPANY
US
11/287036
22/11/2005
PCT/US/2006/040341
WO/2007/061533
3055
?A ‫תכשירי רוקחות המכילים קטעים של‬
191905
INHIBITORS OF SERINE PROTEASES
PARTICULARLY HEPATITIS C VIRUS
NS3 PROTEASE, PHARMACEUTICAL
COMPOSITIONS CONTAINING
THE SAME AND THE USE THEREOF
VERTEX PHARMACEUTICALS
INCORPORATED
US
60/028290
18/10/1996
PCT/US/1997/018968
WO/1998/017679
0090190112
A61K
C09D
‫תכשירי ציפוי עם אפקט דקורטיבי ושיטות‬
‫להכנתם ויישומם‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
0090090112
191907
AZEPINOINDOLE DERIVATIVES AS
PHARMACEUTICAL AGENTS
EXELIXIS, INC.
US
60/750679
15/12/2005
832033823
1321222333
US
PCT/US/2006/061928
WO/2007/070796
1190090112
‫תולדות אזפינואינדול כגורמי רוקחות‬
191910
APPLICATOR THAT IS USED TO
APPLY ONE OR MORE MATERIALS
TO A SURFACE
KIMBERLY-CLARK WORLDWIDE,
INC.
US
11/300855
15/12/2005
PCT/US/2006/046695
WO/2007/078559
0190090112
191911
– ‫ב' בטבת התשס"ט‬
A45D
‫מתקן מוליך לשם ישום והבאת חומר אחד‬
‫או יותר לפני שטח‬
VACCINE COMPRISING
STREPTOCOCCUS PNEUMONIAE
CAPSULAR POLYACCHARIDE
CONJUGATES
GLAXOSMITHKLINE BIOLOGICALS S.A.
GB
0526232.4
22/12/2005
383036053
3023322338
GB
383036652
3023322338
GB
383333252
1623322338
GB
382322856
1221322338
GB
382322058
1221322338
GB
382361351
1321322338
GB
382361853
1321322338
GB
December 29, 2008
C07D
A61K
‫חיסון המכיל תצמידים של‬
‫סטרפטוקוקוס פנאומניה קפסולר‬
‫פוליסכאריד‬
3056
GB
PCT/GB06/004634
PCT/EP/2006/069977
WO/2007/071710
1221222338
1090090112
191912
METHOD FOR CONTROLLING
ARTHROPODS
BAYER CROPSCIENCE AG
DE
102005060497.8 15/12/2005
PCT/EP/2006/011603
WO/2007/073824
0090090112
3057
H04K
‫שיטה ומערכת לתאום מקלט במערכת‬
OFDM
191915
HIGH PURITY 17?-CYANOMETHYL17?-HYDROXY-ESTRA-4,9-DIENE-3ONE AND PROCESS FOR THE
SYNTHESIS THEREOF
RICHTER GEDEON NYRT.
HU
P0501132
05/12/2005
PCT/HU/2006/000091
WO/2007/066158
0191090111
‫שיטה לבקרה על פרוקי רגליים‬
191914
METHOD AND SYSTEM FOR
SYNCHRONIZING A RECEIVER IN AN
OFDM SYSTEM
MOTOROLA, INC.
US
11/301403
13/12/2005
PCT/US/2006/047627
WO/2007/070605
0090190112
A01N
C07J
–‫?–הידרוקסי–אסטרא‬07–‫–ציאנומתיל‬07?
‫–און בעל טוהר גבוה ותהליך‬:–‫–דיאן‬6,4
‫לסינטזה שלו‬
191918
C07D
December 29, 2008
– ‫ב' בטבת התשס"ט‬
FLUVASTATIN SODIUM NOVEL
FORMS AND PREPARATION
THEREOF
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
60/778168
27/02/2006
832006338
2623222338
US
832633821
3321322338
US
PCT/US/2007/005359
WO/2007/100894
1091/90111
‫צורות חדשות של פלובסטטין סודיום‬
‫ודרכים להכנתן‬
‫טבע תעשיות פרמצבטיות בע"מ‬
191919
PROCESS FOR PREPARING A
CRYSTALLINE FORM OF
ATORVASTATIN HEMI-CALCIUM
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
60/778333
01/03/2006
PCT/US/2007/005454
WO/2007/103223
0/91090111
December 29, 2008
‫תהליך להכנת צורה קריסטלינית של‬
‫אטורבסטטין המי–קלציום‬
‫טבע תעשיות פרמצבטיות בע"מ‬
191921
A NOVEL PROCESS FOR THE
PREPARATION OF (S)-(+)-N,NDIMETHYL-3-(1NAPHTHALENYLOXY)-3-(2THIENYL)PROPANAMINE, A
DULOXETINE INTERMEDIATE
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
60/773065
13/02/2006
832068366
2023222338
US
832063263
3323322338
US
832031132
1323322338
US
832613180
1323822338
US
– ‫ב' בטבת התשס"ט‬
C07D
C07D
–‫–דימתיל‬S)–(+)–N,N( ‫תהליך חדש להכנת‬
–0(–:–)‫–נפתלנילוקסי‬0(–:
‫ חומר ביניים של‬,‫תיאניל)פרופאנאמין‬
‫דולוקסטין‬
‫טבע תעשיות פרמצבטיות בע"מ‬
3058
PCT/US/2007/003723
WO/2007/095200
019129011/
191926
NOVEL THIOPHENYLGLYCOSIDE
DERIVATIVES, METHODS FOR
PRODUCTION THEREOF,
MEDICAMENTS COMPRISING SAID
COMPOUNDS AND USE THEREOF
SANOFI-AVENTIS DEUTSCHLAND
GMBH
DE
10231370.9 11/07/2002
PCT/EP/2003/006841
WO/2004/007517
0091090111
C07D
‫נגזרות טריאזולואנילינופירימידין לשימוש‬
‫כגורמים אנטי ויראליים‬
191930
COMPOSITIONS AND METHODS FOR
INDUCING THE ACTIVATION OF
IMMATURE MONOCYTIC
DENDRITIC CELLS
NORTHWEST BIOTHERAPEUTICS,
INC.
US
60/748885
08/12/2005
PCT/US/2006/047083
WO/2007/067782
3059
,‫ שיטות לייצורן‬,‫נגזרות תיאופניל–גליקוסיד‬
‫תרופות המכילות תרכובות אלו ושימושים‬
‫שלהן‬
191928
TRIAZOLOANILINOPYRIMIDINE
DERIVATIVES FOR USE AS
ANTIVIRAL AGENTS
ARROW THERAPEUTICS LIMITED
GB
0600510.2
11/01/2006
381211853
1323822338
GB
PCT/GB/2007/000065
WO/2007/080401
1090090112
C07H
C12N
‫הרכבים ושיטות להשראת שפעול של‬
‫תאים מונוציטים דנדריטיים לא בוגרים‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
0090090112
191932
HYDROXYQUINOLINE DERIVATIVES
MERCK PATENT GMBH
DE
102005059479.4 13/12/2005
PCT/EP/2006/010902
WO/2007/068316
1090090112
191934
FORMATTING MULTI-LAYER
STORAGE MEDIA
KONINKLIJKE PHILIPS
ELECTRONICS N.V.
EP
05301011.2 06/12/2005
PCT/IB/2006/054540
WO/2007/066261
0090090112
191935
WATER-SOLUBLE BENZOAZEPINE
COMPOUND AND ITS
PHARMACEUTICAL COMPOSITION
OTSUKA PHARMACEUTICAL CO.,
LTD.
2005JP
27/12/2005
375457
PCT/JP/2006/326311
WO/2007/074915
0/90090112
191936
4,5-DIHYDRO-(1H)-PYRAZOLE
DERIVATIVES AS CANNABINOID
CB1 RECEPTOR MODULATORS
SOLVAY PHARMACEUTICALS B.V.
EP
05112482.4 20/12/2005
832031880
2321222333
US
PCT/EP/2006/069878
WO/2007/071662
December 29, 2008
– ‫ב' בטבת התשס"ט‬
C07D
‫נגזרות הידרוקסיקוינולין‬
G11B
‫פרמוט מדיית אחסון רבת שכבות‬
C07F
‫תרכובת בנזואזפין מסיסה במים ותכשיר‬
‫רוקחות שלה‬
C07D
‫)–פיראזול‬H0(–‫–דיהידרו‬.,4 ‫תולדות‬
CB0 ‫כמאפנני קולטן קאנאבינואיד‬
3060
0090090112
191939
MANIFOLD FOR USE IN
MEDICAMENT DISPENSER
GLAXO GROUP LIMITED
GB
0525237.4
12/12/2005
382233356
2221122338
GB
PCT/GB/2006/004612
WO/2007/068896
0090090112
A61M
‫סעפת לשימוש במחלק תרופות‬
191940
A61M
‫מנפק תרופות‬
MEDICAMENT DISPENSER
GLAXO GROUP LIMITED
GB
0525238.2
12/12/2005
382233253
2221122338
GB
PCT/GB/2006/004623
WO/2007/068900
0090090112
191941
A61K
‫חיסונים מצומדים‬
CONJUGATE VACCINES
GLAXOSMITHKLINE BIOLOGICALS
S.A.
GB
0526412.2
23/12/2005
383036652
3023322338
GB
PCT/EP/2006/070173
WO/2007/071786
0090090112
3061
191942
H04J
December 29, 2008
– ‫ב' בטבת התשס"ט‬
APPARATUS AND METHOD FOR
FREQUENCY PLANNING FOR A
CELLULER COMMUNICATION
SYSTEM
MOTOROLA, INC.
GB
0525433.9
14/12/2005
PCT/US/2006/045474
WO/2007/070242
1090090112
‫מערכת ושיטה לתכנון תדירות עבור‬
‫מערכת תקשורת סלולרית‬
191945
FELINE EXUDATE APPARATUS AND
METHOD
PET NOVATIONS LTD.
US
11/293178
05/12/2005
PCT/IL/2006/001400
WO/2007/066331
1190090112
‫מתקן לצואת חתולים ושיטה‬
‫פט נוביישנס בע"מ‬
191946
COMMUNICATIONS AND DATA LINK
JAMMER INCORPORATING FIBEROPTIC DELAY LINE TECHNOLOGY
SIERRA NEVADA CORPORATION
US
US60/748093 07/12/2005
PCT/US/2006/061768
WO/2007/081625
1190090112
MODELING MATERIAL AND ITS USE
J.S. STAEDTLER GMBH & CO
DE
102005059143.4 08/12/2005
PCT/EP/2006/011748
WO/2007/065675
December 29, 2008
191950
– ‫ב' בטבת התשס"ט‬
G01S
‫משבש קווי תקשורת ומידע המכיל‬
‫טכנולוגיית השהיית ערוץ סיב אופטי‬
191947
1291/90111
A01K
C08K
‫חומר לעיצוב והשימוש בו‬
H04L
3062
METHOD AND APPARATUS FOR
COMMUNICATING WITH A
WIRELESS NETWORK USING A
SINGLE ADDRESS FOR MULTIPLE
PROCESSORS
QUALCOMM INCORPORATED
US
60/779721
06/03/2006
832620833
2323322338
US
832682233
1321322338
US
112801331
2621322338
US
PCT/US/2007/063427
WO/2007/103948
0/91090112
‫שיטה ומערכת לתקשורת עם רשת‬
‫אלחוטית העושה שימוש בכתובת יחידה‬
‫למעבדים רבי חלקים‬
191951
UNIVERSAL SERIAL BUS (USB)
EXTENSION
AVOCENT CORPORATION
US
11/294563
06/12/2005
PCT/US/2006/001861
WO/2007/067191
0291090111
USB ‫התקן להארכת חיבור‬
191952
PROVIDING AN ADDRESS FORMAT
COMPATIBLE WITH DIFFERENT
ADDRESSING FORMATS USED FOR
ADDRESSING DIFFERENT SIZED
ADDRESS SPACES
IBM CORPORATION
US
11/381712
04/05/2006
PCT/EP/2007/053690
WO/2007/128652
3063
G06F
G06F
‫ התואם‬,‫קביעת פורמט לכתובת‬
‫לפורמטים אחרים של תכובות בהן נעשה‬
‫שימוש לפניה למרחבי כתובות בעלי גודל‬
‫שונה‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
1090090112
191954
PROBE CARD
NHK SPRING CO, LTD.
2005JP
351304
PCT/JP/2006/324183
WO/2007/066622
‫כרטיס גישוש‬
05/12/2005
0090090112
191955
SUBSTITUTED AROMATIC
HETEROCYCLIC COMPOUNDS AS
FUNGICIDES
SYNGENTA LIMITED
US
60/751558
19/12/2005
PCT/US/2006/048065
WO/2007/075487
1090090112
191959
1091/9011/
– ‫ב' בטבת התשס"ט‬
C12M
‫מתקן מאומת מראש התואם לתקנות‬
‫תעשיית סחורה מודולארית‬
191960
HETEROCYCLIC AROMATIC
COMPOUNDS AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
BRISTOL-MYERS SQUIBB COMPANY
US
60/408099
04/09/2002
832331833
2123022332
US
PCT/US/2003/027513
WO/2004/021984
C07D
‫תרכובות ארומטיות הטרוציקליות‬
‫מותמרות כקוטלי פטריות‬
PREVALIDATED, MODULAR GOOD
MANUFACTURING PRACTICECOMPLIANT FACILITY
ERNEST G. HOPE
US
60/742255
05/12/2005
PCT/US/2006/046615
WO/2007/067656
December 29, 2008
G01R
C07D
‫תרכובות ארומתיות הטרוציקליות ותכשירי‬
‫רוקחות המכילים אותן‬
3064
0291/90110
191962
METHOD FOR ASSESSING IF A TEST
COMPOUND IS USEFUL FOR
ALLEVIATING A PNEUMOCOCCAL
INFECTION
THE CHILDEN'S HOSPITAL OF
PHILADELPHIA
US
60/189847
16/03/2000
PCT/US/2001/008442
WO/2001/068903
0190090112
‫שיטה להערבה באם תרכובת בחינה‬
‫יעילה להקלת זיהום פנומוקוקלי‬
191963
POLYOLEFIN FILM CONTAINING
CALCIUM CARBONATE
OMYA DEVELOPMENT AG
US
60/755659
29/12/2005
PCT/US/2006/045179
WO/2007/078454
0/90090112
B32B
‫קרום מפוליאולפין המכיל סידן פחמתי‬
191967
3-(4-{[4-(4-{[3-(3,3-DIMETHYL-1PIPERIDINYL)
PROPYL]OXY}PHENYL)-1PIPERIDINYL]CARBONYL]-1NAPHTHALENYL)PROPANOIC OR
PROPENOIC ACID AS H1 AND H3
RECEPTOR ANTAGONISTS FOR THE
TREATMENT OF INFLAMMATORY
AND/OR ALLERGIC DISORDERS
GLAXO GROUP LIMITED
GB
0525897.5
20/12/2005
3065
A61K
C07D
–0–‫–דימתיל‬:,:(–:[{–4(–4[{– 4( –:
–0–)‫פיפרידיניל)פרופיל]אוקסי}פניל‬
‫–נפתלניל)חומצה‬0–}‫פיפרידיניל]קרבוניל‬
‫פרופאנואית או פרופנואית כאנטגוניסטים‬
‫או‬/‫ לטיפול בדלקת ו‬H:–‫ ו‬H0 ‫של קולטן‬
‫אי–סדרים של אלרגיה‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
382221050
GB
PCT/EP/2006/069943
WO/2007/071691
2121122338
0/90090112
191968
RECOMBINANT PRODUCTION OF
HEPARIN BINDING PROTEINS
GENENTECH, INC.
US
60/753615
22/12/2005
832630322
1323022338
US
PCT/US/2006/062320
WO/2007/130154
/190090112
191969
FLAME RETARDANT SHIELD
HONEYWELL INTERNATIONAL INC.
US
11/295081
06/12/2005
PCT/US/2006/045790
WO/2007/067405
/190090112
191970
FRAGMENT AND STAB RESISTANT
FLEXIBLE MATERIAL WITH
REDUCED TRAUMA EFFECT
HONEYWELL INTERNATIONAL INC.
US
11/295042
06/12/2005
PCT/US/2006/045791
WO/2008/048301
1290090112
191977
IMPROVED INFLUENZA VACCINE
December 29, 2008
– ‫ב' בטבת התשס"ט‬
C12N
‫ייצור רקומביננטי של חלבונים קושרי‬
‫הפרין‬
F41H
‫מגן מעכב הצתה‬
B32B
‫חומר גמיש העמיד בפני דקירה וקטיעה‬
‫עם אפקט טראומה מוקטן‬
A61K
‫חיסון משופר לשפעת‬
3066
YEDA RESEARCH AND
DEVELOPMENT CO. LTD
US
60/742574
06/12/2005
832032323
3821222333
US
PCT/IL/2006/001403
WO/2007/066334
0090090112
191980
PROCESS FLAVOURS WITH LOW
ACRYLAMIDE
DSM IP ASSETS B.V.
EP
05113023.5 28/12/2005
832033213
2621222333
US
PCT/EP/2006/012648
WO/2007/073945
1190090112
3067
‫תהליך תיבול עם אקרילאמיד מועט‬
C07D
‫תולדות דיאוקסולאן לטיפול בסרטן‬
191982
ANTIBODY BINDING TO BREAST
CANCER RESISTANCE PROTEIN
(BCRP)
UNIVERSITY OF MARYLAND,
BALTIMORE
US
60/073763
05/02/1998
PCT/US/1999/002577
WO/1999/040110
0091290110
A23J
191981
DIOXOLANE DERIVATES FOR THE
TREATMENT OF CANCER
CLAVIS PHARMA AS
NO
20055841
08/12/2005
PCT/NO/2006/000469
WO/2007/067071
1091090///
‫ידע חברה למחקר ופיתוח בע"מ‬
C07K
‫נוגדן קושר לחלבון המקנה עמידות בפני‬
)BCRP( ‫סרטן השד‬
191983
H05B
December 29, 2008
– ‫ב' בטבת התשס"ט‬
ELECTRONIC BALLAST
LUTRON ELECTRONICS CO., INC.
US
09/887848
22/06/2001
132338321
3321222331
US
PCT/US/2002/020281
WO/2003/001855
0090090112
191984
ISOQUINOLINE AMINOPYRAZOLE
DERIVATIVES, THEIR
MANUFACTURE AND USE AS
PHARMACEUTICAL AGENTS FOR
THE TREATMENT OF CANCER
F. HOFFMANN-LA ROCHE AG
EP
05027720.1 19/12/2005
PCT/EP/2006/012112
WO/2007/071348
1090090112
191985
WIRE COMB
AVOCENT CORPORATION
US
11/295441
07/12/2005
112330210
3223622338
US
112316333
1223322338
US
PCT/US/2006/046194
WO/2007/067468
0090090112
191986
MULTI-PANEL SLIDING COVER FOR
A DEVICE
WEINSTEIN MARC,
US
60/748952
09/12/2005
PCT/US/2006/061829
WO/2007/067996
1090090112
December 29, 2008
191987
– ‫ב' בטבת התשס"ט‬
‫משנק אלקטרוני‬
C07D
‫ ייצורן‬,‫תולדות איזוקווינולין אמינופיראזול‬
‫ושימושן כחומרים פרמצבטיים לטיפול‬
‫בסרטן‬
H01R
‫מסרק חוטים‬
G06F
‫מכסה מחליק בעל משטחים מרובים‬
‫לכיסוי מכשיר‬
C07D
3068
HETEROCYCLYACRYLAMIDE
COMPOUNDS AS FABI INHIBITORS
AND ANTIBACTERIAL AGENTS
AFFINIUM PHARMACEUTICALS, INC.
US
60/742514
05/12/2005
832033323
2221222333
US
PCT/US/2006/045903
WO/2007/067416
0190090112
191988
BICYCLIC HETEROCYCLES,
MEDICAMENTS CONTAINING SAID
COMPOUNDS, USE THEREOF, AND
METHOD FOR THE PRODUCTION
THEREOF
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
EP
EP05111955.0 12/12/2005
EP
EP06118305.9 3223622338
PCT/EP/2006/068598
WO/2007/068552
0090090112
C07D
,‫תרכובות הטרוציקליות ביציקליות‬
,‫תרופות המכילות את התרכובות האלה‬
‫שימושן והשיטה לייצורן‬
191989
OPTICAL DATA CARRIER, AND
METHOD FOR READING/RECORDING
DATA THEREIN
MEMPILE INC.
US
60/749044
12/12/2005
PCT/IL/2006/001425
WO/2007/069243
3069
‫תרכובות הטרוציקליאקרילאמיד בתור‬
‫ וגורמים אנטיבקטריאליים‬FABI ‫מעכבי‬
G11B
‫נשא למידע אופטי ושיטה‬
‫הקלטת המידע עליו‬/‫לקריאת‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
0090090112
191990
METHODS OF USING CD40 BINDING
AGENTS
SEATTLE GENETICS, INC.
US
60/749246
09/12/2005
832611232
3323822338
US
832611231
3323822338
US
832630223
2323322338
US
PCT/US/2006/047308
WO/2007/075326
1090090112
CD4/ ‫שיטות לשימוש בגורמים הקושרים‬
191991
191992
INHIBITORS OF CYSTEINE
PROTEASES, THE
PHARMACEUTICAL COMPOSITIONS
THEREOF AND THEIR THERAPEUTIC
APPLICATIONS
HYBRIGENICS SA
EP
05292612.8 08/12/2005
112238383
3621222333
US
PCT/IB/2006/003475
WO/2007/066200
December 29, 2008
– ‫ב' בטבת התשס"ט‬
H01R
‫מחבר חשמלי‬
ELECTRIC CONNECTOR
CONNECTEURS ELECTRIQUES
DEUTSCH
FR
0512380
06/12/2005
PCT/FR/2006/002636
WO/2007/065988
1090090112
A61K
C07D
,‫מעכבים חשים של ציסטאין פרוטאזות‬
‫תכשירי רוקחות הכוללים אותם וישומיהם‬
‫הרפואיים‬
3070
0090090112
191993
METHOD OF RECYCLING PAINTS AS
A COMPONENT OF AN IMMISCIBLE
POLYMER BLEND
RUTGERS, THE STATE UNIVERSITY
OF
NEW JERSEY
US
60/748612
09/12/2005
PCT/US/2006/061870
WO/2007/087095
0090090112
‫שיטה למיחזור צבעים כמרכיב של‬
‫תערובת פולימרית שאינה ניתנת למיזוג‬
191994
WATER-SOLUBLE FILMS
COMPRISING LOW-VISCOSITY
ALGINATES
KJELL STENBERG
SE
0502900-4
23/12/2005
PCT/SE/2006/050626
WO/2007/073346
0090090110
C08L
A61K
‫פילמים מסיסים במים המכילים אלגינטים‬
‫בעלי צמיגות נמוכה‬
191995
HYBRID 3' UNTRANSLATED
REGIONS SUITABLE FOR EFFICIENT
PROTEIN EXPRESSION IN
MAMMALIAN CELLS
RESEARCH CORPORATION
TECHNOLOGIES, INC.
C12N
‫ ' היברידים שאינם מתורגמים‬: ‫איזורים‬
‫המתאימים לביטוי חלבוני יעיל בתאים‬
‫אנושיים‬
PCT/EP/2005/013316
WO/2007/068265
3071
December 29, 2008
– ‫ב' בטבת התשס"ט‬
0090090112
191996
PHOTOVOLTAIC DEVICE AND PLANT
WITH SELECTIVE CONCENTRATION OF
THE INCIDENT RADIATION
ERIC RESEARCH S.R.L.
IT
RM2005A000635 19/12/2005
PCT/IT/2006/000850
WO/2007/072530
0/90090112
191997
INHIBITORS OF IAP
GENENTECH, INC.
US
60/751801
PCT/US/2006/062335
WO/2007/106192
‫התקן פוטווולטאי וציוד עם ריכוז‬
‫ברירתי של תקרית קרינה‬
C07D
IAP ‫מעכבים של‬
19/12/2005
1090090112
191999
TARGETING GLI PROTEINS IN
HUMAN CANCER BY SMALL
MOLECULES
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA
US
60/748968
09/12/2005
832082623
2323122338
US
112836130
3021222338
US
PCT/US/2006/047231
WO/2007/067814
0090090112
192001
MEANS AND METHODS FOR
MEDIATING PROTEIN
INTERFERENCE
VRIJE UNIVERSITEIT BRUSSEL
EP
05112761.1 22/12/2005
832032233
2221222333
US
3812316356
3121222338
EP
832602303
3121222338
US
PCT/EP/2006/070184
December 29, 2008
H01L
– ‫ב' בטבת התשס"ט‬
C07D
‫ בסרטן אנושי‬GLI ‫מציאת חלבוני‬
‫באמצעות מולקולות קטנות‬
A61K
‫אמצעים ושיטות לתיווך ממשק חלבוני‬
3072
WO/2007/071789
0/90090112
192002
C07H
‫נוקליאוזידים אנטי–ויראלים‬
ANTIVIRAL NUCLEOSIDES
PHARMASSET, INC.
US
60/749319
09/12/2005
PCT/EP/2006/069060
WO/2007/065829
1090090112
192003
NUCLEIC ACIDS AND METHODS FOR
PRODUCING SEEDS HAVING A FULL
DIPLOID COMPLEMENT OF THE
MATERNAL GENOME IN THE EMBRYO
COUNCIL OF SCIENTIFIC AND
INDUSTRIAL RESEARCH
IN
3337/DEL/2005 09/12/2005
PCT/IB/2006/003529
WO/2007/066214
0190090112
‫חומצות גרעין ושיטות לייצור זרעים‬
‫בעלי דיפלואיד משלים מלא של הגנום‬
‫האימהי בעובר‬
192004
METHOD FOR STABILISING METASTABLE
SOLUBLE ANHYDRITE III, METHOD FOR
PRODUCING A HYDRAULIC BINDER
BASED THEREON, THE OBTAINED
HYDRAULIC BINDER, THE USES THEREOF
AND AN INDUSTRIAL PLANT FOR
CARRYING OUT SAID METHOD
GYPSMIX (SARL)
WO
PCT/IB2005/004006 07/12/2005
1021322338
EP
PCT/EP06/10015
3073
C12N
C04B
III ‫שיטה לייצוב גפרית אלמיימית‬
‫ שיטה ליצור‬,‫מסיסה ברת–שינוי‬
‫חומר קישור הידראולי מבוססת על‬
,‫ חומר הקישור ההידראולי‬,‫זאת‬
‫שימושים בו ומתקן תעשייתי ליישום‬
‫השיטה‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
PCT/EP/2006/010828
WO/2007/065527
0190090112
192005
TRANSMISSION SYSTEM
PARTICULARLY USEFUL AS A
CONTINUOUSLY VARIABLE
TRANSMISSION
RAN SIMAN-TOV
US
60/597567
10/12/2005
PCT/IL/2006/001415
WO/2007/066342
1090090112
‫מערכת גיר שימושית במיוחד כמערכת גיר‬
‫משתנה המשכית‬
‫טוב‬-‫רן סימן‬
192006
ENDOTRACHEAL TUBE AND
INTUBATION SYSTEM INCLUDING
SAME
HOSPITECH RESPIRATION LTD.
US
60/741900
05/12/2005
832623111
1223022338
US
PCT/IL/2006/001401
WO/2007/066332
1190090112
December 29, 2008
– ‫ב' בטבת התשס"ט‬
A61M
‫צינור תוך–קני ומערכת הנשמה הכוללת‬
‫צינור תוך–קני‬
‫הוספיטק הנשמה בע"מ‬
192007
ISOLATED OLIGODENDROCYTELIKE CELLS AND POPULATIONS
COMPRISING SAME FOR THE
TREATMENT OF CNS DISEASES
RAMOT AT TEL-AVIV UNIVERSITY
LTD.
US
60/748219
08/12/2005
PCT/IL/2006/001410
WO/2007/066338
B60K
C12N
‫תאים דומי אוליגודנדרוציטים ושימוש בהם‬
‫לטיפול במחלות של מערכת העצבים‬
‫המרכזית‬
‫אביב בע"מ‬-‫רמות ליד אוניברסיטת תל‬
3074
0/90090112
192009
C07D
QUINAZOLINE DERIVATIVES,
PROCESS FOR THEIR PREPARATION
AND THEIR USE AS ANTI-CANCER
AGENTS
ASTRAZENECA AB
US
60/753313
22/12/2005
PCT/GB/2006/004756
WO/2007/071963
1190090112
‫ תהליך להכנתן‬,‫נגזרות קווינאזולין‬
‫והשימוש בהן כגורמים אנטי–סרטניים‬
192011
SYSTEM AND METHOD FOR
MANAGING WATER CONTENT IN A
FLUID
ADIR SEGAL, LTD
US
60/748123
07/12/2005
PCT/IB/2006/003523
WO/2007/066212
/091090111
‫מערכת ושיטה לניהול תכולת מים בנוזל‬
192012
CYLINDER/PISTON UNIT WITH AT
LEAST THREE SEALING ELEMENTS
LTS-LOHMANN THERAPIE-SYSTEME
AG
DE
102006045959.8 27/09/2006
PCT/EP/2007/007609
WO/2008/037329
0090090112
3075
E03B
A61M
‫בוכנה בעלת לפחות שלוש‬/‫יחידת גליל‬
‫גופי איטום‬
192019
C07D
December 29, 2008
– ‫ב' בטבת התשס"ט‬
HETEROARYL SUBSTITUTED
PYRROLO[2,3-B]PYRIDINES AND
PYRROLO[2,3-B]PYRIMIDINES AS
JANUS KINASE INHIBITORS
INCYTE CORPORATION
US
60/749905
13/12/2005
832613221
3223822338
US
832633823
1321322338
US
832638602
3221122338
US
832633333
1821122338
US
PCT/US/2006/047369
WO/2007/070514
0/90090112
‫]פירידינים‬B–0,:[‫התרואריל מומר פירולו‬
‫] פרימידינים כמעכבי ג'נוס‬B–0,:[ ‫ופירולו‬
‫קינאס‬
192020
METHOD AND SYSTEM FOR THE
OPTICAL INSPECTION OF A PERIODIC
STRUCTURE
ISRA VISION AG
DE
102006000946.0 07/01/2006
PCT/EP/2006/012233
WO/2007/079934
0191090111
0090090112
December 29, 2008
‫שיטה ומערכת לבדיקה האופטית של‬
‫מבנה מחזורי‬
192021
INDOLE SULFONAMIDE
MODULATORS OF PROGESTERONE
RECEPTORS
ELI LILLY AND COMPANY
US
60/761637
24/01/2006
PCT/US/2007/060626
WO/2007/087488
C07D
‫מאפנני אינדול סולפונאמיד של רצפטורים‬
‫לפרוגסטרון‬
192023
– ‫ב' בטבת התשס"ט‬
G06T
C07D
3076
COMPOUNDS AND METHODS FOR
INHIBITING THE INTERACTION OF
BCL PROTEINS WITH BINDING
PARTNERS
INFINITY PHARMACEUTICALS, INC.
US
60/750987
16/12/2005
PCT/US/2006/047861
WO/2007/075387
0090090112
192024
3,5-SUBSTITUTED PIPERIDINE
COMPOUNDS AS RENIN INHIBITORS
NOVARTIS AG
EP
05028771.3 30/12/2005
383322256
3223222338
GB
381123358
3623822338
GB
PCT/EP/2006/012581
WO/2007/077005
1090090112
C07D
–‫ ו‬: ‫תרכובות פיפרידין המותמרות בעמדות‬
‫ כמעכבי רנין‬.
192025
NOVEL N-SULFAMOYLPIPERIDINEAMIDES FOR THE
PROPHYLAXIS OR TREATMENT OF
OBESITY AND RELATED
CONDITIONS
SOLVAY PHARMACEUTICALS GMBH
EP
05111882.6 09/12/2005
PCT/EP/2006/069482
WO/2007/065948
3077
‫תרכובות ושיטות לעיכוב הקישור של‬
‫ עם שותפים לקשר‬BCL ‫חלבוני‬
C07D
‫–סולפאמואיל–פיפרידינאמידים חדשים‬N
‫לטיפול מונע או טיפול בהשמנה ותנאים‬
‫קשורים‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
1091/90112
192026
SYSTEM FOR PARKING MANAGEMENT
KEY-CHANG KHIM
KR
1020050118058 06/12/2005
PCT/KR/2006/003586
WO/2007/066877
0090090112
192027
CONTAINER SYSTEM FOR
RELEASABLY STORING A
SUBSTANCE
DNA GANOTEK INC
US
60/748977
09/12/2005
PCT/CA/2006/002009
WO/2007/068094
1090090112
192029
REFRIGERATOR MAGNET WITH
CLIPPING ACTION
MEIR AMIRAM
US
60/748918
08/12/2005
PCT/US/2006/047037
WO/2007/120233
1090090112
192030
STEAM FLOOR BRUSH
EURO-PRO OPERATING, LLC
CN
20120479.9 10/12/2005
PCT/CN/2006/003342
WO/2007/065371
1290090112
December 29, 2008
192032
– ‫ב' בטבת התשס"ט‬
G08G
‫מערכת לניהול חניה‬
A61B
‫מערכת מיכל לאחסון המאפשר שחרור‬
‫של חומר‬
A47G
‫מגנט הפועל כתפס לדופן מקרר‬
‫מאיר עמירם‬
A47L
‫מברשת קיטור לרצפה‬
A61N
3078
MULTI-ROTATOR MAGNETIC
RESONATOR EMBODYING SACRED
GEOMETRY
SHALLCROSS KIM
CA
2,526,977
06/12/2005
PCT/CA/2006/001984
WO/2007/065257
0/90090112
192033
ARYLPROPIONAMIDE,
ARYLACRYLAMIDE,
ARYLPROPYNAMIDE, OR
ARYLMETHYLUREA ANALOGS AS
FACTOR XIA INHIBITORS
BRISTOL-MYERS SQUIBB COMPANY
US
60/750130
14/12/2005
832621182
3223622338
US
832683211
1321122338
US
PCT/US/2006/062005
WO/2007/070826
0090090112
C07D
,‫אנלוגים של ארילפרופיונאמיד‬
‫ ארילפרופינאמיד או‬,‫ארילאקרילאמיד‬
XIA ‫ארילמתילאוריאה כמעכבים לפקטור‬
192034
POLYCYCLIC INDAZOLE
DERIVATIVES THAT ARE ERK
INHIBITORS
SCHERING CORPORATION
US
60/749856
13/12/2005
PCT/US/2006/046959
3079
‫רזונטור מגנטי עם רוטטור רב צירי ובמבנה‬
‫עם גאומטריה מיוחדת‬
C07D
‫נגזרות אינדול פוליציקליות שהן מעכבות‬
ERK–‫ל‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
WO/2007/070398
0090090112
192035
ASSESSMENT OF DIAMOND COLOR
PLATFORM DEVELOPMENT &
INVESTMENT LTD
US
60/749085
12/12/2005
PCT/IL/2006/001424
WO/2007/069242
1290090112
192036
EMAIL ANTI-PHISHING INSPECTOR
DIGITAL ENVOY INC.
US
11/298370
09/12/2005
PCT/US/2006/046665
WO/2007/070323
0090090112
192039
INTEGRATED SELF CONTAINED
SENSOR ASSEMBLY
WISPI. NET
US
60/750151
14/12/2005
PCT/US/2006/047694
WO/2007/070634
1290090112
192041
SYNTHETIC GENOMES
THE J. CRAIG VENTER INSTITUTE
US
60/742542
06/12/2005
PCT/US/2006/046803
WO/2008/024129
0090090112
December 29, 2008
192044
– ‫ב' בטבת התשס"ט‬
G01N
‫בדיקת צבע של יהלום‬
‫פלטפורמה פיתוח והשקעות בע"מ‬
G06F
‫בודק דואר אלקטרוני נגד פישינג‬
H01M
‫מכלול עצמי של חיישנים משולבים‬
C07H
‫גנומים סנתטיים‬
G06F
3080
SYSTEM AND METHOD FOR
PROVIDING NETWORK SECURITY
TO MOBILE DEVICES
YOGGIE SECURITY SYSTEMS, LTD.
US
60/750326
13/12/2005
112208313
1323222338
US
PCT/IL/2006/001428
WO/2007/069245
0090090112
‫תרכובות כנגד גידולים‬
A61K
‫שברי מעי פפטיד ואזואקטיבי ושיטות‬
‫שימוש‬
192047
ORGAN PRESERVATION AND/OR
PERFUSION
PHILADELPHIA COLLEGE OF
OSTEOPATHIC MEDICINE
US
60/748645
09/12/2005
112231833
2323122338
US
PCT/US/2006/047152
WO/2008/051247
3081
C07D
192046
VIP FRAGMENTS AND METHODS OF
USE
VECTUS BIOSYSTEMS LIMITED
AU
2005906947 09/12/2005
PCT/AU/2006/001869
WO/2007/065226
0090090112
‫ בע"מ‬,‫יוגי מערכות בטחון‬
192045
ANTITUMOUR COMPOUNDS
PHARMA MAR, S.A.
ES
P200503092 15/12/2005
PCT/ES/2006/000687
WO/2007/068776
1090090112
‫מערכת ושיטה לאספקת בטחון רשת‬
‫לאמצעים ניידים‬
A61K
‫או פרפוזיה של איבר‬/‫שימור ו‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
0090090112
192053
‫–אדמנטילאוריה כמעכבים‬0 ‫נגזרות‬
HSD–?110 ‫סלקטיביים של‬
2-ADAMANTYLUREA DERIVATIVES
AS SELECTIVE 11?-HSD1 INHIBITORS
MERCK PATENT GMBH
EP
05292724.1 16/12/2005
PCT/EP/2006/011156
WO/2007/068330
0090090112
192054
METHOD FOR ASSIGNING ONE OR
MORE CATEGORIZED SCORES TO
EACH DOCUMENT OVER A DATA
NETWORK
GROIS INNA
IL
172551
13/12/2005
PCT/IL/2006/001427
WO/2007/069244
0090090112
METHOD FOR ENABLING A USER TO
VOTE FOR A DOCUMENT STORED
WITHIN A DATABASE
GROIS INNA
IL
172551
13/12/2005
PCT/IL/2006/001427
WO/2007/069244
192056
ANTIBACTERIAL
PYRROLOPYRIDINES,
PYRROLOPYRIMIDINES, AND
PYRROLOAZEPINES
ASTRAZENECA AB
US
60/753527
23/12/2005
PCT/GB/2006/004760
WO/2007/071965
December 29, 2008
– ‫ב' בטבת התשס"ט‬
G06F
‫שיטה למתן אחד או יותר ציונים לפי סוגים‬
‫לכל מסמך ברשת נתונים‬
192055
0/90090112
C07C
‫גרוייס דן‬
G06F
‫שיטה המאפשרת למשתמש להצביע‬
‫עבור מסמך השמור בתוך בסיס נתונים‬
‫גרוייס דן‬
C07D
‫ פירולופירימידינים‬,‫פירולופירידינים‬
‫ופירולואזפינים אנטי–בקטריאליים‬
3082
/190090112
192057
C12Q
AUTOMATIC CHARACTERIZATION
OF PATHOLOGICAL SPECIMEN
APPLIED SPECTRAL IMAGING LTD.
US
60/749589
13/12/2005
112363363
3323022338
US
PCT/IL/2006/001382
WO/2007/069233
1190090112
‫אפלייד ספקטרל אימג'ינג בע"מ‬
192059
MANGANESE OXIDE-CERIUM OXIDE
COMPOSITE
BEN GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY
IL
172552
13/12/2005
PCT/IL/2006/001407
WO/2007/069238
1090090112
‫אפיון אוטומטי של דוגמא פתולוגית‬
C01F
‫הרכב של תחמוצת מנגנז ותחמוצת צריום‬
‫ הרשות‬,‫גוריון בנגב‬-‫אוניברסיטת בן‬
‫למחקר ופיתוח‬
192061
‫תולדות דיפניל אוריאה‬
DIPHENYL UREA DERIVATIVES
ARPIDA AG
EP
PCT/EP05/013345 13/12/2005
PCT/EP/2006/011795
WO/2007/068395
1090090112
3083
C07C
192062
December 29, 2008
C07D
– ‫ב' בטבת התשס"ט‬
NOVEL, ACYCLIC SUBSTITUTED
FUROPYRIMIDINE DERIVATIVES AND
USE THEREOF FOR TREATING
CARDIOVASCULAR DISEASES
BAYER HEALTHCARE AG
DE
102005061170.2 21/12/2005
PCT/EP/2006/011826
WO/2007/079862
1091090111
192063
0090090112
C07D
‫אימידזולים מותמרים ושימוש בהם כקוטלי‬
‫מזיקים‬
SUBSTITUTED IMIDAZOLES AND
THEIR USE AS PESTICIDES
PFIZER LIMITED
US
60/760765
19/01/2006
PCT/IB/2007/000071
WO/2007/083207
192065
NOVEL POLYUNSATURATED
COMPOUNDS, METHOD FOR
PREPARING SAME AND
COMPOSITIONS CONTAINING SAME
PIERRE FABRE DERMOCOSMETIQUE
FR
0512661
14/12/2005
PCT/EP/2006/069731
WO/2007/068745
0090090112
C07H
‫ שיטה‬,‫תרכובות מרובות אי–רויון חדשות‬
‫להכנתן ותכשירים המכילים אותן‬
192066
IMPROVED METHOD FOR THE
PRODUCTION OF RAMIPRIL
SANOFI-AVENTIS DEUTSCHLAND
GMBH
DE
102005061756.5 21/12/2005
PCT/EP/2006/011891
WO/2007/079871
December 29, 2008
‫תולדות חדשות של פורופירימידין‬
‫מותמרות באציקליים ושימוש בהן‬
‫לטיפול במחלות כלי דם‬
– ‫ב' בטבת התשס"ט‬
C07C
‫שיטה משופרת לייצור של רמיפריל‬
3084
0190090112
192068
‫מיכל עם מכסה לאריזת מוצרים ברי‬
‫מזיגה‬
CONTAINER WITH LID FOR
PACKAGING POURABLE PRODUCTS
BALL PACKAGING EUROPE GMBH
DE
102005060835.3 20/12/2005
PCT/DE/2006/002291
WO/2007/076827
0090090112
192072
DEVICE, SYSTEM AND METHOD FOR
THE SURFACE TREATMENT OF
SUBSTRATES
GEBR. SCHMID GMBH & CO.
DE
102005062528.2 16/12/2005
PCT/EP/2006/012116
WO/2007/073886
0090090112
3085
B05C
‫ מערכת ושיטה לטיפול בפני‬,‫התקן‬
‫שטח של מצעים‬
192073
APPARATUS, METHOD AND SYSTEM
FOR CONTROL OF AC/AC
CONVERSION
POWEROFFER
US
60/749045
12/12/2005
PCT/IL/2006/001420
WO/2007/069239
0090090112
B65D
H03B
‫מכשיר שיטה ומערכת לבקרת המרת זרם‬
‫זרם חילופין‬/‫חילופין‬
192077
A01H
December 29, 2008
– ‫ב' בטבת התשס"ט‬
INCREASED SEED SIZE AND SEED
NUMBER THROUGH TRANSGENIC
OVER EXPRESSION OF A GROWTH
AND/OR DEVELOPMENT RELATED
GENE DURING EARLY EMBRYO
DEVELOPMENT
TARGETED GROWTH, INC.
US
60/750991
15/12/2005
PCT/US/2006/062200
WO/2007/079353
1/90090111
‫הגברה של גודל וכמות הזרעים דרך ביטוי‬
‫או‬/‫יתר טרנסגני של גן הקשור לגדילה ו‬
‫התפתחות בזמן התפתחות עוברית‬
‫מוקדמת‬
192078
RECOMBINANT ?-LIDURONIDASE,METHODS FOR
PRODUCING AND PURIFYING THE
SAME AND METHODS FOR
TREATING DISEASES CAUSED BY
DEFICIENCIES THEREOF
LOS ANGELES BIOMEDICAL
RESEARCH INSTITUTE AT HARBORUCLA MEDICAL CENTER
US
09/439923
21/11/1999
PCT/US/2000/031293
WO/2002/004616
/19119011/
192079
POWDER INHALER
CHIESI FARMACEUTICI S.P.A.
EP
02016908.2 31/07/2002
PCT/EP/2003/008432
WO/2004/012801
December 29, 2008
– ‫ב' בטבת התשס"ט‬
C12N
‫אלפא–אל–אידורונידאז‬
A61M
‫משאף אבקה‬
3086
1090090112
192081
NOVEL, CYCLIC SUBSTITUTED
FUROPYRIMIDINE DERIVATIVES AND
USE THEREOF FOR TREATING
CARDIOVASCULAR DISEASES
BAYER HEALTHCARE AG
DE
102005061171.0 21/12/2005
PCT/EP/2006/011825
WO/2007/079861
0090090112
‫תולדות חדשות של פורו פירימידינים‬
‫מותמרים בטבעות והשימוש בהן‬
‫לטיפול במחלות כלי דם‬
192082
MILK MINERAL WATER, PROCESSES
FOR MANUFACTURING THEREOF
AND BEVERAGES CONTAINING
MILK MINERAL WATER
ARLA FOODS AMBA
US
60/750401
15/12/2005
832633338
1323322338
US
832622133
2123022338
US
PCT/DK/2006/000717
WO/2007/068253
0190090112
C07D
A23L
‫ תהליכים להכנתו‬,‫חלב מים מינרלים‬
‫ומשקאות המכילים חלב מים מינרלים‬
192084
‫חיסון‬
VACCINE
GLAXOSMITHKLINE BIOLOGICALS S.A.
GB
0526232.4
22/12/2005
383036053
3023322338
GB
383036652
3023322338
GB
383333252
1623322338
GB
382322856
1221322338
GB
382322058
1221322338
GB
382361351
1321322338
GB
382361853
1321322338
GB
GB
PCT/GB06/004634 1221222338
3087
A61K
December 29, 2008
– ‫ב' בטבת התשס"ט‬
PCT/EP/2006/069979
WO/2007/071711
0190090112
192085
‫מיסוך טעם של אבקות‬
MASKING THE TASTE OF POWDERS
BAYER TECHNOLOGY SERVICES
GMBH
DE
102005062270.4 24/12/2005
PCT/EP/2006/012284
WO/2007/073911
0090090112
192086
IMMUNOGLOBULINS DIRECTED
AGAINST NOGO
GLAXO GROUP LIMITED
GB
0525662.3
16/12/2005
PCT/EP/2006/069737
WO/2007/068750
1290090112
MULTIFUNCTIONAL DETONATION
SYSTEM
ERNEST FRIEDEN
EP
05027055.2 12/12/2005
PCT/EP/2006/011711
WO/2007/068386
December 29, 2008
– ‫ב' בטבת התשס"ט‬
F42B
‫מערכת דנוטציה רבת–פונקציות‬
192090
A POROUS MEMBRANE DEVICE
THAT PROMOTES THE
DIFFERENTIATION OF MONOCYTES
INTO DENDRITIC CELLS
VAXDESIGN CORPORATION
C07K
NOGO ‫אימונוגלובולינים מיועדים נגד‬
192087
0090090112
A61K
C12N
‫מתקן ממברנה מחוררת המעודד‬
‫התמיינות של מונוציטים לתאים דנדריטים‬
3088
US
60/752033
PCT/US/2006/049128
WO/2007/076061
0090090112
21/12/2005
192091
A61K
‫תכשירים רפואיים‬
PHARMACEUTICAL COMPOSITIONS
ARCHIMEDES DEVELOPMENT
LIMITED
GB
0525461.0
15/12/2005
PCT/GB/2006/004710
WO/2007/068948
0/90090112
192092
ARYL-ISOXAZOLO-4-YLOXADIAZOLE DERIVATIVES
F. HOFFMANN-LA ROCHE AG
EP
05112956.7 23/12/2005
PCT/EP/2006/069625
WO/2007/071598
0190090112
–‫–יל‬4–‫תולדות אריל–איזוקסאזולו‬
‫אוקסאדיאזול‬
192093
PYRIMIDINYL ARYL UREA
DERIVATIVES BEING FGF
INHIBITORS
NOVARTIS AG
US
60/752711
21/12/2005
PCT/EP/2006/070046
WO/2007/071752
0090090112
C07D
C07D
‫תולדות פירימידיניל אריל אוריאה שהינן‬
FGF ‫מעכבות‬
192094
B65D
‫הרכבת מיכל‬
CONTAINER ASSEMBLY
WYCHWOOD ESTATES PTY LTD
AU
2005907052 16/12/2005
PCT/AU/2006/001896
3089
December 29, 2008
– ‫ב' בטבת התשס"ט‬
WO/2007/068052
0090090112
192095
METHODS FOR OBTAINING
IMMORTALIZED ANTIBODY SECRETING
CELLS
RIBOVAX BIOTECHNOLOGIES S.A.
EP
PCT/EP/2005/056871 16/12/2005
PCT/EP/2006/069780
WO/2007/068758
0090090112
192096
FSH MUTANTS, THEIR
PREPARATION AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THEM
LABORATOIRES SERONO SA
US
60/753637
22/12/2005
PCT/US/2006/048898
WO/2008/010840
0090090112
192097
SOLUBLE IL-17RC VARIANT, ITS
PREPARATION AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THEM
LABORATOIRES SERONO SA
EP
05112854.4 22/12/2005
832033333
1023122338
US
PCT/EP/2006/012467
WO/2007/071439
0/90090112
December 29, 2008
192098
– ‫ב' בטבת התשס"ט‬
C12N
‫שיטות להשגת תאים מפרישי נוגדן‬
‫החיים לנצח‬
C07K
‫ הכנתם ותכשירי‬,FSH ‫מוטנטים של‬
‫רוקחות המכילים אותם‬
C07K
‫ הכנתו‬RC17–IL ‫וריאנט מסיס של‬
‫ותכשירי רוקחות המכילים אותו‬
C12N
3090
COMPOSITIONS AND METHODS FOR
PRODUCING A COMPOSITION
BRISTOL-MYERS SQUIBB COMPANY
US
60/752267
20/12/2005
832032133
2321222333
US
832633332
3321322338
US
PCT/US/2006/049074
WO/2007/076032
0/90090112
192102
1,3-OXAZOLIDIN-2-ONE
DERIVATIVES USEFUL AS CETP
INHIBITORS
MERCK & CO., INC.
US
60/755284
30/12/2005
PCT/US/2006/049494
WO/2007/079186
0/90090112
‫–און‬0–‫–אוקסזולידין‬:,0 ‫נגזרות של‬
CETP–‫המשמשות כמעכבים ל‬
A61K
‫פורמולציות עמידות של חלבון‬
192105
MACROCYCLIC FACTOR VIIA
INHIBITORS USEFUL AS
ANTICOAGULANTS
BRISTOL-MYERS SQUIBB COMPANY
US
60/753786
23/12/2005
832683303
1221122338
US
3091
C07D
192104
STABLE PROTEIN FORMULATIONS
BRISTOL-MYERS SQUIBB COMPANY
US
60/752150
20/12/2005
PCT/US/2006/062297
WO/2007/076354
0090090112
‫תכשירים ושיטות לייצור תרכובת‬
C07D
‫תרכובות מאקרוציקליות כמעכבים‬
‫ שימושיות כנוגדי קרישה‬VIIA ‫לפקטור‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
PCT/US/2006/062469
WO/2007/076431
0090090112
192108
‫טריאזולופירידזינים כמודולטורים לטירוזין‬
‫קינאז‬
TRIAZOLOPYRIDAZINES AS
TYROSINE KINASE MODULATORS
JANSSEN PHARMACEUTICA N.V.
US
60/752634
21/12/2005
PCT/US/2006/048241
WO/2007/075567
0090090112
192110
EXAMPLE BASED 3D
RECONSTRUCTION
YEDA RESEARCH AND
DEVELOPMENT CO. LTD
US
60/750054
14/12/2005
832626182
1023622338
US
PCT/IL/2006/001442
WO/2007/069255
0/91090110
0090090112
December 29, 2008
‫ידע חברה למחקר ופיתוח בע"מ‬
– ‫ב' בטבת התשס"ט‬
C07K
‫חלבונים קולטנים אנושיים; מגיבים כימיים‬
‫ושיטות הקשורים להם‬
192112
COMPOSITIONS AND ARTICLES FOR
DETECTION OF ANALYTES
EXCEEDING A PRESET-TERESHOLD
COMMON SENSE LTD.
G06F
‫שיחזור תלת–מימדי בעזרת דוגמאות‬
192111
HUMAN RECEPTOR PROTEINS;
RELATED REAGENTS AND
METHODS
SCHERING CORPORATION
US
60/207558
25/05/2000
PCT/US/2001/016766
WO/2001/090151
C07D
G01N
‫תכשירים ומוצרים לגילוי של אנליטים‬
‫שריכוזם עובר סף שנקבע מראש‬
‫קומונסנס בע"מ‬
3092
US
60/749043
832006633
US
PCT/IL/2006/001422
WO/2007/069240
12/12/2005
3823222338
0/90090112
192117
SYSTEMS AND METHODS FOR
PROCESSING DATA FLOWS
CROSS-BEAM SYSTEMS, INC.
US
60/749915
13/12/2005
832033883
1321222333
US
832033663
2023322338
US
832033036
2023322338
US
832033668
2023322338
US
832033030
2023322338
US
832033012
2023322338
US
PCT/US/2006/062053
WO/2007/070838
0090090112
WATER HAMMER-LESS VALVE
KABUSHIKI KAISHA FUJIKIN
3093
‫מערכות ושיטות לעיבוד העברת נתונים‬
192119
NOVEL CANCER -ASSOCIATED
ANTIGEN
VIVENTIA BIOTECH INC.
US
60/751965
21/12/2005
PCT/CA/2006/002101
WO/2007/071051
/091190112
G06F
C12N
‫אנטיגן חדש הקשור לסרטן‬
192120
F16K
‫שסתום נטול מכת פטיש‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
2005368730
PCT/JP/2006/315179
WO/2007/072602
JP
21/12/2005
0/91090111
192121
‫טפול בתסמונת מועקת נשימה‬
‫אקוטית‬
TREATMENT OF ACUTE RESPIRATORY
DISTRESS SYNDRDME
ONY, INC
US
60/761250
23/01/2006
WO
PCT/US06/02423 2223122338
PCT/US/2007/060902
WO/2007/087524
0090090112
192122
PATTERN FORMATION METHOD
AND PATTERN FORMATION
APPARATUS, EXPOSURE METHOD
AND EXPOSURE APPARATUS, AND
DEVICE MANUFACYURINGN
METHOD
NIKON CORPORATION
2005JP
28/12/2005
379948
PCT/JP/2006/326249
WO/2007/077926
0090090112
December 29, 2008
H01L
,‫שיטה לזיהוי דוגמא ומתקן ליצור דוגמא‬
‫שיטה ומתקן חישוף ושיטה ליצור המתקן‬
192123
– ‫ב' בטבת התשס"ט‬
A61K
H01L
3094
PATTERN FORMING METHOD,
PATTERN FORMING APPARATUS,
AND DEVICE MANUFACTURING
METHOD
NIKON CORPORATION
2005JP
28/12/2005
377706
PCT/JP/2006/326248
WO/2007/077925
0090090112
‫שיטה ליצור דוגמא ושיטה לייצור המתקן‬
192126
‫תכשירים קוטלי חרקים בעלי השפעה‬
‫משופרת‬
INSECTICIDAL COMPOSITIONS
HAVING IMPROVED EFFECT
BAYER CROPSCIENCE AG
DE
102005059469.7 13/12/2005
PCT/EP/2006/011912
WO/2007/068428
0090090112
192127
ENDOPROSTHESIS WITH
INTERMEDIATE PART
Waldemar Link GmbH & Co.KG
US
60/749103
12/12/2005
832033303
3223122338
US
PCT/EP/2006/011937
WO/2007/068440
0/90090112
A61F
‫תותב פנימי לקרסול–מפרק הירך‬
192128
PIPERAZINE COMPOUNDS WITH A
HERBICIDAL ACTION
BASF SE
EP
06000013.0 02/01/2006
PCT/EP/2006/070271
3095
A01N
C07D
‫תרכובות פיפראזיניות עם פעילות קוטלת‬
‫עשבים‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
WO/2007/077201
0090090112
192129
ANTI-MN ANTIBODIES AND
METHODS OF USING SAME
BAYER HEALTHCARE LLC
US
60/749716
12/12/2005
PCT/US/2006/047445
WO/2007/070538
0090190112
‫ ושיטות לשימוש בהם‬MN–‫נוגדנים אנטי‬
192131
PEPTIDES USEFUL AS CELLPENETRATING PEPTIDES
EVONIK ROHM GMBH
EP
05028755.6 30/12/2005
PCT/EP/2006/010271
WO/2007/076904
0091090111
6-PHENYL-1H-IMIDAZO[4,5C]PYRIDINE-4-CARBONITRILE
DERIVATIVES AS CATHEPSIN K AND
S INHIBITORS
N.V. ORGANON
EP
06100357.0 16/01/2006
PCT/EP/2007/050356
WO/2007/080191
192135
LOW-CARBOHYDRATE MILK WITH
ORIGINAL CALCIUM
ARLA FOODS AMBA
US
60/756213
05/01/2006
PCT/DK/2007/000005
December 29, 2008
– ‫ב' בטבת התשס"ט‬
C07K
‫פפטידים המשמשים כפפטידים החודרים‬
‫לתאים‬
192133
1091090111
C07K
C07D
–.,4[‫–אימידאזו‬H0–‫–פניל‬9 ‫תולדות‬
‫–קרבוניטריל כמעכבות‬4–‫]פירידין‬C
S–‫ ו‬K ‫קאתפסין‬
A23C
‫חלב המכיל כמות מועטה של‬
‫קרבוהידראט וסידן טבעי‬
3096
WO/2007/076873
1090190110
192136
G06F
METHOD AND APPARATUS FOR
DATA
PROCESSING
MAXIMUM AVAILABILITY LIMITED
NZ
507386
09/10/2000
PCT/NZ/2001/000206
WO/2002/031696
109109011/
‫שיטה והתקן לעיבוד מידע‬
192137
FORMULATIONS USEFUL IN THE
TREATMENT OF MALE AND FEMALE
IMPOTENCE
INDENA S.P.A.
IT
MI2002A000994 10/05/2002
PCT/EP/2003/004611
WO/2003/094944
/19109011/
‫תכשיר המשמש לטיפון באין–אונות‬
‫אצל גברים ונשים‬
192138
FORMULATIONS USEFUL IN THE
TREATMENT OF MALE AND FEMALE
IMPOTENCE
INDENA S.P.A.
IT
MI2002A000990 10/05/2002
PCT/EP/2003/004528
WO/2003/094943
0090090112
A61P
B05D
‫הרכבים יעלים לטיפול באין אונות‬
‫גברית ונשית‬
192139
H01Q
‫משושת מערך צורני‬
PHASED ARRAY ANTENNA
SELEX SENSORS AND AIRBORNE
SYSTEMS LIMITED
GB
0526219.1
23/12/2005
3320313352
2221222333
EP
3097
December 29, 2008
– ‫ב' בטבת התשס"ט‬
PCT/GB/2006/050454
WO/2007/072074
0090090112
192141
ANTIBODY CHARACTERIZATION
TEST
LABORATOIRE FRANCAIS DU
FRACTIONNEMENT ET DES
BIOTECHNOLOGIES
FR
0512813
16/12/2005
PCT/FR/2006/002744
WO/2007/080274
0/91090111
‫מבחן אפיון נוגדנים‬
192142
METHOD AND APPARATUS FOR
ERROR RESILIENCE ALGORITHMS
IN WIRELESS VIDEO
COMMUNICATION
QUALCOMM INCORPORATED
US
60/760678
20/01/2006
832083033
2323122338
US
PCT/US/2007/060794
WO/2007/085000
0090090112
ALUMINA PARTICLES AND
METHODS OF MAKING THE SAME
W.R. GRACE & CO. CONN
US
60/749380
12/12/2005
PCT/US/2006/047340
WO/2007/070498
192144
COMBINATION COMPRISING
COMBRETASTATIN AND
ANTICANCER AGENTS
December 29, 2008
– ‫ב' בטבת התשס"ט‬
H04N
‫שיטה ומערכת לאלוגריתם גמיש לטעויות‬
‫בתקשורת וידאו אלחוטית‬
192143
0090090112
G01N
C01F
‫גרגרי תחמוצת אלום ושיטות של עשיית‬
‫כאלה‬
A61K
‫קומבינציה המכילה קומברטסטטין‬
‫וחומרים נוגדי סרטן‬
3098
AVENTIS PHARMA S.A.
FR
0513114
PCT/FR/2006/002771
WO/2007/077309
0090090112
22/12/2005
192145
METHOD FOR PREPARING
ANTIBODIES SELECTIVE FOR
ACTIVATING FC RECEPTORS
LABORATOIRE FRANCAIS DU
FRACTIONNEMENT ET DES
BIOTECHNOLOGIES
FR
0512812
16/12/2005
PCT/FR/2006/002748
WO/2007/080277
0090090112
3099
‫שיטות להכנת נוגדנים סלקטיביים‬
FC ‫לשפעול של רצפטורי‬
192147
METHOD FOR SELECTIVELY
PRODUCING PRIMARY AMINE
COMPOUND
SUMITOMO CHEMICAL COMPANY,
LIMITED
2005JP
15/12/2005
361489
PCT/JP/2006/324938
WO/2007/069685
0090090112
C12P
C07C
‫שיטה עבור ייצור ראשוני סלקטיבי של‬
‫תרכובת אמין‬
192149
A61K
December 29, 2008
– ‫ב' בטבת התשס"ט‬
STABLE S-NITROSOTHIOL
FORMULATIONS
N30 PHARMACEUTICALS, LLC
US
60/754071
21/12/2005
PCT/US/2006/049114
WO/2007/076053
1091090111
192150
THERAPEUTIC AGENT FOR
INFLAMMATORY BOWEL DISEASE
CONTAINING AS ACTIVE
INGREDIENT 2-AMINO-1,3PROPANEDIOL DERIVATIVE, OR
METHOD FOR TREATING
INFLAMMATORY BOWEL DISEASE
KYORIN PHARMACEUTICAL CO.,
LTD.
2006JP
06/02/2006
027883
PCT/JP/2007/051887
WO/2007/091501
0090090112
– ‫ב' בטבת התשס"ט‬
A61K
‫גורם רפואי למחלת המעי הדלקתי המכיל‬
,‫–פרופאנאדיול‬0,:–‫–אמינו‬0 ‫כמרכיב פעיל‬
‫או שיטה לטיפול מחלת המעי הדלקתי‬
192151
METHOD FOR PRODUCING PRIMARY
AMINE COMPOUND
SUMITOMO CHEMICAL COMPANY,
LIMITED
2005JP
26/12/2005
371743
PCT/JP/2006/325752
WO/2007/074762
December 29, 2008
‫–ניטרוסותיול‬S ‫פורמולציות המכילות‬
C07C
‫שיטה לייצור תרכובת אמין בסיסית‬
3100
1291090111
192153
PROCESS FOR MANUFACTURING
ENTACAPONE
ORION CORPORATION
US
60/765196
06/02/2006
PCT/FI/2007/000029
WO/2007/090923
0190090112
A23L
DHA –‫ או נגזרות‬DHA,EPA ‫שימוש של‬
‫ לטיפול בפתולוגיה הקשורה בנזק‬EPA
‫חימצון התא‬
192156
ASSAY MODULES HAVING ASSAY
REAGENTS AND METHODS OF
MAKING AND USING SAME
MESO SCALE TECHNOLOGIES, LLC
US
60/752745
21/12/2005
832032312
2121222333
US
112832303
2121222338
US
PCT/US/2006/049048
3101
‫הליך לייצור אנטהקאפון‬
192154
USE OF DHA, EPA OR DHA-DERIVED
EPA FOR TREATING A PATHOLOGY
ASSOCIATED WITH CELLULAR
OXIDATIVE DAMAGE
BRUDY TECHNOLOGY, S.L.
PES
21/12/2005
200503202
P2323322338
ES
200602417
P2323322338
ES
200602418
P2321222338
ES
200603231
PCT/EP/2006/070016
WO/2007/071733
0090090112
C07C
C08F
‫מודולות לשם בדיקה המכילות מפעילי‬
‫ ושיטות לייצורן ולשימושן‬,‫בדיקה‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
WO/2007/076023
0090090112
192157
ASSAY APPARATUSES, METHODS
AND REAGENTS
MESO SCALE TECHNOLOGIES, LLC
US
60/752745
21/12/2005
832032312
2121222333
US
112832386
2121222338
US
PCT/US/2006/049049
WO/2008/057111
0090090112
‫ שיטות ומפעילים לבדיקה‬,‫מכשירים‬
192159
NANOCLUSTERS FOR DELIVERY OF
THE THERAPEUTICS
UNIVERSITY OF KANSAS
US
60/751172
16/12/2005
PCT/US/2006/062118
WO/2007/076295
0090090112
METHOD AND APPARATUS FOR
SELECTING A TRANSPORT FORMAT
COMBINATION
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/750602
15/12/2005
832620611
3221322338
US
832683332
1121222338
US
PCT/US/2006/047280
WO/2007/078691
December 29, 2008
– ‫ב' בטבת התשס"ט‬
H04L
‫שיטה ומערכת לבחירת צירוף תבנית‬
‫שליחה‬
192162
DOCOSAHEXAENOIC ACID (DHA)
PRODUCING THRAUSTOCHYTRID
STRAIN-SC1
A61K
‫דברים זעירים למתן תרופות‬
192161
0290090110
G01N
C12N
‫) המייצרת‬DHA( ‫חומצה דוקוסהקסאנואית‬
SC0– ‫זן טראוסטוציטריד‬
3102
AVESTHA GENGRAINE
TECHNOLOGIES PTV. LTD.
PCT/IB/2005/003934
WO/2007/068997
0090090112
192164
IMPROVED TARGETED NUCLEOTIDE
EXCHANGE WITH LNA MODIFIED
OLIGONUCLEOTIDES
KEYGENE N.V.
NL
PCT/NL2005/000884 22/12/2005
NL
PCT/NL2006/000244 3323322338
PCT/NL/2006/000653
WO/2007/073170
0190090112
‫חילוף נוקלאוטיד יעד משופר עם‬
LNA ‫אוליגונוקלאוטידים ששונה עם‬
192165
0/91/90112
22/12/2005
3323322338
192167
LABORATORY CULTURE FLASK WITH
SNAP-ON CAP
PENTACORE INTERNATIONAL HOLDING
3103
C12N
‫חילוף נוקלאוטיד יעד משופר עם‬
‫אוליגונוקלאוטידים ששונה עם‬
‫פרופיניל‬
IMPROVED TARGETED NUCLEOTIDE
EXCHANGE WITH PROPYNYL MODIFIED
OLIGONUCLEOTIDES
KEYGENE N.V.
NL
PCT/NL2005/000884
NL
PCT/NL2006/000244
PCT/NL/2006/000649
WO/2007/073166
C12N
C12M
‫בקבוק מעבדתי ופקק‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
EP
PCT/EP2005/057098
PCT/EP/2006/066942
WO/2007/071466
22/12/2005
0090090112
192168
H04B
SYSTEM AND METHODS FOR
INITIATING, MAINTAINING, AND
DELIVERING PERSONALIZED
INFORMATION BY
COMMUNICATION SERVER
SHAUL SHALEV
US
60/750605
15/12/2005
PCT/US/2006/062072
WO/2007/070842
0090090112
‫ ולספק‬,‫ לתחזק‬,‫מערכת ושיטה ליזום‬
‫נתונים אישיים על ידי שרת תקשורת‬
‫שאול שלו‬
192169
BUTYLPHTHALIDE INTRAVENOUS
EMULSION AND APPLICATION
THEREOF
SHIJIAZHUANG PHARMA GROUP NBP
PHARMACEUTICAL CO, LTD.
CH
200510102355.2 16/12/2005
PCT/CN/2006/003434
WO/2007/068212
0090090112
192174
ISENTROPIC COMPRESSION INLET
FOR SUPERSONIC AIRCRAFT
GULFSTREAM AEROSPACE
CORPORATION
December 29, 2008
– ‫ב' בטבת התשס"ט‬
A61K
‫אמולסית בוטילפטאליד תוך–ורידית‬
‫ושימוש בה‬
B64D
‫כונס לדיחוס שווה–אנטרופיה עבור כלי‬
‫טיס עבר–קולי‬
3104
US
60/750345
PCT/US/2006/047738
WO/2008/045108
1190090112
15/12/2005
192176
A SYSTEM AND METHOD FOR
TRIGGERING A DEVICE BASED ON
AN ELECTROCARDIOGRAM SIGNAL
IVY BIOMEDICAL SYSTEMS, INC.
US
11/300959
15/12/2005
PCT/US/2006/046787
WO/2007/073464
0/90090112
BIFURCATED STENT
MEDINOL LTD.
US
08/642297
3105
‫שיטה ומערכת להפעלת מכשיר על פי‬
‫ג‬.‫ק‬.‫אות א‬
192177
APPARATUS AND METHOD FOR
PROVIDING OPEN-HEELED FOOT
APPAREL WITH IMPROVED HEEL
SUPPORT
COCKBURN, ALISTAIR
US
60/749894
13/12/2005
112833633
1221222338
US
PCT/US/2006/062054
WO/2007/070839
/191090//1
A61B
A43B
‫התקן ושיטה לאספקת לבוש רגל עם‬
‫עקב פתוח בעל תמיכה משופרת לעקב‬
192178
A61M
‫סטנט מפולג‬
‫מדינול בע"מ‬
03/05/1996
December 29, 2008
– ‫ב' בטבת התשס"ט‬
0291090111
192179
CLOSING SYSTEM FOR CONTAINERS
LTS-LOHMANN THERAPIE-SYSTEME
AG
DE
102006040888.8 31/08/2006
PCT/EP/2007/007211
WO/2008/025455
0090090112
192182
RNA INTERFERENCE MEDIATED
INHIBITION OF HEPATITIS C VIRUS
(HCV) GENE EXPRESSION USING
SHORT INTERFERING NUCLEIC ACID
(siNA)
SIRNA THERAPEUTICS, INC.
US
11/311826
19/12/2005
112313602
2323622338
US
PCT/US/2006/062252
WO/2007/076328
0091190110
192185
ARRANGEMENT OF OPTICAL
ELEMENTS FOR USE AS A
TRANSMITTER/RECEIVER FOR A
LIGHT DETECTION AND RANGING
(LIDAR) SYSTEM
ROSEMOUNT AEROSPACE INC.
US
09/946057
04/09/2001
PCT/US/2002/022900
WO/2003/021290
1090090112
192186
MICROPUMP
SENSILE PAT AG
December 29, 2008
– ‫ב' בטבת התשס"ט‬
B65D
‫מערכת סגירה למיכלים‬
C12N
‫ של ביטוי‬RNA ‫עיכוב בתיווך התערבות‬
)C (HCV ‫גנים של וירוס הפטיטיס‬
‫באמצעות שימוש בחומצות נוקלאיות‬
)siNA( ‫מפריעות קצרות‬
G01S
‫מכלול של אלמנטים אופטיים לשימוש‬
‫מקלט עבור מערכת גילוי וטיווח‬/‫כמשדר‬
)LIDAR( ‫אור‬
F04B
‫משאבה זעירה‬
3106
EP
05405726.0
3833338253
EP
PCT/IB/2006/003596
WO/2007/074363
0090090112
28/12/2005
3221122338
192187
SECURE SYSTEM-ON CHIP
NAGRACARD S.A.
EP
05112980.7 23/12/2005
PCT/EP/2006/070064
WO/2007/071754
0090090112
C12N
‫מיקרואגריגטים המכילים תאי אנדותל‬
192190
PROCESS FOR THE PREPARATION
OF PHARMACEUTICAL SALTS OF 3O-(3',3'-DIMETHYLSUCCINYL)
BETULINIC ACID
PANACOS PHARMACEUTICALS, INC.
US
60/750805
16/12/2005
PCT/US/2006/047749
WO/2007/078848
3107
‫מערכת משולבת בטוחה‬
192189
MICROAGGREGATES INCLUDING
ENDOTHELIAL CELLS
LARRY MARK WEISENTHAL
US
60/751127
16/12/2005
PCT/US/2006/047954
WO/2007/075440
0090090112
H04L
C07J
‫תהליך להכנת מלחים תרופתיים של‬
–'O–(3',3–: ‫חומצת‬
‫דימתילסוקסיניל)בטולינית‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
0/90090112
192191
A SILVER MIRROR FOR USE IN A
SOLAR REFLECTOR
MIDWEST RESEARCH INSTITUTE
US
11/303836
16/12/2005
PCT/US/2006/062046
WO/2007/076282
0090090112
192192
RESOURCE SHARING AMONG
NETWORK TUNNELS
CORRIGENT SYSTEMS LTD.
US
11/305486
15/12/2005
PCT/IL/2006/001443
WO/2007/069256
0090090112
192193
SUB-MICRON SURFACE PLASMON
RESONANCE SENSOR SYSTEMS
INDIANA UNIVERSITY RESEARCH
AND TECHNOLOGY CORPORATION
US
60/750872
16/12/2005
PCT/US/2006/047959
WO/2007/075444
0090090112
192195
POTENTIATION OF APOPTOSIS BY
MONOCLONAL ANTIBODIES
LFB BIOTECHNOLOGIES
FR
0512815
16/12/2005
PCT/FR/2006/002767
WO/2007/071839
December 29, 2008
– ‫ב' בטבת התשס"ט‬
F21V
‫ראי כסף לשימוש במחזירור שמשי‬
H04J
‫חלוקת משאבים בין תעלות תקשורת‬
‫קוריג'נט מערכות בע"מ‬
G01N
‫מערכות חיישני תהודת פלזמון משטחי‬
‫תת–מיקרוני‬
G01N
–‫חיזוק של אפופטוזים על ידי נוגדנים חד‬
‫שבטיים‬
3108
0090090112
SOIL STABILIZATION
TERRAFUSION, INC.
US
60/751119
PCT/US/2006/048094
WO/2007/070706
0090090112
192196
‫ייצוב קרקע‬
15/12/2005
192198
SKIN CARE COMPOSITIONS AND
TREATMENTS
ORGANOGENESIS, INC.
US
60/750447
14/12/2005
PCT/US/2006/062090
WO/2007/070850
0090090112
A61K
‫הרכבים וטיפולים לטיפול בעור‬
192199
METHODS FOR ASSESSING
PROBABILISTIC MEASURES OF
CLINICAL OUTCOME USING
GENOMIC PROFILING
COLD SPRING HARBOR
LABORATORY
US
60/751353
14/12/2005
832683263
2321122338
US
PCT/US/2006/047913
WO/2008/016374
3109
C12N
C12Q
‫שיטות להערכת מדידות הסתברותיות של‬
‫תוצאות קליניות על ידי שימוש בפרופיל‬
‫גנומי‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
NOTICE UNDER SECTION 26 OF THE
PATENTS LAW, 5727-1967
The applications, particulars of which are set
out below, have been accepted pursuant to
Section 17 of the Patents Law. Any person
wishing to oppose the grant of a patent on any
of the applications published here, may,
within three months from the date of this
journal, give to the Commissioner of Patents
notice under Section 30 of the Patents Law, in
the manner prescribed in regulations 57 et seq
of the Patents Regulations, 5728-1968
Particulars of the applications, where
applicable, are given in the following order:
[11] [21] Number of application
[54] Title of invention
[22] Application date
[31] [32] [33] Number and date of foreign
application – convention country.
*[51] Int.Cl.
[61] Application for patent of addition
[62] Divisional application
[71] Applicant
[72] Inventor
[87] International Publication Number
[74] Address for service
[57] Abridgement of invention (in the
language in which the specification is drawn
up)
*Note: As from Patents and Designs Journal
No.1/06, patent applications are classified
according to the Eighth Edition of the
International Patent Classification (2006)
December 29, 2008
– ‫ב' בטבת התשס"ט‬
- ‫ לחוק הפטנטים תשכ"ז‬09 ‫הודעה לפי סעיף‬
0679
‫הבקשות שפרטיהן מתפרסמים להלן קובלו‬
‫ כל המעונין‬.‫ לחוק הפטנטים‬07 ‫לפי סעיף‬
‫להתנגד למתן פטנט על פי בקשה מהבקשות‬
‫ תוך שלושה חדשים‬,‫המתפרסמות רשאי‬
‫ להגיש לרשם הפטנטים‬,‫מתאריך יומן זה‬
‫ לחוק‬:/ ‫הודעת התנגדות לפי סעיף‬
‫ ואילך‬.7 ‫הפטנטים בדרך הקבועה בתקנה‬
.0698 – ‫ תשכ"ח‬,‫לתקנות הפטנטים‬
‫פרטי הבקשות במידה ויישימים מובאים לפי‬
:‫סדר זה‬
‫מספר הבקשה‬
‫שם האמצאה‬
‫תאריך הבקשה‬
‫מספר ותאריך של בקשות החוץ – מדינת‬
‫האגוד‬
‫*סיווג בינלאומי – מהדורה שביעית‬
‫בקשה לפטנט מוסף‬
‫בקשת חלוקה‬
‫המבקש‬
‫הממציא‬
‫מס' פרסום של בקשה הבינלאומית‬
‫מען למסירת מסמכים‬
)‫תקציר האמצאה (בשפה בה ערוך הפירוט‬
'‫ החל מיומן הפטנטים והמדגמים מס‬:‫*הערה‬
‫ ניתן ציון לבקשות פטנטים הסיווג לפי‬0//9
‫המהדורה השמינית של הסיווג הבינלאומי‬
)0//9 ‫של פטנטים (משנה‬
3110
]00[]00[
973501
‫וירוסים מוחלשים בהנדסה גנטית‬
]00[
GENETICALLY ENGINEERED
ATTENUATED VIRUSES
]00[
]/0[
]00[
]10[
14.04.1993
07/868596
]/0[ 14.04.1992
]//[ US
Int. Cl.8 A61K 039/145, C12N 007/01, 007/04, 015/44
THE MOUNT SINAI SCHOOL OF
MEDICINE OF THE CITY
UNIVERSITY OF NEW YORK,
U.S.A.
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
‫ תל אביב‬,0046/ .‫ד‬.‫ ת‬, 004 ‫אבן גבירול‬
P.O.B. 11490,
TEL AVIV 62038
]10[
[57] An attenuated genetically engineered
influenza virus wherein the amino acids
sequence of the stalk region of the
neuraminidase protein is selected from the
group consisting of:
HSIQTGNQNHTGICNQGSTGNSSLCPI
RG,
.
The applications for division
from this application have
not yet been published
HSIQTGNQNHTGICNQGSLSSLCPIRG,
HSIQTGTGNSSLCPIRG, and
HSIQTGNQNHTGICNQGSTGNSSLCPI
QGSTGNSSLCPIQGSITYKVVAGQDST
SVILTGNSSLCPIR
in which the amino acid residues are
represented by the single letter code.
5132302
‫בקשות חלוקה מבקשה זו‬
5‫שטרם פורסמו‬
__________
3111
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[]00[
995001
‫רצפי דנ"א המקודדים לאנזימים המאיצים‬
‫ לינארים‬α – 1, 4 ‫יצור של גלוקאנים‬
‫ פטריות וחייקטים והשימושים‬,‫בצמחים‬
‫ברצפים האמורים‬
]00[
DNA SEQUENCES CODING FOR
ENZYMES WHICH CATALYZE
THE SYNTHESIS OF LINEAR
ALPHA 1,4 - GLUCANS IN
PLANTS, FUNGI AND
MICROORGANISMS
]00[
]/0[
18.05.1995
P44178794
]/0[ 18.05.1994
]//[ DE
P44473885
0020020//0
DE
Int. Cl.8 A01H 005/00, C12N 001/15, 001/21, 005/10, 015/54, 015/82, C12P 019/18,
C12Q 001/68
BAYER BIOSCIENCE GMBH,
GERMANY
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26 A HABARZEL STREET
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]00[
]10[
]10[
[57] A DNA sequence coding for a
protein having the enzymatic activity of an
amylosucrase which catalyzes the
synthesis of linear α-1,4 glucans from
sucrose, selected from the group consisting
of:
(a) DNA sequences coding for a protein
having the amino acid sequence of the
polypeptide encoded by the coding region
coding for an amylosucrase from Neisseria
polysaccharea as contained in the DNA
insert of plasmid pNB2 (DSM 9196);
(b) the DNA sequence having the
nucleotide sequence of the coding region
coding for an amylosucrase from Neisseria
polysaccharea as contained in the DNA
insert of plasmid pNB2 (DSM 9196);
(c) DNA sequences hybridizing to any of
the sequences of (a) or (b);
(d) DNA sequences which are at least 40%
identical to the DNA sequence as defined
in (b); and
(e) DNA sequences which are degenerate
due to the genetic code in comparison to
the sequences mentioned in (a), (b), (c) or
(d).
_________
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3112
]00[]00[
995313
–'. ‫אסטרים ליפידיים של נוקליאוזיד‬
‫ הכנתם ותרופות המכילות‬,‫מונופוספטים‬
‫אותם‬
]00[
LIPID ESTERS OF NUCLEOSIDE
5'- MONOPHOSPHATES, THEIR
PREPARATION AND DRUGS
CONTAINING THEM
]00[
]/0[
]00[
25.05.1995
P4418690.8
]/0[ 28.05.1994
]//[ DE
Int. Cl.8 A61K 031/675, 038/13, A61P 035/00, 037/06, C07H 019/10, 019/20, C12P
019/28, 019/40
HEIDELBERG PHARMA HOLDING
GMBH, GERMANY
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]10[
]10[
[57] Nucleoside monophosphate
derivatives of the formula
wherein
R1 may be a straight-chain or branched,
saturated or unsaturated alkyl chain having
up to 20 carbon atoms, optionally monoor polysubstituted by halogen, C1-C6
alkoxy, C1-C6 alkylmercapto, C1-C6
alkoxycarbonyl, C1-C6 alkylsulfinyl, or C1C6 alkylsulfonyl groups;
R2 may be hydrogen, a straight-chain or
branched, saturated or unsaturated alkyl
chain having up to 20 carbon atoms,
optionally mono- or polysubstituted by
halogen, C1-C6 alkoxy, C1-C6
alkylmercapto,
3113
C1-C6 alkoxycarbonyl, or C1-C6
alkylsulfonyl groups; R3 represents
hydrogen, hydroxy, azido, amino, cyano,
or halogen;
R4 represents hydroxy, azido, amino,
cyano, or halogen;
R5 represents hydrogen, hydroxy, amino,
cyano, or halogen;
X represents a valence bond, sulfur, a
sulfinyl or sulfonyl group;
Y is a valence bond, an oxygen or sulfur
atom;
B represents a purine or pyrimidine base of
the formula
December 29, 2008
– ‫ב' בטבת התשס"ט‬
wherein
R6 may be hydrogen; an alkyl chain having
1-6 carbon atoms, which may be
substituted by halogen; an alkenyl and/or
alkinyl residue having 2-6 carbon atoms,
optionally substituted by halogen; or
halogen;
R6 may be a hydrogen atom or a benzyl or
phenylthio residue;
R7 may be hydrogen; an alkyl chain having
1-6 carbon atoms, which may be
substituted by halogen; halogen; vinyl,
propenyl, ethinyl or propinyl,
R8 may be hydrogen, an alkyl chain having
1-6 carbon atoms, halogen, or a hydroxy or
an amino group;
R9 may be hydrogen, an amino group or a
halogen atom; and
R10 may be hydrogen, halogen, mercapto,
hydroxy, C1-C6 alkoxy, C1-C6
alkylmercapto, or an amino group which
may be mono-or disubstituted by C1-C6
alkyl, C1-C6 alkoxy, hydroxy-C2-C6 alkyl,
and/or C3-C6 cycloalkyl, aryl, hetaryl,
aralkyl, or hetarylalkyl group, optionally
substituted at the aryl or hetaryl residue by
one or more mercpato, hydroxy, C1-C6
alkoxy, or C1-C6 alkyl groups or halogen;
or C2-C6 alkenyl optionally substituted by
mono-or dialkyl or alkoxy groups; with the
proviso that at least one of the residues R3
or R5 is hydrogen; their tautomers, their
optically active forms and racemic
mixtures, and their physiologically
acceptable salts of inorganic and organic
acids or bases.
__________
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3114
]00[]00[
927121
‫קולטנים כימריים ושיטה לזיהוי תרכבות‬
‫פעילות בקולטני גלוטמט מטבוטרופיים‬
‫והשימוש בתרכבות כאלה בטיפול‬
‫בהפרעות ובמחלות נוירולוגיות‬
]00[
CHIMERIC RECEPTORS AND
METHODS FOR IDENTIFYING
COMPOUNDS ACTIVE AT
METABOTROPIC GLUTAMATE
RECEPTORS AND THE USE OF
SUCH COMPOUNDS IN THE
TREATMENT OF
NEUROLOGICAL DISORDERS
AND DISEASES
]00[
]/0[
]00[
25.07.1996
60/001526
]/0[ 26.07.1995
]//[ US
Int. Cl.8 A61K 038/16, C07K 014/705, C12N 005/10, 015/12, 015/62, 015/63, G01N
033/50, 033/566
ASTRAZENECA AB, SWEDEN
WO/1997/005252
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26 A HABARZEL STREET
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]10[
]01[
]10[
[57] An mGluR/CaR chimeric receptor
comprising an amino acid sequence from a
metabotropic glutamate receptor
substituted with one or more regions of at
least 6 contiguous amino acids from a Gprotein coupled calcium receptor, provided
that said chimeric receptor comprises one
or more regions of at least 6 contiguous
amino acids from said metabotropic
glutamate receptor, wherein said sequence
from a metabotropic glutamate receptor
has at least 90% sequence similarity to a
sequence of said metabotropic glutamate
receptor and the sequence of said at least 6
contiguous amino acids from a G-protein
coupled calcium receptor has as least 90%
sequence similarity to a sequence of said
calcium receptor.
_________
3115
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[]00[
923123
‫ ובקרת סינתזה של‬ADPGPPase ‫האנזים‬
‫עמילן בעגבניות‬
]00[
ADPGPPASE CONTROL OF
STARCH SYNTHESIS IN
TOMATOES
]00[
]00[
]10[
20.07.1998
Int. Cl.8 A01H 001/04, 005/00, 005/08, 005/10
THE STATE OF ISRAEL,
‫ משרד החקלאות ופיתוח‬,‫מדינת ישראל‬
MINISTRY OF AGRICULTURE
‫ מרכז‬,‫ מינהל המחקר החקלאי‬,‫הכפר‬
AND RURAL DEVELOPMENT,
‫ בית דגן‬,‫וולקני‬
AGRICULTURAL RESEARCH
ORGANIZATION, VOLCANI
CENTER
ILAN LEVIN, ARTHUR A.
‫ משה‬,‫ מרינה פטראיקוב‬,‫ ארי שפר‬,‫אילן לוין‬
SCHAFFER, MARINA PETREIKOV,
‫בר‬
MOSHE BAR
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬066.( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
,00 ‫רחוב מנחם בגין‬, 0. ‫ קומה‬,‫מגדל אילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
]10[
]10[
[57] A method for controlling starch
synthesis in tomatoes comprising:
providing a population of plants derived
from interspecific crosses of a greenfruited wild species of the Lycopersicon
genus (Lycopersicon spp.) with
Lycopersicon esculentum genotypes; and
selecting individuals of said population
that each contain an allele of a gene that
encodes for the large subunit (LS1) of
ADP-glucose pyrophosphorylase
(ADPGPPase) and increases the activity of
ADPGPPase, said allel originating from
said Lycopersicon spp.
__________
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3116
]00[]00[
‫תרכיב להמרת אנרגיה‬
]00[
ENERGY CONVERSION
COMPOSITION
]00[
]/0[
28.03.1997
8-116269
]/0[ 10.05.1996
0-0/200/
/121020//2
0-0010/0
0021220//2
0-02/020
0021220//2
0-0/0001
1/21/20//2
0-0/0112
1120020//2
0-0/00/1
1120020//2
0-/11002
0020020//2
0-/1/0/0
0020020//2
0-/10002
0/20020//2
0-/00100
0220020//2
0-/0/001
1/20020//2
0-/0120/
0120020//2
/-00000
0121020//1
/-00002
1021020//1
/-/200/
0121020//1
/-00/00
1121/20//1
Int. Cl.8 C08L 101/00
SHISHIAI-KABUSHIKIGAISHA,
JAPAN
WO/1997/042844
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
]00[
]10[
]01[
]10[
923110
[57] An energy conversion composition,
excluding the conversion of electrical into
mechanical energy, and excluding the
conversion of optical energy, wherein the
composition comprises a base material;
and a moment activator comprising a
.
]//[
JP
JP
JP
JP
JP
JP
JP
JP
JP
JP
JP
JP
JP
JP
JP
JP
JP
,'‫ד"ר שלמה כהן ושות‬
‫ תל אביב‬,0046/ .‫ד‬.‫ ת‬, 004 ‫אבן גבירול‬
diphenyl acrylate radical, in an amount
from 20 to 500 parts by weight per 100
parts by weight of the base material said
amount being effective to increase the
amount of dipole moment in the base
material by 3 to 10 fold.
_________
3117
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[]00[
921501
‫הומולוגים של פקטור גדילה לפיברובלאסט‬
]00[
FIBROBLAST GROWTH FACTOR
HOMOLOGS
]00[
]/0[
]00[
16.10.1997
60/028646
]/0[ 16.10.1996
]//[ US
Int. Cl.8 A61K 038/18, A61P 009/00, 019/00, C07K 014/50, C12N 001/14, 001/16,
005/10, 015/18, 015/19, 015/63
ZYMOGENETICS INC., U.S.A.
WO/1998/016644
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26 A HABARZEL STREET
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]10[
]01[
]10[
[57] An isolated polynucleotide molecule
encoding a fibroblast growth factor (FGF)
homolog polypeptide selected from the
group consisting of:
(a) polynucleotide molecules comprising a
nucleotide sequence as shown in SEQ ID
NO: 1 from nucleotide 82 to nucleotide
621;
(b) allelic variants of (a);
(c) polynucleotide molecules that encode a
polypeptide that is at least 60% identical to
the amino acid sequence of SEQ ID NO: 2
from amino acid residue 28 (Glu) to amino
acid residue 207 (Ala);
(d) polynucleotide molecules comprising a
nucleotide sequence as shown in SEQ ID
NO: 6 from nucleotide 82 to nucleotide
621;
(e) polynucleotide molecules comprising a
nucleotide sequence as shown in SEQ ID
NO:1 from nucleotide 1 to nucleotide 621;
and
(f) polynucleotide molecules comprising a
nucleotide sequence as shown in SEQ ID
NO:6 from nucleotide 1 to nucleotide 621.
_________
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3118
]00[]00[
957571
‫אגוניסטים חדשים של פרוסטאגלנדין‬
‫ותכשירים רפואיים המכילים אותם למניעת‬
‫איבוד ולחידוש מסת העצם‬
]00[
PROSTAGLANDIN AGONISTS
AND PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM FOR PREVENTION OF
LOSS AND FOR THE
RESTORATION OF BONE MASS
]00[
]/0[
]00[
10.11.1997
60/033451
]/0[ 20.12.1996
]//[ US
Int. Cl.8 A61K 031/16, 031/18, 031/335, 031/38, 031/395, A61P 019/08, C07C
059/76, 059/90, 233/16, 233/45, 311/04, 311/06, 311/50, 317/04, 317/26, 317/44,
323/32, 323/59, C07D 207/26, 209/10, 213/36, 215/12, 217/12, 231/12, 233/61,
235/04, 237/08, 239/26, 241/12, 249/04, 257/04, 261/08, 271/06, 271/07, 271/12,
277/28, 277/56, 307/52, 307/68, 307/78, 317/48, 319/18, 333/06, 333/40, 333/52,
409/12
PFIZER INC., U.S.A.
WO/1998/028264
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]10[
]01[
]10[
[57] Compounds of the formula
or pharmaceutically acceptable salts or
prodrugs thereof
wherein either (l):
B is N;
A is (C1-C6) alkylsulfonyl, (C3-C7)
cycloalkylsulfonyl, (C3-C7) cycloalkyl (C1C6) alkylsulfonyl, said A moieties
optionally mono-, di- or tri-substituted on
carbon independently with hydroxy, (C 1C4) alkyl or halo;
Q is –(C2-C6) alkylene-W-(C1-C3)
alkylene-,
-(C3-C8) alkylene-, said –(C3-C8) alkyleneoptionally substituted with, up to four
3119
substituents independently selected from
fluoro or (C1-C4) alkyl,
-X-(C1-C5) alkylene-,
-(C1-C5) alkylene-X-,
-(C1-C3) alkylene-X-(C1-C3) alkylene-,
-(C2-C4) alkylene-W-X-(C0-C3)alkylene-,
-(C0-C4) alkylene-X-W-(C1-C3) alkylene-,
-(C2-C5) alkylene-W-X-W-(C1-C3)
alkylene-, wherein the two occurrences of
W are independent of each other, -(C1-C4)
alkylene-ethenylene-(C1-C4) alkylene-,
-(C1-C4) alkylene-ethenylene-(C0-C2)
alkylene-X-(C0-C2) alkylene-X-(C0-C5)
alkylene-,
December 29, 2008
– ‫ב' בטבת התשס"ט‬
-(C1-C4) alkylene-ethenylene-(C0-C2)
alkylene-X-W-(C1-C3) alkylene-,
-(C1-C4) alkylene-ethynylene-(C1-C4)
alkylene-, or
-(C1-C4) alkylene-ethynylene-X-(C0-C3)
alkylene-;
W is oxy, thio, sulfinyl, sulfonyl,
aminosulfonyl-, mono-N-(C1-C4)
alkyleneaminosulfonyl-, sulfonylamino, N(C1-C4) alkylenesulfonylamino,
carboxamido, N-(C1-C4)
alkylenecarboxamido, carboxamidooxy,
N-(C1-C4) alkylenecarboxamidooxy,
carbamoyl, -mono-N-(C1-C4)
alkylenecarbamoyl, carbamoyloxy, or –
mono-N-(C1-C4) alkylenecarbamoyloxy,
wherein said W alkyl groups are optionally
substituted on carbon with one to three
fluorines; X is tetrahydrofuranyl or a five
or six membered aromatic ring optionally
having one or two heteroatoms selected
independently from oxygen, nitrogen, and
sulfur, said ring optionally mono-, or disubstituted independently with halo, (C1C3) alkyl, trifluoromethyl,
trifluoromethyloxy, difluoromethyloxy,
hydroxyl, (C1-C4) alkoxy, or carbamoyl; Z
is carboxyl, (C1-C6) alkoxycarbonyl,
tetrazolyl, 1,2,4-oxadiazolyl, 5-oxo-1,2,4oxadiazolyl, 5-oxo-1,2,4-thiadiazolyl, (C1C4) alkylsulfonylcarbamoyl or
phenylsulfonylcarbamoyl;
K is a bond, (C1-C8) alkylene, thio (C1-C4)
alkylene or oxy (C1-C4) alkylene, said (C1C8) alkylene optionally mono-unsaturated
and wherein K is optionally mono-, di-or
tri-substituted independently with
hydroxyl, fluoro, methyl or chloro;
M is –Ar, -Ar1-V-Ar2, -Ar1-S-Ar2, -Ar1-OAr2, -Ar1-S-(C1-C3)-Ar2-m –Ar1- (C1-C3)S-Ar2- or –Ar1-(C1-C3)-S-(C1-C3)-Ar2,
wherein C1-C3 represents alkylene and Ar,
Ar1 and Ar2 are each independently a
partially saturated, fully saturated or fully
unsaturated five to eight membered ring
optionally having one to four heteroatoms
selected independently from oxygen, sulfur
and nitrogen, or a bicyclic ring consisting
of two fused partially saturated, fully
saturated or fully unsaturated five or six
membered rings, taken independently,
optionally having one to four heteroatoms
selected independently from nitrogen,
sulfur and oxygen; said Ar, Ar1 and Ar2
moieties optionally substituted, on one ring
if the moiety is monocyclic, or one or both
rings if the moiety is bicyclic, on carbon,
nitrogen or sulfur with up to three
substituents independently selected from
R1, R2 and R3 wherein R1, R2 and R3 are
oxo, hydroxy, nitro, halo, (C1-C6) alkoxy,
(C1-C4) alkoxy (C1-C4) alkyl, (C1-C4)
alkoxycarbonyl, (C1-C7) alkyl, (C3-C7)
cycloalkyl, (C3-C7) cycloalkyl (C1-C4)
alkyl, (C3-C7) cycloalkyl (C1-C4) alkanoyl,
formyl, (C1-C8) alkanoyl, (C1-C6) alkanoyl,
(C1-C6) alkyl, (C1-C4) alkanoylamino, (C1C4) alkoxycarbonylamino, sulfonamide,
(C1-C4) alkylsulfonamido, amino, mono N- or di-N,N-(C1-C4) alkylamino,
carbamoyl, mono-N- or di-N,N-(C1-C4)
alkylcarbamoyl, cyano,thiol, (C1-C6)
alkylthio, (C1-C6) alkylsulfinyl, (C1-C4)
alkylsulfonyl or mono-N- or di-N,N-(C1C4) alkylaminosulfinyl; R1, R2 and R3 are
optionally mono-, di- or tri-substituted on
carbon independently with halo or
hydroxy; and V is a bond or (C1-C3)
alkylene optionally mono-unsaturated and
optionally mono- or di-substituted
independently with hydroxy or fluoro,
with the proviso that when K is (C2-C4)
alkylene and M is Ar and Ar is cyclopent1-yl, cyclohex-1-yl, cyclohept-1-yl or
cyclooct-1-yl then said (C5-C6) cycloalkyl
substituents are not substituted at the one
position with hydroxy;
or (ii);
B is N;
A is (C1-C6) alkanoyl, or (C3-C7)
cycloalkyl (C1-C6) alkanoyl, said A
moieties optionally mono-, di-or trisubstituted independently on carbon with
hydroxy or halo;
Q is
-(C2-C6) alkylene-W-(C1-C3) alkylene-,
– ‫ב' בטבת התשס"ט‬
3120
December 29, 2008
-(C4-C8) alkylene-, said –(C4-C8) alkyleneoptionally substituted with up to four
substituents independently selected from
fluoro or (C1-C4) alkyl,
-X-(C2-C5) alkylene-,
-(C1-C5) alkylene-X-,
-(C1-C3) alkylene-X-(C1-C3) alkylene-,
-(C2-C4) alkylene-W-X-(C0-C3) alkylene-,
-(C0-C4) alkylene-X-W-(C1-C3) alkylene-,
-(C2-C5) alkylene-W-X-W-(C1-C3)
alkylene-, wherein the two occurrences of
W are independent of each other,
-(C1-C4) alkylene-ethenylene-(C1-C4)
alkylene-,
-(C1-C4) alkylene-ethenylene-(C0-C2)
alkylene-X-(C0-C5) alkylene-,
-(C1-C4) alkylene-ethenylene-(C0-C2)
alkylene-X-W-(C1-C3) alkylene-,
-(C1-C4) alkylene-ethynylene- (C1-C4)
alkylene-, or
-(C1-C4) alkylene-ethynylene-X-(C0-C3)
alkylene-;
W is oxy, thio, sulfinyl, sulfonyl,
aminosulfonyl-, mono-N-(C1-C4)
alkyleneaminosulfonyl-, sulfonylamino, N(C1-C4) alkylenesulfonylamino,
carboxamido, N-(C1-C4)
alkylenecarboxamido, carboxamidoxy, N(C1-C4) alkylenecarboxamidooxy,
carbamoyl, -mono-N-(C1-C4)
alkylenecarbamoyl, carbamoyloxy, or –
mono-N-(C1-C4) alkylenecarbamoyloxy,
wherein said W alkyl groups are optionally
substituted on carbon with one to three
fluorines;
X is tetrahydrofuranyl or a five or six
membered aromatic ring optionally having
one or two heteroatoms selected
independently from oxygen, nitrogen, and
sulfur, said ring optionally mono-, or disubstituted independently with halo, -(C1C3) alkyl, trifluoromethyl,
trifluoromethyloxy, difluoromethyloxy,
hydroxyl, (C1-C4) alkoxy, or carbamoyl;
Z is carboxyl, -(C1-C6) alkoxycarbonyl,
tetrazolyl, 1, 2, 4-oxadiazolyl, 5-oxo,1,2,4-oxadiazolyl, 5-oxo-1,2,4-
3121
thiadiazolyl, (C1-C4)
alkylsulfonylcarbamoyl or
phenylsulfonylcarbamoyl; K is (C1-C8)
alkylene, thio -(C1-C4) alkylene or oxy
(C1-C4) alkylene, said -(C1-C8) alkylene
optionally mono-unsaturated and whrein K
is optionally mono-, di- or tri-substituted
independently with fluoro, methyl or
chloro;
M is –Ar, -Ar, -Ar1-V-Ar2, -Ar1-S-Ar2, Ar1-O-Ar2, -Ar1-S-(C1-C3)-Ar2-, -Ar1-(C1C3)-S-Ar2-(C1-C3)-S-(C1-C3)-Ar2 wherein
Ar, Ar1 and Ar2 are each independently a
partially saturated, fully saturated or fully
unsaturated five to eight membered ring
optionally having to four heteroatoms
selected independently from oxygen, sulfur
and nitrogen, or a bicyclic ring consisting
of two fused partially saturated, fully
saturated or fully unsaturated five or six
membered rings, taken independently,
from nitrogen, sulfur and oxygen; said Ar,
Ar1 moieties optionally substituted, on one
ring if the moiety is monocyclic, or one or
both rings if the moiety is bicylic, on
carbon, nitrogen or sulfur with up to three
substituents independently selected from
R1, R2 and R3 wherein R1, R2 and R3 are
oxo, H, hydroxy, nitro, halo, (C1-C6)
alkoxy, (C1-C4) alkoxy (C1-C4) alkyl, (C1C4) alkoxycarbonyl, (C1-C7) alkyl, (C3-C7)
cycloalkyl, (C3-C7) cycloalkyl (C1-C4)
alkyl, (C3-C7) cycloalkyl (C1-C4) alkanoyl,
formyl, (C1-C8) alkanoyl, (C1-C6) alkanoyl
(C1-C6) alkyl, (C1-C4) alkanoylamino, (C1C4) alkoxycarbonylamino, sulfonamide,
(C1-C4) alkylsuflonamido, amino, mono N- or di-N,N-(C1-C4) alkylamino,
carbamoyl, mono-N- or di-N,N-(C1-C4)
alkylcarbamoyl, cyano, thiol, (C1-C6)
alkylthio, (C1-C6) alkylsulfinyl, (C1-C4)
alkylsulfonyl or mono-N- or di-N,N-(C1C4) alkylaminosulfinyl;
R1, R2 and R3 are optionally mono-, di-or
tri-substituted independently on carbon
with halo or hydroxy; and V is a bond or
(C1-C3) alkylene optionally monoDecember 29, 2008
– ‫ב' בטבת התשס"ט‬
unsaturated and optionally mono- or disubstituted independently with hydroxy or
fluoro with the proviso that when A is (C1C6) alkanoyl; B is N; Q is (C1-C5)
alkylene-X- wherein the (C1-C5) alkylene
in the group (C1-C5) alkylene-X is
methylene; X is a five or six membered
aromatic ring wherein the five or six
membered aromatic ring is phenyl; Z is
carboxyl; K is oxy (C1-C4) alkylene
wherein said oxy (C1-C4) alkylene is –OCH2- then M is not phenyl, and with the
further proviso that when K is (C2-C4)
alkylene and M is Ar and Ar is cyclopentl-yl, cyclohex-l-yl, cyclohept-l-yl or
cycloct-l-yl then said (C5-C8) cycloalkyl
substituents are not substituted at the one
position with hydroxyl and with the
proviso that 6-[(3-phenyl-propyl)-(2propyl-pentanoyl)-amino]-hexanoic acid
and its ethyl ester are not included or (iii);
B is C(H);
A is (C1-C6) alkanoyl, or (C3-C7)
cycloalkyl (C1-C6) alkanoyl, said A
moieties optionally mono-, di-or trisubstituted on carbon independently with
hydroxy or halo; Q is –(C2-C6) alkyleneW-(C1-C3) alkylene-, -(C4-C8) alkylene-,
said –(C4-C8) alkylene- optionally
substituted with up to four substituents
independently selected from fluoro or (C1C4) alkyl,
-X-(C1-C5) alkylene-,
-(C1-C5) alkylene-X-,
-(C1-C3) alkylene-X-(C1-C3) alkylene-,
-(C2-C4) alkylene-W-X-(C0-C3) alkylene-,
-(C0-C4) alkylene-X-W-(C1-C3) alkylene-,
-(C2-C5) alkylene-W-X-W-(C1-C3)
alkylene-, wherein the two occurrences of
W are independent of each other, -(C1-C4)
alkylene-ethenylene-(C1-C4) alkylene-,
-(C1-C4) alkylene-ethenylene-(C0-C2)
alkylene-X-(C0-C5) alkylene-,
-(C1-C4) alkylene-ethenylene-(C0-C2)
alkylene-X-W-(C1-C3) alkylene-,
-(C1-C4) alkylene-ethynylene-(C1-C4)
alkylene-, or
-(C1-C4) alkylene-ethynylene-X-(C0-C3)
alkylene-;
W is oxy, thio, sulfinyl, sulfonyl,
aminosulfonyl-, mono-N-(C1-C4)
alkyleneaminosulfonyl-, sulfonylamino, N(C1-C4) alkylenesulfonylamino,
carboxamido, N-(C1-C4)
alkylenecarboxamido, carboxamidooxy,
N-(C1-C4) alkylencarboxamidooxy,
carbamoyl, -mono-N-(C1-C4)
alkylenecarbamoyl, carbamoyloxy, or –
mono-N-(C1-C4) alkylenecarbamoyloxy,
wherein said W alkyl group are optionally
substituted on carbon with one to three
fluorines; X is a five or six membered
aromatic ring optionally having one or two
heteroatoms selected independently from
oxygen, nitrogen and sulfur, said ring
optionally mono-, or di-substituted
independently with halo, (C1-C3) alkyl,
trifluoromethyl, trifluoromethyloxy,
difluoromethyloxy, hydroxy, (C1-C4)
alkoxy, or carbamoyl;
Z is carboxyl, (C1-C6) alkoxycarbonyl,
tetrazolyl, 1,2,4-oxadiazolyl, 5-oxo-1,2,4oxadiazolyl, (C1-C4)
alkylsulfonylcarbamoyl or
phenylsulfonylcarbamoyl; K is a bond,
(C1-C8) alkylene, thio (C1-C4) alkylene,
(C4-C7) cycloalkyl (C1-C6) alkylene or oxy
(C1-C4) alkylene, said (C1-C8) alkylene
optionally mono-unsaturated and wherein
K is optionally mono-, di- or tri-substituted
independently with fluoro, methyl or
chloro; M is –Ar, -Ar1-V-Ar2, -Ar1-S-Ar2
or –Ar1-O-Ar2 wherein Ar, Ar1 and Ar2 are
each independently a partially saturated,
fully saturated or fully unsaturated five to
eight membered ring optionally having one
to four heteroatoms selected independently
from oxygen, sulfur and nitrogen, or, a
bicyclic ring consisting of two fused
partially saturated, fully saturated or fully
unsaturated five or six membered rings,
taken independently, optionally having one
to four heteroatoms selected independently
from nitrogen, sulfur and oxygen; said Ar,
Ar1 and Ar2 moieties optionally
– ‫ב' בטבת התשס"ט‬
3122
December 29, 2008
substituted, on one ring if the moiety is
monocyclic, or one or both rings if the
moiety is bicyclic, on carbon with up to
three substituents independently selected
from R1, R2 and R3 wherein R1, R2 and R3
are H; hydroxy, nitro, halo, (C1-C6)
alkoxy, (C1-C4) alkoxy (C1-C4) alkyl, (C1C4) alkoxycarbonyl, (C1-C7) alkyl, (C3-C7)
cycloalkyl, (C3-C7) cycloalkyl (C1-C4)
alkyl, (C3-C7) cycloalkyl (C1-C4) alkanoyl,
formyl, (C1-C8) alkanoyl, (C1-C6) alkanoyl
(C1-C6) alkyl, (C1-C4) alkanoylamino, (C1C4) alkoxycarbonylamino, sulfonamido,
(C1-C4) alkylsulfonamido, amino, mono N- or di-N,N-(C1-C4) alkylamino,
carbamoyl, mono-N- or di-N,N-(C1-C4)
alkylcarbamoyl, cyano, thiol, (C1-C6)
alkylthio, (C1-C6) alkylsulfinyl, (C1-C4)
alkylsufonyl or mono-N- or di-N,N(C1-C4)
alkylaminosulfinyl; R1, R2 and R3 are
optionally mono-, di- or tri-substituted on
carbon independently with halo or
hydroxy; and V is a bond or (C1-C3)
alkylene optionally mono- or di-substituted
independently with hydroxy or fluoro with
the proviso that then K is (C2-C4) alkylene
and M is Ar and Ar is cyclopent-1-yl,
cylohex-1-yl, cyclohept-1-yl or cyclooct-1yl then said (C5-C8) cycloalkyl substituents
are not substituted at the one position with
hydroxy.
_________
]00[]00[
952955
‫תכשירים המכילים חומר פעיל שטח‬
‫והשימוש בהם לטיפול בדום נשימה‬
]00[
COMPOSITION COMPRISING A
SURFACTANT AND USES
THEREOF FOR TREATING
SLEEP APNEA
]00[
]/0[
]00[
]10[
16.04.1998
08/834369
]/0[ 16.04.1997
]//[ US
Int. Cl.7 A61K 031/66, 031/683, 035/42, 038/00, 038/17, A61M 015/00, A61P 043/00
WISCONSIN ALUMNI RESEARCH
FOUNDATION, U.S.A.
WO/1998/046245
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26 A HABARZEL STREET
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]01[
]10[
[57] Use of a pulmonary alveolar
surfactant in the preparation of a
medicament for treating sleep apnea.
________
3123
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[]00[
952179
‫פטלוציאנינים לשימוש כחומרי סימון עבור‬
‫נוזלים‬
]00[
PHTHALOCYANINES FOR USE
AS MARKING AGENTS FOR
LIQUIDS
]00[
]/0[
]00[
]10[
]01[
]10[
13.05.1998
197213995
]/0[ 22.05.1997
]//[ DE
Int. Cl.8 C07D 487/22, C09B 047/04, C10L 001/22, 001/28, 001/30
BASF SE, GERMANY
WO/1998/052950
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26 A HABARZEL STREET
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
[57]
Phthalocyanines of the formula
where
Me is twice hydrogen, twice lithium,
magnesium, zinc, copper, nickel, VO, TiO,
AlCl, AlOH, AlOCOCH3, AlOCOCF3,
SiCl2 or Si (OH)2, at least four of the
radicals R1 to R16 are each independently
of the others pyrrolidin-l-yl, pyrazolidin-1yl, imidazolidin-l-yl, oxazolidin-3-yl,
isoxazolidin-2-yl, piperidin-l-yl, piperazin1-yl, morpholin-4-yl or thiomorpholin-4yl, which radicals can be monosubstituted
or polysubstituted by C1-C4-alkyl, benzyl,
phenylethyl or phenyl,and which are
bonded to the phthalocyanine structure via
a ring nitrogen atom, and any remaining
radicals R1 to R16 are each hydrogen,
halogen, hydroxysulfonyl or C1-C4dialkylsulfamoyl, for use as marking
agents for liquids.
_________
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3124
]00[]00[
]00[
DEVICE FOR TREATMENT OF
DYSMENORRHEA AND ITS USE
]00[
]/0[
10.06.1998
60/049325
]/0[ 11.06.1997
1/911/0/1
0021020//0
Int. Cl.8 A61F 006/06, 006/14, 013/02
UMD, INC., U.S.A.
WO/1998/056323
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]00[
]10[
]01[
]10[
[57] A medicated intravaginal device for
a transvaginal delivery of a pharmaceutical
agent to the uterus of a female subject,
wherein said device is a vaginal tampon,
vaginal tampon-like device, vaginal ring,
vaginal pessary or vaginal sponge, wherein
said device is impregnated with a
pharmaceutical composition comprising
the pharmaceutical agent; wherein said
device, when inserted intravaginally,
955159
‫מתקן לטיפול בהפרעות מחזור ושימוש בו‬
]//[
US
US
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
maintains contact with the vaginal
epithelium and releases said
pharmaceutical agent, and wherein the
concentration of said pharmaceutical agent
released from the medicated device to the
vaginal epithelium is sufficient for
transvaginal delivery of a therapeutically
effective dose of said pharmaceutical agent
to the uterus of the female subject.
________
]00[]00[
]00[
PROGRESSIVE ADDITION
LENSES HAVING REGRESSIVE
SURFACES
]00[
]/0[
]00[
]10[
31.01.2000
09/244356
]/0[ 04.02.1999
Int. Cl.8 G02C 007/06
ESSILOR INTERNATIONAL
(COMPAGNIE GENERALE
D'OPTIQUE), FRANCE
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
]10[
3125
951573
‫עדשות תוספת פרוגרסיביות בעלות‬
‫שטחים רגרסיביים‬
]//[
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
[57] A multifocal ophthalmic lens
comprising one progressive addition
surface forming the convex or the concave
surface of the lens or being in a layer
between these surfaces characterized in
that it comprises one regressive surface
forming the concave or the convex surface
of the lens or being in a layer between
these surfaces.
________
]00[]00[
953035
‫שיטה לבקרת כוח המשודרת למשיב לוויני‬
‫עבור רשתות לווין מבוזרות לשם פיצוי‬
‫דעיכת גשם‬
]00[
METHOD FOR UPLINK POWER
CONTROL FOR DISTRIBUTED
SATELLITE NETWORKS TO
COMPENSATE FOR RAIN FADE
]00[
]/0[
20.10.1998
60/062497
]/0[ 20.10.1997
]//[ US
21912021/
0120120//1
US
2191200/2
0120120//1
US
Int. Cl.8 H04B 007/005, 007/185, 007/212, H04J 003/00, H04L 001/20, H04Q 007/20
VIASAT, INC., U.S.A.
WO/1999/021378
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
JERUSALEM 91013
]00[
]10[
]01[
]10[
[57] A method for dynamically
determining the power compression point
of an amplifier in a distributed network
under the control of a computer, the
network having a first terminal including
the amplifier operatively coupled to a
plurality of second terminals by a
communication channel, said method
comprising steps for: generating bit error
rate (BER) messages indicative of
measured BER for a signal transmitted at
December 29, 2008
– ‫ב' בטבת התשס"ט‬
N power levels, said BER messages
including respective tags indicative of the
N power levels for that BER, at the second
terminals, wherein N is an integer selected
from the group of positive integers or
integers greater than or equal to 2, and
reducing the maximum allowed power of
the amplifier when it is determined that the
amplifier is approaching saturation
responsive to the BER messages.
3126
_________
]00[]00[
951511
‫תרכובות המונעות רטרווירל פרוטאיזה‬
]00[
RETROVIRAL PROTEASE
INHIBITING COMPOUNDS
]00[
]/0[
21.12.1993
998114
]/0[ 29.12.1992
]//[ US
000001
1020020///
US
Int. Cl.8 A61K 031/415, 031/4164, 031/425, A61P 031/18, C07D 261/06, 263/30,
275/02, 277/22, 277/32, 413/12, 413/14, 417/12, 417/14
DIVISION FROM 112962
ABBOTT LABORATORIES, U.S.A.
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
‫ תל אביב‬,94.0 .‫ד‬.‫ ת‬, 076 ‫רחוב הירקון‬
P.O.B. 6451,
TEL AVIV 61063
]00[
]20[
]10[
]10[
[57] A combination pharmaceutical
agent for the treatment of an HIV infection
comprising (2S, 3S, 5S)-5-(N-(N-((Nmethyl-N-((2-isopropyl-4-thiazolyl)
methyl)-amino) carbonyl) valinyl) amino).
3127
2-(N-((5-thiazolyl) methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane or a
pharmaceutically acceptable salt thereof
and another HIV protease inhibiting
compound.
December 29, 2008
– ‫ב' בטבת התשס"ט‬
________
]00[]00[
951339
PEG – GRF ‫הכנת צמודי‬
]00[
PREPARATION OF PEG-GRF
CONJUGATES
]00[
]/0[
]00[
]10[
01.12.1998
97121264.2
]/0[ 03.12.1997
]//[ EP
Int. Cl.8 A61K 038/25, 047/48, C07K 014/60, 017/10, C12N 015/16
LABORATOIRES SERONO SA,
SWITZERLAND
WO/1999/027897
INTERPHARM LABORATORIES
,‫אינטרפארם מעבדות בע"מ‬
LTD.,
‫ יבנה‬,0.0 .‫ד‬.‫ ת‬, 08 ‫רחוב הקישון‬
18 HAKISHON ST.,
P.O. B. 151,
YAVNE 81220
]01[
]10[
[57] A method for the site-specific
preparation of hGRF-PEG conjugate
containing one or more PEG units (per
hGRF) covalently bound to at least one of
Lys12, Lys21 and Nα comprising carrying
out a pegylation reaction between the
hGRF peptide and an activated PEG in
solution at a pH between 7 and 9 thereafter
isolating and purifying the desired hGRFPEG from the reaction mixture.
_________
]00[]00[
950015
"fused" ‫הומולוג אנושי של חלבון‬
‫ וקטורים המכילים אותו ותאים‬,‫מדרוזופילה‬
‫המותמרים בוקטורים אלו‬
]00[
HUMAN HOMOLOG OF THE
DROSOPHILA PROTEIN
"FUSED", VECTORS
COMPRISING IT AND CELLS
TRANSFORMED WITH SAID
VECTORS
]00[
]/0[
]00[
]10[
]01[
]10[
25.02.1999
09/031563
]/0[ 26.02.1998
]//[
Int. Cl.8 C12N 001/19, 001/21, 009/12, 015/54
GENENTECH, INC., U.S.A.
WO/1999/043828
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
December 29, 2008
– ‫ב' בטבת התשס"ט‬
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
3128
[57] Isolated nucleic acid comprising
DNA having at least an 80% nucleic acid
sequence identity to a DNA molecule
encoding a vertebrate fused polypeptide
comprising the sequence of amino acids 1
to about 260 of Fig. 1 as shown in the
specification (SEQ ID NO:24) and
encoding a polypeptide having the ability
of fused to phosphorylate its substrate.
_________
]00[]00[
950111
‫התקן למתן תאים והשתלת תאים לתוך‬
‫הלב‬
]00[
INTRACARDIAC CELL
DELIVERY AND CELL
TRANSPLANTATION
APPARATUS
]00[
]/0[
]00[
]10[
]10[
18.08.2000
09/379540
]/0[ 24.08.1999
]//[ US
Int. Cl.8 A61F 002/00, A61M 025/01, A61N 001/30
BIOSENSE, INC., U.S.A.
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
‫ תל אביב‬,0046/ .‫ד‬.‫ ת‬, 004 ‫אבן גבירול‬
P.O.B. 11490,
TEL AVIV 62038
[57] An apparatus for intracardiac drug
administration comprising a catheter (20),
said catheter having at least one position
sensor (40) which generates signals
responsive to the position of said catheter,
a drug delivery device (24, 26) for
delivering a cell to a heart of a partient, for
use as a therapeutic agent, and means for
assessing the viability of said heart prior to
delivering said cell, said apparatus being
adapted for inserting said catheter into a
chamber of said heart at a site and for
delivering said cell to said site with said
drug delivery device in response to said
signals from said position sensor.
__________
3129
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[]00[
]00[
DOUBLE SLEEVE ENDOSCOPE
]00[
]00[
]10[
]10[
05.09.2000
Int. Cl.8 A61B 001/00, 017/00
STRYKER GI LTD.
YAACOV BAROR, MICHAEL
VALOSHIN
STRYKER GI LTD.,
ADVANCED TECHNOLOGY
CENTER, P.O.B.15042,
HAIFA 31905
]10[
[57] Endoscopic apparatus, comprising: a
probe (9) comprising an anterior
component and a posterior component; and
a flexible dual-sleeved tube, comprising a
flexible external sleeve (26) and a flexible
internal sleeve (20) within the external
953250
‫אנדוסקופ עם שרוול כפול‬
‫ חיפה‬,‫סטרייקר ג'י אי בע"מ‬
‫ מיכאל וולושין‬,‫יעקב ברור‬
,‫סטרייקר ג'י אי בע"מ‬
‫ חיפה‬,0./40 .‫ד‬.‫ ת‬, ‫מרכז תעשיות מדע‬
sleeve, coupled between the anterior
component and the posterior component so
as to define an enclosure between the
sleeves, which enclosure is inflated in
order to propel the anterior component
within a lumen.
__________
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3130
]00[]00[
]00[
USE OF CHEMOPREVENTATIVE
AGENTS FOR THE
PREPARATION OF
PHARMACEUTICAL
COMPOSITIONS FOR
PREVENTION OF PROSTATE
CANCER
]00[
]/0[
]00[
]10[
07.05.1999
60/084602
]/0[ 07.05.1998
Int. Cl.8 A61K 031/00
UNIVERSITY OF TENNESSEE
RESEARCH FOUNDATION, U.S.A.
WO/1999/056739
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]01[
]10[
953150
‫שימוש של גורמים כימיים לחכנת תכשירי‬
‫תרופות למניעת סרטן הערמונית‬
]//[
US
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,00988 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
[57] A use of a chemopreventive agent of the formula:
wherein R1 and R2, which can be the same
or different, are H or OH; R3 is
OCH2CH2NR4R5, wherein R4 and R5,
which can be the same or different, are H
or an alkyl group of 1 to about 4 carbon
atoms; and their pharmaceutically
acceptable salts, esters, or N-oxides, and
The applications for division
from this application have
not yet been published
mixtures thereof for the manufacture of a
pharmaceutical composition for preventing
prostate carcinogenesis in a mammalian
subject having precancerous precursors of
prostate adenocarcinoma and not having
prostate cancer.
5132221
‫בקשות חלוקה מבקשה זו‬
5‫שטרם פורסמו‬
________
3131
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[]00[
953157
C17 – IL –‫פוליפפטידים הומולוגים ל‬
‫והשימוש בהם ברפואה‬
]00[
IL-17C HOMOLOGOUS
POLYPEPTIDES AND
THERAPEUTIC USES THEREOF
]00[
]/0[
14.05.1999
60/085579
]/0[ 15.05.1998
]//[ US
21900/200
0/20020//0
US
Int. Cl.8 A61K 038/20, C07K 014/54, C12N 001/19, 005/10, 015/12
GENENTECH, INC., U.S.A.
,
WO/1999/060127
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26 A HABARZEL STREET
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]00[
]10[
]01[
]10[
[57] An isolated nucleic acid having at
least 80% nucleic acid sequence identity to
a nucleotide sequence that encodes a
polypeptide selected from the group
consisting of:
(a) an IL-17C (Interleukin 17C)
polypeptide consisting of the sequence of
amino acid residues 1 to 197 shown in
Figure 3 (SEQ ID NO:3), and
(b) an IL-17C polypeptide consisting of
the sequence of amino acid residues 19 to
197 shown in Figure 3 (SEQ ID NO:3) as
shown in the specification.
5132133
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
5‫שטרם פורסמו‬
________
]00[]00[
]00[
COOLING-HEATING
APPLIANCE USING SEMICONDUCTING
THERMOELECTRICAL DEVICE
]00[
]00[
]10[
]10[
27.12.2000
Int. Cl.8 H01L 035/02
VLADIMIR SAKHAROV
VLADIMIR SAKHAROV,
25 ANILEVICH ST., APT. 525,
HAIFA 35027
[57] Cooling-heating appliance
comprising semi-conducting
December 29, 2008
– ‫ב' בטבת התשס"ט‬
917317
–‫ציוד למצנן ומחמם מוליך למחצה תרמו‬
‫חשמלי מכשיר‬
‫ חיפה‬,‫ולדימיר סחרוב‬
,‫ולדימיר סחרוב‬
‫ חיפה‬,0.).0.(‫רחוב אנילביץ מרדכי‬
thermoelectrical devices (1) each
consisting of two semi-conducting "p" and
3132
"n" structures on one side joined with a
unifed bus-bar (17) of the hot soldered
type and on the other side each "p" and "n"
structure joined with a bus-bar of the cold
soldered type each part equipped with an
electric current tap by which each device is
joined with the next and said devices form
a unified electrotransmission line which is
equipped with a device for change of
electric current direction movement,
characterized in that as semi-conducting
thermoelectrical devices are devices in
each semi-conducting "p" and "n" structure
is divided by a space interval and the ends
of divided parts are covered by solder and
electrically joined by taps (2) from
electrical current conductors, the line of
semi-conducting theremoelectrical devices
allocated in a layer of a material with
elastic, dielectric, thermo-insulating
properties so that on one side of the layer
are allocated only bus-bars of the hot
soldered type and on the other side are
allocated only bus-bar of the cold soldered
type, the electric current line of devices
being supplemented by an electric current
starting couple.
_________
]00[]00[
3133
919171
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[
BREAST PUMP INSERT
]00[
]/0[
]00[
]10[
23.08.1999
9818448.4
]/0[ 24.08.1998
Int. Cl.8 A61M 001/06
AVENT LIMITED, UNITED
KINGDOM
WO/2000/010625
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
]01[
]10[
[57] A flexible resilient breast pump
insert adapted to fit into a rigid funnel
portion (1) of a vacuum generating breast
pump operable to generate a negative
pressure, the insert (5) comprising a mouth
portion (6) having an open end shaped to
receive and contact the areola of a
woman's breast and an inner portion (7) of
reduced size to receive the woman's nipple
and having a wall with an inner and outer
surface, connection means around the
mouth portion to connect said mouth
portion to a rigid breast pump funnel
portion to form a pressure tight seal
therewith, the mouth portion having a wall
with an inner surface (6B) adapted to
contact the woman's areola around the
nipple and an outer surface (6A) with at
least one recess (11) formed therein, the
thickness of the wall of the mouth portion
in the region of the or each recess being
less than that of the remainder of the
mouth portion and means (12) operable to
.
December 29, 2008
– ‫ב' בטבת התשס"ט‬
‫תוספת למשאבה לשד‬
]//[
GB
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
connect the or each recess with the source
of negative pressure, characterised in that,
at least one additional recess, spaced from
the at least one recess (14) along the
longitudinal axis of the insert is formed in
the outer surface (1) of the inner portion,
the thickness of the wall of the inner
portion in the region of the or each
additional recess being less than the
remainder of the inner portion; the insert
comprises means (15) operable to connect
the or each additional recess with the
source of negative pressure whereby the or
each region of reduced wall thickness in
the mouth and inner portion is deformed
and deflected into contact with the inert
surface of the rigid funnel portion of the
breast pump in response to a negative
pressure applied to the outer surface of the
wall of said mouth and inner portion
thereby massaging the areole and nipple of
the breast and stimulating the lactation of
milk from the nipple.
3134
‫_________‬
‫ב' בטבת התשס"ט –‬
‫‪December 29, 2008‬‬
‫‪3135‬‬
]00[]00[
915252
–.–]‫–פנילציקלופרופיל)אמינו‬0(–7[–.
–.,4(‫–טריאזולו‬H–3,2,1:–)‫(אלקילתיו‬
–0,0–‫–איל–ציקלופנטאן‬:–‫)פירימידין‬D
‫ תכשירי רוקחות‬,‫ הכנתם‬,‫דיאולים‬
‫המכילים אותם ומספר חומרי ביניים‬
‫כימיים עבורם‬
]00[
5-[7-(2PHENYLCYCLOPROPYL)AMINO]5-(ALKYLTHIO)-3H-1,2,3TRIAZOLO(4,5-D)PYRIMIDIN-3YL-CYCLOPENTANE-1,2-DIOLS,
THEIR PREPARATION,
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM AND SOME NOVEL
CHEMICAL INTERMEDIATES
THEREFOR
]00[
]/0[
02.12.1999
9804211-2
]/0[ 04.12.1998
]//[ SE
//10010-0
1/21020///
SE
Int. Cl.8 A61K 031/519, A61P 007/00, 009/00, C07D 487/04
ASTRAZENECA AB, SWEDEN
SIMON GUILE, DAVID HARDERN,
ANTHONY INGALL, BRIAN
SPRINGTHORPE, PAUL WILLIS
WO/2000/034283
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]00[
]10[
]10[
]01[
]10[
[57] A compound of the formula
wherein:
R1 is C3-5 alkyl optionally substituted by
one or more halogen atoms;
R2 is a phenyl group, optionally substituted
by one or more fluorine atoms;
R3 and R4 are both hydroxy;
December 29, 2008
– ‫ב' בטבת התשס"ט‬
R is XOH, where X is CH2, OCH2,
OCH2CH2 or a bond;
or a pharmaceutically acceptable salt or
solvate thereof, or a solvate of such a salt
provided that: when X is CH2 or a bond,
R1 is not propyl; when X is CH2 and R1 is
CH2CH2CF3, butyl or pentyl, the phenyl
3136
group at R2 must be substituted by
fluorine; when X is OCH2CH2CH2 and R1
The applications for division
from this application have
not yet been published
is propyl, the phenyl group at R2 must be
substituted by fluorine.
5183312
‫בקשות חלוקה מבקשה זו‬
5‫שטרם פורסמו‬
_________
]00[]00[
]00[
3 - (SUBSTITUTED ETHYNYL)
ADENOSINE DERIVATIVES AND
THEIR USE IN MEDICINE
]00[
]/0[
31.01.2000
60/118029
]/0[ 01.02.1999
219000/02
0021/20///
2190///10
0121020///
2190/001/
0021020///
1/9////01
0021220///
219000000
/121020///
Int. Cl.8 C07H 019/167
UNIVERSITY OF VIRGINIA
PATENT FOUNDATION, U.S.A.
WO/2000/044763
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
]00[
]10[
]01[
]10[
911933
‫ – (אתיניל מותמר) – אדנוסין‬: ‫תולדות‬
‫ושימושן התרופתי‬
]//[
US
US
US
US
US
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
[57] A compound of the formula:
3137
December 29, 2008
– ‫ב' בטבת התשס"ט‬
wherein
(a) each R is individually hydrogen, C1-C6
alkyl, C3-C7 cycloalkyl, phenyl or phenyl
(C1-C3)-alkyl;
(b) each X is independently –CH2OH, CO2R2, -OC(O)R2, or C(O)NR3R4;
(c) each of R2, R3 and R4 is individually H,
C1-6-alkyl; C1-6-alkyl substituted with 1-3
C1-6-alkoxy, C3-C7 cycloalkyl, C1-6alkylthio, halogen, hydroxy, amino, mono
(C1-6-alkyl) amino, di(C1-6-alkyl) amino, or
C6-C10-aryl, wherein aryl may be
substituted with 1-3 halogen, C1-6-alkyl,
hydroxy, amino, mono (C1-6-alkyl) amino,
or di(C1-6-alkyl) amino; C6-10-aryl; or C6-10aryl substituted with 1-3 halogen, hydroxy,
amino, mono (C1-6-alkyl) amino, di(C1-6alkyl) amino or C1-6-alkyl;
(d) Z and Z' are individually (C1-C6) alkyl,
optionally interrupted by 1-3 S or nonperoxide O, or are absent, and n is 1-3; or a
pharmaceutically acceptable salt thereof.
__________
]00[]00[
]00[
METHOD AND DEVICE FOR
IMAGE AMPLIFICATION
]00[
]00[
]10[
]10[
16.07.2001
Int. Cl.8 G02B 027/00
VLADIMIR SAKHAROV
VLADIMIR SAKHAROV,
25 ANILEVICH ST., APT. 525,
HAIFA 35027
911551
‫שיטה והתקן להגברת דמויות‬
‫ חיפה‬,‫ולדימיר סחרוב‬
,‫ולדימיר סחרוב‬
‫ חיפה‬,0.).0.(‫רחוב אנילביץ מרדכי‬
[57] A method of image intensification
that comprises power exciting radiation of
discrete electric charge in a medium that
can absorb quanta of visible light projected
onto this image medium, while in
energetically excited condition, and
characterized by that a medium exciting
radiation is performed by continuous
subsequent dense by – the – line scanning
of every point of medium to be excited
with a laser beam, the medium being
mounted on a substrate penetrable for an
exciting laser beam, and that each scanned
point that has absorbed quanta of visible
light projected onto the image medium to
be excited, is used for an amplitude
modulation of a laser beam that passes
through this point, and the said laser beam
is received by a semi-conducting
transducer mounted under the said
substrate and intended for transforming
each beam received at a given moment of
scanning into electric current that will be
further used for electronic intensification
subject to a point obtained by this beam of
amplitude modulation, and such one that
has absorbed quanta of visible light, and
that each electric current intensified in
such a way, is used for amplitude
modulation of a laser beam from the
second laser device operated in a range of
visible light frequencies, and which is
forced to scan a definite area synchronized
with parameters of scanning the excited
medium with an exciting laser beam in the
first laser device.
________
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3138
]00[]00[
]00[
METHOD OF USING
EMAMECTIN TO CONTROL FISH
PARASITES
]00[
]/0[
]00[
]10[
06.04.2000
09/288431
]/0[ 08.04.1999
Int. Cl.8 A23K 001/17
SCHERING-PLOUGH, LTD.,
SWITZERLAND
WO/2000/060952
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
]01[
]10[
[57] Use of emamectin or a salt thereof
for the preparation of a medicated fish feed
for eliminating, reducing or preventing
parasites in a fish population, by feeding
.
913393
‫שיטה לשימוש באממקטין לבקרת טפילי‬
‫דגים‬
]//[
US
,'‫ד"ר שלמה כהן ושות‬
‫ תל אביב‬,0046/ .‫ד‬.‫ ת‬, 004 ‫אבן גבירול‬
emamectin or a salt thereof to said fish
population at a daily dose of 25 μg to 400
μg per kg of fish biomass per day for a
period of 3-14 days.
________
]00[]00[
913331
‫שיטות להכנת תכשיר רפואי המכיל‬
‫טולפריזון למתן דרך הפה‬
]00[
METHODS FOR PRODUCING
TOLPERISON-CONTAINING
PHARMACEUTICAL
PREPARATION FOR ORAL
ADMINISTRATION
]00[
]/0[
]00[
]10[
16.11.1999
A594/99
]/0[ 01.04.1999
]//[ AT
Int. Cl.8 A61K 009/00, 009/22, 009/50, A61P 019/00
SANOCHEMIA PHARMAZEUTIKA
AG, AUSTRIA
WO/2000/059508
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
‫ הרצליה‬,00988 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
P.O.B. 12688,
HERZLIYA 46733
]01[
]10[
[57] Method for producing a
pharmaceutical preparation for oral
administration, which contains Tolperison
or a salt thereof, the preparation being
3139
prepared for delayed release of the active
ingredient Tolperison, characterised in that
crystalline Tolpersion hydrochloride as a
50/50 racemate is coated in a column,
December 29, 2008 – ‫ב' בטבת התשס"ט‬
which is operated with an airflow, with a
mixture of methanol and a solution of ethyl
cellulose and hydroxypropyl cellulose in
chloroform, the solution being sprayed at a
temperature of 60oC at the inlet into the
coating column with 2.5 bar pressure and
at a rate of 60 ml/min, and in that the
Tolpersion crystals provided with the
polymer coating are dried.
________
]00[]00[
913332
– NDISACC – (4 – (4 –‫שימוש ב‬
‫ או‬B82846A )‫כלורופניל) – בנזיל‬
‫ בהכנת תרופות לטיפול ארוך‬,‫טייכופלאנין‬
‫טווח למניעת זיהומים של סטרפטוקוקוס‬
‫פנאומוניאה‬
]00[
USE OF NDISACC - ( 4- (4 CHLOROPHENYL) - BENZYL)
A82846B OR TEICOPLANIN, IN
THE MANUFACTURE OF A
MEDICAMENT FOR LONG TERM PREVENTION OF S.
PNEUMONIAE INFECTION
]00[
]/0[
]00[
]10[
]01[
]10[
19.04.2000
60/132258
]/0[ 03.05.1999
]//[ US
Int. Cl.8 A61K 038/14, 048/00, A61P 031/04
ELI LILLY AND COMPANY, U.S.A.
WO/2000/066144
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
[57] The use of NDISACC-(4-(4chlorophenyl)-benzyl) A82846B or
teicoplanin, or pharmaceutically
acceptable salts, hydrates or solvates
thereof, or mixtures thereof, in the
manufacture of a medicament for the longterm prevention of S. pneumoniae
infection in susceptible individuals.
_________
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3140
]00[]00[
]00[
USE OF THERAPEUTIC CELLS IN
THE MANUFACTURE OF A CELL
SUPPORT COMPLEX FOR
TREATING SCHIZOPHRENIA
]00[
]/0[
]00[
]10[
20.03.2000
09/289576
]/0[ 09.04.1999
Int. Cl.8 A61K 035/12, 045/06
TITAN PHARMACEUTICALS, INC.,
U.S.A.
WO/2000/061556
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
]01[
]10[
[57] Use of therapeutic cells which
produce dopamine or a dopamine
precursor and a first support matrix in the
manufacture of a cell/support complex
comprising therapeutic cells adhered to the
first support matrix, the cell/support
The applications for division
from this application have
not yet been published
913393
‫שימוש בתאים תרפויטיים לייצור‬
‫קומפלקס של "תאי תמיכה" למטרת‬
‫טיפול בסכיזופרניה‬
]//[
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
complex being for treating a negative
symptom of schizophrenia in a subject in a
method comprising administering an
effective amount of the cell/support
complex to the prefrontal cortex of the
subject's brain.
5100326
‫בקשות חלוקה מבקשה זו‬
5‫שטרם פורסמו‬
________
3141
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[]00[
913171
‫סוללה משופרת מבחינה פונקציונלית‬
‫ושיטה לייצורה‬
]00[
FUNCTIONALLY IMPROVED
BATTERY AND METHOD OF
MAKING SAME
]00[
]/0[
]00[
]10[
]10[
]01[
]10[
13.04.2000
60/129234
]/0[ 14.04.1999
]//[ US
Int. Cl.8 A61N 001/30, B32B 009/00, H01M 010/46
POWER PAPER LTD.
‫ תקוה‬- ‫ פתח‬,‫פאור פייפר בע"מ‬
BARUCH LEVANON
‫ברוך לבנון‬
WO/2000/062365
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬066.( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
,00 ‫רחוב מנחם בגין‬, 0. ‫ קומה‬,‫מגדל אילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
[57] A functionally improved battery
comprising: (a) a flexible thin layer
electrochemical cell (10) and (b) an
electronic chip device (60) being integrally
formed on or within said flexible thin layer
electrochemical cell, said electronic chip
device serving to improve a functionality
of the battery.
_________
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3142
]00[]00[
911091
‫מדפסת אינטראקטיבית נישאת‬
]00[
PORTABLE INTERACTIVE
PRINTER
]00[
]/0[
24.05.2000
PQ0559
]/0[ 25.05.1999
]//[ AU
PQ1313
/121220///
AU
PQ3632
0020120///
AU
Int. Cl.8 B41F 031/08, B41J 002/21, B41L 027/10, G06F 003/03, 003/033
SILVERBROOK RESEARCH PTY.
LTD., AUSTRALIA
WO/2000/072129
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
]00[
]10[
]01[
]10[
[57] A portable printer for printing a
second interface onto a second surface, in
response to first indicating data received
from a sensing device, the first indicating
data being sensed by the sensing device
from first coded data, a first interface
disposed on a first surface including the
first coded data, the printer including:
(a) an input module configured to:
(i) receive, from the sensing device, the
first indicating data, the first indicating
data being at least partially indicative of
response data;
(ii) generate second indicating data based
on the first indicating data, the second
indicating data being at least partially
indicative of the response data;
(ii) send the second indicating data to a
computer system; and
(b) a printing module, including a printing
mechanism, configured to:
(i) receive the response data from the
computer system;
(ii) generate the second interface so as to
include second coded data based at least
partially on the response data; and
(iii) print the second interface onto the
second surface including the second coded
data using the printing mechanism.
_________
3143
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[]00[
]00[
METHOD AND DEVICE FOR
PRODUCING A PRODUCT MADE
OF STRIP TAPE, ESPECIALLY A
MEDICAL PRODUCT AND/OR A
PRODUCT CONTAINING ACTIVE
SUBSTANCES, AS WELL AS
FILLABLE RECEPTACLES OR
POUCHES WHOSE EDGES CAN
BE SEALED
]00[
]/0[
]00[
]10[
31.05.2000
19925339.0
]/0[ 02.06.1999
Int. Cl.8 A61F 013/02
LTS LOHMANN THERAPIESYSTEME AG, GERMANY
WO/2000/074618
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]01[
]10[
911391
‫שיטה ומכשיר לייצור מוצר העשוי מרצועת‬
‫או מוצר המכיל‬/‫ במיוחד מוצר רפואי ו‬,‫דבק‬
‫חומרים פעילים וגם כלי קיבול או שקיקים‬
‫הניתנים למילוי שהקצה שלו ניתן לאיטום‬
]//[
DE
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
[57] Process for manufacturing a product
from strip tape, in particular a medicinal
and/or active substance-containing product
such as, for example, a dermal or
transdermal patch or another
administration form, for example for oral
application, as well as fillable containers or
sealed-margin bags, characterized in that a
roll of material with a broad web of
material is mounted, loosely rotatable, on a
take-up mandrel, a web of material is
drawn, in its entire width and without
subjecting the materials to tensile stress,
from the roll of material by means of a
vacuum roll (4), and is separated in the
process into individual strips (6) in the
negative pressure zone of the vacuum roll
by rolling a multiple circular knife roll, at
the end of the negative pressure zone of
the vacuum roll, each strip is drawn from
the said vacuum roll and is introduced in a
take-up channel and continuously
conveyed therein by means of negative
pressure, in the process, each strip is
turned on its way to the channel or through
the channel by about 90o around its
longitudinal axis, and at the end of the
channels the strips are led one upon the
other, at least two a time, and thereafter
conveyed further in a, preferably open,
groove for further processing under
completion to form the finished medicinal
and/or active substance-containing product
or fillable containers or sealed-margin bags
in a conversion equipment where the
products are finished
– ‫ב' בטבת התשס"ט‬
3144
December 29, 2008
_________
]00[]00[
‫הסוואת טעם של תכשירי קווינולון נוזליים‬
‫הניתנים דרך הפה על ידי שימוש במחליף‬
‫יונים משרף‬
]00[
TASTE MASKING OF ORAL
QUINOLONE LIQUID
PREPARATIONS USING ION
EXCHANGE RESINS
]00[
]/0[
]00[
]10[
12.07.2000
09/353549
]/0[ 14.07.1999
Int. Cl.8 A61K 031/74, 047/32
SCHERING-PLOUGH, LTD.,
SWITZERLAND
WO/2001/005431
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
]01[
]10[
910212
[57] An aqueous pharmaceutical
composition for oral administration
comprising:
(a) 0.1% to 10% by weight of a quinolone
compounds; wherein the quinolone
compound is selected from the group
consisting of orbifloxacin, grepafloxacin,
nalidixic acid, sparfloxacin and
trovafloxacin mesylate;
]//[
US
,'‫ד"ר שלמה כהן ושות‬
‫ תל אביב‬,0046/ .‫ד‬.‫ ת‬, 004 ‫אבן גבירול‬
(b) 0.2% to 20% by weight of a cationic
ion exchange resin; and
(c) the remainder of the composition
comprising one or more pharmaceutically
acceptable excipients; wherein the
quinolone compound has a bitter taste that
is eliminated or reduced by the ion
exchange resin.
________
3145
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[]00[
910533
‫שיטה ומערכת לעריכת ועידה‬
]00[
METHOD AND SYSTEM FOR
CONFERENCING
]00[
]/0[
30.06.2000
PQ1313
]/0[ 30.06.1999
]//[ AU
PQ2912
0121/20///
AU
Int. Cl.8 G06F 003/12, G06Q 001/000000 H04M 003/56, H04N 007/15
SILVERBROOK RESEARCH PTY.
LTD., AUSTRALIA
WO/2001/002940
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
]00[
]10[
]01[
]10[
[57] A method of enabling remote
conferencing between conference
participants, the method including the
steps of: providing a participant with at
least one printed conferencing form
containing information relating to a remote
conferencing session and including coded
data printed as collection of tags, each tag
identifying an identity of the conferencing
form and a location of the tag on the
conferencing form; operatively positioning
an optically imaging pen relative to the
conferencing form, said pen having a nib;
imaging a tag on the conference form;
computing the position of the nib from an
observed perspective distortion on the
imaged tag and a known spatial
relationship between the pen's physical
axis and the pen's optical axis, said axes
being different from each other;
transmitting, to a computer system,
indicating data from the pen, said
indicating data regarding the identity of the
conferencing form and a position of the nib
relative to the conferencing form;
identifying in the computer system and
from the indicating data, at least one
parameter relating to the conferencing
session; and providing at least one other
conference participant remote from said
conference containing information
representative of that at least one
parameter.
– ‫ב' בטבת התשס"ט‬
3146
December 29, 2008
_________
]00[]00[
910301
‫תרכובת דבק בקפסולה זעירה‬
]00[
MICROENCAPSULATED
ADHESIVE COMPOSITION
]00[
]/0[
]00[
]10[
]01[
]10[
30.08.2001
60/230365
]/0[ 06.09.2000
]//[
Int. Cl.8 A61K 009/00, 009/50, B32B 015/02
APPLETON PAPERS INC., U.S.A.
WO/2002/020683
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
[57] A microencapsulated adhesive
composition wherein an adhesive is
formed in situ in microcapsules, the
microencapsuled adhesive composition
3147
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
comprising: a substantially water insoluble
adhesive-forming core material, said core
material comprising at least a first addition
polymerizable pre-polymer material whose
December 29, 2008
– ‫ב' בטבת התשס"ט‬
homopolymer has a Tg of less than about
0oC, a flash point of at least 75oC, and a
boiling point of at least 175oC at one
atmosphere, and including in addition a
second substantially water insoluble
polymerizable pre-polymer which is multifunctional having at least two addition
polymerizable sites, selected from the
group consisting of allyl methacrylate,
alkene glycol dimethacrylate, alkyl
dimethacrylate, alkyldiol dimethacrylate,
alkoxy alkanol diacrylate, trialkanol
triacrylate, alkoxy (alkoxy)n alkyl
triacylate, alkoxy (alkoxy) alkyl
dimethacrylate, aralkyl dimethacrylate,
cycloalkyl dimethacrylate, alkoxy
dimethacrylate, bicycloalkyl
dimethacrylate, cycloalkoxy
dimethacrylate, allyl acrylate, alkene
glycol diacrylate, alkyl diacrylate,
alkyldiol diacrylate, alkoxy alkanol
dimethacrylate, trialkanol trimethacrylate,
alkoxy (alkoxy)n alkyl trimethacrylate,
alkoxy (alkoxy)n alkyl diacrylate, aralkyl
diacrylate, cycloalkyl diacrylate, alkoxy
diacrylate, bicycloalkyl diacrylate, and
cycloalkoxy diacrylate; wherein the alkyl
moieties are of 1 to 16 carbons; wherein
the cycloalkyl moieties are of 4 to 8
carbons; and wherein n is an integer from
1 to 6; and, a catalytically effective amount
of a substantially water insoluble free
radical initiator, said free radical initiator
having a half-life of at least 1 hour at 25oC,
said free radical initiator being soluble in
the polymerizable pre-polymer material
and solvent, microcapsules obtained by
providing an aqueous mixture containing a
colloidal dispersion of wall-forming
material for forming microcapsules,
wherein high shear agitation is applied to
the aqueous mixture to achieve a particle
size of the core material of less than about
250μ, wherein stirring at a first
temperature effects microcapsule wall
formation of the microcapsule wallforming material, and wherein heating to a
second temperature polymerizes the prepolymer of the core material to form an
adhesive in situ in the formed
microcapsules.
__________
]00[]00[
913791
–‫מעכבים לא פפטידים של קישור ליגנד ל‬
VLA – 4
]00[
NON - PEPTIDE INHIBITORS OF
LIGAND BINDING TO VLA - 4
]00[
]/0[
]00[
14.08.2000
60/148845
]/0[ 13.08.1999
]//[ US
Int. Cl.8 A61K 031/185, 031/395, 038/00, A61P 029/00, 043/00, C07C 311/20, C07D
205/04, 207/26, 207/48, 209/10, 401/12, 403/12, 405/14, 409/06, C07F 009/547,
C07K 005/06
BIOGEN IDEC MA INC., U.S.A.
WO/2001/012186
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26 A HABARZEL STREET
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]10[
]01[
]10[
[57] Compounds of the formula:
R3–L–L'–R1
December 29, 2008 – ‫ב' בטבת התשס"ט‬
wherein
3148
R1 is optionally substituted pyrrolidinyl,
wherein the optional substituent is a SO2optionally substituted phenyl group; L' is a
hydrocarbon linker moiety having 1 carbon
chain atom and is
(i) terminally attached to R1 by –
NHC(=O)-; and
(ii) substituted with –COOH;
L is C1-4 alkyl terminally attached to R3 by
–C(=O)NH-; and
R3 is of the formula R4-Y5-N(R5)-CH(R6)where R6 is alkyl; R5 is hydrogen or alkyl;
Y5 is –C(=O)- and R4 is an optionally
substituted aralkyl; or pharmaceutically
acceptable salts thereof.
_________
]00[]00[
913513
‫תרכובות למניעת התרבות תאים של‬
‫יונקים ושימושיהן‬
]00[
COMPOSITIONS FOR
INHIBITING THE
PROLIFERATION OF
MAMMALIAN CELLS AND THE
USE THEREOF
]00[
]/0[
]00[
]10[
29.08.2000
09/385411
]/0[ 30.08.1999
]//[ US
Int. Cl.8 A61K 038/46, 048/00, A61P 035/00
YISSUM RESEARCH
‫יישום חברה לפיתוח המחקר של‬
DEVELOPMENT COMPANY OF
‫ ירושלים‬,‫האוניברסיטה העברית בירושלים‬
THE HEBREW UNIVERSITY OF
JERUSALEM
WO/2001/015531
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬066.( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
,00 ‫רחוב מנחם בגין‬, 0. ‫ קומה‬,‫מגדל אילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
]01[
]10[
[57] A pharmaceutical composition
comprising, as an active ingredient, a
therapeutically effective amount of a
ribonuclease of the T2 family having actin
The applications for division
from this application have
not yet been published
binding activity, and a pharmaceutically
acceptable carrier.
5132338
‫בקשות חלוקה מבקשה זו‬
5‫שטרם פורסמו‬
_________
]00[]00[
3149
913153
December 29, 2008
– ‫ב' בטבת התשס"ט‬
‫שיטה לייצור חומרים חלבוניים ברקמת‬
‫פרוטונמה מוס‬
]00[
METHOD FOR PRODUCTION OF
PROTEINACEOUS SUBSTANCES
IN PROTONEMA MOSS TISSUE
]00[
]/0[
]00[
]10[
27.09.2000
19947290.4
]/0[ 01.10.1999
]//[ DE
Int. Cl.8 A01H 011/00, C07K 014/52, C12N 015/82, C12P 021/02
GREENOVATION BIOTECH GMBH,
GERMANY
WO/2001/025456
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26 A HABARZEL STREET
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]01[
]10[
[57] A method for the production of
heterologous proteinaceous substances in
plant material, characterized in that
protonema moss tissue is used as plant
.
The applications for division
from this application have
not yet been published
material and that the proteinaceous
substances produced are obtained from the
culture medium without disrupting the
producing tissues or cells.
5132338
‫בקשות חלוקה מבקשה זו‬
5‫שטרם פורסמו‬
________
]00[]00[
]00[
DNA SEQUENCING METHOD
]00[
]/0[
]00[
]10[
06.10.2000
9923644.0
]/0[ 06.10.1999
Int. Cl.8 C12Q 001/68
MEDICAL BIOSYSTEMS LTD.,
UNITED KINGDOM
WO/2001/025480
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
]01[
]10[
[57] A method for determining the
sequence of a polynucleotide, comprising
the steps of: (i) reacting a target
polynucleotide with an enzyme that
interacts with and processes along the
polynucleotide, under conditions sufficient
December 29, 2008
– ‫ב' בטבת התשס"ט‬
913103
DNA ‫שיטה לעריכה ברצף של‬
]//[
GB
,‫ד"ר יצחק הס ושותפיו‬
‫ תל אביב‬,94.0 .‫ד‬.‫ ת‬, 076 ‫רחוב הירקון‬
to induce enzyme activity; and (ii)
detecting conformational changes in the
enzyme as the enzyme processes along the
polynucleotide, and thereby determining
the sequence of the polynucleotide,
wherein the enzyme comprises a bound
3150
fluorescent molecule, the characteristics of
which alter as the enzyme undergoes
conformational change, and wherein the
target polynucleotide does not comprise a
label prior to, or after the enzyme
processes along the polynucleotide, and
wherein if step (i) is carried out in the
presence of polynucleotide monomers, the
polynucleotide monomers do not comprise
a label.
_________
]00[]00[
913319
‫ תכשירי רוקחות המכילים‬,‫תולדות אינדול‬
‫אותן והשימוש בהן להכנת תרופות‬
]00[
INDOLE DERIVATIVES ,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND THEIR USE FOR
MANUFACTURING
MEDICAMENTS
]00[
]/0[
]00[
16.10.2000
60/160356
]/0[ 19.10.1999
]//[ US
Int. Cl.8 A61K 031/47, A61P 031/00, 035/00, 043/00, C07D 401/04, 401/14, 405/14,
409/14, 413/14, 417/14
MERCK & CO., INC., U.S.A.
WO/2001/029025
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26 A HABARZEL STREET
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]10[
]01[
]10[
[57] Compounds of the formula
or pharmaceutically acceptable salts or
stereoisomers thereof, wherein
Z is
s is 1 or 2;
3151
December 29, 2008
– ‫ב' בטבת התשס"ט‬
t is 1, 2, or 3; and R1, R2, R3, R4 are as
defined in the specification.
__________
]00[]00[
911590
,0( –‫אגוניסטים של קולטן אדרנרגי‬
‫תכשירים רוקחיים המכילים אותם‬
‫ושימושם בייצור של תרופות‬
]00[
(2 - ADRENERGIC RECEPTOR
AGONISTS, PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM AND USES THEREOF IN
THE PREPARATION OF
MEDICAMENTS
]00[
]/0[
06.12.2000
09/457618
]/0[ 08.12.1999
]//[ US
1/92/10//
0021020111
US
Int. Cl.8 A61K 031/167, 045/06, A61P 011/00, 025/00, C07C 233/43
THERAVANCE, INC., U.S.A.
WO/2001/042193
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26 A HABARZEL STREET
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]00[
]10[
]01[
]10[
[57] A compound of the formula:
or a pharmaceutically acceptable salt thereof.
_________
]00[]00[
]00[
APPARATUS COMPRISING
MULTI-LUMEN TUBE FOR
APPLYING NEGATIVE
PRESSURE THERAPY TO A
WOUND
]00[
08.11.2000
December 29, 2008
– ‫ב' בטבת התשס"ט‬
911371
‫התקן הכולל צינור רב – תאי עבור מתן‬
‫רפוי לחץ שלילי לפצע‬
3152
]/0[
]00[
]10[
]01[
]10[
9926538.1
]/0[ 09.11.1999
Int. Cl.8 A61M 001/00
KCI LICENSING, INC., U.S.A.
WO/2001/034223
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
[57] Apparatus for applying negative
pressure therapy to a wound which
comprises a porous pad (1) for application
to the wound, a suction tube (2) linking the
porous pad to a source (103) of negative
pressure, a container (6) for collecting
fluid exudates from the wound interposed
between the porous pad and the source of
negative pressure and a quick disconnect
connector (8) linking a first section (11) of
the suction tube leading to the porous pad
with a second section leading to the
container, said connector comprising two
3153
]//[
GB
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
separable and non-interchangeable parts
(9, 10) said second section of the suction
tube comprising a multi-lumen tube (12),
one lumen being provided for applying
suction to the porous pad and another
being provided for monitoring pressure,
said multi-lumen tube being fixedly
attached at one end to the container and at
the other end to one of said separable parts,
said one separable part including sealing
means whereby the lumens are connected
in air-tight manner to said first section of
the suction tube.
December 29, 2008
– ‫ב' בטבת התשס"ט‬
_________
]00[]00[
]00[
PROCESS FOR THE
PREPARATION OF KETIMINES
]00[
]/0[
]00[
]10[
07.11.2000
99811054.8
]/0[ 16.11.1999
Int. Cl.8 C07C 249/02, 251/20
CIBA SPECIALTY CHEMICALS
HOLDING INC., SWITZERLAND
WO/2001/036378
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
]01[
]10[
911321
‫תהליך להכנת קטאימינים‬
]//[
EP
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
[57] A process for the preparation of
compounds of the formula
in which R1, R2 and R3 independently of
one another are hydrogen, halogen,
December 29, 2008
– ‫ב' בטבת התשס"ט‬
trifluoromethyl or C1-C4 alkoxy, wherein a
compound of the formula
3154
in which R1, R2 and R3 are as defined in
formula (1), is reacted with methylamine
in the presence of a sulfonic acid catalyst
and of a non-alcoholic solvent to give the
compound of the formula (1).
__________
]00[]00[
911359
,‫–דסמתיל ונלאפאקסין‬O ‫אתרים של‬
‫תהליך להכנתם והשימוש בהם להכנת‬
‫תרופות‬
]00[
ETHERS OF O-DESMETHYL
VENLAFAXINE, PROCESS FOR
THEIR PREPARATION AND
THEIR USE FOR
MANUFACTURING
MEDICAMENTS
]00[
]/0[
]00[
]10[
]01[
]10[
21.11.2000
09/448268
]/0[ 24.11.1999
]//[ US
Int. Cl.8 A61K 031/135, 031/343, A61P 025/24, C07C 217/54, C07D 307/89
WYETH, U.S.A.
WO/2001/038293
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26 A HABARZEL STREET
3155
December 29, 2008
– ‫ב' בטבת התשס"ט‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
[57] A compound of the formula:
wherein
the configuration at the stereogenic center
(*) may be R, S or Rs (the racemate); R1 is
:
selected from C1-C6 alkyl, C1-C6 alkyl, C1C6 alkoxy, C3-C6 cycloalkyl, or the moiety
R2 is selected from H, or C1-C6 alkyl; or
R1 and R2 may be concatenated such that
form a moiety of the formula
R3 is selected from H or C1-C6 alkyl; and
R4 and R5 are independently selected from
H, C1-C6 alkyl, C3-C6 cycloalkyl, C1-C6
alkoxy, C1-C6 alkylthio, -CN, -OH-, -CF3,
-OCF3, halogen, NH2, -NO2, or mono or
dialkylamino wherein each alkyl group has
1 to 6 carbon atoms, or a pharmaceutically
acceptable salt or hydrate thereof.
________
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3156
]00[]00[
911333
‫אורגניזם רב–תאי לא–אנושי ושיטות‬
‫לבקרתו‬
]00[
NON-HUMAN MULTICELLULAR
ORGANISM AND METHODS FOR
CONTROLLING THE SAME
]00[
]/0[
]00[
]10[
29.11.2000
9928181.8
]/0[ 29.11.1999
]//[ GB
Int. Cl.8 A01H 001/00, A01K 067/033, C12N 015/63
ISIS INNOVATION LIMITED,
UNITED KINGDOM
WO/2001/039599
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]01[
]10[
[57] A method of population control of a
non-human multicellular animal in a
natural environment thereof, comprising:
(i) breeding a stock of the animal, the
animal carrying a dominant lethal genetic
system, the lethal effect of the lethal
system being conditional and occurring in
the said natural environment via the
expression to a lethal gene, the expression
of said lethal gene being under the control
of a repressible transactivator protein, the
said breeding being under permissive
conditions in the presence of the substance,
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
the substance being absent from the said
natural environment and able to repress
said transactivator;
(ii) distributing the said stock animals into
the environment at a locus for population
control; and
(iii) achieving population control through
embryonic lethality by expression of the
lethal system in embryos of offspring that
result from interbreeding of the said stock
individuals with individuals of the opposite
sex of the wild population.
________
]00[]00[
]00[
PROCESS FOR THE
PREPARATION OF 5 - (1 PIPERAZINYL)BENZOFURAN - 2 CARBOXAMIDE BY TRANSITION
METAL-CATALYSED
AMINATION AND SOME NOVEL
COMPOUNDS
]00[
]/0[
]00[
]10[
29.11.2000
19958496.6
]/0[ 04.12.1999
Int. Cl.8 C07D 405/00
MERCK PATENT GMBH,
GERMANY
3157
911101
‫ – פיפרזיניל) בנזופורן‬0( – . ‫תהליך להכנת‬
‫ – קרבוקסאמיד על ידי אמינציה בעזרת‬0 –
‫קטליזת מתכת מעבר ומספר תרכובות‬
‫חדשות‬
]//[
DE
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]01[
]10[
WO/2001/040219
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
[57] Process for the preparation of 5-(1piperazinyl) benzofuran-2-carboxamide,
characterized in that
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
‫ הרצליה‬,0/80 .‫ד‬.‫ ת‬, 0/ ‫שדרות אבא אבן‬
(a) 5-bromosalicylaldehyde is reacted in a
one-pot reaction firstly with a compound
of the formula
Hal-CH2-COOR1
in which
Hal is Cl, Br or I, and
R1 is alkyl having 1-6 carbon atoms or
benzyl, and subsequently with formamide
to give 5-Hal-benzufuran-2-carboxamide
(II), in which Hal is Cl, Br or I, compound
(II) is then reacted in a transition
metalcatalysed amination with R2piperazine, in which R2 is H or an amino
protecting group, to give the compound of
the formula
in which R2 is H or an amino protecting
group, and subsequently, if R2 ≠ H, R2 is
cleaved off, or
(b) a compound of the formula
in which
L is Cl, Br, I or a reactively esterified OH
group, R3 is H or CH2R6, R4 and R5 are
each, independently of one another, OR7,
OR8, SR7 or SR8, R4 and R5 together are
alternatively carbonyl, =S, =N-C(R7)2, =NC(R8)2, =N-C(R8)2, =N-OH, =N-OR7, =NN [(R7)2], =N-N[(R8)2] or –O-(CH2)n-O-,
R6 is CN, COOH, COOR7 or CONH2, R7
is alkyl having 1-6 carbon atoms, R8 is
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3158
phenyl which is unsubstituted or mono-or
disubstituted by R7, OR7, SR7 or Hal, n is 2
or 3, is reacted in a transition metal-
catalysed amination with R2-piperazine, in
which R2 is H or an amino protecting
group, to give a compound of the formula
in which R2 is H or an amino protecting
group, R3 is H or CH2R6, R4 and R5 are
each, independently of one another, OR7,
OR8, SR7 or SR8, R4 and R5 together are
alternatively carbonyl, =S, =N -C(R7)2, =NC(R8)2, =N-OH, =N-OR7, =N-N[(R7)2],
=N-N[(R8)2] OR –O-(CH2)n-O-, R6 is CN,
COOH, COOR7 or CONH2, R7 is alkyl
having 1-6 carbon atoms, R8 is phenyl
which is unsubstituted or mono-or
disubstituted by R7, OR7, SR7 or Hal, n is 1
or 3, which is subsequently reacted in a
one-pot reaction firstly with a compound
of the formula
L-CH2-COOR1
in which
L is Cl, Br, I or a reactively esterified
OH group, and R1 is alkyl having 1-6
carbon atoms or benzyl, and subsequently
with formamide to give a compound of the
formula
in which R2 is H or an amino protecting
group, and subsequently, if R2 ≠ H, R2 is
cleaved off,
(c) a compound of the formula V
in which
R2 is an amino protecting group,
R3 is H or CH2R6, R4 and R5 are each,
independently of one another, OR7, OR8,
SR7 or SR8, R4 and R5 together are
alternatively carbonyl, =S, =N-C(R7)2, =NC(R8)2, =N-OH, =N-OR7, =N-N [(R7)2],
=N-N[(R8)2] or –O-(CH2)n-O-, R6 is CN,
COOH, COOR7 or CONH2, R7 is alkyl
3159
December 29, 2008
– ‫ב' בטבת התשס"ט‬
having 1-6 carbon atoms, R8 is phenyl
which is unsubstituted or mono- or
disubstituted by R7, OR7, SR7 or Hal, n is 2
or 3, is reacted with chloroacetamide to
give a compound of the formula III in
which R2 is an amino protecting group,
and R2 is subsequently cleaved off, and/or
in that 5-(1-piperazinyl) benzofuran-2carboxamide is converted into one of its
acid-addition salts by treatment with an
acid.
________
]00[]00[
]00[
DISPENSING DEVICE FOR
CLEANING AGENTS
]00[
]00[
]10[
]10[
09.06.2002
Int. Cl.8 E03D 009/02
AVIV KARIRI
GOLD PATENTS LTD.,
43 RUBINSTEIN ST.,
HAIFA 34987
[57] A dispensing device adapted to
dispense a predetermined amount of
cleaning agent (32) into a toilet tank
wherein the cleaning agent is flushed into a
toilet bowl with water that is received in
the toilet tank, the dispensing device
comprising: a container (10) having a
bottom side and an upper side, said
container is provided with a first opening
(12) in the upper side that is adapted to
receive the cleaning agent and a second
opening (20) in the bottom side that is
adapted to dispense the cleaning agent,
wherein the container is adapted to be
mounted on the toilet tank so that the first
opening is positioned externally to the
toilet tank and the second opening is
positioned inside the toilet tank; a float
(21) provided with a passage (26), said
December 29, 2008
– ‫ב' בטבת התשס"ט‬
937711
‫התקן לשחרור גורמי ניקוי‬
‫ חיפה‬,‫אביב קרירי‬
,‫) בע"מ‬0660( ‫גולד פטנטים וייעוץ כלכלי‬
‫ חיפה‬,4:‫רובינשטיין‬
float being adapted to float on the water in
the toilet tank, wherein the float moves
between two extreme positions: an
uppermost position in which said passage
is fluidically connected to said second
opening, and a lower position in which a
portion of the float blocks said second
opening and said passage is fluidically
connected to the toilet tank; a shutter (30)
provided opposite said second opening,
said shutter blocks said passage when said
float is in the uppermost position; whereby
in the uppermost position, a portion of the
cleaning agent is received in said passage,
and in the lower position, the portion
dispenses into the toilet tank so that when
water enters the toilet tank, it mixes with
cleaning agent, ready to be flushed into the
toilet bowl.
3160
__________
]00[]00[
937219
‫ממירי תולדות פאניל פיפראזין מותמרות‬
‫ותרכובות תכשירי רוקחות המכילים אותם‬
]00[
SUBSTITUTED PHENYL
PIPERAZINE DERIVATIVES AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM
]00[
]/0[
]00[
]10[
]01[
]10[
20.12.2000
PA199901885 ]/0[ 30.12.1999
]//[ DK
Int. Cl.8 A61K 031/496, A61P 025/00, C07D 403/00, 403/06, 405/06, 409/06
H. LUNDBECK A/S, DENMARK
WO/2001/049678
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
‫ תל אביב‬,94.0 .‫ד‬.‫ ת‬, 076 ‫רחוב הירקון‬
P.O.B. 6451,
TEL AVIV 61063
[57] A compound of the formula
3161
December 29, 2008
– ‫ב' בטבת התשס"ט‬
wherein
Z represents NH, NR'", O or S; R'"
represents hydrogen or C1-6-alkyl; R7 and
R8 independently represent hydrogen,
halogen, C1-6-alkyl, C3-8-cycloalkyl, CN,
CF3 or C1-6-alkoxy; or R7 and R8 together
form a 5- to 6-membered aryl or heteroaryl
fused to the benzene ring, Y represents N,
C or CH; the dotted line represents an
optional bond; R6 and R6' represent H or
C1-6-alkyl; X represents –O- or –S-; n is 2,
3, 4 or 5; m is 2 or 3; R1, R2, R3, R4, and R5
are independently selected from a group
consisting of hydrogen, halogen, C1-6alkyl, C2-6-alkenyl, C2-6-alkynyl, C3-8-
cycloalkyl, aryl, hydroxy, hydroxy-C1-6alkyl, C1-6-alkoxy, C3-8-cycloalkoxy, C1-6 –
alkylsulfanyl, acyl, and NR9R10 wherein R9
and R10 independently represent hydrogen,
C1-6-alkyl, C2-6-alkenyl, C2-6-alkynyl, C3-8cycloalkyl or aryl; or R9 and R10 together
with the nitrogen to which they are
attached form a 1-morpholinyl, 1piperidinyl, 1-homopiperidinyl, 1piperazinyl, 1-homopiperazinyl, 1imidazolyl, 1-pyrroyl, or pyrazolyl, all of
which may be further substituted with C1-6alkyl; or two adjacent substituents of R1-R5
together form a ring fused to the phenyl
ring selected from the group consisting of
wherein W is O or S, and R' and R" are
hydrogen or C1-6-alkyl.
_________
]00[]00[
December 29, 2008
– ‫ב' בטבת התשס"ט‬
937539
3162
‫מאפננים של העברה עצבית על ידי‬
‫דופאמין‬
]00[
MODULATORS OF DOPAMINE
NEUROTRANSMISSION
]00[
]/0[
]00[
]10[
22.12.2000
9904724-3
]/0[ 22.12.1999
]//[ SE
Int. Cl.8 A61K 031/445, A61P 025/00, C07D 211/18
NEUROSEARCH SWEDEN AB,
SWEDEN
BENGT ANDERSSON, CLAS
SONESSON, SUSANNA WATERS,
NICHOLAS WATERS, JOAKIM
TEDROFF
WO/2001/046145
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O. B. 2081,
‫ הרצליה‬,0/80 .‫ד‬.‫ ת‬, 0/ ‫שדרות אבא אבן‬
HERZLIYA 46120
]10[
]01[
]10[
[57] 4-(Phenyl-N-alkyl)-piperidine
compounds of the Formula
wherein:
R1 is selected from the group consisting of
OSO2CF3, -OSO2CH3, SOR3, SO2R3,
COCH3, and COCH2CH3, wherein R3 is as
defined below; R2 is selected from the
group consisting of C2-C4 branched or
unbranched alkyls, terminal allyl,
CH2CH2OCH3, CH2CH2CH2F, CH2CF3,
3,3,3-trifluoropropyl, and 4,4,4trifluorobutyl, R3 is selected from the
group consisting of C1-C3 alkyls, CF3, and
N(CH3)2; or pharmaceutically acceptable
salts thereof, wherein the compounds do
not have a high binding affinity to sigma
receptors.
__________
]00[]00[
3163
937130
December 29, 2008
– ‫ב' בטבת התשס"ט‬
‫דיאנטרוקואינונים רב–טבעתיים כמונעי‬
‫הווצרות כלי דם וכגורמים אנטי–סרטניים‬
]00[
POLYCYCLIC
DIANTHRAQUINONES AS ANTICANCER AND ANTIANGIOGENIC AGENTS
]00[
]/0[
]00[
31.01.2001
09/494296
]/0[ 31.01.2000
]//[ US
Int. Cl.8 A61K 031/122, 031/136, 031/235, A61P 009/10, 027/02, 035/00, 035/04,
C07C 050/00, 050/36, 069/95, 225/32
YEDA RESEARCH AND
‫ רחובות‬,‫ידע חברה למחקר ופיתוח בע"מ‬
DEVELOPMENT CO. LTD.
,‫המרכז הרפואי של אוניברסיטת ניו יורק‬
NEW YORK UNIVERSITY
MEDICAL CENTER, U.S.A.
YEHUDA MAZUR, GAD LAVIE
‫ גד לביא‬,‫יהודה מזור‬
WO/2001/056558
WEBB & ASSOCIATES,
,'‫ד"ר וב ושות‬
2 PEKERIS ST., P.O.B. 2189,
‫ רחובות‬,0086 .‫ד‬.‫ ת‬, 0 ‫רח' פקריס‬
REHOVOT 76121
]10[
]10[
]01[
]10[
[57] Use of a helianthrone compound or a
derivative thereof for the preparation of a
pharmaceutical composition for treatment
of angiogenesis-associated ophthalmologic
disorders and for the prevention or
inhibition of restenosis, said compound
being of the formula
wherein R is selected from the group
consisting of hydroxy, C1-C10 alkoxy, NHC1-C10 alkyl, and NH-hydroxy (C1-C10)
alkyl; R' is selected from the group
consisting of hydroxy and C1-C10 alkoxy;
and R1, R2, R3, R4, R5 and R6 are
independently selected from the group
consisting of hydrogen, hydroxy, chloro,
bromo, C1-C10 alkyl, C1-C10 alkoxy, and
C1-C10 alkoxycarbonyl.
__________
]00[]00[
December 29, 2008
– ‫ב' בטבת התשס"ט‬
937102
3164
‫מצע נושא שבבים‬
]00[
CHIP CARRIER SUBSTRATE
]00[
]00[
]20[
]10[
24.01.1999
Int. Cl.8 B32B 015/04, H01B 013/00, H01L 021/48, 023/498, H05K 001/09
DIVISION FROM 128200
AMITEC- ADVANCED
‫ אדוואנס מולטילאייר אנטרקונקט‬-‫אמיטק‬
MULTILAYER INTERCONNECT
‫ מגדל העמק‬,‫טכנולוג'יס בע"מ‬
TECHNOLOGIES LTD.
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
‫ תל אביב‬,0409 .‫ד‬.‫ ת‬, :0 ‫רח' יבנה‬
P.O.B. 1426,
TEL AVIV 61013
]10[
[57] A process for manufacturing a chip
carrier substrate, the process comprising
the steps of:
(a) providing at least first and second
layers of copper conductors on a base;
(b) electrically connecting said layers of
copper conductors by aluminum studs
formed by anodization;
The applications for
division from this
application have not yet
been published
(c) providing an electrically connecting
layer of barrier metal between each
aluminum stud and interconnected
conductors, before said step of electrically
connecting; and
(d) surrounding said studs and at least said
first layer of copper conductor with a
polymeric dielectric.
5163232
‫בקשות חלוקה מבקשה זו‬
5‫שטרם פורסמו‬
________
]00[]00[
3165
937100
December 29, 2008
– ‫ב' בטבת התשס"ט‬
‫זני וירוסים‬
]00[
VIRUS STRAINS
]00[
]/0[
22.01.2001
0001475.3
]/0[ 21.01.2000
]//[ GB
111000020
1021020111
GB
101100021
1021020110
GB
10110/120
1221020110
GB
Int. Cl.8 A61K 048/00, A61P 035/00, C12N 007/01, 015/869, C12Q 001/02, 001/68
BIOVEX LIMITED, UNITED
KINGDOM
WO/2001/053506
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26 A HABARZEL STREET
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]00[
]10[
]01[
]10[
[57] Use of a modified, oncolytic, herpes
simplex virus (HSV) strain in the
manufacture of a medicament for the
oncolytic treatment of cancer, which HSV
strain:
(a) has a greater ability than HSV1 17+,
HSV1 F and HSV1 KOS strains with
eqeuivalent modifications to replicate in or
kill tumour cells; and
(b) is produced by isolating an HSV strain
from a host and modifying the isolated
HSV strain to provide for selective
replication in tumour cells.
________
]00[]00[
937103
‫זני וירוסים של הרפס‬
]00[
HERPES VIRUS STRAINS
]00[
]/0[
22.01.2001
0001475.3
]/0[ 21.01.2000
]//[ GB
111000020
1021020111
GB
101100021
1021020110
GB
10110/120
1221020110
GB
Int. Cl.8 A61K 048/00, A61P 035/00, C12N 007/01, 015/869
BIOVEX LIMITED, UNITED
KINGDOM
WO/2001/053505
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26 A HABARZEL STREET
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]00[
]10[
]01[
]10[
[57] A herpes virus which comprises a
gene encoding an immunomodulatory
protein, which lacks a functional ICP34.5
December 29, 2008
– ‫ב' בטבת התשס"ט‬
encoding gene and a functional ICP47
encoding gene and which is replication
competent in tumour cells.
3166
________
]00[]00[
937329
‫חומרים בעלי פעילות היפוליפדימית‬
‫ תהליכים להכנתם‬,‫והיפוכולסטרימית‬
‫ותרכובות פרמצבטיות המכילות אותם‬
]00[
COMPOUNDS HAVING
HYPOLIPIDEMIC AND
HYPOCHOLESTEREMIC
ACTIVITIES, PROCESS FOR
THEIR PREPARATION AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM
]00[
]/0[
]00[
]10[
17.01.2001
57/MUM/2000 ]/0[ 19.01.2000
]//[ IN
Int. Cl.8 A61K 031/404, A61P 003/00, 003/06, C07D 207/325, 207/34
CADILA HEALTHCARE LIMITED,
INDIA
WO/2001/053257
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬
]01[
]10[
[57] Compounds of the formula
their tautomeric forms, their stereoisomers,
their polymorphs, their pharmaceutically
acceptable salts and their pharmaceutically
acceptable solvates, wherein one or more
groups R1, R2, R3, R4 may be same or
different and represent hydrogen, halogen,
perhaloalkyl, hydroxy, thio, amino, nitro,
cyano, formyl, amidino, guanidino,
substituted or unsubstituted groups
selected from linear or branched (C1-C12)
alkyl, (C2-C12) alkenyl, (C3-C7) cycloalkyl,
(C3-C7) cycloalkenyl, bicycloalkyl,
3167
bicycloalkenyl, (C1-C12) alkoxy, cyclo (C3C7) alkoxy, aryl, aryloxy, aralkyl,
aralkoxy, heterocyclyl, heteroaryl,
heterocyclylalkyl, heteroaralkyl,
heteroaryloxy, heteroaralkoxy,
heterocyclylalkyloxy, acyl, acyloxy,
acylamino, monoalkylamino,
dialkylamino, arylamino, aralkylamino,
alkoxycarbonyl, aryloxycarbonyl,
aralkoxycarbonyl,
heterocycloalkoxycarbonyl,
heteroaryloxycarbonyl,
December 29, 2008
– ‫ב' בטבת התשס"ט‬
heteroaralkoxycarbonyl, hydroxyalkyl,
aminoalkyl, monoalkylaminoalkyl,
dialkylaminoalkyl, alkoxyalkyl,
aryloxyalkyl, aralkoxyalkyl, alkylthio,
thioalkyl, alkoxycarbonylamino,
aryloxycarbonylamino,
aralkyloxycarbonylamino,
aminocarbonylamino,
alkylaminocarbonylamino, alkylamidino,
alkylguanidino, dialkylguanidino,
hydrazino, hydroxylamino, carboxylic acid
and its derivatives, sulfonic acid and its
derivatives, phosphonic acid and its
derivatives, or the adjacent groups R2 and
R3 together may form a five or a six
membered ring, optionally containing one
or more double bonds and optionally
containing one or more heteroatoms
selected from O, N, or S; n is an integer
ranging from 1 to 8; W represents O, S or
NR9 where R9 represents alkyl aryl; Ar
represents a substituted or unsubstituted
divalent single or fused aromatic,
heteroaromatic or heterocyclic group; R5
and R6 represent both hydrogen or together
represent a bond; R5 and R6 may also
represent a hydroxy, alkyl, alkoxy,
halogen, acyl, substituted or unsubstituted
aralkyl group; X represents O or S; R7
represents hydrogen, perfluoroalkyl,
substituted or unsubstituted groups
selected from alkyl, cycloalkyl, aryl,
aralkyl, heteroaryl, heteroaralkyl,
heterocyclyl, alkoxyalkyl, aryloxyalkyl,
alkoxycarbonyl, aryloxycarbonyl,
cycloalkyloxycarbonyl,
alkylaminocarbonyl, arylaminocarbonyl,
acyl groups; Y represents O or S; Z
represents oxygen or NR10, where R10
represents hydrogen or substituted or
unsubstituted groups selected from alkyl,
aryl, aryalkyl, hydroxyalkyl, aminoalkyl,
heteroaryl, heteroaralkyl groups; R8
represents hydrogen, substituted or
unsubstituted groups selected from alkyl,
aryl, aralkyl, heteroaryl, heteroaralkyl,
heterocyclyl, heterocyclylalkyl,
hydroxyalkyl, alkoxyalkyl,
alkylaminoalkyl groups; R10 and R8
together may form a 5 or 6 membered
substituted or unsubstituted cyclic ring
structure containing carbon atoms or
containing one or more heteratoms
selected from O, N and S and intermediate
compounds of the formula
wherein one or more groups R1, R2, R3, R4
may be same of different and represent
hydrogen, halogen, perhaloalkyl, hydroxy,
thio, amino, nitro, cyano, formyl, amidino,
guanidino, substituted or unsubstituted
groups selected from linear or branched
(C1-C12) alkyl, (C2-C12) alkenyl, (C3-C7)
cycloalkyl, (C3-C7) cycloalkenyl,
bicycloalkyl, bicycloalkenyl, (C1-C12)
alkoxy, cyclo (C3-C7) alkoxy, aryl,
aryloxy, aralkyl, aralkoxy, heterocyclyl,
heteroaryl, heterocyclylalkyl,
heteroaralkyl, heteroaryloxy,
heteroaralkoxy, heterocyclalkyloxy, acyl,
acyloxy, acylamino, monoalkylamino,
dialkylamino, arlyamino, aralkylamino,
alkoxycarbonyl, aryloxycarbonyl,
aralkoxycarbonyl,
heterocycloalkoxycarbonyl,
heteroaryloxycarbonyl,
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3168
heteroaralkoxycarbonyl, hydroxyalkyl,
aminoalkyl, monoalkylaminoalkyl,
dialkylaminoalkyl, alkoxyalkyl,
aryloxyalkyl, aralkoxyalkyl, alkylthio,
thioalkyl, alkoxycarbonylamino,
aryloxycarbonylamino,
aralkyloxycarbonylamino,
aminocarbonylamino,
alkylaminocarbonylamino, alkylamidino,
alkylguandino, dialkylguanidino,
hydrazino, hydroxylamino, carboxylic acid
and its derivatives, sulfonic acid and its
derivatives, phosphonic acid and its
derivatives; or the adajacent group R2 and
R3 together may form a five or a six
membered ring, optionally containing one
or more double bonds and optionally
containing one or more heteroatoms
selected from O, N, or S; n is an integer
ranging from 1 to 8; W represents O, S or
NR9 where R9 represents alkyl or aryl; Ar
represents a substituted or unsubstituted
divalent single or fused aromatic,
heteroaromatic or heterocyclic group.
__________
]00[]00[
939753
‫שימוש בתרכובות המכילות גורם נוגד‬
‫חיידק עמיד בחומצה המכיל חומצות‬
‫קרבוקאליות של פרידון כמרכיב פעיל‬
]00[
USE OF ANTI-ACID-FAST
BACTERIAL COMPOSITIONS
CONTAINING
PYRIDONECARBOXYLIC ACIDS
AS THE ACTIVE INGREDIENT
]00[
]/0[
]00[
07.02.2001
2000-038099 ]/0[ 09.02.2000
]//[ JP
Int. Cl.8 A61K 031/47, 031/4709, 031/496, 031/4995, A61P 031/04, C07D 401/04,
405/14, 417/14, 471/04, 487/08, 498/06
DAIICHI SANKYO COMPANY,
LIMITED, JAPAN
WO/2001/058876
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26 A HABARZEL STREET
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]10[
]01[
]10[
[57] Use of a compound of the formula
3169
December 29, 2008
– ‫ב' בטבת התשס"ט‬
a salt thereof, or a hydrate thereof wherein
A1 represents a partial structure of the
formula
A1, A2 and A3 form a partial structure
together with the carbon atoms which are
combined therewith,
Y represents a hydrogen atom, a phenyl
group, an acetoxymethyl group, a choline
group, a dimethylaminoethyl group, a 5indanyl group, a phthalidinyl group, a 5alkyl-2-oxo-1,3-dioxol-4-ylmethyl group,
a 3-acetoxy-2-oxobutyl group, an alkyl
group having 1 to 6 carbon atoms, an
alkoxymethyl group having 2 to 7 carbon
atoms, or a phenylalkyl group which is
constituted by an alkylene group having 1
to 6 carbon atoms and a phenyl group, Z
represents a heterocyclic substituent of the
formula
and R1, R2, R3, R4, R5, R5', R6, R6', R7, R8,
X1, X2, are as defined in the specification
for preparing a pharmaceutical
composition for treating a disease caused
by acid-fast bacteria, wherein the acid-fast
bacteria are selected from the group
consisting of Mycobacterium tuberculosis,
Mycobacterium bovis, and Mycobacterium
aftricanum.
___________
]00[]00[
December 29, 2008
– ‫ב' בטבת התשס"ט‬
939713
3170
‫אוראט אוקסידאז חופשי מאגרגאטים‬
‫להכנת תצמידי פולימרים לא אימונוגניים‬
]00[
AGGREGATE-FREE URATE
OXIDASES, POLYMER
CONJUGATES THEREOF AND
COMPOSITIONS PREPARED
THEREFROM
]00[
]/0[
]00[
]10[
07.02.2001
09/501730
]/0[ 10.02.2000
]//[
Int. Cl.8 A61K 047/48, C12N 009/06, 009/96
DUKE UNIVERSITY, U.S.A.
MOUNTAIN VIEW
PHARMACEUTICALS, INC., U.S.A.
WO/2001/059078
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
]01[
]10[
[57] Purified urate oxidase (uricase) that
contains not more than about 2% of
aggregates larger than octamers, wherein
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
greater than about 20% of said uricase is in
the tetrameric or octameric form.
5132283
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
5‫שטרם פורסמו‬
__________
]00[]00[
]00[
SEQUENCE-DEPENDENT GENE
SORTING TECHNIQUES
]00[
]/0[
]00[
]10[
23.03.2001
09/538709
]/0[ 30.03.2000
Int. Cl.8 C12Q 001/68
QUARK PHARMACEUTICALS,
3171
939517
‫שיטות תלויות–רצף למיון גנים‬
]//[
US
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]01[
]10[
INC., U.S.A.
WO/2001/075180
DR. J. ABRAHAMS,
P.O.B. 4071, NES ZIONA
,‫דר' יהודית אברהמס‬
‫ נס‬,4/70 .‫ד‬.‫ ת‬, ‫אי מפעלים בע"מ‬.‫בי‬.‫קיו‬
‫ציונה‬
[57] A method of sorting genes
comprising:
(1) preparing ds cDNA molecules from
mRNA molecules by reverse transcription,
using a poly-T primer optionally having a
general primer-template sequence
upstream from the poly-T sequence,
yielding ds cDNA molecules having the
poly-T sequence, optionally having the
general primer-template sequence;
(2) digesting the ds cDNA molecules with
a restriction enzyme that produces digested
cDNA molecules with cohesive ends
having overhanging ssDNA sequences of a
constant number of arbitrary nucleotides;
(3) ligating to the digested cDNA
molecules a set of dsDNA oligonucleotide
adaptors, each of which adaptors has at
one of its ends a cohesive-end ssDNA
adaptor sequence complementary to one of
the possible overhanging ssDNA
sequences of the digested cDNA, at the
.
opposite end a specific primer-template
sequence specific for the ssDNA adaptor
complementary sequence, and in between
the ends a constant sequence that is the
same for all of the different adaptors of the
set;
(4) amplifying by separate PCRs the
ligated cDNA molecules, utilizing for each
separate PCR a primer that anneals to the
cDNA poly-T sequence optionally having
the cDNA general primer-template, and a
primer from a set of different specific
primers that anneal to the cDNA specific
primer-template sequences; and
(5) sorting the amplified cDNA molecules
into non-redundant groups by collecting
the amplification products after each
separate PCR, each group of amplified
cDNA molecules determined by the
specific primer that annealed to the
specific primer-template sequence and
primed the PCR.
___________
]00[]00[
]00[
KEY AND LOCK DEVICE
]00[
]/0[
]00[
]10[
]01[
09.03.2001
0000794-8
]/0[ 10.03.2000
Int. Cl.8 E05B 049/00
ASSA ABLOY AB, SWEDEN
WO/2001/066887
December 29, 2008
– ‫ב' בטבת התשס"ט‬
939157
‫התקן מפתח ונעילה‬
]//[
SE
3172
]10[
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,00988 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
[57] An electro-mechanical key and lock
device, comprising: keys (101) having a
mechanical code and key electronic
circuitry comprising a key memory
adapted for storing a public identification
item (PKID) of said key, and a key
contact; and a stand-alone lock (20) having
a lock electronic circuitry comprising a
lock memory, a lock contact arranged to
co-operate with said key contact, and a
blocking mechanism adapted to block
operation of said lock unless an authorized
key is inserted in the lock; characterised in
that said public identification item (PKID)
of said keys comprises a group
identification item (GR) identifying a
group of keys having identical mechanical
codes, and said lock memory stores a list
of said public identification item (PKID)
and a secret identification item (SKID) of
authorized keys identifying said authorized
keys, and a list of said public identification
item (PKID) of non-authorised keys,
wherein a key is authorized if said public
and secret identification items thereof are
present in the list of authorized keys and
said public identification item thereof is
absent in the list of non-authorised keys.
_________
]00[]00[
]00[
APPARATUS AND METHOD FOR
CHARACTERIZING, ENCODING,
STORING AND SEARCHING
IMAGES BY SHAPE
]00[
]/0[
23.05.2000
09/536426
3173
]/0[
27.03.2000
939303
‫ אחסון וחיפוש‬,‫ קידוד‬,‫התקן ושיטה לאפיון‬
‫דמויות באמצעות צורה‬
]//[
US
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[
]10[
]01[
]10[
Int. Cl.8 G06K 009/52
LOOK DYNAMICS, INC., U.S.A.
WO/2001/073681
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[57] A method of characterizing an image
for shape content, comprising: creating an
optical Fourier transform pattern of the
image with light energy; spatial filtering
the light energy from the Fourier transform
pattern in the Fourier plane with a rotating
slit to create a filtered pattern of light
energy; detecting, at a distance from the
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
Fourier plane, intensities of light energy as
it is distributed in the filtered pattern at
discrete angular orientations of the slit; and
storing the intensities of light energy
detected in the filtered pattern at a plurality
of levels along with the discrete angular
orientation of the slit at which such
intensities of light energy are detected.
__________
]00[]00[
]00[
OLIGONUCLEOTIDES FOR
TARGETED ALTERATION OF A
GENETIC SEQUENCE AND
METHODS UTILIZING THE
SAME
]00[
]/0[
27.03.2001
60/192179
]/0[ 27.03.2000
2190/0012
0121/20111
2190100/0
1021220111
219000/0/
/120120111
Int. Cl.8 C12N 005/10, 015/09, 015/90
UNIVERSITY OF DELAWARE,
U.S.A.
WO/2001/073002
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]00[
]10[
]01[
]10[
[57] A method of optimizing an
oligonucleotide for in vitro targeted
choromosmal sequence alteration,
comprising:
(a) providing a first oligonucleotide and a
second oligonucleotide for alteration of a
targeted nucleic acid sequence,
(i) wherein said first oligonucleotide:
December 29, 2008
– ‫ב' בטבת התשס"ט‬
939113
‫אוליגונוקליאוטידים לשינוי יעודי של רצף‬
‫גנטי ושיטות המשתמשות בהן‬
]//[
US
US
US
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
(1) is a single-stranded nonhairpin
oligonucleotide 17-121 nucleotides in
length,
(2) has an unmodified DNA domain of at
least 8 contiguous deoxyribonucleotides,
(3) is fully complementary in sequence to
the sequence of a first strand of the nucleic
acid target but for one or more mismatches
as between the sequences of said
deoxyribonucleotides domain and its
3174
complement on the target nucleic acid first
strand, each of said mismataches
positioned at least 8 nucleotides from said
first oligonucleotide's 5' and 3' termini, and
(4) has at least one terminal modification
selected from the group consisting of: at
least one terminal locked nucleic acid
(LNA), at least one terminal 2'-O-Me base
analog, and at least three terminal
phophorothioate linkages, and
(ii) wherein said second oligonucleotide is
selected from the group consisting of
(1) an oligonucleotide that is fully
complementary to the target and lacks the
mismatch,
(2) a fully modified phosphothiolated
oligonucleotide,
(3) a fully modified 2'-O-methylated
oligonucleotide, and
(4) a chimeric double-stranded double
hairpin containing RNA and DNA
nucleotides, and
(iii) wherein the targeted nucleic acid
sequence alteration is not in human
embryonic stem cells;
(b) combining the targeted nucleic acid
with said first or said second
oligonucleotide in the presence of cellular
repair proteins;
(c) combining the targeted nucleic acid
with the other of said first or second
oligonucleotide in the presence of cellular
repair proteins;
(d) quantifying the percentage of target
molecules that undergo a sequence
alteration event;
(e) comparing the efficiency of alteration
of said targeted nucleic acid sequence by
said first oligonucleotide with the
efficiency of alteration of the same
targeted nucleic acid sequence by said
second oligonucleotide; and
(f) repeating steps (a) through (e) two or
more times to optimize said first
oligonucleotide for in vitro targeted
chromosomal sequence alteration.
__________
]00[]00[
]00[
3175
DNA ENCODING MAMMALIAN
SPHINGOSINE KINASE TYPE 2
ISOFORMS, PROTEINS ENCODED
BY SAID DNA AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM
932793
‫דנא המקודד איזופורמים של ספינגוסין קינז‬
‫ חלבונים המקודדים על ידי‬,‫ יונקי‬0 ‫צורה‬
‫הדנא ותכשירי רוקחות המכילים אותם‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[
]/0[
]00[
]10[
]01[
]10[
26.03.2001
60/194318
]/0[ 03.04.2000
]//[ US
Int. Cl.8 A61K 038/45, C07K 016/40, C12N 009/12, 015/52
GEORGETOWN UNIVERSITY,
U.S.A.
DAIICHI SANKYO COMPANY
LIMITED, JAPAN
WO/2001/074837
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[57] An isolated and purified nucleic acid
which encodes a mammalian sphingosine
kinase type 2 isoform selected from the
following (a) to (f):
(a) DNA having a nucleotide sequence
comprising the nucleotide sequence shown
in SEQ ID NO 11;
(b) DNA encoding a protein having the
amino acid sequence shown in SEQ ID NO
12;
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
(c) DNA encoding a protein having the
amino acid sequence labelled mSPHK2 in
Fig 1;
(d) DNA having a nucleotide sequence
comprising the nucleotide sequences
shown in SEQ ID NO 13;
(e) DNA encoding a protein having the
amino acid sequence shown in SEQ ID NO
14;
(f) DNA encoding a protein having the
amino acid sequence labeled hSPHK2 in
Fig 1, as shown in the specification.
_________
]00[]00[
]00[
IN SITU RECOVERY OF
HYDROCARBONS FROM A
KEROGEN-CONTAINING
FORMATION
]00[
]/0[
24.04.2001
60/199215
]/0[ 24.04.2000
2190//000
0021020111
2190//00/
0021020111
Int. Cl.8 E21B 043/24
]00[
December 29, 2008
– ‫ב' בטבת התשס"ט‬
932133
‫קבלה מחדש בו–זמנית של פחמימנים‬
‫משכבת אדמה המכילה קרוגן‬
]//[
US
US
US
3176
]10[
]01[
]10[
SHELL INTERNATIONALE
RESEARCH MAATSCHAPPIJ B.V.,
THE NETHERLANDS
WO/2001/081720
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
[57] A method for the in-situ pyrolysis of
hydrocarbons in a subterranean kerogencontaining formation, comprising:
providing heat to at least a portion of the
kerogen-containing formation such that at
least a part of the heated portion reaches
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
the pyrolysis temperature of kerogen,
yielding pyrolysis products; and collecting
pyrolysis products from the substerranean
formation; wherein the subterranean
formation is selected to comprise kerogen
with a vitrinite reflectance of 0.2 to 3.0%.
_________
]00[]00[
]00[
TRANSDERMAL DELIVERY
SYSTEM FOR WATER
INSOLUBLE DRUGS
]00[
]00[
]10[
]10[
31.10.2002
Int. Cl.8 A61M 037/00, A61N 001/30
TRANSPHARMA MEDICAL LTD.
WEBB & ASSOCIATES,
2 PEKERIS ST., P.O.B. 2189,
REHOVOT 76121
[57] A system for transdrmal delivery of
a water-insoluble drug, comprising: an
apparatus for facilitating transdermal
delivery of a drug through skin of a
subject, said apparatus capable of
generating at least one micro-channel in an
932303
‫מערכת להולכה דרך העור של תרופות לא‬
‫מסיסות במים‬
‫ לוד‬,‫טראנספארמה מדיקל בע"מ‬
,'‫ד"ר וב ושות‬
‫ רחובות‬,0086 .‫ד‬.‫ ת‬, 0 ‫רח' פקריס‬
area on the skin of the subject, and a patch
comprising a pharmaceutical composition
comprising at least one water-insoluble
drug and at least one carrier molecule that
enhances the solubility of the drug in
aqueous solution.
_________
]00[]00[
]00[
3177
TOPICAL COMPOSITION FOR
THE TREATMENT OF PSORIASIS
AND RELATED SKIN DISORDERS
932312
‫תכשיר לטיפול מקומי בפסוריאזיס ומחלות‬
‫עור דומות‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[
]/0[
]00[
]10[
]01[
]10[
01.05.2001
09/562400
]/0[ 01.05.2000
]//[ US
Int. Cl.8 A61K 003/600000 009/00, 009/06
BIODERM, INC., U.S.A.
WO/2001/083031
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
[57] A topical skin preparation adaptedto-the treatment of psoriasis, the
preparation comprising: a
pharmaceutically effective amount of
glucosamine, or salt thereof, in an
approximate amount of more than 5% of
the preparation by weight; a
pharmaceutically effective amount of
berberine, or salt thereof, in an
approximate amount of at least 1% by
weight; and a pharmaceutically effective
amount of oleuropein, or salts thereof, in
an approximate amount of at least 0.5% by
weight of the preparation.
_________
]00[]00[
]00[
COMPOSITION COMPRISING
SUSPENDED MICROPARTICLES
FOR INJECTION THROUGH A
NEEDLE
]00[
]/0[
]00[
]10[
19.04.2001
09/577875
]/0[ 25.05.2000
Int. Cl.8 A61K 009/00
ALKERMES CONTROLLED
THERAPEUTICS, INC., U.S.A.
WO/2001/091720
]01[
December 29, 2008
– ‫ב' בטבת התשס"ט‬
932010
‫תכשיר המכיל מיקרוחלקיקים מורחפים‬
‫להזרקה דרך מחט‬
]//[
US
3178
]10[
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[57] A composition suitable for injection
suspension has a viscosity greater than
through a needle into a host, comprising:
about 20 cp and less than about 600 cp at
microparticles comprising a polymeric
20oC wherein the viscosity of said fluid
binder; and an injection vehicle, wherein
phase of said suspension provides
said microparticles are suspended in said
injectability of the composition through a
injection vehicle at a concentration of
needle ranging in diameter from 18-22
greater than about 30 mg/ml to form a
gauge.
suspension, wherein a fluid phase of said
__________
]00[]00[
932003
‫תהליך להכנת אסטרים של חומצה‬
‫ציקלופרופיל קרבוקסילית ונגזרות‬
]00[
PROCESS FOR THE
PREPARATION OF
CYCLOPROPYL CARBOXYLIC
ACID ESTERS AND
DERIVATIVES
]00[
]/0[
31.05.2001
0013487.4
]/0[ 02.06.2000
]//[ GB
1110010-0
1221220111
SE
Int. Cl.8 C07C 067/347, 069/00, 069/743, 211/40, 247/22
ASTRAZENECA AB, SWEDEN
]00[
]10[
3179
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]10[
]01[
]10[
ADRIAN CLARK, ELFYN JONES,
ULF LARSSON, ANNA MINIDIS
WO/2001/092200
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
[57] A process for the preparation of a
compound of the formula
wherein: R is phenyl substituted with one
or more halogen; Y is OR1, where R1 is a
straight chain alkyl, branched alkyl,
cycloalkyl, or a substituted bicycloheptyl
group; which comprises: reacting a
trimethylsulfoxonium salt with a solid
metal hydroxide in dimethyl sulfoxide at
ambient or an elevated termperature to
produce dimethylsulfoxonium methylide;
and, contacting a compound of the formula
in which R and Y are as defined above,
with the dimethylsulfoxonium methylide
in the presence of a solvent at a
temperature of -10oC-90oC.
The applications for division
from this application have
not yet been published
51323015162362
‫בקשות חלוקה מבקשה זו‬
5‫שטרם פורסמו‬
___________
]00[]00[
]00[
WOUND BODY FOR USE AS AN
AMMUNITION SHELL
]00[
]/0[
12.05.2001
10025418.7
011/01002/
December 29, 2008
]/0[
24.05.2000
1/21020111
– ‫ב' בטבת התשס"ט‬
935793
‫גוף מסובב לשימוש כמעטפת של‬
‫תחמושת‬
]//[
DE
DE
3180
]00[
]10[
]01[
]10[
Int. Cl.8 F42B 005/192
RUAG AMMOTEC GMBH,
GERMANY
WO/2001/090681
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
[57] A casing for ammunition, in which
the wall of the casing comprises a
combustible or consumable wound body,
the wound body preferably being wound
from synthetic and inorganic chemical
fibres, characterised in that the wound
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
body is wound from a blend of threads
(31) each made from a different fibre type,
and in that the threads having a higher
tensile strength are deposited on the wound
body in the direction of the higher load.
_________
]00[]00[
935577
‫מערכת תקשורת בטוחה בין מערכות‬
‫מחשבי לקוח‬
]00[
SYSTEM FOR SECURELY
COMMUNICATING AMONGST
CLIENT COMPUTER SYSTEMS
]00[
]/0[
]00[
]10[
07.06.2001
09/589814
]/0[ 07.06.2000
]//[ US
Int. Cl.8 G06F 009/46, G06Q 001/000000 002/000000 H04L 029/06, H04M 011/00
CYBERFONE TECHNOLOGIES,
INC., U.S.A.
WO/2002/001778
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
]01[
]10[
3181
December 29, 2008
– ‫ב' בטבת התשס"ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
[57] A two-way communication device
for communicating with a network across a
communication line, said two-way
communication device comprising: a
display to display information; a network
interface to communicate across said
communication line; and a client module
running on a processor, said client module
generating and sending a data transaction
to a remote processing capability on the
network across the communication line,
said client module receiving a response
from said remote processing capability and
displaying information on said display
based on said response, and said client
module generating and sending a voice
signal across said communication line.
_________
]00[]00[
]00[
TOASTER WITH REINFORCED
WALLS
]00[
]/0[
]00[
]10[
]01[
]10[
18.06.2001
00/07877
]/0[ 20.06.2000
Int. Cl.8 A47J 037/08
SEB S.A., FRANCE
WO/2001/097666
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
December 29, 2008
– ‫ב' בטבת התשס"ט‬
935511
‫מצנם עם דפנות מוחזקות‬
]//[
FR
,'‫זליגסון גבריאלי ושות‬
‫ תל אביב‬,0409 .‫ד‬.‫ ת‬, :0 ‫רח' יבנה‬
3182
[57] A toaster having a toaster housing
(2) and stiffening means for stiffening said
toaster housing, said housing being open at
its top while being defined by one or more
vertical walls (2a) resting on a soleplate
(2b), said toaster being characterized in
that the stiffening means consist of a ring
(60) or portion of ring that is mechanically
coupled to the top portions of the walls of
the housing.
__________
]00[]00[
]00[
CATION MEDIATED TRIPLEX
HYBRIDIZATION ASSAY
]00[
]/0[
]00[
]10[
]01[
]10[
09.07.2001
613263
]/0[ 10.07.2000
Int. Cl.8 C07H 021/04, C12Q 001/68
INGENEUS INC., BELIZE
WO/2002/004655
REINHOLD COHN AND
PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
3183
935313
‫בדיקת הכלאה משולשת מתווכת על ידי‬
‫קטיון‬
]//[
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
[57] A triplex complex comprising a
single-stranded probe bound to a doublestranded nucleic acid target, wherein said
probe comprises a heteropolymeric nucleic
acid or a heteropolymeric nucleic acid
analog, and all base triplets of said
complex are members selected from the
group consisting of A-T-A, T-A-T, U-A-T,
T-A-U, A-U-A, U-A-U, G-C-G and C-GC, and wherein said triplex complex
further comprises a cation selected from
the group consisting of alkali metal ions,
alkaline earth metal ions, divalent
transition metal ions, Co(NH3)6+3, trivalent
spermidine and tetravalent spermine.
__________
]00[]00[
]00[
CROSS-LINKED HIGH AMYLOSE
STARCH FOR USE IN
CONTROLLED-RELEASE
PHARMACEUTICAL
FORMULATIONS AND
PROCESSES FOR ITS
MANUFACTURE
]00[
]/0[
]00[
26.06.2001
606399
]/0[ 29.06.2000
Int. Cl.8 A61K 009/00
December 29, 2008
– ‫ב' בטבת התשס"ט‬
935131
‫עמילן מצולב המכיל ריכוז גבוה של אמילוז‬
‫לשימוש בתכשירי רוקחות לשחרור‬
‫מושהה ותהליכים לייצורו‬
]//[
US
3184
]10[
]01[
]10[
FRANCOIS CHOUINARD, CANADA
VINCENT LENAERTS, CANADA
ROLAND HERWIG FRIEDRICH
BECK, U.S.A.
ELSIE VAN BOGAERT, BELGIUM
REINER HOPCKE, GERMANY
CYRIL DESEVAUX, CANADA
WO/2002/002084
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
[57] A controlled release tablet
comprising a compressed blend of at least
two dry powders, including a powder of at
least one pharmaceutical agent and a
powder of a controlled release excipient:
wherein said controlled release excipient
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
further comprises a cross-linked high
amylase starch obtainable by
(a) cross-linking and chemical
modification of high amylase starch;
(b) gelatinization; and
(c) drying to obtain a powder of said
controlled release excipient.
__________
]00[]00[
]00[
LASER DIRECTIONAL
INFRARED
COUNTERMEASURES (DIRCM)
SYSTEM FOR PROTECTING
AIRCRAFT WITH A LARGE
THERMAL SIGNATURE
AGAINST MISSILES
]00[
]00[
]10[
02.01.2003
Int. Cl.8 F41H 011/02
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.
3185
935039
‫מערכת לייזר אינפרא–אדום למדידות‬
‫מכוונות נגד להגנת כלי טיס עם חתימה‬
‫טרמית גדולה נגד טילים‬
,‫רפאל מערכות לחימה מתקדמות בע"מ‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]10[
]10[
PATRICK BAR-AVI, ARYE PICK
DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
[57] A method for neutralizing the threat
posed by a guided missile comprising:
(a) detecting the guided missile;
(b) detecting a trajectory of the guided
missile; and
(c) illuminating the guided missile with at
least one beam emitted by a device
including:
‫חיפה‬
‫ אריה פיק‬,‫אבי‬-‫פטריק בר‬
,‫ד"ר מרק פרידמן בע"מ‬
,7 ‫ רח ז'בוטינסקי‬, .4.‫ ק‬,‫מגדל משה אביב‬
‫ גן‬-‫רמת‬
(i) at least one laser light source;
(ii) a DIRCM control system, configured
to aim at least one beam produced by said
at least one laser light source at the missile
based on a trajectory of the missile; and
(iii) a beam expander functionally
associated with at least one of said at least
one laser light source.
__________
]00[]00[
]00[
PROCESS AND METHOD FOR
RECOVERY OF HALOGENS
]00[
]/0[
]00[
]10[
21.07.2001
PQ8915
]/0[ 21.07.2000
Int. Cl.8 C25B 001/24
IODINE TECHNOLOGIES
AUSTRALIA PTY LTD.,
AUSTRALIA
WO/2002/008492
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]01[
]10[
December 29, 2008
– ‫ב' בטבת התשס"ט‬
935177
‫תהליך ושיטה להחזרות הלוגנים‬
]//[
AU
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
3186
[57] An apparatus for the recovery of a
halogen or pseudohalogens from a halide
compound in solution; wherein the
apparatus includes; an electrochemical cell
including, an electrode assembly including
at least first and second electrodes in
communication with a controller for
providing a current to at least two of said
electrodes; wherein, upon delivery of a
predetermined voltage, said halide
compound is oxidized at one or more said
electrodes to form a halogen corresponding
to said halide in solution whereupon said
halogen is deposited on said one or more
electrode upon completion of oxidation.
_________
]00[]00[
]00[
3187
QUINOLINE DERIVATIVES
HAVING VEGF INHIBITING
ACTIVITY, PROCESSES FOR
THEIR PREPARATION AND USE
THEREOF IN THE
MANUFACTURE OF
MEDICAMENTS FOR USE IN THE
PRODUCTION OF AN
ANTIANGIOGENIC AND/OR
VASCULAR PERMEABILITY
REDUCING EFFECT IN WARMBLOODED ANIMALS
935110
‫נגזרות קווינולין בעלות פעילות מעכבת‬
‫ תהליכים להכנתן והשימוש בהן‬,VEGF
‫לייצור ת רופות לשימוש ביצירת אפקט נוגד‬
–‫או מפחית חדירות כלי‬/‫היווצרות כלי–דם ו‬
‫דם בחיות בעלות דם חם‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[
]/0[
]00[
]10[
]01[
]10[
08.08.2001
00402254.7
]/0[ 09.08.2000
]//[ EP
Int. Cl.8 A61K 031/47, A61P 009/00, 035/00, 043/00, C07D 401/12, 401/14, 405/14,
413/14, 417/14, 471/04
ASTRAZENECA AB, SWEDEN
WO/2002/012226
S. HOROWITZ & CO.,
,'‫ הורוביץ ושות‬.‫ש‬
ZION HOUSE,
‫ תל‬,40-4. ‫ שדרות רוטשילד‬,‫בית ציון‬
41-45 ROTHSCHILD BLVD.,
‫אביב‬
TEL AVIV 65784
[57] Compounds of the formula
wherein:
Z is –O-, -NH-, -S-, -CH2- or a direct
bond;
n is an integer from 0 to 5; any of the
substituents R1 may be attached at any free
carbon atom of the indole; m is an integer
from 0 to 3; Ra represents hydrogen or
fluoro; Rb represents hydrogen, C1-4 alkyl,
C1-4 alkoxy C1-4 alkyl, amino C1-4 alkyl, C13 alkylamino C1-4 alkyl, di(C1-3 alkyl) amino
C1-4 alkyl, C2-5 alkenylamino C1-4 alkyl, C25 alkynylamino C1-4 alkyl, - C1-5 alkyl (ring
A) wherein ring A is selected from
azetidinyl, pyrrolidinyl, piperidinyl,
piperazinyl, morpholino and
thiomorpholino and wherein ring A may
bear one or more substituents selected
from C1-4 alkyl, C2-5 alkenyl, C2-5 alkynyl,
hydroxy, oxo, halogeno, cyano, cyano C1-4
alkyl, C1-4 alkylsulphonyl and C1-4
alkanoyl; R1 represents hydrogen, oxo,
hydroxy, halogeno, C1-4 alkyl, C1-4 alkoxy,
C1-4 alkoxy C1-4 alkyl, amino C1-4 alkyl, C13 alkylamino C1-4 alkyl, di(C1-3 alkyl)
amino C1-4 alkyl, - C1-5 alkyl (ring B)
wherein ring B is selected from azetidinyl,
pyrrolidinyl, piperidinyl, piperazinyl, Nmethylpiperazinyl, N-ethylpiperazinyl,
morpholino and thiomorpholino; and R2 is
as defined in the specification.
_________
]00[]00[
December 29, 2008
– ‫ב' בטבת התשס"ט‬
935103
3188
]00[
FOLDED CAVITY-BACKED
SLOT ANTENNA
]00[
]00[
]10[
]01[
]10[
24.08.2001
Int. Cl.8 H01Q 001/28
RAYTHEON COMPANY, U.S.A.
WO/2002/019468
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[57] An antenna (20) comprising: a
rectangular housing (22) having a plurality
of walls forming an enclosure containing a
cavity (24), the plurality of walls including
a first wall (30), a second wall (26)
opposite and generally parallel to the first
wall, and side walls therebetween, said
side walls being perpendicular to the first
wall; a slot (28) formed in the first wall of
the housing, the slot being shaped to
produce circularly polarized radiation;
means for injecting RF energy into the
cavity whereby the slot produces circularly
polarized radiation; characterised in that:
the second wall has a partially planar shape
and comprises an integral combination of:
an outer planar part which is parallel to the
first wall; a shaft part with rectangular
cross-section, protruding from the planar
part into the housing in a direction
perpendicular to the first wall, and a top
part of rectangular cross-section, said top
part extending at all sides beyond the shaft
3189
‫אנטנת בעלת חליל מקופל הנתמך בחריץ‬
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
part, wherein said top part of the second
wall is parallel to both the first wall and
the outer planar part of the second wall, the
combination of the shaft part and the top
part having a height which is less than the
height of the rectangular housing, said
combination of shaft part and top part
being centrally located within the housing
such that the cavity defined by first,
second and side walls has a folded shape,
wherein said cavity defines a compound
cavity having: a first cavity portion (32)
being defined in between the top part of
the second wall and the first wall, and a
second cavity portion (34) being defined in
between the side walls and the top part of
the second wall and in between the top part
of the second wall and the outer planar part
of the second wall, the cavity thereby
achieving a lowered resonant frequency in
relation to the physical size of the housing,
without the use of dielectric material.
December 29, 2008
– ‫ב' בטבת התשס"ט‬
__________
]00[]00[
935131
‫תיאום לביצוע בו–זמני בתחנת בסיס של‬
‫ עבור‬,‫אותות המשודרים ממספר מסופים‬
FDMA ‫מערכות תקשורת מסוג‬
]00[
SYNCHRONIZING, IN A BASE
STATION, SIGNALS
TRANSMITTED BY SEVERAL
TERMINALS FOR FDMA
COMMUNICATION SYSTEMS
]00[
]/0[
]00[
]10[
23.11.2000
00/09372
]/0[ 17.07.2000
]//[
Int. Cl.8 H04B 007/26, H04L 005/02, 005/04
TELEDIFFUSION DE FRANCE,
FRANCE
WO/2002/007375
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
]01[
]10[
[57] FDMA signal formed from a
multiplex of carrier frequencies
transmitted from at least two distinct
terminals and that will be processed in the
form of a single signal in a base station,
characterised in that it carries temporal
synchronization information, at least for
December 29, 2008
– ‫ב' בטבת התשס"ט‬
FR
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
some of the said terminals, comprising a
deterministic phase value transmitted
simultaneously and continuously on at
least two of the said carrier frequencies,
for a duration greater than or equal to two
symbol times.
3190
__________
]00[]00[
]00[
FAST ADAPTIVE POWER
CONTROL FOR A VARIABLE
MULTIRATE COMMUNICATIONS
SYSTEM
]00[
]/0[
12.07.2001
60/221348
]/0[ 26.07.2000
21900//10
1121020111
Int. Cl.8 H04B 001/04, 007/005, 007/26
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2002/009311
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
]00[
]10[
]01[
]10[
[57] A method of controlling transmitter
power in a wireless communication system
in which user data is processed as a
variable rate signal having a rate N(t)
where N(t) is a function of time,
characterized in that the user data signal
3191
931701
‫ספק כוח הניתן להתאמה במהירות עבור‬
‫מערכות תקשורת מהירות‬
]//[
US
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
having rate N(t) is converted into a
transmission data signal having a faster
rate N(t) for transmission by a transmitter
(10) and in that the transmission power is
adjusted by means of a transmitter scale
factor based in part on quality of data
December 29, 2008
– ‫ב' בטבת התשס"ט‬
received by a receiver (30) of the
transmitted data, the method including:
determining the transmitter scale factor as
a function of N(t)/M(t) based on which a
change in the user data signal rate or the
rate of the transmission data signal is
compensated for in advance of a quality of
data based adjustment associated with such
data rate change.
5132216
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
5‫שטרם פורסמו‬
_________
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3192
]00[]00[
]00[
PROCESS FOR THE
PREPARATION OF 5 - [(4 CHLOROPHENYL) - METHYL] 2, 2 DIMETHYLCYCLOPENTANONE
]00[
]00[
]10[
]10[
11.08.2000
Int. Cl.7 C07C 045/00, 045/67, 067/343
KUREHA CORPORATION, JAPAN
KAZUHIKO SUNAGAWA, HAJIME
HOSHI, SHIGERU MIZUSAWA,
NOBUYUKI KUSANO, SATORU
KUMAZAWA
WO/2001/012580
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
]01[
]10[
[57] A process for producing 5-[(4chlorophenyl) methyl]-2,2dimethylcyclopentanone, comprising:
(1) reacting dimethyl adipate or diethyl
adipate with metal alkoxide;
(2) after removing alcohol as produced
therefrom, reacting the reaction product
obtained with methyl halide;
(3) after completion of the reaction,
reacting the reaction product obtained with
metal alkoxide;
(4) after removing alcohol as produced
therefrom, reacting the reaction product
obtained with (4-chlorophenyl) methyl
chloride;
931270
]‫ – כלורופניל)–מתיל‬4([ – . ‫תהליך להכנת‬
‫ – דימתילציקלופנטנון‬0 ,0 –
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
,4./87 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬
(5) reacting the obtained 1-[(4chlorophenyl) methyl]-3-methyl-2oxocylopentanecarboxylic acid methyl
ester or 1-[(4-chlorophenyl) methyl]-3methyl-2-oxocyclopentanecarboxylic acid
ethyl ester with sodium hydride and
methyl halide; and
(6) hydrolyzing the obtained 1-[(4chlorophenyl) methyl]-3,3-dimethyl-2oxocyclopentanecarboxylic acid methyl
ester or 1-[(4-chlorophenyl) methyl]-3,3dimethyl-2-oxocyclopentanecarboxylic
acid ethyl ester.
_________
3193
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[]00[
931259
‫תולדות פיפרידין ותכשירים המכילים‬
‫תולדות אלה כמרכיב פעיל‬
]00[
PIPERIDINE DERIVATIVES AND
COMPOSITIONS CONTAINING
THESE DERIVATIVES AS THE
ACTIVE INGREDIENT
]00[
]/0[
09.08.2001
2000-243881 ]/0[ 11.08.2000
]//[ JP
0111-/01001
0020020111
JP
Int. Cl.8 A61K 031/451, A61P 001/16, 003/00, 019/00, 025/00, 029/00, 037/08,
C07D 211/22, 211/64
ONO PHARMACEUTICAL CO.,
LTD., JAPAN
WO/2002/014280
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
]00[
]10[
]01[
]10[
[57] Piperidine compounds of the formula
(wherein R1 represents (1) a hydrogen
atom or (2) a cyano group; R2 and R3 each
independently represents (1) a C1-8 alkyl
group, (2) a C3-7 cycloalkyl group, (3) a
C1-8 alkyl group substituted with a C3-7
cycloalkyl group, (4) a C1-8 alkyl group
December 29, 2008
– ‫ב' בטבת התשס"ט‬
substituted with 1 to 3 halogen atom (5), a
hydrogen atom, (6) a C1-8 alkyl gorup
substituted with a phenyl group, (7) a C1-8
alkyl group substituted with a C1-8 alkoxy
group, or
3194
(in which n represents 1 to 5); R4 and R5
each independently represents (1) a
hydrogen atom or (2) a C1-8 alkyl group,
or R4 and R5 are taken together with the
binding carbon atom to represent a C3-7
saturated carbocyclic ring; R6 represents
(1) a hydroxyl group, (2) a C1-8 alkoxy
group, (3) –NHOH, or (4) a C1-8 alkoxy
group substituted with a phenyl group; and
m is 0 or an integer of 1 to 4, or nontoxic
salts thereof.
__________
]00[]00[
931573
‫ מבוקרים‬ACK/NAK ‫שיטה והתקן לנתיב‬
‫בשערים במערכת תקשורת‬
]00[
METHOD AND APPARATUS FOR
GATED ACK/NAK CHANNEL IN
A COMMUNICATION SYSTEM
]00[
]/0[
]00[
]10[
28.08.2001
09/653744
]/0[ 01.09.2000
]//[ US
Int. Cl.8 H04J 003/00, 013/00, H04L 001/18, 029/08, H04Q 007/22
QUALCOMM INCORPORATED,
U.S.A.
WO/2002/019605
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]01[
]10[
[57] An apparatus in a communication
system comprising: a transmitter operative
to transmit ACK/NAK information on an
ACK/NAK channel; a channel gate for
3195
gating said ACK/NAK channel based on
whether a companion receiver has detected
a matching preamble in a data unit
received by said receiver.
December 29, 2008
– ‫ב' בטבת התשס"ט‬
‫__________‬
‫‪3196‬‬
‫ב' בטבת התשס"ט –‬
‫‪December 29, 2008‬‬
]00[]00[
]00[
DEVICE FOR PRODUCTION OF
SURFACES HAVING THERMAL
RESISTIVITY
]00[
]/0[
]00[
]10[
20.02.2003
02/02215
]/0[ 21.02.2002
Int. Cl.8 B21D 013/02
SOCIETE D'ETUDES ET DE
CONSTRUCTIONS AERONAVALES, FRANCE
REINHOLD COHN AND
PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
]10[
[57] A device for forming heat exchange
elements having corrugated heat exchange
surfaces from a sheet of formable material,
comprising: a first part having two spaced
apart plates (6, 7) having a corrugated
surface profile; and a second part having
two plates (7a, 7b) that are spaced apart by
the same distance as are the plates of said
first part and that also have said corrugated
surface profile, wherein said first and
second parts are movable into and out of a
sheet corrugation-forming position in
which said sheet is disposed in a space
provided between two of said corrugated
surface profiles of opposing ones of said
plates of said first and second parts for
3197
931313
‫התקן לייצור משטחים עמידים בחום‬
]//[
FR
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
having a sheet corrugation formed in said
sheet, wherein said plates have
substantially the same thickness, wherein
the sheet, when provided with said sheet
corrugation, has a substantially uniform
thickness along its corrugation, and
wherein a distance between two opposing
corrugated surface profiles of said plates in
said sheet corrugation-forming positions is
constant in a direction of a thickness of the
sheet along the corrugations thereof and is
greater than such thickness of the sheet by
an amount that allows for the presence of a
film of lubricant between the sheet and
said opposing corrugated surface profiles.
December 29, 2008
– ‫ב' בטבת התשס"ט‬
________
]00[]00[
931303
‫תהליך להכנתם‬, ‫פפטידים טבעתיים‬
‫ושימוש בהם בהכנת תרופה לטיפול‬
‫במחלות הקשורות עם פעילות של‬
R – 4 MC
]00[
CYCLIC PEPTIDES , PROCESS
FOR THEIR PREPARATION AND
USES THEREOF IN THE
PREPARATION OF A
MEDICAMENT FOR THE
TREATMENT OF DISEASES
ASSOCIATED WITH MC4-R
ACTIVITY
]00[
]/0[
]00[
]10[
21.08.2001
60/229184
]/0[ 30.08.2000
]//[ US
Int. Cl.8 A61K 038/34, A61P 003/04, C07K 014/435, 014/68
F. HOFFMANN-LA ROCHE AG,
SWTIZERLAND
WO/2002/018437
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]01[
]10[
[57] Compounds of the formula:
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3198
wherein
R1 and R12 together with X and Y form a
phenyl ring and X is C and Y is C, or R1 is
hydrogen,
R12 is hydrogen, with either X and Y being
each C and the bond between X and Y
being a double bond, or with X and Y
being each CH and the bond between X
and Y being a single bond; R2 is alkyl
having from 1 to 5 carbon atoms, alkenyl
having from 2 to 5 carbon atoms, or
alkynyl having from 2 to 5 carbon atoms;
R14 is alkyl having from 1 to 5 carbon
atoms; n is 0 or 1; and Q is
wherein R3, R4 and R5 are independently
hydrogen, halo, alkyl having from 1 to 4
carbon atoms, hydroxy or alkoxy having
from 1 to 4 carbon atoms, wherein when
R4 is not hydrogen, R3 and R5 are both
hydrogen; and R6 is hydrogen, alkyl
having from 1 to 3 carbon atoms, alkoxy
having from 1 to 3 carbon atoms, phenoxy,
or halo; R11 and R13 are each
independently hydrogen, alkyl having 3 or
4 carbons, cycloalkyl having 5 or 6 carbon
atoms, or R11 and R13 are both phenyl; R7
is O or NH; R8 is hydrogen or methyl; R9
is
3199
December 29, 2008
– ‫ב' בטבת התשס"ט‬
R10 is hydrogen or methyl; p is 0 or 1; m is
0, 1, 2, or 3; and Z is
R17 is hydrogen or alkyl having from 1 to 6
carbon atoms; and pharmaceutically
acceptable salts thereof.
__________
]00[]00[
]00[
ELECTROFUSION COUPLING
PARTICULARLY USEFUL FOR
COUPLING PLASTIC PIPES
]00[
]00[
]10[
]10[
]10[
23.02.2003
Int. Cl.8 F16L 047/03
PLASSON LTD.
NIMROD BAHARAV
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
[57] An electrofusion coupling for
coupling a first device to a second device,
comprising: a first part (10) having a first
end for coupling to said first device, and a
second end formed with a surface (13) of a
December 29, 2008
– ‫ב' בטבת התשס"ט‬
931303
‫מחבר היתוך לשימוש במיוחד עבור חיבור‬
‫צינורות פלסטיק‬
‫פלסאון בע"מ‬
‫נמרוד בהרב‬
,‫) בע"מ‬066.( ‫ארליך‬.‫אי‬.‫ג'י‬
,00 ‫רחוב מנחם בגין‬, 0. ‫ קומה‬,‫מגדל אילון‬
‫רמת גן‬
curved configuration; and a second part
(20) having an end engaging said second
end of the first part and formed with a
surface (23) of a complementary curved
configuration as said first part, the curved
3200
configurations of the two parts being such
that said second part may be pivoted to
locate its longitudinal axis at different
angles with respect to the longitudinal axis
of said first part; at least one of said parts
being of a thermoplastic material and
including an electrical heater coil (14)
embedded therein along its curved surface
for fixing by electrofusion the angular
position of said second part with respect to
said first part.
_________
3201
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[]00[
931121
‫מערכת ושיטה לניהול משאבי רשת‬
‫טלפוניה‬
]00[
SYSTEM AND METHOD FOR
MANAGING TELEPHONY
NETWORK RESOURCES
]00[
]/0[
]00[
]10[
]01[
]10[
29.08.2001
09/655930
]/0[ 06.09.2000
]//[ US
Int. Cl.8 H04M 015/00, 017/00, H04Q 003/00
SIGVALUE TECHNOLOGIES LTD.
‫ הוד השרון‬,‫סיגואליו טכנולוגיות בע"מ‬
WO/2002/021805
BOROCHOV, KORAKH, ELIEZRI &
,'‫בורוכוב קורח אליעזרי ושות‬
CO.,
‫אביב‬-‫ תל‬,.80// .‫ד‬.‫ ת‬, ‫מגדל כלל עתידים‬
15TH FLOOR, ATIDIM TOWER,
KIRYAT ATIDIM,
P.O.B. 58100,
TEL AVIV 61580
[57] Network architecture for establishing
telephony connection comprising: a call
management node; a first network node,
coupled to said call management node via
a first signaling link and further coupled to
at least one first node telephony
subscriber; a second network node,
coupled to said call management node via
a second signaling link, to said first
network node via at least one voice link,
and further coupled to at least one second
node telephony subscriber, wherein said
first network node defines said call
management node as the destination node
for said at least one voice link.
_________
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3202
]00[]00[
931111
‫ שיטה ליצורם‬,‫–מתילן סטרואידים‬70
‫ותכשירי רוקחות המכילים תרכובות אלו‬
]00[
17-METHYLENESTEROIDS,
METHOD FOR THE
PRODUCTION THEREOF AND
PHARMACEUTICAL
COMPOSITIONS
CONTAINING THESE
COMPOUNDS
]00[
]/0[
]00[
]10[
29.08.2001
10043846.6
]/0[ 04.09.2000
]//[ DE
Int. Cl.8 A61K 031/56, A61P 005/00, C07J 013/00
BAYER SCHERING PHARMA AG,
GERMANY
WO/2002/019971
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26 A HABARZEL STREET
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]01[
]10[
[57] 17-Methylenesteroids of the formula
in which R4 is a halogen atom or a
pseudohalogen, R10 is a hydrogen atom or
a straight-chain or branched C1-4-alkyl
group, R20 and R20a are, independently of
one another, a hydrogen atom, a straightchain or branched C1-4-alkyl or hydroxyC1-4-alkyl group or one of the radicals R20
and R20a is a hydrogen atom, a straight-
chain or branched C1-4-alkyl or hydroxyC1-4-alkyl group, and the other radical is a
halogen atom or a pseudohalogen, with the
exception of the following compounds: 4chloro-17- methylene-4-androsten-3-one
and 4-chloro-20ζ-fluoro-21hydroxypregna-4, 17(20)-dien-3-one.
__________
3203
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[]00[
933711
‫תולדות מלונאמיד ואסטר מלונמי בעלות‬
‫ הכנתן והשימוש‬,‫פעילות אנטיטרומבוטית‬
‫בהן‬
]00[
MALONAMIDE AND
MALONAMIC ESTER
DERIVATIVES WITH
ANTITHROMBOTIC ACTIVITY,
THEIR PREPARATION AND
THEIR USE
]00[
]/0[
]00[
20.09.2001
00121551.6
]/0[ 30.09.2000
]//[ EP
Int. Cl.8 A61K 031/335, 031/395, A61P 007/02, 009/00, C07C 257/18, 257/20,
317/32, C07D 209/04, 213/36, 213/78, 231/56, 233/54, 235/04, 237/20, 241/36,
263/30, 263/54, 271/07, 277/20, 277/62, 285/06, 307/79, 317/58, 319/18, 413/04
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2002/028823
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
‫ הרצליה‬,00988 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
P.O.B. 12688,
HERZLIYA 46733
]10[
]01[
]10[
[57] Compounds of the formula
(I)
wherein
A is a residue of the formula
wherein R3 is hydrogen atom, -OH or –
(C1-C6)-alkyl, wherein R4 and R5
independently from one another are
hydrogen atom, -(C1-C6)-alkyl, -OH, -ODecember 29, 2008
– ‫ב' בטבת התשס"ט‬
(C1-C6)-alkyl, halogen, -NH2 or –NO2,
wherein X1 and X2 independently from one
another are selected from the group
consisting of a carbon atom substituted by
3204
R4, wherein R4 is as defined above, and a
nitrogen atom, wherein D1 and D2
independently from one another are
hydrogen atom, -C(O)-( C1-C6)-alkyl, C(O)-aryl,
-C(O)-(C1-C6)-alkyl-aryl, -C(O)-O-(C1C6)-alkyl, C(O)-O-(C1-C6)-alkyl-aryl or
C(O)-O-aryl, or D1 is hydrogen atom,
when D2 is –OH, -O-C(O)-(C1-C6)-alkyl, O-C(O)-aryl or –O-C(O)-(C1-C6)-alkylaryl, or D1 and D2 together with the
nitrogen atom to which they are attached
form a cycle of the formula
R1 is hydrogen atom, -(C1-C6)-alkyl, -OH,
-O- (C1-C6)-alkyl or –N-(R6)2, wherein R6
is independently of one another hydrogen
atom, -C(O)-aryl, -C(O)-(C1-C6)-alkylaryl, -C(O)-(C1-C6)-alkyl, -(C1-C6)-alkyl, C(O)-N(H)-aryl, -C(O)-N(H)-(C1-C6)alkyl-aryl, -(C1-C6)- N(H)-alkyl, -C(O)-Oaryl, -C(O)-O-(C1-C6)-alkyl-aryl, -C(O)-O(C1-C6)-alkyl-, S(O2)-aryl, -S(O2)-(C1-C6)alkyl
R2 is aryl, wherein aryl is unsubstituted or
mono-to tri-substituted independently of
one another by –CF3, halogen, -OH, -CN,
sulfo, -NO2, -NH2, -O-(C1-C6)-alkyl,
substituted amino, -COOH, -(C1-C6)-alkyl,
carbamyl, carbonyl, alkoxycarbonyl,
methylendioxyl, aryloxy, wherein aryloxy
is unsubstituted or mono- to tri-substituted
independently of one another as defined
above, –O-(C1-C6)-alkyl-aryl, wherein aryl
is unsubstituted or mono- to tri-substituted
independently of one another as defined
above, het-group, wherein het-group is
unsubstituted or mono- to tri-substituted
independently of one another as defined
above or –(C1-C4)-alkyl-aryl, wherein aryl
is unsubstituted or mono- to tri-substituted
independently of one another as defined
above, hydrogen atom, het-group, wherein
the het-group is unsubstituted or mono-to
tri-substituted independently of one
another as defined above, –(CH2)m-Yn(CH2)o-aryl, wherein m, n and o are
independently of one another the integer
zero, 1 or 2, provided that at least one of
m, n and o is not zero, aryl is unsubstituted
or mono-to tri-substituted independently as
defined above, Y is-O-, -S- or –N-(R6),
wherein R6 is hydrogen atom or -(C1-C6)alkyl, provided n is the integer 1, or Y is –
N(R6)-N(R6)-, wherein R6 is independently
of one another hydrogen atom or -(C1-C6)alkyl, or –N=N-, provided n is the integer
2, or –(CH2)m-Yn-(CH2)o-Het-group,
wherein m, n and o are independently of
one another the integer zero, 1 or 2,
provided that at least one of m, n and o is
not zero, Het-group is unsubstituted or
mono- to tri-substituted independently as
defined above and Y is as defined above,
or R1 and R2 together with the carbon atom
to which they are bonded form a (C3-C7)cycloalkyl, wherein cycloalkyl is
unsubstituted or mono-to tri-substituted
independently of one another as defined a
(C3-C7)-cycloalkyl, wherein cycloalkyl is
unsubsituted or mono-to disubstituted
independently of one another and fused to
an aryl-or Het-group-ring, which itself is
unsubstituted or mono-to tri-substituted
independently of one another as defined
above or
3205
December 29, 2008
– ‫ב' בטבת התשס"ט‬
a Het-group, wherein the Het-group is
unsubstituted or mono-to tri-substituted
independently of one another as defined
above, a keto-group, which may partially
or even totally exist in a hydrated state,
provided that, when R1 is as defined above
then R2 is not directly bond to formula I
via a oxygen-, sufur-or nitrogen-atom,
B is –N(R7)-(CH-(R8))p-aryl, wherein aryl
is unsubstituted or mono- to tri-substituted
indepdnently of one another as defined
above, p is zero 1 or 2, R7 is hydrogen
atom, -(C1-C6)-alkyl, -OH or –N-(R6)2,
wherein R6 is independently of one another
hydrogen atom or -(C1-C6)-alkyl, R8 is
hydrogen atom, -(C1-C6)-alkyl, -(C2-C6)alkenyl, -(C2-C6)-alkinyl, -(C0-C3)-alkyl(C3-C7)-cycloalkyl, -CN aryl, aryl is
unsubstituted or mono- or di-substituted as
defined above, a Het-group, wherein the
Het-group is unsubstituted or mono- or disubstituted as defined above, -(CH-(R8))form a –(C3-C7)-cycloalkyl residue or –
(C0-C4)-alkyl –O-(C1-C6)-alkyl, -O-(CH(R8))p-aryl, wherein aryl, R8 and p are as
defined above, -N(R7)-(CH-(R8))p-Hetgroup, wherein the Het-group is
unsubstituted or mono-or di-substituted as
defined above and R7, R8 and p are as
defined above, -N(R9)-N(R9)-(CH-(R8))qaryl, wherein aryl is unsubstituted or
mono- to tri-substituted independently of
one another as defined above, q is zero, 1
or 2, R9 and R9 are independently of one
another hydrogen, (C1-C6)-alkyl or –(C1C3)-alkyl-aryl and R8 is as defined above, O-N(R9)-(CH-(R8))q-aryl, wherein aryl is
unsubstituted or mono- to tri-substituted
independently of one another as defined
above, q is zero, 1 or 2, and R8 and R9 are
as defined above, -N(R9)-N(R9)-(CH(R8))q-Het-group, wherein Het-group is
unsubstituted or mono-to tri-substituted
independently of one another as defined
above, q is zero, 1 or 2, and R8, R9 and R9
are as defined above, -O-N(R9)-(CH(R8))q-Het-group, wherein Het-group is
unsubsituted or mono-to tri-substituted
independently of one another as defined
above, q is the integer zero, 1 or 2, and R8
and R9 are as defined above; in all their
stereoisomeric forms and mixtures thereof
in any ratio, and their physiologically
tolerable salts.
__________
]00[]00[
December 29, 2008
– ‫ב' בטבת התשס"ט‬
933913
3206
‫שיטה לגלוי רב מטרות מיושמת במיוחד‬
‫למכ"מי ניטור עם ייצור רב–קרנות בגובה‬
]00[
MULTI-TARGETS DETECTION
METHOD APPLIED IN
PARTICULAR TO
SURVEILLANCE RADARS WITH
MULTI -BEAMFORMING IN
ELEVATION
]00[
]/0[
]00[
]10[
31.03.2003
1020287
]/0[ 02.04.2002
]//[ NL
Int. Cl.8 G01S 007/292, 013/42, 013/524, 013/72
THALES NEDERLAND B.V., THE
NETHERLANDS
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]10[
[57] Method for detecting a target having
a radar comprising transmitter means for
generating bursts of radar pulses, each scan
of a radar consisting of a number (Nb(k))
of bursts, characterised in that, for each
scan k: in a first step, a radar cell is preselected by a detection process; in a second
step, a Track-Before-Detect process is
initialized upon the pre-selected cells,
3207
using a track filter to construct the
validation gate associated to the next scan
k+1; in a third step, the data in the
validation gate of scan k+1 is used to
update the Track-Before-Detect process
and used to construct the validation gate
associated to the next scan k+2; the third
step being repeated scan to scan.
December 29, 2008
– ‫ב' בטבת התשס"ט‬
_________
]00[]00[
933310
‫שיטה לאיבחון וטיפול בהפרעות של‬
‫הסחוס‬
]00[
METHOD OF DIAGNOSING AND
TREATING CARTILAGINOUS
DISORDERS
]00[
]/0[
]00[
]10[
]01[
]10[
07.12.2001
60/254513
]/0[ 08.12.2000
]//[ US
Int. Cl.8 A61K 038/17, C07K 014/47, C12N 015/12
GENENTECH, INC., U.S.A.
,
WO/2002/059308
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26 A HABARZEL STREET
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
[57] An isolated nucleic acid molecule
which comprises DNA having at least 80%
sequence identity to (a) a DNA molecule
encoding a PR021074 polypeptide
comprising the sequence of amino acid
residues from 1 or 24 to 1313 of Figure 2,
as shown in the specification or (b) the
complement of the DNA molecule of (a).
_________
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3208
]00[]00[
933179
‫תהליך להכנת פנטופראזול המיובש‬
‫בהקפאה ותכשירי פנטופראזול שעברו‬
‫ליאופילציה המיוצרים על ידו‬
]00[
PROCESS FOR PREPARING
FREEZE-DRIED PANTOPRAZOLE
AND LYOPHILIZED
PANTOPRAZOLE
PREPARATIONS PREPARED
THEREBY
]00[
]/0[
]00[
]10[
]01[
]10[
17.11.2001
00125569.4
]/0[ 22.11.2000
]//[ EP
Int. Cl.8 A61K 009/00, 009/19, 031/4439, 047/18
NYCOMED GMBH, GERMANY
WO/2002/041919
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[57] Process for the production of a
freeze-dried preparation comprising 5difluoromethoxy-2-[(3,4-di-methoxy-2pyridinyl) methylsulfinyl]-1Hbenzimidazole (pantoprazole), a salt
thereof, a solvate of pantoprazole or a salt
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
thereof, comprising freeze-drying of an
aqueous solution of pantoprazole, a salt
thereof, a solvate of pantoprazole or a salt
thereof, ethylenediamine tetraacetic acid
and/or a suitable salt thereof, and sodium
hydroxide and/or sodium carbonate.
__________
]00[]00[
933313
‫קביעת מיקום במערכת תקשורת אלחוטית‬
‫עם גלוי ופיצוי לחוזרים‬
]00[
POSITION DETERMINATION IN A
WIRELESS COMMUNICATION
SYSTEM WITH DETECTION AND
COMPENSATION FOR
REPEATERS
]00[
]/0[
14.11.2001
60/249846
]/0[ 16.11.2000
]//[ US
1/9/00//1
1/21020110
US
Int. Cl.8 G01S 001/00, 005/02, 005/14, H04B 001/707, 007/26, H04Q 007/38
QUALCOMM INCORPORATED,
U.S.A.
WO/2002/059638
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]00[
]10[
]01[
]10[
3209
December 29, 2008
– ‫ב' בטבת התשס"ט‬
[57] A method for determining a position
of a remote terminal in a wireless
communication network having included
therein a plurality of transmitting sources,
the method comprising: obtaining a set of
time measurements for a set of
transmitting sources, wherein each time
measurement is derived based on a
transmission received at the remote
terminal from a respective transmitting
source that is either an origination source
or a repeater associated with the
origination source; identifying a particular
origination source for each received time
measurement; comparing a list of
originating sources for the received time
measurements against a list of probable
orgination sources for each of at least one
repeater in the network; and determining
whether the remote terminal is under a
coverage of a particular repeater based on
a result of the comparing.
_________
]00[]00[
933117
‫פרומוטרים בעלי יחודיות לתאים‬
‫אנדותליאליים ושיטות לשימוש בהם‬
]00[
PROMOTERS EXHIBITING
ENDOTHELIAL CELL
SPECIFICITY AND METHODS OF
USING SAME
]00[
]/0[
]00[
]10[
]10[
]01[
]10[
15.11.2001
60/248582
]/0[ 17.11.2000
]//[ US
Int. Cl.8 A61K 048/00, C12N 005/10, 015/10, 015/11
VASCULAR BIOGENICS LTD.
‫ אור יהודה‬,‫וסקולר ביוג'ניק בע"מ‬
DROR HARATS, NIRA BLOOM
‫ נירה בלום‬,‫דרור הרץ‬
WO/2002/040629
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬066.( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
,00 ‫רחוב מנחם בגין‬, 0. ‫ קומה‬,‫מגדל אילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
[57] An isolated polynucleotide
functional as a promoter in eukaryotic
cells, the isolated polynucleotide
comprising an enhancer element including
at least one copy of the sequence set forth
in SEQ ID NO:8.
_________
]00[]00[
December 29, 2008
– ‫ב' בטבת התשס"ט‬
931737
3210
]00[
INTERACTIVE PRINTER
]00[
]/0[
]00[
]10[
26.11.2001
09/722142
]/0[ 25.11.2000
Int. Cl.8 B41J 002/00, 029/38
SILVERBROOK RESEARCH PTY.
LTD., AUSTRALIA
WO/2002/042894
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]01[
]10[
[57] A printer for printing a second
interface onto a second surface, in
response to first indicating data received
from a sensing device, the first indicating
data being sensed by the sensing device
from first coded data, a first interface
disposed on a first surface including the
first coded data, the printer including:
(a) an input module configured to:
(i) receive, from the sensing device, the
first indicating data, the first indicating
data being at least partially indicative of
response data;
(ii) generate second indicating data based
on the first indicating data, the second
3211
‫מדפסת אינטראקטיבית‬
]//[
US
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
indicating data being at least partially
indicative of the response data;
(iii) send the second indicating data to a
computer system; and
(b) a printing module, including a printing
mechanism, configured to:
(i) receive the response data from the
computer system;
(ii) generate the second interface based at
least partially on the response data; and
(iii) print the second interface onto the
second surface using the printing
mechanism; wherein said first indicating
data includes location data sensed by said
sensing device from said first coded data.
December 29, 2008
– ‫ב' בטבת התשס"ט‬
__________
]00[]00[
]00[
LOW DIELECTRIC MATERIALS
AND METHODS FOR MAKING
SAME
]00[
]/0[
]00[
]10[
26.05.2003
158511
]/0[ 30.05.2002
Int. Cl.8 C01B 033/16, H01L 021/70
AIR PRODUCTS AND CHEMICALS,
INC., U.S.A.
REINHOLD COHN AND PARTNERS
26 A HABARZEL ST., RAMAT
HACHAYAL 69710
[74]
[57] A process for forming a film with a
low dielectric constant, the process
December 29, 2008
– ‫ב' בטבת התשס"ט‬
931970
‫חומרים בעלי דיאלקטריות נמוכה ושיטות‬
‫לייצורם‬
]//[
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬09 ‫רחוב הברזל‬
comprising: providing a first film made
from a mixture comprising at least one
3212
porogen and a product from the hydrolysis
and condensation of at least one silica
source; measuring the elastic modulus
value and the dielectric constant value of
the first film; calculating a void fraction
value of the first film from the dielectric
constant; determining the normalized wall
elastic modulus of the first film from the
elastic modulus and void fraction values;
and adjusting the void fraction for a second
film to increase or decrease the elastic
The applications for division
from this application have
not yet been published
modulus of the second film wherein the
increased or decreased elastic modulus
results is accompanied by an increase or a
decrease in the dielectric constant of the
second film, the second film having
substantially the same normalized elastic
modulus as the first film, wherein the
second film is made from a mixture
comprising at least one porogen and a
product from the hydrolysis and
condensation of at least one silica source.
51620105162018
‫בקשות חלוקה מבקשה זו‬
5‫שטרם פורסמו‬
__________
]00[]00[
]00[
PROCESS FOR THE PREPARATION
OF IOPAMIDOL
]00[
]/0[
]00[
]10[
]01[
]10[
29.11.2001
MI2000A002601 ]/0[ 01.12.2000
Int. Cl.8 C07C 237/46
BRACCO IMAGING S.P.A., ITALY
WO/2002/044132
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
[57] Process for the preparation of (S)N,N'-bis[2-hydroxy-1-(hydroxymethyl)
ethyl]-5-[(2-hydroxy-1-oxopropyl)amino]-
3213
931933
‫תהליך להכנת יופמידול‬
]//[
IT
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
2,4,6-triiodo-1,3-benzenedicarboxamide of
the formula
December 29, 2008
– ‫ב' בטבת התשס"ט‬
starting from the compound of the formula
which process comprises
(a) reacting the compound of formula (II)
with a suitable protecting agent, to give a
compound of the formula
wherein –R is a group of the formula
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3214
wherein R1 is a hydrogen atom, a C1-C4
straight or branched alkoxy group, R2 is
hydrogen, a C-C4 straight or branched
alkyl group or a C-C4 straight or branched
alkoxy group and R3 is a C-C4 straight or
branched alkyl group, a trifluoromethyl or
a trichloromethyl group;
(b) acylating the amino group in position 5
of the intermediate compound of formula
(III), by reaction with a (S)-2-(acetyloxy)
propanoyl chloride to give a compound of
the formula
(c) removing all the acyl groups present in
the compound of formula (IV) under basic
conditions, with prior cleavage of the
cyclic protection under acidic conditions
when R is a group of formula A.
_________
]00[]00[
]00[
PROCESS FOR THE PREPARATION
OF N,N'- SUBSTITUTED 5 - AMINO 1,3 - BENZENEDICARBOXAMIDES
AND THEIR USE FOR THE
PREPARATION OF X - RAY
CONTRAST AGENTS
]00[
]/0[
28.11.2001
MI2000A002600
3215
]/0[
01.12.2000
931931
– .–‫ – מותמרים‬N,N ‫תהליך להכנת‬
‫ – בנזנדיקרבוכסאמידים‬: ,0 – ‫אמינו‬
‫והשימוש בהם להכנת חומר ניגוד‬
X ‫לקרינת‬
]//[
IT
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[
]10[
]01[
]10[
Int. Cl.8 C07C 237/30
BRACCO IMAGING S.P.A., ITALY
WO/2002/044125
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
[57] A process for the preparation of a
compound of the formula
wherein R represents a 2,3-dihydroxy-1propyl or a 1,3-dihydroxy-2-propyl radical,
which comprises reacting a di-alkyl ester
of 5-amino-1,3-benzenedicarboxylic acid
of the formula
wherein R1 represents a straight or
branched (C1-C4)-alkyl group with at least
two moles of an amine of formula H2NR.
__________
]00[]00[
931215
‫שיטה ומערכות להסרת עיוות של זמן‬
) PRT( ‫הישנות פעימה לא סדירה‬
‫ושימושיהם‬
]00[
IRREGULAR PRT
DECONVOLUTION METHOD
AND SYSTEMS AND THEIR USES
]00[
]/0[
]00[
03.06.2003
1020763
]/0[ 05.06.2002
]//[ NL
Int. Cl.8 G01S 007/285, 007/41, 013/22, 013/524
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3216
]10[
]10[
THALES NEDERLAND B.V., THE
NETHERLANDS
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[57] Deconvolution method of irregular
pulse repetition time sampled signal x™
wherein it comprises the following steps:
[S1] conversion of the irregular samples
x™ to regular samples r(iTε);
[S2] computation of the spectrum dft(r) of
these regular samples;
[S3] isolation of the clutter spectra in dft(r)
by assuming clutter spreads over more
than a few range gates;
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
[S4] estimation of the clutter spectral lines
from the mean and the width of the
isolated clutter spectra;
[S5] subtraction of the estimated clutter
spectra from the total spectrum dft(r); and
[S6] deconvolution of the remaining
spectra.
__________
3217
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[]00[
]00[
METHOD FOR PREPARING
SUBMICRON PARTICLE
SUSPENSIONS
]00[
]/0[
20.12.2001
60/258160
]/0[ 22.12.2000
0100//
1021220110
0102/1
1021220110
0101//
1021220110
/0//1/
0121/20110
1/0000
0/20120110
1002/0
0020020110
Int. Cl.8 A61K 009/00
BAXTER INTERNATIONAL INC.,
U.S.A.
WO/2002/055059
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
]00[
]10[
]01[
]10[
[57] A method for preparing submicron
sized particles of a pharmaceutically-active
compound, the solubility of which is
greater in a water-miscible first solvent
than in a second solvent which is aqueous,
the process comprising the steps of:
(i) dissolving the pharmaceutically-active
compound in the water-miscible first
solvent to form a solution, the first solvent
being selected from the group consisting of
N-methyl-2-pyrrolidinone, 2-pyrrolidone,
dimethyl sulfoxide, dimethylacetamide,
lactic acid, methanol, ethanol, isopropanol,
3-pentanol, n-propanol, glycerol butylene
December 29, 2008
– ‫ב' בטבת התשס"ט‬
931597
‫שיטה להכנת תרחיפים של חלקיקים תת‬
‫מיקרוניים‬
]//[
US
US
US
US
US
US
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
glycol, ethylene glycol, propylene glycol,
mono- and diacylated monoglycerides,
dimethyl isosorbide, acetone,
dimethylformamide, 1,4-dioxane, ethyl
acetate, propyl acetate, polyethylene
glycol, polyethylene glycol esters,
polyethylene glycol sorbitans,
polyethylene glycol monoalkyl ethers,
polypropylene glycol, polypropylene
alginate, propylene glycol-10 butanediol,
propylene glycol-10 methyl glucose ether,
propylene glycol-20 methyl glucose ether,
propylene glycol-15 stearyl ether,
propylene glycol dicaprylate, propylene
3218
particle size of less than about 2 μm, and
said adding energy step comprises
homogenization, counter-current flow
homogenization, microfluidization or
sonication.
glycol dicaprate, propylene glycol laurate;
(ii) mixing the solution with the second
solvent to define a pre-suspension; and
(iii) adding energy to the pre-suspension to
form particles having an average effective
The applications for division
from this application have
not yet been published
5132331
‫בקשות חלוקה מבקשה זו‬
5‫שטרם פורסמו‬
__________
]00[]00[
931591
‫אמידים של חומצות קרבוקסיליות פורן‬
‫וטיופן שעברו ארילציה בעלות השפעה‬
‫חוסמת על תעלות אשלגן‬
]00[
ARYLATED FURANE AND
THIOPHENE CARBOXYLIC ACID
AMIDES WITH POTASSIUM
CHANNEL BLOCKING EFFECT
]00[
]/0[
]00[
]10[
29.11.2001
10061876.6
]/0[ 12.12.2000
]//[ DE
Int. Cl.8 A61K 031/34, 031/38, A61P 009/00, 009/06, C07D 307/00, 307/68, 333/38
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2002/048131
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
‫ הרצליה‬,00988 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
P.O.B. 12688,
HERZLIYA 46733
]01[
]10[
[57] A compound of the formula
in which:
X is oxygen or sulfur;
3219
R(1) is C(O)OR(9), SO2R(10), COR(11),
C(O)NR(12)R(13) or C(S)NR(12)R(13);
R(9), R(10), R(11) and R(12)
December 29, 2008
– ‫ב' בטבת התשס"ט‬
independently of one another are CxH2xR(14);
x is 0, 1, 2, 3 or 4, where x cannot be 0 if
R(14) is OR(15) or SO2Me; R(14) is alkyl
having 1, 2, 3, 4, 5 or 6 carbon atoms,
cycloalkyl having 3, 4, 5, 6, 7, 8, 9, 10 or
11 carbon atoms, cycloalkyl having 3, 4, 5,
6, 7, 8, 9, 10 or 11 carbon atoms, CF3, C2F5
C3F7, CH2F, CHF2, OR(15), SO2Me,
phenyl, naphthyl, biphenylyl, furyl, thienyl
or an N-containing heteroaromatic having
1, 2, 3, 4, 5, 6, 7, 8, or 9 carbon atoms,
where phenyl, naphthyl, biphenylyl, furyl,
thienyl and the N-containing
heteroaromatic are unsubstituted or
substituted by 1, 2 or 3 substitutents
selected from the group consisting of F, Cl,
Br, I, CF3, OCF3, NO2, CN, COOMe,
CONH2, COMe, NH2, OH, alkyl having 1,
2, 3 or 4 carbon atoms, alkoxy having 1, 2,
3 or 4 carbon atoms, dimethylamino,
sulfamoyl, methylsulfonyl and
methylsulfonylamino; R(15) is alkyl
having 1, 2, 3, 4 or 5 carbon atoms,
cycloalkyl having 3, 4, 5 or 6 carbon
atoms, CF3 or phenyl, which is
unsubstituted or substituted by 1, 2 or 3
substitutents selected from the group
consisting of F, Cl, Br, I, CF3, NO2, CN,
COOMe, CONH2, COMe, NH2, OH, alkyl
having 1, 2, 3 or 4 carbon atoms, alkoxy
having 1, 2, 3 or 4 carbon atoms,
dimethylamino, sulfamoyl, methylsulfonyl
and methylsulfonylamino; R(13) is
hydrogen, alkyl having 1, 2, 3 or 4 carbon
atoms or CF3; R(2) is hydrogen, alkyl
having 1, 2, 3 or 4 carbon atoms or CF3;
R(3) is CyH2y-R(16); y is 0, 1, 2, or 4,
where y cannot be 0 if R(16) is OR(17) or
SO2Me; R(16) is alkyl having 1, 2, 3, 4, 5
or 6 carbon atoms, cycloalkyl having 3, 4,
5, 6, 7, 8, 9, 10 or 11 carbon atoms, CF3,
C2F5, C3F7, CH2F, CHF2, OR(17), SO2Me,
phenyl, naphthyl, furyl, thienyl or an Ncontaining heteroaromatic having 1, 2, 3,
4, 5, 6, 7, 8 or 9 carbon atoms, where
phenyl, naphthyl, furyl, thienyl and the Ncontaining heteroaromatic are
unsubstituted or substituted by 1, 2 or 3
substitutents selected from the group
consisting of F, Cl, Br, I, CF3, OCF3, NO2,
CN, COOMe, CONH2, COMe, NH2, OH,
alkyl having 1, 2, 3 or 4 carbon atoms,
alkoxy having 1, 2, 3 or 4 carbon atoms,
dimethylamino, sulfamoyl, methylsulfonyl
and methylsulfonylamino, R(17) is
hydrogen, alkyl having 1, 2, 3, 4 or 5
carbon atoms, cycloalkyl hving 3, 4, 5 or 6
carbon atoms, CF3, phenyl or 2-,3- or 4pyridyl, where phenyl or 2-, 3- or 4pyridyl is unsubsituted or substituted by 1,
2 or 3 substituents selected from the group
consisting of F, Cl, Br, I, CF3, OCF3, NO2,
CN, COOMe, CONH2, COMe, NH2, OH,
alkyl having 1, 2, 3 or 4 carbon atoms,
alkoxy having 1, 2, 3 or 4 carbon atoms,
dimethylamino, sulfamoyl, methylsulfonyl
and methylsulfonylamino; or R(3) is
CHR(18)R(19); R(18) is hydrogen or
CzH2Z-R(16), where R(16) is defined as
indicated above; z is 0, 1, 2 or 3; R(19) is
COOH, CONH2, CONR(20)R(21),
COOR(22) or CH2OH; R(20) is hydrogen,
alkyl having 1, 2, 3, 4 or 5 carbon atoms,
CvH2v-CF3 or CwH2w-phenyl, where the
phenyl ring is unsubstituted or substituted
by 1, 2 or 3 substituents selected from the
group consisting of F, Cl, Br, I, CF3, NO2,
CN, COOMe, CONH2, COMe, NH2, OH,
alkyl having 1, 2, 3 or 4 carbon atoms,
alkoxy having 1, 2, 3 or 4 carbon atoms,
dimethylamino, sulfamoyl, methylsufonyl
and methylsulfonylamino; v is 0, 1, 2 or 3;
w is 0, 1, 2 or 3; R(21) is hydrogen or alkyl
having 1, 2, 3, 4 or 5 carbon atoms; R(22)
is alkyl having 1, 2, 3, 4 or 5 carbon atoms;
R(4) is hydrogen, alkyl having 1, 2, 3, 4, 5
or 6 carbon atoms or CF3; or R(3) and R(4)
together are a chain of 4 or 5 methylene
groups, of which one methylene group can
be replaced by –O-, -S-, -NH-, -N(methyl)or –N(benzyl)-; R(5), R(6) and R(7)
independently of one another are F, Cl, Br,
I, CF3, NO2, CN, COOMe, CONH2,
COMe, NH2, OH, alkyl having 1, 2, 3 or
carbon atoms, alkoxy having 1, 2, 3 or 4
– ‫ב' בטבת התשס"ט‬
3220
December 29, 2008
carbon atoms, dimethylamino, sulfamoyl,
methylsulfonyl or methylsulfonylamino,
R(30) and R(31) independently of one
another are hydrogen or alkyl having 1, 2
or 3 carbon atoms; or R(30) and R(31)
together are oxygen or a chain of 2
methylene groups; or its pharmaceutically
acceptable salts.
_________
]00[]00[
931521
‫ראש פנס רב זרועות‬
]00[
FLASHLIGHT HEAD WITH
MULTIPLE ILLUMINATING
EXTENSIONS
]00[
]00[
]10[
]10[
04.06.2003
Int. Cl.8 F21L 011/00, F21V 005/00, 021/32
AVIV ZIFFER
‫ תל אביב‬,‫אביב ציפר‬
SOROKER-AGMON,
,‫אגמון‬-‫סורוקר‬
14 SHENKAR ST.,
‫ הרצליה פיתוח‬,04 ‫ רחוב שנקר‬,‫בית נולטון‬
HERZLIYA PITUAH 46725
[57] A removable multiple-extension
flashlight head (50) configured to be fitted
into a hand-held commercial flashlight
housing (10) and to reversibly replace the
original bulb assembly (16) of the
flashlight for providing a plurality of
spaced apart areas located at different
planes, the flashlight housing including at
least one battery (12), the flashlight head
comprising: a main body comprising a
power distributing element adapted to be
brought into electrical contact with said at
least one battery; a plurality of light
generating devices, each in electrical
3221
contact with the power distributing
element; and a plurality of elongated
flexible extensions (80) made of semi-rigid
material that can be deformed to assume
and retain any curvature, each having a
proximal end (84) connected to said main
body and a free distal illuminating end (82)
directable to a desired direction in space,
each of the plurality of extensions is
coupled to one of the plurality of light
generating devices wherein energy is
transferred along each of the extensions
such that light is emitted from the distal
end thereof.
December 29, 2008
– ‫ב' בטבת התשס"ט‬
__________
]00[]00[
]00[
CHASSIS WITH
REPOSITIONABLE PLATES
]00[
]/0[
]00[
]10[
]01[
]10[
18.12.2001
748747
]/0[ 22.12.2000
Int. Cl.8 H05K 007/14
AURORA NETWORKS, INC., U.S.A.
WO/2002/052907
REINHOLD COHN AND
PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
[57] An apparatus, comprising: a chassis
including a first plate mounting bracket
(38) and a second plate mounting bracket
(38), said chassis defining a first module
bay and a second module bay; a modular
repositionable plate (20) removably
connected to said first plate mounting
December 29, 2008
– ‫ב' בטבת התשס"ט‬
931513
‫תושבת עם לוחות הניתנים לכיוון מחדש‬
]//[
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
bracket and removably connectable to
either said first plate mounting bracket or
said second plate mounting bracket; and a
module inserted and positioned at least in
part within said first module bay, coupled
to said repositionable plate, and separable
from said repositionable plate while said
3222
repositionable plate remains removably
connected to said first plate mounting
bracket allowing replacement of only a
part that needs replacements, wherein said
modular repositionable plate includes an
optical feedthrough (26).
_________
]00[]00[
931111
‫שיטה לזיהוי הבדלים בביטוי של‬
‫פוליפפטידים בשתי דוגמאות‬
]00[
METHOD OF IDENTIFYING
DIFFERENCES IN EXPRESSION
OF POLYPEPTIDES BETWEEN
TWO SAMPLES
]00[
]/0[
]00[
]10[
]01[
]10[
13.12.2001
60/255577
]/0[ 14.12.2000
]//[ US
Int. Cl.8 C12N 015/10, C12Q 001/68, C40B 003/004000 G01N 033/68
PAUL STROOBANT, U.S.A.
WO/2002/048716
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26 A HABARZEL STREET
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
[57] A method of identifying differences
in expression of polypeptides between two
samples, said method comprising:
(a) providing one or more first arrays
comprising one or more polypeptides from
a first complex biological sample adhered
to a first type of support;
(b) providing one or more second arrays
comprising one or more polypeptides from
3223
a second complex biological sample
adhered to a second type of support;
(c) exposing a peptide-nucleic acid
coupled library comprising a plurality of
members (i) to one of said first arrays at
least one time to create a first product, said
first product comprising one or more
members of said peptide-nucleic acid
coupled library that reversibly bind to said
first array and (ii) to one of said second
December 29, 2008
– ‫ב' בטבת התשס"ט‬
arrays at least one time to create a third
product, said third product comprising one
or more members of said peptide-nucleic
acid coupled library that reversibly bind to
said second array; (d) exposing said first
product to one of said second arrays at
least one time to create a second product,
said second product comprising one or
more members of said first product that do
not bind to said second array and; (e)
exposing said third product to one of said
first arrays at least one time to create a
fourth product, said fourth product
comprising one or more members of said
third product that do not bind to said first
array, wherein a member of said peptidenucleic acid coupled library in said second
product binds to a polypeptide in said first
biological complex sample that is
expressed in a greater amount than in said
second complex biological sample and a
member of said peptide-nucleic acid
coupled library in said fourth product
binds to a polypeptide in said second
biological sample that is expressed in a
greater amount than in said first biological
sample.
_________
]00[]00[
]00[
DEPLOYABLE ANTENNA
REFLECTOR
]00[
]/0[
]00[
]10[
]10[
25.06.2003
02017163.3
]/0[ 31.07.2002
Int. Cl.8 H01Q 001/08, 015/16
EADS ASTRIUM GMBH, GERMANY
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
[57] A deployable antenna reflector,
comprising: a central dish fixedly mounted
on a central supporting body; a plurality of
deployable sheet-like panels hinged to said
central supporting body and arranged
around the central dish; wherein the
rotation axes of each of individual ones of
said deployable sheet-like panels are tilted
December 29, 2008
– ‫ב' בטבת התשס"ט‬
931153
‫מחזיר קרינת אנטנה הניתן לפריסה‬
]//[
EP
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
with respect to a center point of the central
dish, and wherein, in a stowed
configuration of the reflector, the
deployable sheet-like panels are at least
partially deflected in order to minimize an
envelope of the reflector and the panels
relax upon entering a deployment
configuration.
3224
_________
]00[]00[
]00[
CUTTING HEAD FOR MACHINE
TOOL
]00[
]/0[
]00[
]10[
]01[
]10[
15.01.2002
20010380
]/0[ 23.01.2001
Int. Cl.8 B23B 027/00, 029/04
TEENESS ASA, NORWAY
WO/2002/058869
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[57] A cutting head for being secured to
an adapter in a machine tool for chip
removing machining, where the cutting
head comprises a flange with a first side
creating a coupling surface adapted for
being secured to the adapter and an on the
opposite side of the flange situated, other
side creating at least one surface (1A) with
an outwardly extending protrusion (8) with
securing means adapted for the securing of
a cutting insert (5) with at least one cutting
edge, the at least one surface defining a
3225
931317
‫ראש חיתוך לכלי עבודה‬
]//[
NO
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
plane creating an inclined angle in relation
to a plane parallel to the coupling surface,
whereby the cross-sectional thickness of
the flange increases from a first lateral side
to an oppositely situated other lateral side;
characterized in that a concave surface
with a radius between the at least one
surface of the flange and the protrusion
creates a smooth transition between the
flange and the protrusion and the
protrusion extends from that part of the
flange having the increased thickness; and
December 29, 2008
– ‫ב' בטבת התשס"ט‬
the protrusion and the flange with the at
least one surface with an inclined angle in
relation to the plane parallel with the
coupling surface is one integrated piece
whereby the weight of the cutting head is
reduced as compared to the strength of the
cutting head, and the natural frequency of
the cutting head is increased when this is
secured to the adapter.
__________
]00[]00[
]00[
IDENTIFICATION AND CLONING
OF A NOVEL HUMAN GENE
RET16
]00[
]/0[
15.02.2002
60/269366
]/0[ 16.02.2001
2190/0000
0/21020110
Int. Cl.8 C12N 015/12
BRISTOL-MYERS SQUIBB
COMPANY, U.S.A.
WO/2002/066494
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]00[
]10[
]01[
]10[
[57] An isolated polynucleotide
comprising a polynucleotide sequence
having the sequence of SEQ ID NO:12,
December 29, 2008
– ‫ב' בטבת התשס"ט‬
931117
TER61 ‫זהוי ושיבוט של גן אנושי חדש‬
]//[
US
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
wherein said polynucleotide encodes a cell
signaling a polypeptide involved in the
intracellular signaling cascade.
3226
The applications for division
from this application have
not yet been published
513330151333035163312
‫בקשות חלוקה מבקשה זו‬
5‫שטרם פורסמו‬
__________
]00[]00[
930727
‫סטנט מפרקי‬
]00[
ARTICULATED STENT
]00[
]00[
]20[
]10[
]10[
25.07.1995
Int. Cl.8 A61F 002/06, A61M 029/00
DIVISION FROM 114731
MEDINOL LTD.
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
[57] An expandable articulated stent
having a longitudinal axis and a
circumferential axis, including:
(a) a plurality of substantially tubular and
substantially rigid segments (102) defining
a longitudinal aperture, and
‫אביב‬-‫ תל‬,‫מדינול בע"מ‬
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
‫ הרצליה‬,0/80 .‫ד‬.‫ ת‬, 0/ ‫שדרות אבא אבן‬
(b) a plurality of flexible connecting links
(110, 112) connecting said rigid segments,
each of said flexible links having a first
portion and a second portion, each of said
links when viewed laterally having an area
of inflection disposed between said
portions.
_________
3227
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[]00[
930711
‫שיטה ומערכת לאחסון והפצה של‬
‫מפתחות מקודדים‬
]00[
METHOD AND APPARATUS FOR
STORING AND DISTRIBUTING
ENCRYPTION KEYS
]00[
]/0[
]00[
]10[
]01[
]10[
18.01.2002
785849
]/0[ 16.02.2001
]//[ US
Int. Cl.8 H04L 009/08, 009/32, 029/06, H04Q 007/28, 007/38
MOTOROLA, INC., U.S.A.
WO/2002/067486
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
[57] A method comprising the steps of:
generating, by a first infrastructure system
device, a first encryption key associated
with traffic encryption for group
communications; forwarding the first
encryption key from the first infrastructure
system device ; storing the first encryption
key at the second infrastructure system
device; generating, by the second
infrastructure system device, a second
December 29, 2008
– ‫ב' בטבת התשס"ט‬
encryption key associated with traffic
encryption for group communications by
combining the first encryption key with a
third encryption key; and forwarding the
second encryption key to a third
infrastructure system device other than the
first and second infrastructure system
devices, wherein the second encryption
key is used for encrypting messages for
communicating over an air interface.
3228
_________
]00[]00[
]00[
ILLUMINATION DEVICE FOR
SIMULATION OF NEON
LIGHTING
]00[
]/0[
11.12.2001
60/265522
]/0[ 31.01.2001
/00110
0020120110
Int. Cl.8 F21S 003/00, F21V 021/00
ILIGHT TECHNOLOGIES, INC.,
U.S.A.
WO/2002/061328
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
]00[
]10[
]01[
]10[
[57] An illumination device, comprising:
a rod-like member (12) having a
predetermined length and a curved light
emitting surface (13); an elongated light
source (24) extending substantially along
the predetermined length of said rod-like
member at a fixed distance from said light
emitting surface; and a housing (14) for
said elongated light source, said housing
including opposing and substantially
3229
930711
‫התקן הארה להדמיה של תאורת ניאון‬
]//[
US
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
parallel side walls (20, 22) with internally
light reflecting surfaces (32), such that said
housing serves to collect and direct light
emitted by said light source into said rodlike member, with such light then passing
through and being scattered by said rodlike member so as to exit the curved light
emitting surface in a substantially uniform
light intensity pattern.
December 29, 2008
– ‫ב' בטבת התשס"ט‬
‫__________‬
‫‪930705‬‬
‫‪3230‬‬
‫[‪]00[]00‬‬
‫ב' בטבת התשס"ט –‬
‫‪December 29, 2008‬‬
‫פפטידים לשימוש תרפויטי עבור מצבים‬
‫המתבטאים בדה–מיאליניזציה‬
]00[
THERAPEUTIC PEPTIDES FOR
DEMYELINATING CONDITIONS
]00[
]/0[
]00[
]10[
24.01.2002
60/263569
]/0[ 24.01.2001
]//[ US
Int. Cl.8 A61K 038/00, 038/16, A61P 021/00, 025/00, C07K 007/00, 014/435, 014/47
PRESIDENT AND FELLOWS OF
HARVARD COLLEGE, U.S.A.
WO/2002/059143
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
‫ תל אביב‬,0046/ .‫ד‬.‫ ת‬, 004 ‫אבן גבירול‬
P.O.B. 11490,
TEL AVIV 62038
]01[
]10[
[57] A composition comprising a
synthetic peptide having an amino acid
sequence selected
from the group consisting of:
EAAKYEAYKAAAAAA,
(SE ID NO: 64)
EKAKYEAYKAAAAAA,
(SEQ ID NO: 65)
EAKKYEAYKAAAAAA,
(SEQ ID NO: 66)
EAPKYEAYKAAAAPA,
(SEQ ID NO: 84)
EAPKYEAYKAAAAPA,
(SEQ ID NO: 86)
APEKAKYEAYKAAAAAA,
(SEQ ID NO: 88)
APEKAKYEAYKAAAAAAPA,
(SEQ ID NO: 89)
EKAKYEAYKAAAAAAPA,
(SEQ ID NO: 90)
EKPKFEAYKAAAAPA,
(SEQ ID NO: 91)
EKPKVEAYKAAAAPA,
(SEQ ID NO: 93)
EKAKFEAFKAAAAAA,
(SEQ ID NO: 95)
APEKAKFEAEKAAAAPA,
(SEQ ID NO: 96)
and
APEKAKFEAYKAAAAPA,
(SEQ ID NO: 97).
__________
]00[]00[
3231
930203
December 29, 2008
– ‫ב' בטבת התשס"ט‬
‫שטיחון רצפה עם תצוגה המגיבה לקול‬
]00[
FLOOR MAT WITH VOICERESPONSIVE DISPLAY
]00[
]/0[
]00[
]10[
]01[
]10[
13.02.2002
60/268409
]/0[ 14.02.2001
]//[ US
Int. Cl.8 A47G 027/00, A47L 023/22, G10L 011/02
INTELLIMATS, LLC, U.S.A.
WO/2002/065451
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26 A HABARZEL STREET
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]57] A method comprising:
(i) providing a floor mat having a voiceresponsive display device in a humantrafficked area;
(ii) receiving an utterance requesting
information to be displayed on said voiceresponsive display device;
.
(iii) processing said utterance to obtain
said requested information; and
(iv) displaying said requested information
on said voice-responsive display device.
__________
]00[]00[
December 29, 2008
– ‫ב' בטבת התשס"ט‬
930153
3232
]00[
METHOD AND APPARATUS
PROVIDING IMPROVED
POSITION ESTIMATE BASED ON
AN INITIAL COARSE POSITION
ESTIMATE
]00[
]/0[
01.03.2002
60/273570
]/0[ 05.03.2001
1/9010//0
0021220110
Int. Cl.8 G01S 001/00, 005/14
QUALCOMM INCORPORATED,
U.S.A.
WO/2002/071095
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]00[
]10[
]01[
]10[
[57] A computer program product for
determining the location of a device,
comprising: (a) computer readable
instructions for receiving a coarse position
estimate for the device based in a part on
initial estimates of the positions of a
plurality of transmitters; (b) computer
readable instructions for receiving revised
position estimates for the transmitters; (c)
computer readable instructions for
correcting the coarse position estimate an
iterative algorithm comprising: (i)
initializing the value of a variable
representing a current more accurate
position location estimate such that the
variable is made to be equal to the coarse
position estimate; (ii) determining pseudo
range measurements equal to those that
would be measured by the device if the
device were located at the current more
accurate position location and the
transmitters were located at the relatively
more accurate location of the plurality of
transmitters; (iii) computing a least mean
square to determine the position that the
receiver device would have calculated
itself to be at, if it had been at the current
3233
‫שיטה ומכשיר לספק אומדן מיקום משופר‬
‫המבוסס על אומדן מיקום גס ראשוני‬
]//[
US
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
more accurate position location and the
transmitters had been at the position
indicated by the initial estimates of the
position of the plurality of transmitters;
(iv) defining a geometry matrix Ha, and a
geometry matrix He; (v) generating a final
geometry matrix Ht; (vi) computing an
update vector from the final geometry
matrix; and (vii) obtaining a new value for
the current more accurate position location
by adding the update vector to the old
value of the current more accurate position
location (d) initializing a revised position
estimate for the device; (e) computer
readable instructions for computing an
update vector based on the revised position
estimate for the device and the initial and
revised position estimates for the
transmitters; (f) computer readable
instructions for updating the revised
position estimate for the device based on
the update vector; (g) computer readable
instructions for repeating the computing
and updating a plurality of times, and (h) a
data storage medium configured to store
the codes.
December 29, 2008
– ‫ב' בטבת התשס"ט‬
5132682
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
5‫שטרם פורסמו‬
_________
]00[]00[
]00[
FOAM CUSHION AND METHOD
FOR MAKING THE SAME
]00[
]/0[
]00[
]10[
]01[
]10[
01.02.2002
60/270688
]/0[ 23.02.2001
Int. Cl.8 C08J 009/00
PHAT CUSHION LLC, U.S.A.
WO/2002/068515
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
December 29, 2008
– ‫ב' בטבת התשס"ט‬
930313
‫כרית קצפית ושיטה להכנתה‬
]//[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
3234
[57] A foam cushion formed from:
(a) natural rubber;
(b) ethylene-vinyl acetate (EVA)
copolymer;
(c) azodicarbonamide (AC);
(d) a polymeric adhesion modifier;
(e) dicumyl peroxide; and
(f) a combination of zinc oxide and stearic
acid.
__________
]00[]00[
]00[
METHOD AND DEVICE FOR
DETECTING FUNCTIONAL AND
METABOLIC DATA OF A LIVING
ORGANISM
]00[
]/0[
]00[
]10[
]01[
]10[
09.04.2002
10119527.3
]/0[ 12.04.2001
Int. Cl.8 A61B 005/05
TEXMED GMBH, GERMANY
WO/2002/082983
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[57] A method for detecting corporeal
functional and metabolic data of a person
by detecting in the person a substance
which influences at least one of natural and
artificial electric, electrochemical, and
electromagnetic fields in the person,
comprising: applying electrodes to the
person; activating the electrodes
alternatingly as sensors and as actuators;
detecting signals resulting from said
activating of the electrodes; said signals
933712
‫שיטה והתקן לגילוי נתונים תפעוליים ושל‬
‫חילוף חומרים של גוף חי‬
]//[
DE
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
representing changes of a physical
parameter of said natural and artificial
electric, electrochemical, and
electromagnetic fields; registering and
storing the detected signals; inputting the
stored signals into data processing
equipment; processing the stored signals in
the data processing equipment thereby to
measure said substance; wherein said
physical parameter is strength of said field.
_________
3235
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[]00[
933937
‫תרכובות ותכשירים המכילים אותם להגנה‬
‫נגד קרינה‬
]00[
COMPOUNDS AND
PHOTOPROTECTIVE
COMPOSITIONS COMPRISING
THEM
]00[
]/0[
]00[
26.03.2002
60/281626
]/0[ 30.03.2001
]//[ US
Int. Cl.8 A61K 000/892000 A61Q 001/900000 C07C 069/00, C10M 101/04, 107/34,
145/36
YISSUM RESEARCH
‫יישום חברה לפיתוח המחקר של‬
DEVELOPMENT COMPANY OF
‫ ירושלים‬,‫האוניברסיטה העברית בירושלים‬
THE HEBREW UNIVERSITY OF
JERUSALEM
WO/2002/079121
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26 A HABARZEL STREET
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]10[
]01[
]10[
[57] A compound of the formulas
CH3(CH2)iCH(CH2)mCOO(CH2)nCH(CH2)kCH3
│
│
XO
OX
CH3(CH2)iCH – CH (CH2)mCOO(CH2)mCH – CH(CH2)kCH3
│
│
│
│
XO
OX
XO
OX
wherein x is an organic group which
absorbs light in the ultraviolet region and
wherein each of i, m, n and k indicates
from 5 to 30 methylene groups.
_________
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3236
]00[]00[
]00[
METHOD AND SYSTEM FOR
DECODING MULTILEVEL
SIGNALS
]00[
]/0[
]00[
]10[
]01[
]10[
28.03.2002
60/281526
]/0[ 04.04.2001
Int. Cl.8 H04L 001/00, 025/03
QUELLAN, INC., U.S.A.
WO/2002/082694
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
[57] An optical receiver for receiving and
decoding a multilevel optical
communication signal, comprising: a
plurality of first comparators for estimating
a transmitted level based on the received
multilevel signal; a decoder coupled to the
first comparators; a second comparator
connected in parallel with the first
comparators, for indicating when the
received signal exceeds a voltage;
933299
‫מערכת ושיטה לפיענוח אותות מרובי רמות‬
]//[
US
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,00988 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
a filter coupled to the second comparator,
for calculating a calculating distribution
function for the received multilevel signal;
an analog-to-digital converter coupled to
the filter for sampling a cumulative
distribution function; and a microcontroller
for processing the cumulative distribution
function to determine threshold voltage
values, for feeding the threshold voltage
values to the first comparators for
decoding the multilevel signal.
_________
3237
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[]00[
933311
‫תמציות איזופלאבון ושיטות להכנתן‬
]00[
ISOFLAVONE CONCENTRATES
AND METHODS FOR THE
PRODUCTION THEREOF
]00[
]00[
]10[
29.06.2002
Int. Cl.8 A23L 001/30, A61K 009/107, 031/352, C07D 311/00, 311/76
AQUANOVA GERMAN
SOLUBILISATE TECHNOLOGIES
(AGT) GMBH, GERMANY
WO/2004/002469
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
JERUSALEM 91013
]01[
]10[
[57] Method for the production of an
isoflavone concentrate, which contains
genistein, diadcein, glycitein, and/or their
glycosides, characterized in that an extract
containing isoflavone, preferably of
vegetable origin, is added to polysorbate
that has been heated to about 60oC up to
about 100oC, and the warm mixture is
evenly stirred until it has turned into a
clear, sediment-free and water soluble
concentrate.
_________
]00[]00[
933091
‫מערכת ושיטה למדידת איגוד נתוני תחום‬
‫ביישומים של איתור רציף פסיבי‬
]00[
SYSTEM AND METHOD FOR
MEASUREMENT OF DOMAIN
DATA ASSOCIATION IN PASSIVE
COHERENT LOCATION
APPLICATIONS
]00[
]/0[
]00[
]10[
06.05.2002
60/288450
]/0[ 04.05.2001
]//[ US
Int. Cl.8 G01S 005/06, 013/00, 013/02, 013/46, 013/66, 013/72
LOCKHEED MARTIN
CORPORATION, U.S.A.
ROBERT H. BRENNER, JOSEPH
SAWYER
WO/2002/091017
SOROKER-AGMON,
,‫אגמון‬-‫סורוקר‬
14 SHENKAR ST.,
‫ הרצליה פיתוח‬,04 ‫ רחוב שנקר‬,‫בית נולטון‬
HERZLIYA PITUAH 46725
]10[
]01[
]10[
[57] A method for associating a detection
report having measurements to a line track,
wherein said line track correlates to a
signal transmitted from a source of
December 29, 2008
– ‫ב' בטבת התשס"ט‬
opportunity, reflected from a target, and
detected by a passive coherent location
system, comprising: estimating a line track
state vector from said measurements using
3238
a set of Kalman filters, wherein said
measurements are at least partially derived
by comparing said signal to a reference
transmission from said source of
opportunity; and initializing said line track.
_________
]00[]00[
933173
‫נגזרות בנזוקסאזאפין ושימוש בהן כמאפנני‬
AMPA ‫קולטן‬
]00[
BENZOXAZEPINE DERIVATIVES
AND THEIR USE AS AMPA
RECEPTOR STIMULATORS
]00[
]/0[
]00[
]10[
05.06.2002
01202215.8
]/0[ 11.06.2001
]//[ EP
Int. Cl.8 A61K 031/553, 031/554, A61P 025/00, C07D 498/04, 515/04
N.V. ORGANON, THE
NETHERLANDS
WO/2002/100865
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26 A HABARZEL STREET
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]01[
]10[
[57] A benzoxazepine derivative of the formula
3239
December 29, 2008
– ‫ב' בטבת התשס"ט‬
wherein
X represents CO or SO2; R1, R2, R3 and R4
are independently selected from H, (C1-4)
alkyl, (C1-4) alkyloxy, (C1-4) alkyloxy (C1-4)
alkyl, CF3, halogen, nitro, cyano, NR8R9,
NR8COR10, and CONR8R9; R5, R6 and R7
are independently H or (C1-4) alkyl; R8 and
R9 are independently H or (C1-4) alkyl; or
R8 and R9 form together with the nitrogen
atom to which they are bound a 5- or 6membered saturated heterocyclic ring,
optionally containing a further heteroatom
selected from O, S or NR11; R10 is (C1-4)
alkyl; R11 is (C1-4) alkyl; A represents a
bivalent radical containing 2-5 carbon
atoms, one carbon of which may be
substituted by oxygen, such that A and the
two atoms to which it is attached form a 47 membered saturated heterocyclic ring,
the ring being optionally substituted with
1-3 substituents selected from (C1-4) alkyl,
(C1-4) alkyloxy, hydroxy, halogen and oxo;
or a pharmaceutically acceptable salt
thereof; with the proviso that the
compounds of formula I wherein X is CO;
each of R1-R7 is H, and A represents
(CH2)3 or (CH2)4; the compounds of
formula I wherein X is CO; R1 is H; R2 is
methyl; each of R3-R7 is H; and A
represents (CH2)3; the compound of
formula I wherein X is CO; R1 and R2 are
H; R3 is methyl; each of R4-R7 is H; and A
represents (CH2)3; the compound of
formula I wherein X is CO; each of R1-R3
is H; R4 is methyl; each of R5-R7 is H; and
A represents (CH2)3; and the compound of
formula I wherein X is CO; each of R1-R4
is H; R5 is methyl; R6 and R7 are H; and A
represents (CH2)3; are excluded.
_________
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3240
]00[]00[
933129
‫ חד– שבטיים‬NGF ‫שימוש בנוגדי נוגדני‬
hNGF ‫כימריים ממקור אנושי הקושרים‬
‫בזיקתיות גבוהה ליצירת תרופות לטיפול‬
‫ אשר אינן‬NGF– ‫בדלקות הקשורות ל‬
‫ על מערכת‬NGF ‫קשורות בהשפעת‬
‫העצבים‬
]00[
USE OF A CHIMERIC,
HUMANIZED ANTI-HUMAN NGF
MONOCLONAL ANTIBODY
CAPABLE OF BINDING HNGF
WITH HIGH AFFINITY IN THE
MANUFACTURE OF A
MEDICAMENT FOR USE IN
TREATING AN NGF - RELATED
INFLAMMATORY CONDITION
OTHER THAN INFLAMMATORY
CONDITION ASSOCIATED WITH
THE EFFECT OF NGF ON THE
NEURONAL SYSTEM
]00[
]/0[
]00[
]10[
]01[
]10[
09.05.2002
60/294392
]/0[ 30.05.2001
]//[
Int. Cl.8 A61K 039/395, A61P 011/06, 029/00
GENENTECH, INC., U.S.A.
WO/2002/096458
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
[57] Use of a chimeric, humanized or
human anti-human NGF monoclonal
antibody capable of binding hNGF with an
affinity in the nanomolar range, and
inhibiting the binding of hNGF to human
TrkA in vivo, wherein said antibody has
no significant adverse effect on the
US
,
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
immune system of a patient, in the
manufacture of a medicament for use is
treating an NGF-related inflammatory
condition other than inflammatory
condition associated with the effect of
NGF on the neuronal system.
__________
3241
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[]00[
933115
‫חומרים לחיזוק השיניים‬
]00[
DENTAL RESTORATIVE
MATERIALS
]00[
]/0[
]00[
]10[
21.05.2002
PR5177
]/0[ 21.05.2001
]//[ AU
Int. Cl.8 A61K 006/00, 006/033, 038/00
THE UNIVERSITY OF
MELBOURNE, AUSTRALIA
ERIC CHARLES REYNOLDS,
‫ מרטין ג'ון טייס‬,‫אריק צ'רלס ריינולדס‬
MARTIN JOHN TYAS
WO/2002/094204
WEBB & ASSOCIATES,
,'‫ד"ר וב ושות‬
2 PEKERIS ST., P.O.B. 2189,
‫ רחובות‬,0086 .‫ד‬.‫ ת‬, 0 ‫רח' פקריס‬
REHOVOT 76121
]10[
]01[
]10[
[57] A composition for dental restoration
including a dental restorative material and
an effective amount of a casein
phosphopeptide (CPP)-amorphous calcium
phosphate (ACP) complex or casein
phosphopeptide (CPP)-amorphous calcium
fluoride phosphate (ACFP) complex.
__________
]00[]00[
]00[
METHOD FOR PRODUCING NPHOSPHONOMETHYLGLYCINE
]00[
]/0[
]00[
]10[
21.06.2002
10130136.7
]/0[ 22.06.2001
Int. Cl.8 C07F 009/00, 009/38
BASF AKTIENGESELLSCHAFT,
GERMANY
WO/2003/000704
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
]01[
]10[
931702
‫–פוספונומתילגליצין‬N ‫שיטה לייצור‬
]//[
DE
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
[57] A process for the recovery of Nphosphonomethylglycine from an aqueous
mixture which contains Nphosphonomethylglycine, ammonium
halides, and alkali metal or alkaline earth
metal halides and optionally organic
impurities in dissolved form, where
(a) the pH of the mixture is adjusted to a
value in the range from 2 to 8,
(b) a separation of the mixture on a
selective nanofiltration membrane is
performed, a retentate which is richer in Nphosphonomethylglycine and poorer in
halides and a permeate which is richer in
– ‫ב' בטבת התשס"ט‬
3242
December 29, 2008
halides and poorer in Nphosphonomethylglycine being obtained,
and
(c) the N-phosphonomethylglycine is
recovered from the retentate.
__________
]00[]00[
]00[
BIRTH MONITORING SYSTEM
]00[
]/0[
05.06.2002
60/295569
]/0[ 05.06.2001
2190/001/
1021220110
219/1/10/
1221020110
219//0210
0020020110
Int. Cl.8 A61B 005/00, 008/08
BARNEV LTD.
YEHUDA SHARF
WO/2002/098271
FENSTER & COMPANY,
INTELLECTUAL PROPERTY LTD.,
12 BASEL ST.,
ENTRANCE 1,
P.O.B. 10256 ,
PETACH TIKVA
]00[
]10[
]10[
]01[
]10[
[57] A birth monitoring system (200),
comprising: an ultrasonic transmitter (204)
comprising at least one transmission
element; an electromagnetic RF receiver
(206) comprising at least one RF antenna;
at least two transponders (202) adapted to
attached to a cervix and which generate RF
931901
‫מערכת לניתור לידה‬
]//[
US
US
US
US
‫ נתניה‬,‫ברנב בע"מ‬
‫יהודה שרף‬
,‫קניין רוחני בע"מ‬,'‫פנסטר ושות‬
,0/0.9 .‫ד‬.‫ ת‬, ‫ קרית אריה‬,0 ‫ כניסה‬00 ‫בזל‬
‫פתח תקוה‬
signals responsive to excitation by an
ultrasonic signal; a signal distinguisher
which distinguishes between RF signals
from different transponders; and a
controller (212) configured to analyze said
RF signals to produce an indication of a
progress of a birth.
__________
3243
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[]00[
931515
‫ שירותי שידור עבור‬,‫שידור מולטימדיה‬
‫טלפון סלולרי ועבור משתמשים אחרים‬
‫ ואמצעים דומים‬SIM ‫וכרטיס מותאם‬
‫המאפשרים קליטת שידור זה‬
]00[
MULTIMEDIA BROADCASTING
SERVICES FOR CELL PHONE
AND OTHER USERS AND
MODIFIED SIM CARD FOR
ENABLING BROADCAST
RECEPTION
]00[
]/0[
24.06.2002
0115346.9
]/0[ 22.06.2001
]//[ GB
100011220
0220120110
GB
Int. Cl.8 H04L 029/06, 029/08, H04M 001/00, 011/08, H04Q 007/22, 007/38
PAPERLESS INTERACTIVE
NEWSPAPER, LLC, U.S.A.
WO/2003/001772
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]00[
]10[
]01[
]10[
[57] A computerized cell phone capable
of telephone communication on a cellular
phone system, the cellular phone system
having a transmitter-receiver providing
broadcast transmissions of large data files,
each broadcast transmission being
simultaneously receivable by multiple
enabled cell phone users in range of the
transmitter receiver, the cell phone
comprising a remobale electronic
accessory device provided with a machinereadable electronic key and having the
ability to receive the broadcast
transmission from the cellular phone
system, wherein the cell phone is capable
of receiving large data files and wherein
the electronic key enables reception of the
broadcast transmission without
initialization with the cellular phone
system.
_________
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3244
]00[]00[
]00[
MONITORING USAGE OF MEDIA
DATA WITH NON-PROGRAM
DATA ELIMINATION
]00[
]/0[
]00[
]10[
]01[
]10[
19.09.2002
956368
]/0[ 19.09.2001
Int. Cl.8 H04H 001/00, H04N 017/00
ARBITRON INC., U.S.A.
WO/2003/026317
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
[57] A method for gathering data for
producing audience survey data,
comprising: conducting an evaluation of
monitored data having intervals which
include media data and intervals from
which media data is absent to determine
whether media data potentially is present
in the monitored data of each of a plurality
of the intervals; producing media data
3245
931503
‫שימוש לניטור נתוני תקשורת עם הסרת‬
‫נתונים שאינם ברי תכנות‬
]//[
US
,'‫ד"ר שלמה כהן ושות‬
‫ תל אביב‬,0046/ .‫ד‬.‫ ת‬, 004 ‫אבן גבירול‬
presence data indicating a potential
presence of media data in the monitored
data of respective ones of the plurality of
the intervals based on the evaluation; and
separating first monitored data in which
media data potentially is present from
second monitored data in which media
data is absent based on the media data
presence data.
December 29, 2008
– ‫ב' בטבת התשס"ט‬
_________
]00[]00[
]00[
ENHANCED LOCATION
METHODOLOGY FOR A
LOCATION SYSTEM
]00[
]/0[
]00[
]10[
]01[
]10[
13.05.2002
897007
]/0[ 29.06.2001
Int. Cl.8 G01S 005/12
MOTOROLA, INC., U.S.A.
WO/2003/003040
REINHOLD COHN AND
PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
December 29, 2008
– ‫ב' בטבת התשס"ט‬
931332
‫מתודולוגיית איתור משופרת עבור שיטת‬
‫איתור‬
]//[
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
3246
[57] A location method used in a location
system, the method comprising the steps
of: at a first device, transmitting a first
signal to a second device at a first time; at
a third device, detercting a second signal
from the second device at a second time,
wherein the second signal was transmitted
in response to detection of the first signal;
based on the first and second times,
estimating a sum of a first propagation
delay and a second propagation delay,
wherein the first propagation delay is
between the first device and the second
device, and the second propagation delay
is between the second device and the third
device; and using the sum of the first and
second propagation delays to estimate a
location of the second device.
__________
]00[]00[
]00[
MODULAR MARINE
STRUCTURES
]00[
]/0[
]00[
]10[
27.06.2002
60/301133
]/0[ 28.06.2001
Int. Cl.8 B63B 035/44, E04B 001/49
OCEAN BRICK SYSTEM (O.B.S.)
LTD.
WO/2003/002827
DR. EYAL BRESSLER,
11 TUVAL ST.,
RAMAT GAN 52522
]01[
]10[
[57] A 3-D structural module (3-D
module) (10) for assembly in a loadcarrying modular structure, said 3-D
module being designed as a body
constituting a complete or partially cut-out
3247
931177
‫מבנים ימיים מודולרים‬
]//[
US
,‫דר' אייל ברסלר עו"פ‬
‫ גן‬- ‫ רמת‬,00 ‫תובל‬
parallelepiped (12) with rectangular sides
and comprising at least one reinforcing
diagonal beam (RDB) disposed along a
diagonal (R-diagonal) that connects
vertices (R-corners) of said parallelepiped,
December 29, 2008
– ‫ב' בטבת התשס"ט‬
said body having flat faces constituting
part of said rectangular sides, said RDB
including means for rigid assembly to a
RDB of another 3-D module, such that a
plurality of 3-D modules can adjoin each
other along their flat faces, and their RDBs
(30) can be assembled to each other at said
flat faces so as to form a 3-D rigid multitetrahedron lattice in said modular
structure, whereby said modular structure
behaves under load as a multi-tetrahedron
structure.
__________
]00[]00[
]00[
ELECTRIC MOTOR
COMPRISING A COOLING
SYSTEM
]00[
]/0[
]00[
]10[
]01[
]10[
10.05.2002
1594/01
]/0[ 29.08.2001
Int. Cl.8 H02K 009/16
ETEL SA, SWITZERLAND
WO/2003/019754
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
917972
‫מנוע חשמלי המכיל מערכת קרור‬
]//[
CH
,‫ד"ר יצחק הס ושותפיו‬
‫ תל אביב‬,94.0 .‫ד‬.‫ ת‬, 076 ‫רחוב הירקון‬
[57] An electric motor having a cooling
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3248
system, comprising a primary part (1) and
a secondary part (14), whose primary part
is made up of an iron core (2) and coils (3)
that lie in gaps (4) and encircle teeth (5) of
the iron core; and comprising a housing (6)
which accommodates the iron core, so that
a first flow chamber and a second flow
chamber for a coolant is formed on both
sides of the iron core, wherein the coils are
at least partially surrounded by potting
compound (13) so that the first flow
chamber and the second flow chamber are
at least connected by channels in the gaps.
_________
]00[]00[
]00[
SLURRY COMPOSITION FOR
USE IN CHEMICAL
MECHANICAL POLISHING OF
METAL WIRING
]00[
]/0[
06.08.2002
2001-47895
]/0[ 09.08.2001
0110-00100
0021020110
Int. Cl.8 H01L 021/304
CHEIL INDUSTRIES INC.,
REPUBLIC OF KOREA
JAE SEOK LEE, WON JOONG DO,
HYUN SOO ROH, KIL SUNG LEE,
JONG WON LEE, BO UN YOON,
SANG ROK HAH, JOON SANG
PARK, CHANG KI HONG
WO/2003/015148
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
]00[
]10[
]10[
]01[
]10[
[57] A slurry composition for use in
chemical mechanical polishing of metal,
comprising a peroxide, an inorganic acid, a
917931
‫תרכובת תערובת דלילה לשימוש בליטוש‬
‫מכני כימי של חוט מתכת‬
]//[
KR
KR
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
,4./87 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬
PDTA (propylenediaminetetraacetate)metal complex, a carboxylic acid, a metal
oxide powder, and de-ionized water.
_________
3249
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[]00[
]00[
PLASTER COMPRISING
SERTACONAZOLE FOR THE
TREATMENT OF
DYSFUNCTIONS AND
DISORDERS OF NAILS
]00[
]/0[
04.09.2002
01121200.8
]/0[ 04.09.2001
219/00/01
0021/20110
Int. Cl.7 A61K 009/60
TROMMSDORFF GMBH & CO. KG
ARZNEIMITTEL, GERMANY
WO/2003/020248
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
]00[
]10[
]01[
]10[
[57] Plaster comprising: a layer being
designed to be in close contact with the
nail and optionally with the surrounding
skin; said layer comprising:
(a) an adhesive;
917332
‫פלסטר המכיל סרטקונאזול לטיפול‬
‫בהפרעות בתפקוד ובמחלות של‬
‫הציפורניים‬
]//[
ES
US
,'‫ד"ר שלמה כהן ושות‬
‫ תל אביב‬,0046/ .‫ד‬.‫ ת‬, 004 ‫אבן גבירול‬
(b) at least one skin and/or nail permeation
enhancer; and
(c) a therapeutically effective amount of
sertaconazole.
_________
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3250
]00[]00[
917137
‫חומרים דוחי מזיקים ושילובם באריזות מזון‬
]00[
PEST-IMPERVIOUS
PACKAGING MATERIAL AND
PEST-CONTROL COMPOSITION
]00[
]00[
]10[
18.03.2004
Int. Cl.8 A01N 031/02, 065/00, B65D 065/42
THE STATE OF ISRAEL‫ משרד החקלאות ופיתוח‬- ‫מדינת ישראל‬
MINISTRY OF AGRICULTURE &
‫ מרכז‬,‫ מינהל המחקר החקלאי‬,‫הכפר‬
RURAL DEVELOPMENT,
‫ בית דגן‬,‫וולקני‬
AGRICULTURAL RESEARCH
‫ ראשון לציון‬,‫ביופאק בע"מ‬
ORGANIZATION VOLCANI
CENTER
BIOPACK LTD.
SHLOMO NAVARRO, DOV
‫ שמחה‬,‫ מרים רינדנר‬,‫ דב זהבי‬,‫שלמה נברו‬
ZEHAVI, MIRIAM RINDNER,
‫ פאדל‬,‫ סם אנגל‬,‫ רפאל דיאס‬,‫פינקלמן‬
SIMCHA FINKELMAN, REFAEL
‫מנסור‬
DIAS, SAM ANGEL, FADEL
MANSUR
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬066.( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
,00 ‫רחוב מנחם בגין‬, 0. ‫ קומה‬,‫מגדל אילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
]10[
]10[
[57] A pest control composition
comprising an effective amount of at least
The applications for
division from this
application have not yet
been published
one sesquiterpene alcohol and/or a
turmeric oleoresin solid residue.
5132333
‫בקשות חלוקה מבקשה זו‬
5‫שטרם פורסמו‬
_________
3251
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[]00[
]00[
METHODS FOR DISTRIBUTED
PROGRAM EXECUTION WITH
FILE - TYPE ASSOCIATION IN A
CLIENT-SERVER NETWORK
]00[
]/0[
01.10.2002
09/970038
]/0[ 02.10.2001
1/9/111/1
1020120110
1/9/11020
1020120110
Int. Cl.8 G06F 009/445, 009/46, 015/16
CITRIX SYSTEMS, INC., U.S.A.
WO/2003/029977
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]00[
]10[
]01[
]10[
[57] In a network including a client
system and a plurality of server systems, a
method for enabling distributed program
execution, the method comprising the
steps:
(a) presenting, by a web browser executing
on a client system, a graphical depiction of
a data file stored on a web server;
(b) receiving, by the client system, a
request from the web server to execute a
first executable program on the client
system, said request including information
concerning a second program associated
with the data file, the second executable
December 29, 2008
– ‫ב' בטבת התשס"ט‬
919919
‫שיטות לביצוע תוכנית מבוזרת עם‬
‫שיתוףסוג קבוץ ברשת שרת לקוח‬
]//[
US
US
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
program selected according to a mapping
specifying an association between the
second executable program and a type of
the data file accepted for processing by the
second executable program, the second
executable program executing on either the
client system or one of a plurality of server
systems;
(c) receiving application output data from
the second executable program by the first
executable program; and
(d) formatting, by the first executable
program, received application output data
for presentation.
3252
__________
]00[]00[
919111
‫ – הדרוקסי–בקאטין‬β 14 ‫תהליך להכנת‬
‫ – קרבונאט‬III – 1, 14
]00[
PROCESS FOR THE PREPARATION
OF THE 14 BETA-HYDROXYBACCATIN III-1, 14-CARBONATE
]00[
]/0[
]00[
]10[
]01[
]10[
18.07.2002
MI2001A002185 ]/0[ 19.10.2001
]//[
Int. Cl.8 C07D 305/00, 305/14, 493/04, 493/08
INDENA S.P.A., ITALY
WO/2003/035634
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
3253
IT
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
[57] A process for the preparation of 14βhydroxy-1, 14-carbonate-baccatin III,
which comprises:
(a) treatment of 7-Boc – 13-ketobaccatin
III of the formula
with suitable bases and oxidizing agents, to
give 7-Boc-13-keto-14-hydroxy-baccatin
III:
(b) carbonation of the 1 and 14 hydroxy
groups to give 14β-Hydroxy-7-Boc-13keto-baccatin III-1, 14-carbonate:
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3254
(c) reduction of the ketone at the 13
position and cleavage of the protective
group in 7.
51633215163323
The applications for division
from this application have not
yet been published
‫בקשות חלוקה מבקשה זו‬
5‫שטרם פורסמו‬
_________
]00[]00[
]00[
SCINTILLATOR HAVING
INTEGRATED COLLIMATOR
AND METHOD OF
MANUFACTURING SAME
]00[
]/0[
]00[
]10[
18.04.2004
249699
]/0[ 30.04.2003
Int. Cl.8 G21K 001/02
GE MEDICAL SYSTEMS GLOBAL
TECHNOLOGY COMPANY, LLC,
U.S.A.
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
]10[
[57] A method of manufacturing a
detector having an integrated scintillator
and collimator, the method comprising the
steps of: positioning a block of scintillator
pack on a tooling base; positioning a
collimator mold housing having a
919111
‫מנצנץ עם קולימטור משולב ושיטה לייצורו‬
]//[
US
,'‫זליגסון גבריאלי ושות‬
‫ תל אביב‬,0409 .‫ד‬.‫ ת‬, :0 ‫רח' יבנה‬
collimator mold cavity therein on the
block; aligning the block and the mold
housing; disposing a collimator mixture
into the mold cavity; and curing the
collimator mixture to form an integrated
scintillator and collimator.
_________
3255
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[]00[
919352
‫מאיץ מוליך למחצה מיקרו–מכני‬
]00[
MICRO-MECHANICAL
SEMICONDUCTOR
ACCELEROMETER
]00[
]/0[
]00[
]20[
]10[
]01[
]10[
22.07.1999
09/127643
]/0[ 31.07.1998
Int. Cl.8 G01P 015/125
DIVISION FROM 135290
LITTON SYSTEMS, INC., U.S.A.
WO/2000/007028
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]//[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
[57] A method for producing a
having opposite faces, a continuous,
semiconductor accelerometer of the
marginal frame around said proofmass and
differential capacitor type, comprising the
a flexible hinge connecting said proofmass
steps of:
to said frame;
(a) selecting a semiconductor proofmass
(f) assembling said proofmass wafer
wafer, and a pair of SOI wafers of the type
between opposed ones of said SOI wafers
that have an oxide layer between
such that said frames of said wafers are in
semiconductor handle and device layers;
alignment, said proofmass is centered
(b) fixing a first thickness of dielectric
between and spaced apart from respective,
material on said opposite sides of each said
opposed ones of said electrodes by a
SOI wafer;
distance equal to the sum of said first and
(c) fixing a second thickness of dielectric
second thicknesses of dielectric material,
material on opposite sides of said
and said proofmass is articulated to rotate
proofmass wafer;
between said electrodes at said hinge; and
(d) etching said device layer and said first
then
thickness of dielectric material overlying
(g) bonding each said SOI wafer to a
said device layer of each said SOI wafer
respective one of said opposed sides of
through to said underlying oxide layer to
said proofmass wafer such that a
define on said device layer an associated
respective one of said first thicknesses of
central electrode and a continuous,
dielectric material on said frames around
marginal frame around said electrode;
said electrodes is fused to a respective one
(e) etching said proofmass wafer and said
of said second thicknesses of dielectric
second thicknesses of dielectric material
material on said opposed sides of said
on said opposite sides thereof to define
frame around said proofmass, thereby
within said wafer a central proofmass
forming a hermetically sealed assembly.
___________
]00[]00[
December 29, 2008
– ‫ב' בטבת התשס"ט‬
919070
3256
]00[
METHOD OF PRODUCING A
CONTACTLESS CHIP CARD OR A
CONTACT/CONTACTLESS
HYBRID CHIP CARD WITH
IMPROVED FLATNESS
]00[
]/0[
12.09.2003
02/11387
]/0[ 13.09.2002
1/910000
002102011/
Int. Cl.8 G06K 019/077
ASK S.A., FRANCE
WO/2004/025553
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
]00[
]10[
]01[
]10[
[57] A method of manufacturing a
contactless chip card or a
contact/contactless hybrid chip card having
an antenna support, two card bodies on
either side of said antenna support and an
electronic module or a chip linked to the
antenna comprising: a first lamination step
comprising fusing two homogeneous
sheets of thermoplastic on each side of said
antenna support by pressing at a
temperature sufficient for the material of
which the sheets are made to soften and to
‫שיטה ליצור כרטיס שבב ללא מגע או‬
‫ללא מגע בעל‬/‫כרטיס שבב משולב מגע‬
‫שטיחות משופרת‬
]//[
FR
FR
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
flow wholly so as to eliminate any
differences in thickness from the antenna
support and to form a plasticised antenna
support having even faces, and a second
lamination step carried out after a period of
time corresponding to the period of time
necessary for said sheets of thermoplastic
to be solidified, said second step
comprising fusing by hot pressing two
plastic layers making up the card bodies
onto the even faces of said plasticised
antenna support.
__________
]00[]00[
]00[
AUTOMATIC SAUCEPAN FOR
BOILING EGGS
]00[
]00[
]10[
]10[
02.05.2004
Int. Cl.8 A47J 029/02
ANATOLI PLOTNIKOV
ANATOLI PLOTNIKOV,
8 MIVTZA OVDA,
KIRIAT GAT
3257
919027
‫סיר אוטומטי לבישול ביצים‬
‫ קרית גת‬,‫אנטולי פלוטניקוב‬
,‫אנטולי פלוטניקוב‬
‫ קרית גת‬,8 ‫מבצע עובדה‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
[57] Apparatus (21) for boiling an egg
(24), comprising: an egg-boiling container
(2) which is adapted to contain the egg and
a first volume of water; a heater (11)
which is adapted to boil the water in the
container; one or more valves (16, 17)
which are coupled to drain the first volume
of water from the egg-boiling container
and to introduce a second volume of cold
water into the egg-boiling container in
place of the first volume; and an automated
controller (3), which is coupled to actuate
the heater so as to cook the egg in the first
volume of the water for a preset time
period, and to actuate the one or more
valves at the conclusion of the preset time
period so as to replace the boiled water
with the cold water.
__________
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3258
]00[]00[
]00[
ROTATION TYPE SILICON
WAFER CLEANING EQUIPMENT
]00[
]/0[
]00[
]10[
11.09.2003
2002-276818 ]/0[ 24.09.2002
Int. Cl.8 H01L 021/30
TADAHIRO OHMI, JAPAN
FUJIKIN INCORPORATED, JAPAN
PRE-TECH CO., LTD., JAPAN
]01[
]10[
WO/2004/036637
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[57] A rotation silicon wafer cleaning
device for performing drying and hydrogen
termination treatment on a outer surface of
a silicon wafer (4), comprising:
(a) a case body (2);
(b) a silicon wafer support and rotation
driving mechanism (3) disposed inside the
case body; and
(c) a silicon wafer drying device (1)
including:
(i) a gas supply panel (5) having a gas
mixer, the supply panel being disposed to
supply a mix of hydrogen gas and inert
gas, the mix comprising greater than
0.05% by volume of hydrogen;
3259
919015
‫ציוד מסוג סיבובי לניקוי פרוסות סיליקון‬
]//[
JP
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
(ii) a mixed gas supply pipe (A) coupled to
the gas mixer;
(iii) a mixed gas heating device (B)
disposed to heat the mixed gas in the
mixed gas supply pipe; and
(iv) a hydrogen radical formation and
dispersion apparatus disposed to receive
the heated mixed gas from the mixed gas
supply pipe, having a platinum film
disposed to form hydrogen radicals in the
heated mixed gas, the hydrogen radical
formation and dispersion apparatus
disposed to direct the mixed gas containing
hydrogen radicals onto a rotating silicon
wafer.
December 29, 2008
– ‫ב' בטבת התשס"ט‬
__________
]00[]00[
]00[
METHOD AND APPARATUS FOR
PROVIDING EMBOSSED
HIDDEN IMAGES
]00[
]00[
]20[
]10[
29.04.2003
Int. Cl.8 B42D 015/10
155659
STARBOARD TECHNOLOGIES
LTD.
RON GOLAN
SOROKER-AGMON,
14 SHENKAR ST.,
HERZLIYA PITUAH 46725
]10[
]10[
December 29, 2008
– ‫ב' בטבת התשס"ט‬
919171
‫שיטה והתקן להטבעת דמויות חבויות‬
‫ אור עיקבא‬,‫סטארבורד טכנולוגיות בע"מ‬
‫רון גולן‬
,‫אגמון‬-‫סורוקר‬
‫ הרצליה פיתוח‬,04 ‫ רחוב שנקר‬,‫בית נולטון‬
3260
[57] A method for providing at least one
hidden image within a substrate, the
method comprising irradiating a substrate
with a light beam, the irradiating light
causing an interaction with the substrate,
the interaction generating at least one
hidden image, whereby the at least one
hidden image can be viewed with the use
of at least one decoder.
___________
3261
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[]00[
]00[
METHOD AND APPARATUS FOR
A REVERSE LINK
SUPPLEMENTAL CHANNEL
SCHEDULING
]00[
]/0[
27.11.2002
60/336756
]/0[ 04.12.2001
019011/01
0021220110
Int. Cl.8 G06K 017/00, H04Q 007/20
QUALCOMM INCORPORATED,
U.S.A.
WO/2003/049005
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]00[
]10[
]01[
]10[
[57] A method for transmitting reverse
link supplemental channel scheduling
information in a communication system,
comprising: grouping a number of mobile
stations in said communication system into
a plurality of groups of mobile stations;
assigning a corresponding number of
forward link common assignment channels
to said plurality of groups of mobile
912291
‫שיטה והתקן לזמנון ערוץ קישור מהופך‬
‫משלים‬
]//[
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
stations; and transmitting said reverse link
supplemental channel scheduling
information on said corresponding number
of forward link common assignment
channels assigned to said plurality of
groups of mobile stations, wherein the
corresponding number of forward link
common assignment channels have a data
rate lower than forward link data channels.
5132212
The applications for division
from this application have
not yet been published
US
US
‫בקשות חלוקה מבקשה זו‬
5‫שטרם פורסמו‬
__________
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3262
]00[]00[
]00[
DETECTION OF ODOURS USING
INSECTS
]00[
]/0[
]00[
]10[
20.12.2002
01310855.9
]/0[ 22.12.2001
Int. Cl.8 G01N 033/00, 033/497
INSCENTINEL LIMITED, UNITED
KINGDOM
WO/2003/056292
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
]01[
]10[
[57] A holding unit (100) for housing at
least two insects in predetermined
positions, wherein the holding unit
comprises a housing and two or more
removable insect holders, each for holding
a respective insect (90) of a particular type
in a predetermined position, the holding
unit being adapted to be removably
3263
912323
‫גילוי ריחות באמצעות חרקים‬
]//[
EP
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
associated with a detector unit (150), for
exposing insects in the holding unit to a
sample of gas to be tested and monitoring
a response of the insects to the sample
thereby to detect a response indicative of
the target odour.
December 29, 2008
– ‫ב' בטבת התשס"ט‬
_________
]00[]00[
912313
‫–אוקסוקווינולין ותכשירי רוקחות‬4 ‫תולדות‬
‫המכילים אותן‬
]00[
4-OXOQUINOLINE DERIVATIVES
AND PHARMACEUTICAL
COMPOSITIONS CONTAINING
THE SAME
]00[
]/0[
20.11.2003
336843/2002
]/0[ 20.11.2002
]//[ JP
200119011/
0021/2011/
JP
0//2029011/
022102011/
JP
Int. Cl.8 A61K 031/4375, 031/47, 031/4709, A61P 031/12, 031/18, C07D 215/56,
401/06, 409/06, 417/06
JAPAN TOBACCO INC., JAPAN
WO/2004/046115
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
JERUSALEM 91013
]00[
]10[
]01[
]10[
[57] An anti-HIV agent comprising a 4oxoquinoline compound of the formula
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3264
or a pharmaceutically acceptable salt
thereof as an active ingredient, wherein
ring Cy is a C3-10 carbon ring group
optionally substituted by 1 to 5
substituents selected from the following
group A or a heterocyclic group optionally
substituted by 1 to 5 substituents selected
from the following group A wherein the
heterocyclic group is a saturated or
unsaturated ring containing, besides carbon
atom(s), at least one heteroatom selected
from a nitrogen atom, an oxygen atom and
a sulfur atom, group A is a group
consisting of cyano group, phenyl group,
nitro group, halogen atom, C1-4 alkyl
group, halo C1-4 alkyl group, halo C1-4
alkyloxy group, -ORa1, -NRa1Ra2, CONRa1Ra2, -SO2NRa1Ra2, -CORa3,SO2Ra3, -NRa1SO2Ra3, -COORa1 and –
NRa2COORa3 wherein Ra1 and Ra2 are the
same or different and each is hydrogen
atom, C1-4 alkyl group or benzyl group and
Ra3 is C1-4 alkyl group; R1 is a substituent
selected from the following group B or a
C1-10 alkyl group substituted by 1 to 3
substituents selected from halogen atom
and the following group B wherein group
B is a group consisting of C3-10 carbon ring
group optionally substituted by 1 to 5
substituents selected from the abovementioned group A, heterocyclic group (as
defined above) optionally substituted by 1
to 5 substituents selected from the abovementioned group A, -ORa4, - SRa4, NRa4Ra5, -CORa6, -NRa4CORa6, -SO2Ra6, NRa4SO2Ra6, -COORa4 and –NRa5COORa6
wherein Ra4and Ra5 are the same or
3265
different and each is hydrogen atom, C1-4
alkyl group, C3-10 carbon ring group
optionally substituted by 1 to 5
substitutents selected from the abovementioned group A or heterocyclic group
as defined above optionally substituted by
1 to 5 substituents selected from the abovementioned group A, and Ra6 is C1-4 alkyl
group, C3-10 carbon ring group optionally
substituted by 1 to 5 substituents selected
from the above-mentioned group A or
heterocylic group as defined above
optionally substituted by 1 to 5
substituents selected from the abovementioned group A; R2 is a hydrogen atom
or a C1-4 alkyl group; R31 is a hydrogen
atom, a cyano group, a hydroxy group, an
amino group, a nitro group, a halogen
atom, a C1-4 alkyl group, a C1-4 alkoxy
group, a C1-4 alkylsulfanyl group, a halo
C1-4 alkyl group or a halo C1-4 alkyloxy
group; X is a C-R32 or a nitrogen atom; and
Y is a C-R33 or a nitrogen atom wherein
R32 and R33 are the same or different and
each is hydrogen atom, cyano group, nitro
group, halogen atom, C3-10 carbon ring
group optionally substituted by 1 to 5
substituents selected from the abovementioned group A, heterocylic group (as
defined above) optionally substituted by 1
to 5 substituents selected from the abovementioned group A or, C1-10 alkyl group
substituted by 1 to 3 substituents selected
from halogen atom and the abovementioned group B, -ORa7, -SRa7, NRa7Ra8, -NRa7CORa9, -COORa10 or –
N=CH-NRa10Ra11 wherein Ra7 and Ra8 are
December 29, 2008
– ‫ב' בטבת התשס"ט‬
the same or different and each is hydrogen
atom, group B or C1-10 alkyl group
substituted by 1 to 3 substituents selected
from halogen atom and the above-
mentioned group B, Ra9 is C1-4 alkyl group,
and Ra10 and Ra11 are the same or different
and each is hydrogen atom or C1-4 alkyl
group.
__________
]00[]00[
912330
‫כרסום קשיח – פיתול‬
]00[
TORSIONALLY-STIFF END
MILL
]00[
]00[
]10[
]10[
17.06.2004
Int. Cl.8 B23C 005/10
HANITA METAL WORKS LTD.
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
‫חניתה מפעלי מתכת בע"מ‬
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,00988 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
[57] A soft-materials-cutting end mill
being configured to rotate in a cutting
direction about a central, rotational axis
and cut soft materials such as free-cutting
steel, non-ferrous metals, and plastics, said
end mill comprising: a shaft portion being
configured to be gripped by a tool; a
cutting portion comprising a plurality of
flutes and a plurality of cutting teeth; each
pair of adjacent flutes of said plurality of
flutes being configured and disposed to
define a cutting tooth disposed
therebetween; each of said cutting teeth
comprising: a peripheral land surface being
disposed to run substantially along the
outermost periphery of said end mill from
a leading flute disposed ahead of said
peripheral land surface in the cutting
direction to a trailing flute disposed behind
said peripheral land surface in the cutting
direction; a cutting edge being formed at
the intersection of said land surface and
said leading flute; a corner being formed at
the intersection of said land surface and
said trailing flute; said land surface
comprising: a relief section extending from
said cutting edge opposite the cutting
direction; and an arcuate tooth-backing
section extending opposite the cutting
direction from said relief section to said
corner; said tooth-backing section being
substantially longer than said relief
section; in a plane perpendicular to the
rotational axis of said end mill, said corner
being disposed a first distance from the
rotational axis of said end mill and said
cutting edge being disposed a second
distance from the rotational axis of said
end mill, which said first distance being in
the range of sixty to one hundred percent
of the amount of said second distance; and
each of said flutes having a cross-sectional
volume of sufficient size to provide both;
(i) sufficient flow of chips during a cutting
operation; and
(ii) maximized size of said cutting teeth to
extend a substantial portion of said cutting
teeth and their corresponding land surfaces
to at least said first distance from the
rotational axis of said end mill to provide
sufficient material adjacent the outer
periphery of said end mill to both;
(a) maximize the polar moment of inertia
with respect to the rotational axis of said
end mill and thus maximize the torsional
rigidity of said end mill; and maximize the
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3266
resistance to bending of said end mill.
__________
]00[]00[
]00[
METHOD FOR PRODUCING
IRON OXIDE NANO PARTICLES
]00[
]00[
]10[
27.06.2004
Int. Cl.8 B01J 023/74, C01G 049/08
JOMA INTERNATIONAL AS,
NORWAY
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]10[
3267
912012
‫תהליך להכנת חלקיקי ננו של תחמוצת‬
‫ברזל‬
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
December 29, 2008
– ‫ב' בטבת התשס"ט‬
[57] A method for the formation of smallsize iron oxide particles, comprising the
steps of:
(a) preparing a fresh starting aqueous
solution comprising at least one of ferric
ions and complexes thereof, at a
concentration of at least 0.1% w/w iron
and at a pH greater than about 1.5 and
maintaining said freshly prepared solution
at a temperature lower than 55oC for a
retention time in which hydrolysis takes
place, the extent of said hydrolysis being
sufficient to decrease the pH by at least 0.2
units, wherein said time does not exceed
14 days, to form a system containing a
modified solution; and
(b) adjusting the conditions in said system
by at least one of the steps of:
(i) heating the modified solution to elevate
the temperature thereof by at least 10oC;
(ii) elevating the pH of the modified
solution by at least 0.3 units; and
(iii) diluting the modified solution by at
least 20%;
whereby there are formed particles,
wherein the majority of the particles
formed are between 2nm and 500nm in
size.
_________
]00[]00[
]00[
METHOD OF MAKING A
ROTARY TOOL FOR CHIP
REMOVING MACHINING
]00[
]/0[
06.07.2004
0302135-9
]/0[ 28.07.2003
1/1/001-0
0/2002011/
Int. Cl.8 B23P 015/28
SANDVIK INTELLECTUAL
PROPERTY AB, SWEDEN
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]00[
]10[
]10[
[57] A method for manufacturing a rotary
tool for chip removing machining having
at least one external chip flute that extends
in the longitudinal direction of the tool,
comprising the steps of:
(a) preparing a mixture of a cemented
carbide, cermet or ceramics powder and a
carrier, such as a polymer,
(b) placing the mixture in an extruding
machine,
(c) extruding the mixture in a feed
direction (F) through a die (3) forming the
diameter of a mixture body,
December 29, 2008
– ‫ב' בטבת התשס"ט‬
912301
‫שיטה ליצור מכשיר סיבובי עבור עיבוד‬
‫מכני להסרת שבבים‬
]//[
SE
SE
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
(d) allowing the mixture body to exit the
die and pass means (9) to form at least one
chip flute,
(e) displacing the means out of contact
with the mixture body to form an unfluted
shank portion,
(f) allowing the mixture body to solidify
and form a green body,
(g) sintering the green body and then
(h) optionally finish machining such as
grinding characterised in that said at least
one chip flute is formed by means
performing chip removing machining.
3268
___________
]00[]00[
]00[
SYSTEM FOR ANALYZING AND
IMAGING RESPIRATORY
TRACT SOUNDS
]00[
]/0[
]00[
]10[
]01[
]10[
12.01.2003
041494
]/0[ 10.01.2002
Int. Cl.8 A61B 005/08
DEEPBREEZE LTD.
WO/2003/057037
REINHOLD COHN AND
PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
[57] A system (100) for analyzing sounds
in at least a portion of an individual's
respiratory tract comprising:
(a) a plurality of N transducers (105) each
transducer configured to be fixed on a
surface of the individual over the thorax,
the ith transducer being fixed at a location
χi and generating a signal P(χi, t) indicative
of pressure waves at the location χi for i=1
to N;
3269
912179
‫מערכת לניתוח והדמיה של קולות מקנה‬
‫הנשימה‬
]//[
US
‫ אור עיקבא‬,‫דיפבריז בע"מ‬
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
(b) a processor (135) configured to receive
the signals P(χit) and determine an average
acoustic energy P · ƒ (x, t1, t2) at at least
one position χ on the surface over a time
interval from a first time t1 to a second
time t2, P · ƒ being determined in an
algorithm involving at least one of the
signals P(χi, t).
December 29, 2008
– ‫ב' בטבת התשס"ט‬
_________
]00[]00[
]00[
DUAL BANDWIDTH PHASE
LOCK LOOP FILTERS FOR
MULTIMODE RADIOS
]00[
]/0[
]00[
]10[
28.01.2003
10/060547
]/0[ 29.01.2002
Int. Cl.8 H04B 003/04
QUALCOMM INCORPORATED,
U.S.A.
WO/2003/065584
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]01[
]10[
912133
‫מסנני לולאה נועלת מופע בעלי רוחב–פס‬
‫כפול למכשירי רדיו רב–תצורות‬
]//[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
[57] An apparatus for filtering a phase
error signal, comprising: a first filter
subcircuit (202A) receiving a phase error
signal from a phase comparator and
filtering the error signal with the first filter
subcircuit when enabled; a second filter
subcircuit (202B) receiving the phase error
signal from the phase comparator and
filtering the error signal with the second
filter subcircuit when enabled; a first
enable switch (204A) and a second enable
switch (204B) which are activated in
combination to control filtering of the error
signal; a fast acquisition subcircuit (214)
including a fast acquisition enable switch
(218) for changing a charge pump current
through at least one of the first and second
filter subcircuits; and wherein the first
filter subcircuit is enabled by activating a
first combination of the first and second
enable switches and the second filter
subcircuit is enabled by activating a
second combination of the first and second
enable switches.
– ‫ב' בטבת התשס"ט‬
3270
December 29, 2008
__________
]00[]00[
]00[
VENOUS PULSE OXIMETRY
]00[
]/0[
31.01.2003
0202285.3
]/0[ 31.01.2002
1000120/2/
/021020110
Int. Cl.8 A61B 005/145
LOUGHBOROUGH UNIVERSITY
ENTERPRISES LTD., UNITED
KINGDOM
WO/2003/063697
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
]00[
]10[
]01[
]10[
[57] A method of non-invasively
measuring venous oxygen saturation,
3271
915905
‫אוקיסמטריה של דופק ורידי‬
]//[
GB
EP
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
comprising applying a pressure transducer
at a first site on a body having venous and
December 29, 2008 – ‫ב' בטבת התשס"ט‬
arterial systems, applying a drive signal to
the pressure transducer at a predetermined
frequency, to cause a series of pulsations
of a predetermined magnitude in the
venous blood volume in the vicinity of said
first site, the magnitude of the pulsations
being adjusted such that the arterial system
is minimally disturbed, applying an
oximeter device at a second site on the
body, measuring output signals received
from said oximeter device, said output
signals containing a component
representative of the modulation of venous
blood volume due to said pulsations,
deriving a measure of venous oxygen
saturation from the frequency response of
said output signals.
_________
]00[]00[
]00[
BLOWING-AGENT MIXTURES
COMPRISING 1,1,1,3,3PENTAFLUOROBUTANE AND
1,1,1,2,3,3,3HEPTAFLUOROPROPANE
]00[
]/0[
]00[
]10[
27.11.2002
10203779.5
]/0[ 30.01.2002
Int. Cl.8 C08J 009/14
SOLVAY FLUOR GMBH,
GERMANY
WO/2003/064508
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
]01[
]10[
[57] A blowing-agent mixture, containing
or consisting of
(A) 1, 1, 1, 3, 3-pentafluorobutane and
(B) 1, 1, 1, 2, 3, 3-heptafluoropropane and
(C) 1, 1, 1, 2-tetrafluoroethane and/or
1,1,1,3,3-pentafluoropropane, with the
following provisos:
(a) per 100 parts by weight of the blowingagent mixture, 65 to 85 parts by weight are
allotted to the total of constituents (A) and
(B);
(b) per 100 parts by weight of the total of
the constituents (A) and (B) mentioned
under (a), 80 to 95 parts by weight are
allotted to 1,1,1,3,3-pentafluorobutane, and
December 29, 2008
– ‫ב' בטבת התשס"ט‬
915212
–0,0,0,:,: ‫תערובות לקצף הכוללות‬
–0,0,0,0,:,:,:–‫פנטאפלואורובוטאן ו‬
‫הפטאפלואורופרופאן‬
]//[
DE
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
the remainder of the total of (A) and (B) is
formed by 1, 1, 1, 2, 3, 3, 3heptafluoropropane and
(C) 1, 1, 1, 2-tetrafluoroethane and/or 1, 1,
1, 3,3-pentafluoropropane, with the
following provisos:
(a) per 100 parts by weight of the blowingagent mixture, 65 to 85 parts by weight are
allotted to the total of constituents (A) and
(B);
(b) per 100 parts by weight of the total of
the constituents (A) and (B) mentioned
under (a), 80 to 95 parts by weight are
allotted to 1, 1, 1, 3, 3-pentafluorobutane,
and the remainder of the total of (A) and
3272
(B) is formed by 1, 1, 1, 2, 3, 3, 3heptafluoropropane;
(c) per 100 parts by weight of the blowingagent mixture, at least 15 parts by weight
are allotted to constituent (C).
_________
]00[]00[
]00[
POURING SPOUT FOR LIQUID
CONTAINERS AND LIQUID
CONTAINERS CONSTRUCTED
THEREWITH
]00[
]/0[
]00[
]10[
30.01.2003
10/066746
]/0[ 06.02.2002
Int. Cl.8 B65D 005/72
YOAV TIKOCHINSKY
ISHAI OREN
ERAN ZUR
]01[
]10[
WO/2003/066453
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
[57] A pouring spout (7) for a liquid
container (2) comprising a non-resilient,
pliable plastic sheet (3, 4) defining one
side of the pouring spout and movable
towards and away from an opposite side of
the pouring spout to close and open the
pouring spout for dispensing liquid
therethrough; said non-resilient, pliable
plastic sheet being dimensioned such that
when liquid is to be dispensed, the nonresilient, pliable plastic sheet is freely
3273
915575
‫זרבוביות מזיגה למכלי נוזלים ומכלי נוזלים‬
‫הבנויים עמה‬
]//[
US
‫ תל אביב‬,‫יואב טיקוצ'ינסקי‬
‫ תל אביב‬,‫ישי אורן‬
‫ ירושלים‬,‫ערן צור‬
,‫) בע"מ‬066.( ‫ארליך‬.‫אי‬.‫ג'י‬
,00 ‫רחוב מנחם בגין‬, 0. ‫ קומה‬,‫מגדל אילון‬
‫רמת גן‬
movable away from said opposite side by
the liquid to permit the liquid to be
dispensed, and when liquid is not being
dispensed through the pouring spout, the
non-resilient, pliable plastic sheet moves
towards and into contact with said opposite
side and adheres to said opposite side
solely by surface tension of the liquid to
produce a liquid dependent self-sealing
action with respect to said pouring spout.
December 29, 2008
– ‫ב' בטבת התשס"ט‬
_________
]00[]00[
]00[
SYSTEM FOR ASSIGNING A
STANDARDIZED UNIQUE
IDENTIFICATION NUMBER TO
FEET AND SHOES
]00[
]00[
]10[
]10[
]10[
02.08.2004
Int. Cl.8 A63D 001/06
FITRACKS LTD.
NOAM DANENBERG
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[57] A system for establishing a
standardized unique identification number
for feet, shoes, and shoe lasts said system
comprising:
(a) a central server;
(b) an electronic measuring device for
capturing digital images of shoe lasts,
wherein all the relevant data concerning
the dimension and shape of each of said
shoe lasts is transmitted to said server, is
stored in the memory of said server, and is
December 29, 2008
– ‫ב' בטבת התשס"ט‬
915522
‫מערכת למתן מספר זיהוי סטנדרטי וייחודי‬
‫לרגליים ולנעליים‬
‫ רעננה‬,‫פיטרקס בע"מ‬
‫נועם דננברג‬
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
identified by a unique scan number
generated by said server;
(c) an electronic measuring device for
capturing digital images of the feet of a
purchaser, wherein all the relevant data
concerning the dimensions and shape of
each of said feet is transmitted to said
server, is stored in the memory of said
server, and is identified by a unique scan
number generated by said server; and
(d) communication means linking said
server to said electronic measuring
3274
devices; wherein, within said memory of
said server is stored a predetermined set of
unique identification numbers (UIN) that
are determined according to selected
criteria, each UIN representing a specific
range of measurement values; and
dedicated software, which compares said
relevant data concerning the dimensions
and shape of each of said shoe lasts and
said feet with said set of UINs and assigns
to each of said scan numbers the UIN that
most closely corresponds to said relevant
data identified by said scan number.
_________
]00[]00[
]00[
PROTECTED DIHYDROXY ACID
DERIVATIVES AND PROCESSES
FOR MAKING A
DIPHENYLPHOSPHINE OXIDE
INTERMEDIATE THERETO
]00[
]/0[
]00[
]20[
]10[
15.02.2000
9903472.0
]/0[ 17.02.1999
Int. Cl.8 C07D 405/06
DIVISION FROM 144793
ASTRAZENECA AB, SWEDEN
SHIONOGI & COMPANY LIMITED,
JAPAN
WO/2000/049014
S. HOROWITZ & CO.,
ZION HOUSE,
41-45 ROTHSCHILD BLVD.,
TEL AVIV 65784
]01[
]10[
915503
‫נגזרות חומצה דיהידרוקסית מוגנות‬
‫ותהליכים להכנת חומר ביניים אוקסיד‬
‫דיפנילפוספין עבורן‬
]//[
GB
,'‫ הורוביץ ושות‬.‫ש‬
‫ תל‬,40-4. ‫ שדרות רוטשילד‬,‫בית ציון‬
‫אביב‬
[57] A compound of the formula
wherein
P1 and P2 are
alcohol protecting groups, or P1 and P2,
taken together, form a 1, 3-diol protecting
group; and
P3 is a carboxylic acid protecting group.
__________
3275
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[]00[
]00[
SAMPLE DIMENSION
MEASURING METHOD AND
SCANNING ELECTRON
MICROSCOPE
]00[
]/0[
]00[
]10[
19.05.2003
2002-143960 ]/0[ 20.05.2002
Int. Cl.8 G01B 015/04
HITACHI HIGH-TECHNOLOGIES
CORPORATION, JAPAN
WO/2003/098149
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]01[
]10[
915313
‫שיטה למדידת ממדי דגימה ומיקרוסקופ‬
‫אלקטרוני סורק‬
]//[
JP
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
[57] A scanning electron microscope
comprising an electron source (1), a
focusing lens (5) for focusing an electron
beam (4) emitted from said electron
source, a scan deflector (11) for scanning
said electron beam on a sample (9), a
detector (12) for detecting electrons (10)
emitted from said sample, and an operation
unit (30) for measuring dimensions of
patterns on said sample on the basis of the
output of said detector, wherein said
operation unit includes a storage medium
for storing measured value data obtained
when patterns at plural sites on said sample
are measured plural measurement times,
wherein mean value of variance
representative of difference between the
measured value data in the plural
measurement times and a function
representative of reduction of the measured
value with change of the measurement
times is calculated so that the function is
formed to make the mean value small, and
wherein the formed function is stored with
respect to each kind of the patterns and a
dimension of said pattern before it reduces
is measured on the basis of the stored
function.
– ‫ב' בטבת התשס"ט‬
3276
December 29, 2008
__________
]00[]00[
]00[
DAMPING ELEMENT FOR A
SHOE
]00[
]/0[
]00[
]10[
15.04.2003
20206927.3
]/0[ 01.05.2002
Int. Cl.8 A43B 013/18, 013/20
PUMA AKTIENGESELLSCHAFT
RUDOLF DASSLER SPORT,
GERMANY
WO/2003/092423
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
]01[
]10[
3277
915010
‫אלמנט מלחלח לנעל‬
]//[
DE
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
[57] Damping element (1) for a shoe, in
particular for a sports shoe, consisting of at
least one first element (2) which
essentially extends over a predetermined
height (H) in a loading direction (R) in the
unladen state of the damping element and
embodied as a hollow body, defines a
receiving space (3) into which a
corresponding second element (4) of
smaller dimensions in cross-section than
the first element, can at least partly
penetrate, the second element essentially
extending over a predetermined height (h)
in the loading direction (R) in the unladen
state of the damping element and being
arranged coaxially with the first element,
wherein the second element is also
embodied as a hollow body and wherein
the two associated elements are connected
to one another through an elastic
connecting portion (5) which only extends
between the first element and the second
element, characterised in that the elements
form a gas-tight chamber.
_________
]00[]00[
]00[
PORTABLE DISPLAY SYSTEM
]00[
]/0[
]00[
]10[
]01[
]10[
14.03.2003
2376896
]/0[ 15.03.2002
Int. Cl.8 G09F 003/06, 021/02
PIXMAN CORPORATION, CANADA
WO/2003/079319
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
911751
‫מערכת תצוגה נישאת‬
]//[
CA
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,00988 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
[57] A portable display system
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3278
comprising a video image display (70) for
displaying a video image, said video image
display being disposed on a support
structure mountable on a human body; a
storage device for storing at least one
video program including data for
generating said video image; and a video
drive (110) connected to said video image
display and said storage device for
receiving said at least one video program,
generating said image, and sending signals
to said video image display to display said
3279
video image display; characterized in that
said support structure is mountable on the
back of said human body and comprises: a
general support frame (20) having shoulder
straps (100, 102) for strapping said frame
on said human body; and a base support
member (30) attached to said frame, and
an elongated support member (50) is
attached at one end to said base support
member (30), and at the other end to said
video image display (70).
December 29, 2008
– ‫ב' בטבת התשס"ט‬
___________
]00[]00[
]00[
PACIFIER
]00[
]/0[
22.09.2004
10212847.2
]/0[ 22.03.2002
0100110121
0021220110
Int. Cl.8 A61J 017/00
NOVATEX GMBH, GERMANY
WO/2003/079960
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
]00[
]10[
]01[
]10[
911220
‫מוצץ‬
]//[
DE
DE
,'‫זליגסון גבריאלי ושות‬
‫ תל אביב‬,0409 .‫ד‬.‫ ת‬, :0 ‫רח' יבנה‬
[57] A teat, comprising a body (1) as
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3280
well as a shaft (2), whereby the body is
provided with a recess (3) which extends
longitudinally along the entire length of
the teat, wherein the recess, when viewed
in a longitudinal section, tapers off flat
towards the front free end of the body and
wherein the body is conically tapered
towards the free front end, when seen from
above.
_________
]00[]00[
]00[
TEAT CUP CARRIER
]00[
]/0[
]00[
]10[
28.09.2004
1024522
]/0[ 13.10.2003
Int. Cl.8 A01J 005/00
LELY ENTERPRISES AG,
SWITZERLAND
REINHOLD COHN AND
PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
]10[
[57] An assembly comprising a teat cup
carrier and a movable feed platform
characterized in that, said teat cup carrier
3281
911513
‫נשא של כוס לפטמה‬
]//[
NL
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
is freely movable relative to the feed
platform and is a self-propelled
autonomous mobile teat cup-carrying robot
December 29, 2008
– ‫ב' בטבת התשס"ט‬
(424), comprising a control unit for
controlling the functioning of the mobile
teat-cup-carrying robot including
cooperating with the movable feed
platform.
________
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3282
]00[]00[
]00[
PRODUCTION OF
CRYSTALLINE MATERIALS BY
USING HIGH INTENSITY
ULTRASOUND
]00[
]00[
]10[
08.05.2003
Int. Cl.8 B01D 009/00, B01J 003/08
ACCENTUS PLC, UNITED
KINGDOM
WO/2003/101577
REINHOLD COHN AND
PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
]01[
]10[
[57] A method for production of
crystalline material, the method
comprising forming a saturated solution of
the material, gradually changing the
temperature of the solution so it becomes
supersaturated, and subjecting the solution
to irradiation by high-intensity ultrasound,
wherein the method involves:
(a) finding the temperature which provides
the least degree of supersaturation at which
911331
–‫ייצור חומרים גבישיים באמצעות גלים על‬
‫קוליים בעוצמה גבוהה‬
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
crystals form from the solution on brief
application of ultrasound, and then
(b) subjecting the solution while it is
supersaturated, at this temperature, to
ultrasound for a brief interval such that
crystals are formed, and then
(c) allowing the crystals in the solution to
grow without irradiation by continuing
gradually to change the temperature of the
solution.
_________
]00[]00[
]00[
CONTROLLED ATMOSPHERIC
PRESSURE RESIN INFUSION
PROCESS
]00[
]/0[
]00[
]10[
]01[
]10[
28.05.2003
60/384154
]/0[ 29.05.2002
Int. Cl.8 B29C 070/44
THE BOEING COMPANY, U.S.A.
WO/2003/101708
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
3283
911131
‫תהליך מבוקר בלחץ אטמוספירי להזרקת‬
‫שרף‬
]//[
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
[57] In a resin infusion process wherein
resin flows into a prrform within at least
one vacuum bag to form a composite part
having a high fiber volume fraction, the
improvement comprising: providing a
resin inlet reservoir; reducing the pressure
in the resin inlet reservoir to below
atmospheric pressure; and while
maintaining the pressure in the resin inlet
reservoir into the preform to maintain a net
compaction pressure on the preform
adequate to retain compaction at a
predetermined level, thereby allowing
manufacture of a quality composite part.
____________
]00[]00[
913957
‫שיטה ליצור קרום תרמופלסטי בעל‬
‫ הקרום הנוצר ושימוש בו‬,‫כיווניות נמוכה‬
]00[
METHOD FOR THE
PRODUCTION OF LOW
ORIENTATION
THERMOPLASTIC FILM, THE
FILM PRODUCED THUS AND USE
THEREOF
]00[
]/0[
]00[
]10[
13.06.2003
10236045.6
]/0[ 06.08.2002
]//[
Int. Cl.8 B29C 047/90, B32B 003/71500
ROHM GMBH & CO. KG,
GERMANY
WO/2004/014634
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
]01[
]10[
December 29, 2008
– ‫ב' בטבת התשס"ט‬
DE
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
3284
[57] Process for producing films in the
thickness range from 20 μm to 1000 μm
from thermoplastics through extrusion of
the plastic through a slot die (4) and
smoothing the melt film (5) emerging from
the slot die in a polishing stack, composed
of at least three or four rollers, where a
first roller pair (1, 2) forms a polishing nip
to receive the melt film and, downstream
of this polishing stack nip, the melt film is
passed through a subsequent polishing nip
(3, 31) or through a subsequent pressure
nip, characterized in that the ratio between
the width of the die gap and the film
thickness is in the range from 1 : 1 to 6 : 1,
and in that the quotient obtained by
dividing the film web speed in the
subsequent polishing nip or in the
subsequent pressure nip by the film web
speed in the polishing nip formed by the
roller pair (1, 2) is in the range from 0.8 to
1.05.
_________
]00[]00[
913291
‫טיפול בלחות בסיבים הידרופיליים‬
]00[
MOISTURE-MANAGEMENT IN
HYDROPHILIC FIBERS
]00[
]00[
]10[
]10[
15.11.2004
Int. Cl.8 B32B 005/00, 005/08, D01D 001/00, D03D 011/00
DELTA GALIL INDUSTRIES LTD.
‫ תל אביב‬,‫דלתא גליל תעשיות בע"מ‬
YECHIEL NAOR, YEHUDA
‫ מונדר מואיס‬,‫ יהודה ברק‬,‫יחיאל נאור‬
BARAK, MONDER MOIS
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]10[
3285
December 29, 2008
– ‫ב' בטבת התשס"ט‬
[57] A nano technology process for the
manufacture of a fabric comprising fibers,
said fibers being essentially hydrophilic,
with improved moisture-management
performance, said process comprising the
step of individually encapsulating said
fibers with a nano chemistry water
repellant surface.
_________
]00[]00[
]00[
DRUG DELIVERY ASSEMBLY
]00[
]/0[
]00[
]10[
16.05.2003
0211753.9
]/0[ 22.05.2002
Int. Cl.8 A61M 015/00
CHIESI FARMACEUTICI S.P.A.,
ITALY
WO/2003/097140
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACJAYAL
69710
]01[
]10[
December 29, 2008
– ‫ב' בטבת התשס"ט‬
913571
‫התקן למתן תרופה‬
]//[
GB
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
3286
[57] Drug delivery assembly comprising:
a pressurized container (10) holding a drug
formulation with a propellant; a sealed
enclosure (12) which surrounds the
container and which is made of a moisture
impermeable or substantially moisture
.
impermeable material; and a gas adsorbing
material (24) within the enclosure, wherein
the gas adsorbing material is a
microporous zeolite or molecular sieve
having a pore opening size comprised
between 4 Å and 20 Å.
_________
]00[]00[
913011
‫טבליה של שכבת רוקחות המצופה בציפוי‬
‫ממסך ובציפוי ממרק‬
]00[
PHARMACEUTICAL FILM
TABLET COATED WITH AN
OPACIFYING COAT AND A
POLISH COAT
]00[
]/0[
]00[
]10[
]01[
]10[
30.06.2003
60/395090
]/0[ 10.07.2002
]//[ US
Int. Cl.8 A61K 009/00, 009/20, 009/30, 031/40, C07D 207/06
PFIZER PRODUCTS, INC., U.S.A.
WO/2004/006895
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
[57] A pharmaceutical film coated tablet
consisting of a tablet core, an opacifying
coat and a polish coat wherein the tablet
core consists of 0.341 mg lasofoxifene
3287
tartrate, 70.159 mg anhydrous lactose,
25.000 mg of microcrystalline cellulose,
3.000 mg croscarmellose sodium, 0.500
mg silicon dioxide and 1.000 mg
December 29, 2008
– ‫ב' בטבת התשס"ט‬
magnesium stearate; the opacifying coat is
4.000 mg of Opadry II® , wherein the
Opadry II® consists of 1.6 mg lactose
monohydrate, 1.12 mg hydroxypropyl
methyl cellulose 2910-15 cP, 0.94 mg
titanium dioxide, 0.32 mg triacetin and
0.02 mg FD&C Yellow No. 6 Aluminium
Lake 15%-18%; and the polish coat is
0.500 mg of Opadry Clear® , wherein the
Opadry Clear® consists of 0.45 mg
hydroxypropyl methylcellulose 2910-15cP
and 0.05 mg triacetin.
_________
]00[]00[
]00[
VEHICLE MOUNTED NIGHT VISION
IMAGING SYSTEM AND METHOD
]00[
]/0[
]00[
]10[
]01[
]10[
05.08.2003
WO/2004/013654 ]/0[ 05.08.2002
Int. Cl.8 G01S 017/93
ELBIT SYSTEMS LTD.
WO/2004/000136
BOROCHOV, KORAKH, ELIEZRI &
CO.,
15TH FLOOR, ATIDIM TOWER,
KIRYAT ATIDIM,
P.O.B. 58100,
TEL AVIV 61580
[57] An imaging system (10) for
mounting on a vehicle (20), comprising: a
light source (30), for providing a pulse-like
light energy, said pulse-like light energy
defining a substantial pulse width, T Laser;
and a camera (40), for receiving said pulse
like light energy reflected from objects,
said camera being operational for a gated
detection of said pulse-like light energy
reflected from objects located within a
depth of field to be imaged, said depth of
field having a minimal range, Rmin, said
camera starting to detect light energy after
a delay timing substantially given by the
time it takes the substantial pulse width of
said pulse-like light energy to reach said
minimal range and complete reflecting
back to said camera from said minimal
range; said system being characterized in
that: said gated detection of said pulse-like
light energy reflected from objects defines
an ON time span, TII, during which said
December 29, 2008
– ‫ב' בטבת התשס"ט‬
913331
‫מערכת ושיטה להדמיית ראיית לילה על‬
‫גבי רכב‬
]//[
US
‫ חיפה‬,‫אלביט מערכות בע"מ‬
,'‫בורוכוב קורח אליעזרי ושות‬
-‫ תל‬,.80// .‫ד‬.‫ ת‬, ‫מגדל כלל עתידים‬
‫אביב‬
camera receives reflections from objects,
an OFF time span, Toff, between two
adjacent ON time spans, during which said
camera does not receive reflections from
objects and a synchronization timing
between said ON time span and the time
said pulse-like light energy reflects back
from objects located within said depth of
field to be imaged; wherein said
synchronization timing defines the amount
of overlap between said ON time span and
said pulse-like light energy reflected from
objects, and said camera being operational
for creating a sensitivity as a function of
range for said imaging system, through
said synchronization timing such that said
overlap between said pulse like light
energy reflected from objects and said ON
time span increases as a function of range
up to an optimal range, Ro, of said depth of
field to be imaged, thereby increasing the
portion of said substantial pulse width of
3288
said pulse-like light energy reflected from
objects located between said minimal
range and said optional range reaching said
camera during said ON time span.
_________
]00[]00[
]00[
HIGHLY STEREOREGULAR
POLYPROPYLENE WITH
IMPROVED PROPERTIES,
METHOD FOR PREPARATION
AND MULTILAYER LAMINATED
ARTICLES PREPARED
THEREFROM
]00[
]/0[
30.07.2003
02017287.0
]/0[ 01.08.2002
219002//0
1020120110
Int. Cl.8 C08F 002/00, 010/06
BASELL POLIOLEFINE ITALIA
S.P.A., ITALY
WO/2004/013193
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
]00[
]10[
]01[
]10[
[57] Propylene polymers having the
following features:
(1) a content of isotactic pentads (mmmm),
measured by NMR, higher than 97%,
911577
‫פוליפרופילן סטריורגולרי באופן מיוחד בעל‬
‫ שיטה להכנתו ודגמים‬,‫תכונות משופרות‬
‫מצופים על ידו‬
]//[
EP
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
(2) a molecular weight distribution,
expressed by M /Mn ratio, equal to or
higher than 6; and
(3) a value of M : / M ratio equal to or
lower than 5.5.
________
3289
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[]00[
]00[
IMAGING SYSTEM AND
METHOD FOR BODY
CONDITION EVALUATION
]00[
]00[
]10[
]01[
]10[
27.07.2003
Int. Cl.8 G06T 007/00
VET-TECH LTD.
WO/2004/012146
REINHOLD COHN AND
PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
911137
‫מערכת הדמיה ושיטה להערכת מצב הגוף‬
‫ קצרין‬,‫טק בע"מ‬-‫וט‬
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
[57] An imaging method for use in
automatic monitoring the body condition
of an animal, the method comprising:
(i) imaging a predetermined region of
interest on the animal body, and generating
data indicative thereof;
(ii) processing the generated data to obtain
a three-dimensional representation of the
region of interest;
(iii) analyzing said three-dimensional
representation to determine a
predetermined measurable parameter
indicative of a surface relief of the region
of interest indicative of the body condition.
_________
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3290
]00[]00[
]00[
POLYTHIOPHENE
FORMULATIONS FOR IMPROVING
ORGANIC LIGHT-EMITTING
DIODES
]00[
]/0[
]00[
]10[
]10[
08.02.2005
102004006583.7 ]/0[ 10.02.2004
Int. Cl.8 C08L 065/00, H01L 051/30
H.C. STARCK GMBH, GERMANY
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
911053
‫פורמולציות של פוליתיאופן לשיפור‬
‫דיודות אורגניות הפולטות אור‬
]//[
DE
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
[57] Formulation containing at least one
polythiophene containing repeating units
of the formula
wherehin
X denotes –(CH2)x-CR1R2-(CH2)y-,
wherein
R1 denotes –(CH2)s-O-(CH2)p-R3,
where
R3 denotes SO3M+ or COO-M+, where M+
denotes H+, Li+, Na+, K+, Rb+, Cs+ or
NH4+,
s is an integer from 0 to 10 and
p is an integer from 1 to 18,
or denotes –(CH2)q-O(CH2CH2O)rR4,
wherein
R4 denotes optionally substituted C1-C4alkyl,
q denotes an integer from 0 to 10 and
r denotes an integer from 1 to 12,
R2 independently of R1 denotes H, a linear
or branched optionally substituted C1-C20alkyl radical, a C6-C14-aryl radical or –
(CH2)s-O-(CH2)pR3 or –(CH2)qO(CH2CH2O)rR4, where R3, s, p, R4, q and
r have the meanings given for R1, and x, y
in each case independently of one another
denote an integer from 0 to 9, and at least
one further polymer containing SO3-M+ or
COO-M+ groups, where M+ denotes H+,
Li+, Na+, K+, Rb+, Cs+ or NH4+.
_________
3291
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[]00[
911112
‫התקן עיגון ויישומו‬
]00[
ANCHORING DEVICE AND ITS
IMPLEMENTATION
]00[
]/0[
15.08.2003
2002951024
]/0[ 23.08.2002
]//[ AU
0110/00000
0120120110
AU
011//1000/
0/2102011/
AU
Int. Cl.8 A61B 017/00, 017/04, A61F 002/08
KVINNO CENTRE PTY LTD.,
AUSTRALIA
PETER EMMANUEL PETROS
WO/2004/017845
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
,4./87 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬
JERUSALEM 91450
]00[
]10[
]10[
]01[
]10[
[57] A tissue anchor (15) formed of a
material which is compatible for location
in human and/or animal muscle and/or
ligament tissue, the anchor comprising a
base (53) and a head (57), the head having
a configuration to facilitate insertion of the
head into the tissue and retention of the
head in the tissue once inserted, the base
December 29, 2008
– ‫ב' בטבת התשס"ט‬
formed with an aperture (61) adapted to
receive a length of a filamentary element
(13) and permit slidable movement of the
filamentary element through the aperture
in one direction but to restrict movement
of the filamentary element through the
aperture in the opposite direction.
3292
_________
]00[]00[
]00[
BUFFER STORAGE UNIT FOR
TUBES, ESPECIALLY CARDBOARD
TUBES FOR THE PRODUCTION OF
LOGS
]00[
]/0[
]00[
]10[
]01[
]10[
17.10.2003
FI2002A000219 ]/0[ 08.11.2002
Int. Cl.8 B65G 047/51
FABIO PERINI, ITALY
WO/2004/041689
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
[57] Store for stocking tubes therein
comprising: means (4) for feeding tubes
(1) into the store, and means (7) for
unloading the tubes therefrom, the store
being located between said supply means
and said unloading means; a plurality of
supports (8) each of which defines a plane
inclined towards said unloading means and
able to receive a plurality of tubes from
said supply means: each of said supports
being movable between a stand-by position
3293
910275
‫ ביחוד‬,‫יחידת חיץ לאיחסון שפופרות‬
‫שפופרות קרטון לייצור קורות‬
]//[
IT
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
where it is empty, a position of transit of
tubes in which it defines an inclined plane
which connects said tube-supplying means
to said tube-unloading means, and a stock
position in which it is full up; each of said
supports consisting of a central bar (80) or
cross-piece to which more rods (81) are
fixed orthogonally thereto, characterized in
that the said supports are connected to each
other via two open side chains (85) and the
December 29, 2008
– ‫ב' בטבת התשס"ט‬
said side chains are connected to said
central bars on cross-pieces.
___________
]00[]00[
]00[
TEXTILE CONSTRUCTION
]00[
]/0[
]00[
]10[
02.03.2005
2459451
]/0[ 02.03.2004
Int. Cl.8 A47G 009/02
ROBERT J. MACDONALD,
CANADA
DANIEL FREIMANN & CO.,
5 DROYANOV ST., 10TH FLOOR ,
TEL AVIV 63143
]10[
[57] A mattress pad (1) having:
(i) a central rectangular panel (2)
comprising a plurality of layers including
an upper textile layer, a lower textile layer,
and a batting layer quilted to at least one of
the upper and lower textile layers, said
central panel having a length of about the
December 29, 2008 – ‫ב' בטבת התשס"ט‬
910273
‫מבנה טקסטיל‬
]//[
CA
,'‫דניאל פריימן ושות‬
‫ תל אביב‬,0/ ‫ בית כלל קומה‬.‫דרויאנוב‬
length of a selected mattress plus twice the
depth thereof, said central panel having a
lengthwise direction;
(ii) side panels (3) depending from said
central panel, comprising a single layer of
a textile fabric, said side panels having a
3294
width 1.2 to 2 times the depth of said
selected mattress; and
(iii) end panels having end panel ends
defined by the ends of said central panel,
said end panel ends being arcuate, said
side panels being joined to said end panels
by seams extending in a transverse
direction in relation to the lengthwise
direction of said rectangular central panel.
________
3295
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[]00[
]00[
ALIGNMENT AND POSITIONING
SYSTEM FOR INSTALLING A
FUEL INJECTOR IN A GAS
TURBINE ENGINE
]00[
]/0[
]00[
]10[
]10[
]10[
30.03.2005
60/561116
]/0[ 09.04.2004
Int. Cl.8 F02C 007/22
DELAVAN INC., U.S.A.
DANIEL E. BLEEKER
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
[57] A fuel injector (100) for a gas
turbine engine, the gas turbine engine
having an engine case that includes a
reception bore for accommodating the fuel
injector, the fuel injector comprising: a
fuel inlet fitting (112) having an annular
mounting flange (118) defining opposed
upper (118a) and lower end (118b)
surfaces and a generally cylindrical body
portion (115) which depends axially from
the lower end surface of the mounting
flange, the fuel inlet fitting having a pair of
910032
‫מערכת להיערכות ומיקום עבור התקנת‬
‫מזרק דלק בתוך מנוע מסוג טורבינת גז‬
]//[
US
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
,4./87 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬
alignment structures depending from the
lower end surface of the mounting flange
and extending radially outwardly from the
body portion of the fuel inlet fitting,
wherein one of the alignment structures
(114, 116) has a camming facet that is
adapted and configured to interact with an
edge of the reception bore of the engine
case, so as to facilitate pivotal movement
of the fuel injector into an installed
position within the reception bore of the
engine case.
________
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3296
]00[]00[
]00[
MULTISTAGE AIR CLEANER
INCLUDING PULSE CLEANING
SYSTEM
]00[
]/0[
02.06.2000
09/325697
]/0[ 03.06.1999
1/9000/00
1020020///
Int. Cl.8 B01D 017/00, 046/00, 053/00
DIVISION FROM 146813
DONALDSON COMPANY, INC.,
U.S.A.
WO/2000/074818
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]00[
[62]
]10[
]01[
]10[
[57] A filter mountable in and removable
from an assembly, the fiter comprising:
(a) a closed frame structure and an open
frame structure;
(b) first (97) and second (98) filtration
media panels mounted in extension
between the closed frame structure and the
open frame structure;
(i) the first and second filtration media
panel forming a V-shape with an angle of
at least about 5 degrees;
3297
910013
‫מנקה אויר רב שלבים הכולל מערכת ניקוי‬
‫פועמת‬
]//[
US
US
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
(ii) the first and second filtration media
panels and the open frame structure
defining an air flow aperture;
(c) the closed frame structure defining a
first receiver indent oriented between the
first filtration media panel and the second
filtration media panel, the first receiver
indent sized and positioned to receive a
first interlocking member of the assembly
in which the filter is mounted in use.
December 29, 2008
– ‫ב' בטבת התשס"ט‬
5132132
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
5‫שטרם פורסמו‬
_________
]00[]00[
]00[
MODULAR SURFACE MOUNT
FLUID SYSTEM
]00[
]/0[
25.11.2003
60/429088
]/0[ 26.11.2002
2190///10
0/20020110
Int. Cl.8 F15B 013/00
SWAGELOK COMPANY, U.S.A.
WO/2004/048784
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
]00[
]10[
]01[
]10[
913033
‫מערכת נוזלים מודולרית הנטענת על‬
‫משטח‬
]//[
US
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
[57] A bridge fitting (50) for use in a
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3298
fluid manifold system (10) for being in
fluid communication with two or more
surface mounted fluid components having
an inlet port and an adjacent outlet port,
the bridge fitting comprising: a housing
(52) comprising a first port (54) disposed
at a first end portion of the housing
connected to a second port (56) disposed at
a second end portion of the housing, with
an internal fluid passageway joining said
first port and said second port and spacing
the first port and the second port apart; a
first projection extending from less than an
entirety of a substantially planar surface of
the first end portion of the housing and a
second projection extending from less than
an entirety of a substantially planar surface
of the second end portion of the housing,
wherein at least one of the first and second
projections is spaced apart from the first
and second ports.
_________
3299
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[]00[
911722
‫מערכת ושיטה לדחיפת מידע ממערכת‬
‫מארחת להתקן תקשורת נתונים נייד‬
]00[
SYSTEM AND METHOD FOR
PUSHING INFORMATION FROM
A HOST SYSTEM TO A MOBILE
DATA COMMUNICATION
DEVICE
]00[
]/0[
]00[
]20[
]10[
28.05.1999
09/087623
]/0[ 29.05.1998
]//[ US
Int. Cl.8 G06F 013/00, G06Q 001/000000 H04L 012/28, 012/58, 029/06
DIVISION FROM 139839
RESEARCH IN MOTION LIMITED,
CANADA
WO/1999/063709
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26 A HABARZEL STREET
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]01[
]10[
[57] A method of replicating electronic
messages between a messaging server and
a plurality of wireless mobile
communication devices using a redirection
server program, comprising the steps of:
receiving electronic messages at the
messaging server and storing the
electronic messages in a message store
having a plurality of mailboxes, wherein
each of the plurality of wireless mobile
communication devices is associated with
at least one of the plurality of mailboxes;
and without receiving a request to
download the received electronic messages
at the messaging server, continuously
pushing copies of the received electronic
messages from the mailboxes associated
with each of the wireless mobile
communication devices to the wireless
mobile communication devices, wherein
the continuously pushing step includes the
steps of:
December 29, 2008
– ‫ב' בטבת התשס"ט‬
(A) for each of the wireless mobile
communication devices, the redirection
server program registering with a software
interface associated with the messaging
server to automatically receive a
notification signal when an electronic
message is received and stored in the
mailbox associated with the wireless
mobile communication device;
(B) detecting the received electronic
message at the redirection server program
by receiving the notification signal from
the messaging server's software interface;
and
(C) upon receipt of the notification signal,
the redirection server program accessing
the mailbox associated with the wireless
mobile communication device and
transmitting a copy of the received
electronic message to the wireless mobile
communication device.
3300
________
]00[]00[
911952
‫בקר מגנטי לזרימת נוזל‬
]00[
MAGNETIC FLUID FLOW
CONTROLLER
]00[
]00[
]10[
]10[
14.06.2005
Int. Cl.8 F16K 031/66, G02F 001/09, G09F 009/00
YOSSI DANA
‫ ירושלים‬,‫יוסי דנה‬
BLUM, GADOR & CO.,
,'‫ גדור ושות‬,‫בלום‬
53 HASHALOM RD.,
,‫ מגדל הורד‬0: ‫ קומה‬,.: ‫דרך השלום‬
GIVATAYIM 53454
‫גבעתיים‬
[57] A magnetic flow controller (10)
comprising: a fluid flow passage (12)
having an inlet (14) and an outlet (16); a
stop member (20) mounted across said
inlet; and a displaceable member (30)
disposed in said passage adjacent said stop
member, wherein at least one of said stop
member and said displaceable member
includes a magnet (34), and the other of
said stop member and said displaceable
member includes a ferromagnetic portion,
so as to create a magnetic force, acting on
said displaceable member, sufficient to
cause the displaceable member to engage
3301
said stop member so as to close and seal
the flow passage; said displaceable
member and said flow passage being
configured and adapted to maintain sealing
engagement (22) for a distance while said
displaceable member is urged through said
flow passage towards said outlet by a force
created by a pressure differential between
a pressure at the inlet and a pressure at the
outlet, said distance being sufficient to
permit said displaceable member to
accelerate to a desired speed before said
displaceable member releases said sealing
engagement to unseal said flow passage.
December 29, 2008
– ‫ב' בטבת התשס"ט‬
_________
]00[]00[
911215
‫תכשירים רוקחיים לטיפול אנטי ויראלי‬
‫באמצעות צירופים‬
]00[
PHARMACEUTICAL
COMPOSITIONS FOR
COMBINATION ANTIVIRAL
THERAPY
]00[
]/0[
13.01.2004
60/440308
]/0[ 14.01.2003
]//[ US
219001002
002102011/
US
Int. Cl.8 A61K 031/395, 031/66, A61P 031/18, C07D 411/02, 473/00, C07F 009/38
GILEAD SCIENCES, INC., U.S.A.
WO/2004/064845
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26 A HABARZEL STREET
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]00[
]10[
]01[
]10[
[57] Use of a therapeutically effective
amount of a composition comprising [2-(6amino-purin-9-yl)-1-methylethoxymethyl]-phosphonic acid
diisopropoxycarbonyloxy-methyl ester
fumarate (tenofovir disoproxil fumarate)
December 29, 2008
– ‫ב' בטבת התשס"ט‬
and (2R, 5S, cis)-5-amino-5-fluoro-1-(2hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)pyrimidin-2-one (emtricitabine) in the
manufacture of a medicament for the
treatment of a patient in need of antiviral
therapy consisting of anti-HIV therapy.
3302
‫ לתקנות‬23 ‫פירוט זה נבחן בהתאם לתקנה‬
1386 – ‫ תשכ"ח‬5‫הפטנטים‬
This specification was examined in accordance
with regulation 35 of the Patent Regulations,
5728 - 1968
_________
]00[]00[
911399
‫התקן לבדיקת תרופות רב שכבתי ורב‬
‫ערוצי‬
]00[
MULTICHANNEL AND
MULTILAYER
PHARMACEUTICAL TESTING
DEVICE
]00[
]/0[
]00[
]10[
]01[
]10[
25.11.2003
10/338093
]/0[ 07.01.2003
]//[ US
Int. Cl.8 B01L 003/00, B29C 065/00, B32B 018/00, C03B 029/00
IBM CORPORATION, U.S.A.
WO/2004/063103
IBM LABORATORIES,
,‫מעבדות יבמ מחלקת קנין רוחני‬
HAIFA UNIVERSITY,
‫ חיפה‬,‫אוניברסיטת חיפה הר הכרמל‬
HAIFA 31905
[57] A method of forming a plate for the
substantially direct passage through a set
of apertures of a precision volume of at
least one liquid substance from a first side
to a second side comprising the steps of:
forming a plurality of vertical apertures in
a first ceramic greensheet by a material
removal technique; forming a plurality of
horizontal apertures in a second ceramic
greensheet by a material removal
technique; forming a plurality of vertical
apertures in a third ceramic greensheet by
a material removal technique, in which at
least some of said horizontal apertures in
said second greensheet connect a first
aperture in said first greensheet extending
in a substantially straight line through said
third greensheet with a related aperture in
said third greensheet so that a substance
3303
entering one of said apertures in said first
ceramic greensheet exits in both said first
aperture and said related aperture; filling at
least some of said apertures with a filter
material containing a fugitive material;
laminating said first, second and third
ceramic greensheets together, and sintering
said first, second and third greensheets,
thereby forming said plate and releasing
said fugitive material, in which: said
fugitive material combines with material in
said greensheets, leaving a residue during a
sintering process that forms a non-porous
liner on the interior of said vertical
apertures in said first and third greensheets
and said horizontal apertures in said
second greensheet, whereby said liquid
does not react with said first second or
third ceramic greensheet.
December 29, 2008
– ‫ב' בטבת התשס"ט‬
__________
]00[]00[
]00[
NON-DISCOLORED STERILE
WIPE AND PROCESS FOR ITS
PREPARATION
]00[
]00[
]10[
04.07.2005
Int. Cl.8 A61F 013/00, A61L 015/00
FISCHER FARMACEUTICALS
LTD.
JOSEF PESSO
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]10[
]10[
911323
‫מגבון סטרילי בלתי–מוכתם ותהליך לייצורו‬
‫ בני ברק‬,‫פישר תעשיות פרמצבטיות בע"מ‬
‫יוסף פסו‬
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
[57] A sterile non-discolored eyelid
cleansing pad, which has been sterilized by
exposure to γ-radiation at a dose level of 2
Mrad.
This specification was examined in
accordance with regulation 35 of the Patent
Regulations, 5728 - 1968
‫ לתקנות‬23 ‫פירוט זה נבחן בהתאם לתקנה‬
1386 – ‫ תשכ"ח‬5‫הפטנטים‬
_________
]00[]00[
December 29, 2008
– ‫ב' בטבת התשס"ט‬
911031
3304
]00[
SCREW DEVICE FOR HEIGHTADJUSTING A TRACK SPAN
]00[
]/0[
15.11.2003
10302021.7
]/0[ 21.01.2003
01/0200/21
1/2102011/
Int. Cl.8 E01B 001/00, 029/40
RAIL.ONE GMBH, GERMANY
WO/2004/065692
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
]00[
]10[
]01[
]10[
[57] Spindle device for the height
adjustment and alignment of tracks on a
substructure (1), having a transverse
cantilever which is fixed to an elongate nut
(4) adjustable in height on a height
adjustment spindle (3) and which engages
under a rail (13), characterised in that the
transverse cantilever is formed as a
‫התקן בר הברגה לויסות גובה של מרווח‬
‫מסילה‬
]//[
DE
DE
,‫פרל כהן צדק לצר‬
,007/4 .‫ד‬.‫ ת‬, . ‫ רח' שנקר‬,0 ‫ים‬-‫מרכז גב‬
‫הרצליה‬
horizontal spindle plate (7) which is
mounted on the elongate nut pivotably
about a horizontal axis (20) and on which a
slide (8) provided with a clamping mount
device (10) for the rail foot (12) is
displaceable by means of a second spindle
device (17) transverse to the height
adjustment spindle.
________
]00[]00[
3305
909793
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[
PREPARATION OF
HOMOGENEOUSLY LOADED ION
EXCHANGERS
]00[
]/0[
]00[
]10[
12.04.2004
10/411900
]/0[ 11.04.2003
Int. Cl.8 B01D 015/00, B01J 047/00
CALGON CARBON CORPORATION,
U.S.A.
WO/2004/091790
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
]01[
]10[
[57] A continuous or substantially
continuous process for preparing a
substantially homogeneous ionexchangeable media within a moving-bed
or simulated moving-bed device that
creates a media flow or simulated media
flow, said process comprising the steps of
(a) packing said bed with ionexchangeable media containing a first
‫הכנה של מחליפי יונים טעונים בצורה‬
‫הומוגנית‬
]//[
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
ionic species, (b) directing a solution
through said media at least partly countercurrent to said media flow, wherein said
solution contains a second ionic species, or
said first ionic species and a second ionic
species, whereby said ionic species are
loaded to a desired level upon equilibration
onto said media, and (c) directing a rinse
into said media flow.
_________
]00[]00[
December 29, 2008
– ‫ב' בטבת התשס"ט‬
905272
3306
]00[
METHOD AND KIT FOR
PREPARING A DENTAL
ABUTMENT
]00[
]/0[
25.07.2004
60/489965
]/0[ 25.07.2003
219010//0
0221/2011/
21902/000
0021020110
Int. Cl.8 A61C 008/00, 013/30
MICHEL DADI
MICHEL DADI
WO/2005/009272
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
]00[
]10[
]10[
]01[
]10[
[57] An amenable abutment device for
interfacing a dental prosthesis to a dental
implant or to a dental implant analog, the
device comprising: a prefabricated intraimplant analog, the device comprising: a
prefabricated intra-implant element that
fits the dental implant or the dental implant
analog; a prefabricated intra-crown
element (13) to be connected to the dental
prosthesis; an intermediary connection
3307
‫שיטה וערכה להכנת ירכה דנטלית‬
]//[
US
US
US
‫ הרצליה‬,‫מישל דאדי‬
‫מישל דאדי‬
,‫פרל כהן צדק לצר‬
,007/4 .‫ד‬.‫ ת‬, . ‫ רח' שנקר‬,0 ‫ים‬-‫מרכז גב‬
‫הרצליה‬
element for connecting between the intracrown element and the intra-implant
element (21) comprising a deformable
element (22), adjustable in height
orientation and lateral position, that is used
to determine a proper relative position of
the intra-implant element with respect to
the intra-crown element so as to facilitate
forming a model abutment or a permanent
abutment.
December 29, 2008
– ‫ב' בטבת התשס"ט‬
‫ לתקנות‬23 ‫פירוט זה נבחן בהתאם לתקנה‬
1386 – ‫ תשכ"ח‬5‫הפטנטים‬
This specification was examined in
accordance with regulation 35 of the Patent
Regulations, 5728 - 1968
________
]00[]00[
901713
‫תערובות קוטלות פטריות המבוססות על‬
‫תרכובות אמידיות ותולדות פירידיניות‬
]00[
FUNGICIDAL MIXTURES BASED
ON AMIDE COMPOUNDS AND
PYRIDINE DERIVATIVES
]00[
]/0[
]00[
]20[
]10[
]01[
]10[
15.12.1998
19756379.1
]/0[ 18.12.1997
]//[ DE
Int. Cl.8 A01N 043/30, 043/40, 043/54, C07D 213/81, 401/12, 405/12
DIVISION FROM 136469
BASF SE, GERMANY
WO/1999/031981
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26 A HABARZEL STREET
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
[57] A fungicidal composition
comprising, as a first active component:
December 29, 2008
– ‫ב' בטבת התשס"ט‬
(a) an amide compound of the formula
3308
A-CO-NR1R2
in which
A is pyridyl which is unsubstituted or
carries 1, 2 or 3 substituents selected from
alkyl, halogen, CHF2, CF3, alkoxy,
haloalkoxy, alkylthio, alkylsulfinyl and
alkylsulfonyl; R1 is a hydrogen atom; R2 is
phenyl which is unsubstituted or carries 1,
2 or 3 substituents selected-from alkyl,
alkenyl, alkynyl, alkoxy, alkenyloxy,
alkynyloxy, cycloalkyl, cycloalkenyl,
cycloalkyloxy, cycloalkenyloxy, phenyl
and halogen, where the aliphatic and
cycloaliphatic radicals are unsubstituted or
in which R is methyl, propyn-1-yl or
cyclopropyl,
are partially or fully halogenated, and the
cycloaliphatic radicals optionally carry
from 1 to 3 alkyl groups, and where the
phenyl group is unsubstituted or carries
from 1 to 5 halogen atoms and/or from 1 to
3 substituents selected from alkyl,
haloalkyl, alkoxy, haloalkoxy, alkylthio
and haloalkylthio; and, as a second active
component, a compound selected from the
group consisting of (c), (d), (e), (f) and (g),
wherein:
(c) is a pyrimidine compound of the
formula
(d) is an active ingredient of the formula
(e) is a phthalimide compound of the formula
3309
December 29, 2008
– ‫ב' בטבת התשס"ט‬
(f) is a dinitroaniline of the formula
and
(g) is an arylsulfamide of the formula
and wherein the active components are
present in synergistically effective
amounts.
_________
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3310
]00[]00[
]00[
SYSTEM FOR ELECTRICITY
PRODUCTION BY HYDRAULIC
VOLUMETRIC REPLACEMENT
]00[
]00[
]10[
01.01.2007
Int. Cl.8 F16H 039/00
VLADIMIR KLUGERMAN
ROMAN KLUGERMAN
]10[
VLADIMIR KLUGERMAN,
18/9 NAHUM ST.,
NETANYA 42334
[57] A system for producing electricity
by hydraulic volumetric displacement
being a submerged system in a water
reservoir (6) filled with a water or other
liquid, the flexible capacities are fixed on
an endless chain (3) that moves
rotationally inside the water reservoir, as
the air tank capacities move to the top of
the water reservoir, the air tank capacities
are filled with air or other gas by an air
3311
937102
‫מערכת הידראולית ליצירת חשמל‬
‫באמצעות שינויי נפח‬
‫ נתניה‬,‫ולדימיר קלוגרמן‬
‫ נתניה‬,‫רומן קלוגרמן‬
,‫ולדימיר קלוגרמן‬
‫ נתניה‬,08/6‫נחום‬
compressor which is attached to each an
air tank capacity from an accumulation
unit, which action creates an elevating
force which pushes the air tank capacities
to the top of the water reservoir, reaching
the top of the reservoir the air is pumped
out from the air tank capacities back to an
accumulation unit (2) and the air tank
capacities travel empty to a lowermost
point of the reservoir.
December 29, 2008
– ‫ב' בטבת התשס"ט‬
‫ לתקנות‬23 ‫פירוט זה נבחן בהתאם לתקנה‬
1386 – ‫ תשכ"ח‬5‫הפטנטים‬
This specification was examined in
accordance with regulation 35 of the Patent
Regulations, 5728 - 1968
_________
]00[]00[
]00[
INFORMATION CARRIER AND
DEVICES FOR SCANNING THE
INFORMATION CARRIER
]00[
]/0[
]00[
]20[
]10[
25.04.2001
00201728.3
]/0[ 16.05.2000
Int. Cl.8 G11B 007/00
DIVISION FROM 147610
KONINKLIJKE PHILIPS
ELECTRONICS N.V., THE
NETHERLANDS
WO/2001/088908
]01[
December 29, 2008
– ‫ב' בטבת התשס"ט‬
932111
‫נשא של מידע והתקנים לסריקת הנשא‬
]//[
EP
3312
]10[
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
[57] An information carrier (1)
comprising a recording area for writing
patterns which represent user information
and a header area (3) comprising patterns
which represent header information, said
header area comprising a synchronization
area comprising a predetermined
synchronization pattern (31) for
synchronizing a clock frequency in a
device in which the information carrier is
used, characterized in that the
predetermined synchronization pattern
comprises a first part (41) and a second
part (42), the second part being
distinguishable from the first part,
characterized in that the predetermined
synchronization pattern is composed of
marks and of spaces (30) between the
marks, and in that the first part of the
predetermined synchronization pattern
contains marks having a first length and
spaces having a second length whereas the
second part of the synchronization pattern
contains marks having a third length and
spaces having a fourth length, the first
length being different from the third length
and the second length being different from
3313
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
the fourth length, in that the header
information is converted into patterns in
the header area according to a (d, k) Run
Length Limited modulation code, in which
d represents a predetermined natural
number larger than zero and k represents a
predetermined natural number larger than
d, and the length of each mark and each
space expressed as a number of channel bit
lengths (T), and in that the first part of the
predetermined synchronization pattern
contains marks having a first length of
(d+1) times the channel bit length, and
spaces having a second length of (d+1)
times the channel bit length, and the
second part of the predetermined
synchronization pattern contains marks
having a third length of (k+1) times the
channel bit length and spaces having a
fourth length of (k+1) times the channel bit
length, and in that the predetermined
synchronization pattern also comprises a
third part, which third part contains marks
having a length of (k-d) times the channel
bit length and spaces also having a length
of (k-d) times the channel bit length.
December 29, 2008
– ‫ב' בטבת התשס"ט‬
_________
]00[]00[
]00[
INFORMATION CARRIER AND
DEVICES FOR SCANNING THE
INFORMATION CARRIER
]00[
]/0[
]00[
25.04.2001
00201728.3
]/0[ 16.05.2000
Int. Cl.8 G11B 007/00
December 29, 2008
– ‫ב' בטבת התשס"ט‬
932113
‫נשא של מידע והתקנים לסריקת הנשא‬
]//[
EP
3314
]20[
]10[
]01[
]10[
DIVISION FROM 147610
KONINKLIJKE PHILIPS
ELECTRONICS N.V., THE
NETHERLANDS
WO/2001/088908
REINHOLD COHN AND PARTNERS,
26 A HABARZEL STREET
RAMAT HACHAYAL
69710
[57] An information carrier comprising a
synchronization area (40), said
synchronization area comprising a
predetermined synchronization pattern
composed of marks and of spaces between
the marks for synchronizing a clock
frequency in a device in which the
information carrier is used, characterized
in that the predetermined synchronization
pattern comprises a plurality of sequences,
each sequence including a first part (41), a
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,A 09 ‫רחוב הברזל‬
second part (42) and a third part (43), the
first part containing a mark having a first
length and a space having a second length,
the second part containing a mark having a
third length and a space having a fourth
length, and the third part containing a mark
having a fifth length and a space having a
sixth length, wherein the first, third and
fifth lengths are different, and wherein the
second, fourth and sixth lengths are
different.
________
3315
December 29, 2008
– ‫ב' בטבת התשס"ט‬
]00[]00[
]00[
METHOD AND SYSTEM FOR
REDUCING GRAPHICAL
DISPLAY DATA FOR
TRANSMISSION OVER A LOW
BANDWIDTH TRANSPORT
PROTOCOL MECHANISM
]00[
]/0[
29.05.2001
60/207532
]/0[ 26.05.2000
219000001
0021020111
Int. Cl.8 G06F 017/30, H04L 029/06
DIVISION FROM 152797
CITRIX SYSTEMS, INC., U.S.A.
WO/2001/092973
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]00[
]20[
]10[
]01[
]10[
[57] A method of reducing the amount of
data transmitted from a server to a client
via a communication network, the method
being performed at the client and
comprising the steps of: receiving a
protocol stream, the protocol stream
including an indicia of graphical data, a
command associated with the graphical
data, and a plurality of other commands;
December 29, 2008
– ‫ב' בטבת התשס"ט‬
931319
‫שיטה ומערכת להפחתה יעילה של נתוני‬
‫תצוגה גרפית לשידור באמצעות מנגנון‬
‫פרוטוקול תובלה רוחב פס נמוך‬
]//[
US
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
searching for the graphical data using the
indicia; upon failing to locate the graphical
data, storing the command associated with
the graphical data together with the
plurality of other commands in a queue;
receiving the graphical data; processing the
received graphical data using the
associated command, and processing at
least some of the plurality of other
commands in the queue.
3316
_________
‫פטנטים‬
PATENTS
‫פטנטים שניתנו‬
PATENTS GRANTED
00122/
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3318
‫פטנטים שחודשו‬
PATENTS RENEWED
/0000
/0001
/00/0
/0000
/0202
011200
00100/
00111/
001120
001011
001000
001/01
001/11
00/020
000210
00001/
002111
002001
00/00/
0/11/0
0//001
0/0002
0/0000
0/0001
0/00/0
0/022/
0/0000
0/0/1/
0/01/2
0/00/0
0/0///
0/2/0/
000020
000001
0000//
00011/
00001/
00001/
00/100
000011
0020/0
00100/
000//0
00/0/1
3319
/0/1/
/0000
/00/1
/0020
/0200
011202
001000
001100
001110
001000
00102/
001/00
001///
00100/
000210
0000/1
002110
0020//
00/100
0/1020
0//000
0/00/0
0/0010
0/002/
0/00/1
0/0210
0/00/0
0/0/00
0/0100
0/0001
0/0/00
0/1000
000001
00000/
000010
00010/
0000/0
000101
000000
000021
002/10
001001
000/01
00/021
/0/00
/000/
/0000
/002/
/0220
01/010
00100/
001100
00111/
001000
00102/
001/01
001//0
001010
000201
000/00
002101
0020/1
00/100
0/0000
0//000
0/0/10
0/00//
0/0020
0/0210
0/02//
0/00//
0/0/0/
0/0101
0/0000
0/0/00
0/1001
000001
002000
0000/0
000120
0000//
000020
0002/0
000000
002012
001100
00/101
00///1
/0//0
/0021
/0000
/0010
/0200
01/001
0012/1
001102
001100
001001
001011
001/00
000101
000/00
00012/
000/01
0021//
002102
00/111
0/0120
0//100
0/0/1/
0/0012
0/0012
0/0201
0/011/
0/001/
0/0/20
0/0121
0/0000
0/0//0
0/0020
000020
002020
001000
000002
000210
00/101
000111
000000
00220/
00100/
00/100
021111
/000/
/0010
/0000
/0000
/0200
001002
001201
001100
0011/0
0010/1
001010
001//1
000100
000000
00010/
000/00
002100
000///
00/010
0/0121
0//0/0
0/0010
0/0001
0/0000
0/02/2
0/0100
0/0010
0/0/01
0/0120
0/0021
0/0000
0//12/
00020/
00100/
001200
0000/0
0002//
00//21
0000//
000//0
002/00
001//1
00/001
02100/
/000/
/001/
/0001
/0001
/011/
001///
001210
001100
0011/1
0010/0
001010
001/00
000100
000001
000002
000/20
00210/
00/00/
00/010
0/0002
0/0000
0/0002
0/0001
0/000/
0/0201
0/0120
0/0010
0/0//0
0/0111
0/0010
0/0//0
0//022
00/200
001001
00110/
0000/1
0002/0
00/000
0000//
00210/
002/10
0001//
00/001
0210/0
December 29, 2008
/00/0
/0001
/00/0
/00//
/0102
0010/0
001200
001121
0011/0
00100/
001000
001/20
000100
000200
000001
000//1
002010
00//10
00//11
0/0000
0/0020
0/0000
0/0000
0/00/0
0/0200
0/012/
0/0001
0/0110
0/0010
0/001/
0/21//
0//202
00/001
001/0/
001001
000/00
00010/
00/0/2
000110
002020
002//2
000010
00/200
021002
/0000
/000/
/000/
/0201
011200
001020
0012/0
001120
001010
001000
001/10
001/22
000120
000200
000000
002110
002010
00//02
00///0
0//020
0/0000
0/00/0
0/00/2
0/00//
0/022/
0/0010
0/00//
0/01/0
0/0000
0/0001
0/2000
000100
00/010
000001
000111
0000/2
0001/2
00/0/0
000002
00201/
0010/0
0000/1
00/2/0
021001
– ‫ב' בטבת התשס"ט‬
‫‪021021‬‬
‫‪0212/0‬‬
‫‪021000‬‬
‫‪02010/‬‬
‫‪020121‬‬
‫‪020000‬‬
‫‪020/00‬‬
‫‪021/22‬‬
‫‪011/01‬‬
‫‪3320‬‬
‫‪021001‬‬
‫‪021200‬‬
‫‪0212/2‬‬
‫‪0202/0‬‬
‫‪0200/0‬‬
‫‪020010‬‬
‫‪0200/0‬‬
‫‪021101‬‬
‫‪0121//‬‬
‫‪021/0/‬‬
‫‪021200‬‬
‫‪021210‬‬
‫‪020000‬‬
‫‪020001‬‬
‫‪020021‬‬
‫‪020100‬‬
‫‪022110‬‬
‫‪01/21/‬‬
‫‪021000‬‬
‫‪021001‬‬
‫‪02121/‬‬
‫‪0200/0‬‬
‫‪0200//‬‬
‫‪020112‬‬
‫‪020110‬‬
‫‪022220‬‬
‫‪01/212‬‬
‫‪021010‬‬
‫‪021022‬‬
‫‪021210‬‬
‫‪020100‬‬
‫‪020001‬‬
‫‪020100‬‬
‫‪0202//‬‬
‫‪022002‬‬
‫‪02/002‬‬
‫‪0000//‬‬
‫‪021010‬‬
‫‪021020‬‬
‫‪0212//‬‬
‫‪021//0‬‬
‫‪0201//‬‬
‫‪02/100‬‬
‫‪020000‬‬
‫‪020000‬‬
‫‪02//0/‬‬
‫‪0000/0‬‬
‫‪02102/‬‬
‫‪021020‬‬
‫‪0212/2‬‬
‫‪021/10‬‬
‫‪0201/2‬‬
‫‪02/200‬‬
‫‪020000‬‬
‫‪020//0‬‬
‫‪020000‬‬
‫‪00/1/2‬‬
‫ב' בטבת התשס"ט –‬
‫‪02100/‬‬
‫‪02100/‬‬
‫‪0212/0‬‬
‫‪0210/1‬‬
‫‪0201/0‬‬
‫‪02/120‬‬
‫‪020000‬‬
‫‪020//1‬‬
‫‪020//0‬‬
‫‪001000‬‬
‫‪December 29, 2008‬‬
‫פטנטים שתוקפם פקעו בגלל אי תשלום אגרת חידוש‬
PATENTS NOT IN FORCE DUE TO NON-PAYMENT OF RENEWAL
FEES
/010/
/000/
/0//2
//010
000001
000/0/
00/10/
0////0
002101
0/1011
0/112/
0/1000
0/0000
0/0/20
001200
00010/
0/1210
010010
010/02
010021
000100
3321
/0100
/0/10
//1/2
//0/0
0000//
000/02
00/100
001/10
002101
0/1002
0/1121
0/1002
0/000/
0//10/
00/0/0
000200
0/000/
010020
010//0
010011
00000/
/012/
/0/00
//10/
//0/2
00000/
000//1
00/120
000020
002/2/
0/121/
0/11/0
0/1/20
0/0000
0//000
00/000
0/0/00
000102
010010
0100/0
000///
000/01
/01//
/0/20
//100
//0//
000000
000/01
00/1/2
000210
002/22
0/12/1
0/1012
0/1/00
0/0/20
0//000
00/011
0/0/0/
02010/
010/00
0100/0
0002/0
0000//
/0000
/0/20
//120
/1000
000010
000/20
00/00/
000012
0010/0
0/1200
0/10/0
0/0101
0/00//
0//0/1
001101
0/0001
0102/1
010/00
0100//
000100
000200
/0000
/0/20
//12/
001210
000002
000/10
00/000
000120
000010
0/1201
0/10/2
0/0100
0/0020
0//0/0
001/11
0/0201
012/0/
010/0/
010000
00/000
002/1/
December 29, 2008
/0000
/0/11
//121
000101
000001
00/10/
000/10
000122
00/201
0/12/1
0/1020
0/0102
0/0220
0//01/
000002
0/0001
0100//
010/1/
010000
00/0//
00100/
/0021
/0/00
//11/
0001/1
000/10
00/100
00000/
0001/2
00/01/
0/11/0
0/102/
0/0110
0/0111
0//20/
000101
0/2///
010011
010/00
010020
00/010
– ‫ב' בטבת התשס"ט‬
‫פטנטים שחודשו לעשרים שנה‬
‫‪PATENTS RENEWED FOR 20 YEARS‬‬
‫‪022/00‬‬
‫‪3322‬‬
‫‪001/0/‬‬
‫‪00010/‬‬
‫‪000/0/‬‬
‫ב' בטבת התשס"ט –‬
‫‪001020‬‬
‫‪December 29, 2008‬‬
‫צווי הארכה שחודשו‬
EXTENSION ORDERS RENEWED
00102
3323
00/00
000/0
0021/
December 29, 2008
– ‫ב' בטבת התשס"ט‬
‫פטנטים שפג תוקפם‬
‫‪PATENTS EXPIRED‬‬
‫‪00/12‬‬
‫‪0010/‬‬
‫‪00002‬‬
‫‪000//‬‬
‫‪00/02‬‬
‫‪00///‬‬
‫‪00000‬‬
‫‪00001‬‬
‫‪00000‬‬
‫‪00200‬‬
‫‪00220‬‬
‫‪00001‬‬
‫‪00/11‬‬
‫‪00/10‬‬
‫‪02100‬‬
‫‪020/0‬‬
‫‪02000‬‬
‫‪02002‬‬
‫‪02/02‬‬
‫‪02/10‬‬
‫‪02001‬‬
‫‪02010‬‬
‫‪0200/‬‬
‫‪0220/‬‬
‫‪02100‬‬
‫‪02120‬‬
‫‪02000‬‬
‫‪02/0/‬‬
‫‪01102‬‬
‫‪0100/‬‬
‫‪01010‬‬
‫‪01000‬‬
‫‪/2/0/‬‬
‫‪011/0/‬‬
‫‪0100/1‬‬
‫‪3324‬‬
‫‪000//‬‬
‫‪00100‬‬
‫‪000/1‬‬
‫‪00001‬‬
‫‪00//0‬‬
‫‪00//2‬‬
‫‪0000/‬‬
‫‪00001‬‬
‫‪00001‬‬
‫‪00210‬‬
‫‪00221‬‬
‫‪00101‬‬
‫‪000/0‬‬
‫‪00/20‬‬
‫‪02100‬‬
‫‪02002‬‬
‫‪02001‬‬
‫‪02000‬‬
‫‪020/0‬‬
‫‪02/20‬‬
‫‪02000‬‬
‫‪020//‬‬
‫‪02000‬‬
‫‪02200‬‬
‫‪022/1‬‬
‫‪02100‬‬
‫‪02000‬‬
‫‪02///‬‬
‫‪01100‬‬
‫‪010//‬‬
‫‪01000‬‬
‫‪01001‬‬
‫‪/2/00‬‬
‫‪//011‬‬
‫‪0100/0‬‬
‫‪00022‬‬
‫‪00100‬‬
‫‪00000‬‬
‫‪00001‬‬
‫‪00/01‬‬
‫‪00///‬‬
‫‪00000‬‬
‫‪0001/‬‬
‫‪00010‬‬
‫‪00211‬‬
‫‪00201‬‬
‫‪00120‬‬
‫‪00002‬‬
‫‪00/00‬‬
‫‪02100‬‬
‫‪02001‬‬
‫‪020/1‬‬
‫‪020/0‬‬
‫‪020/2‬‬
‫‪02/21‬‬
‫‪02000‬‬
‫‪020/0‬‬
‫‪0200/‬‬
‫‪02210‬‬
‫‪02200‬‬
‫‪02100‬‬
‫‪02001‬‬
‫‪02001‬‬
‫‪011//‬‬
‫‪01001‬‬
‫‪01010‬‬
‫‪010/0‬‬
‫‪01020‬‬
‫‪/010/‬‬
‫‪010200‬‬
‫‪00002‬‬
‫‪00112‬‬
‫‪0000/‬‬
‫‪000//‬‬
‫‪00/02‬‬
‫‪00//0‬‬
‫‪00000‬‬
‫‪000/0‬‬
‫‪00020‬‬
‫‪00212‬‬
‫‪00201‬‬
‫‪00111‬‬
‫‪00000‬‬
‫‪00/0/‬‬
‫‪02100‬‬
‫‪0200/‬‬
‫‪02000‬‬
‫‪020/1‬‬
‫‪02000‬‬
‫‪02/0/‬‬
‫‪02001‬‬
‫‪02000‬‬
‫‪02002‬‬
‫‪02210‬‬
‫‪02220‬‬
‫‪02100‬‬
‫‪02002‬‬
‫‪02011‬‬
‫‪011/0‬‬
‫‪01102‬‬
‫‪01010‬‬
‫‪0100/‬‬
‫‪01021‬‬
‫‪/0100‬‬
‫‪010000‬‬
‫‪00000‬‬
‫‪00110‬‬
‫‪00000‬‬
‫‪000/0‬‬
‫‪00/00‬‬
‫‪00//1‬‬
‫‪000/0‬‬
‫‪00001‬‬
‫‪00001‬‬
‫‪00211‬‬
‫‪00200‬‬
‫‪00200‬‬
‫‪00012‬‬
‫‪00//0‬‬
‫‪02101‬‬
‫‪02000‬‬
‫‪02011‬‬
‫‪0200/‬‬
‫‪02011‬‬
‫‪02/01‬‬
‫‪02000‬‬
‫‪02000‬‬
‫‪02001‬‬
‫‪0200/‬‬
‫‪02202‬‬
‫‪021/2‬‬
‫‪0201/‬‬
‫‪02000‬‬
‫‪02//2‬‬
‫‪01112‬‬
‫‪01020‬‬
‫‪01000‬‬
‫‪0100/‬‬
‫‪/0100‬‬
‫‪01000/‬‬
‫‪0///1‬‬
‫‪00/01‬‬
‫‪00000‬‬
‫‪0000/‬‬
‫‪00/00‬‬
‫‪00/00‬‬
‫‪00000‬‬
‫‪0001/‬‬
‫‪000/0‬‬
‫‪000/0‬‬
‫‪00200‬‬
‫‪00210‬‬
‫‪00010‬‬
‫‪00/0/‬‬
‫‪02101‬‬
‫‪021//‬‬
‫‪02020‬‬
‫‪02001‬‬
‫‪02010‬‬
‫‪02/00‬‬
‫‪02010‬‬
‫‪02000‬‬
‫‪020/0‬‬
‫‪02000‬‬
‫‪02200‬‬
‫‪021/0‬‬
‫‪021//‬‬
‫‪02001‬‬
‫‪02/1/‬‬
‫‪01110‬‬
‫‪01021‬‬
‫‪01000‬‬
‫‪01000‬‬
‫‪/0200‬‬
‫‪010002‬‬
‫‪1001/‬‬
‫‪1/10/‬‬
‫‪00/01‬‬
‫‪00010‬‬
‫‪00020‬‬
‫‪000/2‬‬
‫‪00/10‬‬
‫‪00001‬‬
‫‪00010‬‬
‫‪000/0‬‬
‫‪000/0‬‬
‫‪00201‬‬
‫‪0021/‬‬
‫‪00011‬‬
‫‪00/0/‬‬
‫‪02110‬‬
‫‪021/1‬‬
‫‪02000‬‬
‫‪0200/‬‬
‫‪02000‬‬
‫‪02//0‬‬
‫‪02///‬‬
‫‪02012‬‬
‫‪02000‬‬
‫‪02011‬‬
‫‪02200‬‬
‫‪02100‬‬
‫‪0210/‬‬
‫‪02001‬‬
‫‪02/1/‬‬
‫‪01110‬‬
‫‪0100/‬‬
‫‪01000‬‬
‫‪01000‬‬
‫‪/000/‬‬
‫‪01110/‬‬
‫‪1//2/‬‬
‫ב' בטבת התשס"ט –‬
‫‪10000‬‬
‫‪00/00‬‬
‫‪001/0‬‬
‫‪00020‬‬
‫‪000/0‬‬
‫‪00/00‬‬
‫‪00010‬‬
‫‪0002/‬‬
‫‪0000/‬‬
‫‪0000/‬‬
‫‪00202‬‬
‫‪00210‬‬
‫‪00001‬‬
‫‪00/10‬‬
‫‪00/00‬‬
‫‪02100‬‬
‫‪02002‬‬
‫‪02001‬‬
‫‪02001‬‬
‫‪02/01‬‬
‫‪02/1/‬‬
‫‪02002‬‬
‫‪0201/‬‬
‫‪02001‬‬
‫‪022/0‬‬
‫‪0210/‬‬
‫‪02111‬‬
‫‪02000‬‬
‫‪02/20‬‬
‫‪01121‬‬
‫‪01000‬‬
‫‪0100/‬‬
‫‪01000‬‬
‫‪/12/0‬‬
‫‪011200‬‬
‫‪00010/‬‬
‫‪December 29, 2008‬‬
‫הודעה‬
NOTICE
‫ לחוק‬9/ ‫לפי סעיף‬
0697-‫ תשכ"ז‬,‫הפטנטים‬
‫הוגשה בקשה להחזר‬
‫תוקפו של הפטנט המפורט‬
‫ שתוקפו פקע מחמת‬,‫מטה‬
‫אי תשלום אגרות החידוש‬
:‫הקבועות‬
Under section 60 of the
Patent Law, 5727-1967
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent
Acceptance published in
journal no:
Proprietors:
‫מס' הפטנט‬
:'‫קיבול פורסם ביומן מס‬
000000
090110
:‫שם בעל הפטנט‬
‫ולדימיר קליאצקין‬
VLADIMIR KLIATZKIN
:‫שם האמצאה‬
‫קומפוננטים בעלי מבנה עשוי מחומר מרוכב‬
STRUCTURAL COMPONENTS MADE OF COMPOSITE MATERIAL
Any person may oppose the
‫כל אדם רשאי להתנגד‬
said application within three
‫לבקשה האמורה תוך‬
months from the date of this
‫שלושה חודשים מתאריך‬
Patents Journal, as
‫ כפי שנקבע‬,‫יומן פטנטים זה‬
prescribed by section 61 of
60 ‫ לחוק ובתקנה‬90 ‫בסעיף‬
the law and by regulation 92
-‫ תשכ"ח‬,‫לתקנות הפטנטים‬
of the Patent Regulations,
5728-1968
0698
Title of invention:
3325
December 29, 2008
– ‫ב' בטבת התשס"ט‬
‫הודעה‬
NOTICE
‫ לחוק‬9/ ‫לפי סעיף‬
0697-‫ תשכ"ז‬,‫הפטנטים‬
‫הוגשה בקשה להחזר‬
‫תוקפו של הפטנט המפורט‬
‫ שתוקפו פקע מחמת‬,‫מטה‬
‫אי תשלום אגרות החידוש‬
:‫הקבועות‬
Under section 60 of the
Patent Law, 5727-1967
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent
Acceptance published in
journal no:
Proprietors:
000100
/90112
‫מס' הפטנט‬
:'‫קיבול פורסם ביומן מס‬
:‫שם בעל הפטנט‬
AOTI OPERATING COMPANY, INC.
Title of invention:
:‫שם האמצאה‬
‫שיטה לאיתור זיהום פני השטח של מתכת‬
METHOD TO DETECT SURFACE METAL CONTAMINATION
Any person may oppose the
‫כל אדם רשאי להתנגד‬
said application within three
‫לבקשה האמורה תוך‬
months from the date of this
‫שלושה חודשים מתאריך‬
Patents Journal, as
‫ כפי שנקבע‬,‫יומן פטנטים זה‬
prescribed by section 61 of
60 ‫ לחוק ובתקנה‬90 ‫בסעיף‬
the law and by regulation 92
‫ תשכ"ח‬,‫לתקנות הפטנטים‬
of the Patent Regulations,
5728-1968
0698
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3326
‫הודעה‬
NOTICE
Under section 66 of the Patents
Law, 5727-1967
This is to notify that permission
has been granted to the owner of
Patent Application No.
Acceptance published in journal
To amend the specification of the
said Patent Application.
Any person may oppose such
grant of permission within three
months from the date of this
Patents Journal, as prescribed by
section 67 of the Law and by
regulation 99 of the Patent
Regulations, 5728-1968.
3327
0//1//
090112
,‫ לחוק הפטנטים‬99 ‫לפי סעיף‬
0697-‫תשכ"ז‬
‫מודע בזאת כי ניתנה רשות‬
'‫לבעלת בקשת הפטנט מס‬
‫דבר הקיבול פורסם ביומן‬
‫לתקן את הפירוט של בקשת‬
‫הפטנט האמורה‬
‫כל אדם רשאי להתנגד למתן‬
‫הרשות תוך שלושה חודשים‬
‫ כפי‬,‫מתאריך יומן פטנטים זה‬
‫ לחוק ובתקנה‬97 ‫שנקבע בסעיף‬
-‫ התשכ"ח‬,‫ לתקנות הפטנטים‬66
.0698
December 29, 2008
– ‫ב' בטבת התשס"ט‬
‫הודעה‬
NOTICE
Under section 66 of the Patents
Law, 5727-1967
This is to notify that permission
has been granted to the owner of
Patent Application No.
Acceptance published in journal
To amend the specification of the
said Patent Application.
Any person may oppose such
grant of permission within three
months from the date of this
Patents Journal, as prescribed by
section 67 of the Law and by
regulation 99 of the Patent
Regulations, 5728-1968.
December 29, 2008
– ‫ב' בטבת התשס"ט‬
002002
190112
,‫ לחוק הפטנטים‬99 ‫לפי סעיף‬
0697-‫תשכ"ז‬
‫מודע בזאת כי ניתנה רשות‬
'‫לבעלת בקשת הפטנט מס‬
‫דבר הקיבול פורסם ביומן‬
‫לתקן את הפירוט של בקשת‬
‫הפטנט האמורה‬
‫כל אדם רשאי להתנגד למתן‬
‫הרשות תוך שלושה חודשים‬
‫ כפי‬,‫מתאריך יומן פטנטים זה‬
‫ לחוק ובתקנה‬97 ‫שנקבע בסעיף‬
-‫ התשכ"ח‬,‫ לתקנות הפטנטים‬66
.0698
3328
‫הודעה‬
‫תיקון טעות‬
NOTICE
CORRIGENDUM
Patent Application No.
131083
'‫בקשת פטנט מס‬
Acceptance published in Journal
/90110
‫דבר הקיבול פורסם ביומן‬
Proprietors:
‫שם בעל הבקשה‬
PFIZER
RESEARCH
AND
DEVELOPMENT
COMPANY,
N.V./S.A.
Title of invention:
CONTROLLED-RELEASE
PHARMACEUTICAL
FORMULATIONS CONAINING
A CGMP PDE-5 INHIBITOR
:‫שם האמצאה‬
‫פורמולציות רוקחיות בעלות‬
‫שחרור מבוקר המכילות מעכב‬
CGMP-PDE-5 ‫של‬
The application was published
with incorrect claims. The correct
claims have now been substituted
‫הבקשה פורסמה תחת תביעות‬
‫לא נכונות התביעות הנכונות‬
.‫הוחלפו‬
Any person wishing to oppose the
grant of this patent, may, within
three months from the data of this
journal, give to the Commissioner
of Patent notice under Section 30
of the Patent Law, in the manner
prescribed in regulations 57 et seq
of the Patents Regulations, 57281968.
‫כל המעונין להתנגד למתן פטנט‬
‫ תוך שלושה חודשים‬,‫זה רשאי‬
‫מתאריך יומן זה להגיש לרשם‬
‫הפטנטים הודעת התנגדות לפי‬
‫ לחוק הפטנטים בדרך‬:/ ‫סעיף‬
‫ ואילך‬.7 ‫הקבועה בתקנה‬
.0698–‫ תשכ"ח‬,‫לתקנות הפטנטים‬
3329
December 29, 2008
– ‫ב' בטבת התשס"ט‬
‫שינויים בפרטים רשומים בפנקס‬
CHANGES IN PARTICULARS ENTERED IN REGISTER
‫שינוי בעלות‬
CHANGES IN PROPRIETORSHIP
No. of Patent:
001/22
Previous Proprietors:
JAPAN ABSORBENT TECHNOLOGY
INSTITUTE
MITSUBISHI CORPORATION
New Proprietors:
JAPAN ABSORBENT TECHNOLOGY
INSTITUTE
DSG INTERNATIONAL LIMITED
December 29, 2008
– ‫ב' בטבת התשס"ט‬
:‫מס' פטנט‬
:‫הבעלים הקודמים‬
:‫הבעלים החדשים‬
3330
‫קודים למדינת המופיעים ביומן‬
COUNTRY CODES APPEARING IN THIS JOURNAL
Code
AR
AT
AU
BA
BE
BR
CA
CH
CN
CU
CZ
DE
DK
EC
EP
ES
FI
FR
GB
GE
GR
GT
HR
HU
IE
IL
IN
IT
JP
KR
LK
LU
LV
MX
3331
Country or Organization
Argentina
Austria
Australia
Herzegovina
Belgium
Brazil
Canada
Switzerland
China
Cuba
Czech Republic
Germany
Denmark
Ecuador
European Patent Office
Spain
Finland
France
United Kingdom
Georgia
Greece
Guatemala
Croatia
Hungary
Ireland
Israel
India
Italy
Japan
Republic of Korea
Sri Lanka
Luxembourg
Latvia
Mexico
December 29, 2008
– ‫ב' בטבת התשס"ט‬
MY
NL
NO
NZ
PL
PT
RU
SE
SG
SI
SK
TH
TR
TW
UA
US
UY
UZ
WO
ZA
Malaysia
The Netherlands
Norway
New Zealand
Poland
Portugal
Russian Federation
Sweden
Singapore
Slovenia
Slovakia
Thailand
Turkey
Taiwan
Ukraine
United States of America
Uruguay
Uzbekistan
World Intellectual Property Organization (W.I.P.O.)
South Africa
December 29, 2008
– ‫ב' בטבת התשס"ט‬
3332
‫מדגמים‬
DESIGNS
‫מדגמים שנרשמו‬
DESIGNS REGISTERED
41195
Class
22(01)
‫סוג‬
9. 8.2005
MENACHEM GRINSHSPAN AND AVI
‫מנחם גרינשפן ואבי זילברט וניסים זיסמן‬
ZILBERT AND NISSIM ZYSMAN
Cross clip for magazine
‫צולבת למחסנית‬
Class
43314
24(02)
13. 11.2006
‫סוג‬
‫קיו קור בע"מ‬
‫משאבה פריסטלטית‬
Q-CORE LTD.
Peristaltic pump
Class
43317
24(02)
13. 11.2006
‫קיו קור בע"מ‬
‫מתקן למשאבה פריסטלטית עם‬
‫מערכת בקרה‬
Q-CORE LTD.
Device for controlled infusion peristaltic
pump with a control unit
Class
‫סוג‬
43956
11(02)
20. 3.2007
‫סוג‬
‫ערן גרבלר‬
‫סביבון‬
ERAN GREBLER
Dreidel
Class
43986
9(03)
26. 3.2007
‫סוג‬
‫קרן עזר‬
‫מארז‬
KEREN EZER
Package
3333
December 29, 2008
– ‫ב' בטבת התשס"ט‬
44008
7(07)
29. 3.2007
Class
‫סוג‬
MARLA WOLFSON
‫מתקן לגלילי נייר‬
Paper roll dispenser
44109
24(01)
2. 5.2007
Class
‫סוג‬
TRIXELL S.A.S.
Digital radiography cassette
Convention date (OHIM)
00.00.2006
44135
9(05)
6. 5.2007
Class
‫קלטת לרדיולוגיה דיגיטלית‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
‫גלי הרשנזון‬
‫מנשא לבקבוק שתייה‬
GALI HERSHENZON
Carrier for drinking bottle
44168
24(01)
10. 5.2007
Class
‫סוג‬
TRIXELL S.A.S.
Docking station for radiography cassettes
Convention date (OHIM)
0/.00.2006
44277
2(02)
5. 6.2007
Class
‫תחנת עגינה לקלטות רדיוגרופיה‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
DIESEL S.P.A.
‫מכנסיים‬
Pants
Class
44359
9(01)
14. 6.2007
‫סוג‬
NEMIROFF INTELLECTUAL PROPERTY ESTABLISHMENT
‫בקבוק‬
Bottle
Class
December 29, 2008
– ‫ב' בטבת התשס"ט‬
44389
10(06)
20. 6.2007
‫סוג‬
3334
FOX 40 INTERNATIONAL INC.
Whistle
Convention date (U.S.A.)
Class
02.0 .2007
44484
7(02)
10. 7.2007
‫משרוקית‬
)‫הברית‬
)‫(ארצותהברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
KONINKLIJKE PHILIPS ELECTRONICS N.V.
Toaster
Convention date (OHIM)
Class
0/.0 .2007
44499
6(04)
12. 7.2007
‫סוג‬
‫שילב שיווק ישיר לבית היולדת בע"מ‬
SHILAV DIRECT MARKETING TO
MOTHERS TO BE LTD.
Chest
Class
‫מצנם‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫שידה‬
44527
8(08)
18. 7.2007
‫סוג‬
‫מאיר עמירם‬
‫התקן לתלייה‬
MEIR AMIRAM
Hanging device
Class
44742
7(06)
3. 9.2007
‫סוג‬
UNISTRAW PATENT HOLDINGS LTD.
Drinking straw
Convention date (Australia)
Class
00.2 .2007
44809
9(03)
18. 9.2007
‫קש שתיה‬
)‫הברית‬
)‫(אוסטרליה‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
COLGATE-PALMOLIVE COMPANY
Container
Convention date (U.S.A.)
Class
00./ .2007
44870
8(07)
9. 10.2007
‫מיכל‬
)‫הברית‬
)‫(ארצותהברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
‫משה דולב‬
NOSHE DOLEV
3335
December 29, 2008
– ‫ב' בטבת התשס"ט‬
‫מנעול לדלת‬
Door lock
Class
44909
11(01)
21. 10.2007
‫סוג‬
DYNAMIC DIAMOND CORP.
‫יהלום‬
Diamond
44940
10(05)
9. 9.2007
Class
‫סוג‬
BUNDESDRUCKEREI GMBH
‫התקן בקרה‬
Verifier
Class
44942, 44943, 44944,
44945, 44946, 44947,
44948
25(01)
29. 10.2007
‫סוג‬
‫אקסטל בע"מ‬
‫פרופיל‬
EXTAL LTD.
Profile
Class
45129
23(02)
15. 10.2006
‫סוג‬
VIEGA GMBH & CO. KG
Wall-mounted panel for toilet flushing system
‫פנל קיר למערכת שטיפה סניטרית‬
Convention date (OHIM)
01.0 .2006
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
Class
45208
24(02)
12. 12.2007
‫סוג‬
BIOLASE TECHNOLOGY, INC.
‫קצה למכשיר רפואי‬
Tip for medical instrument
Class
45209
24(02)
12. 12.2007
‫סוג‬
BIOLASE TECHNOLOGY, INC.
Medical instrument
December 29, 2008
– ‫ב' בטבת התשס"ט‬
‫מתקן רפואי‬
3336
Class
45230
13(03)
18. 12.2007
‫סוג‬
SIEMENS AKTIENGESELLSCHAFT
Mounting device for electric power
Convention date (OHIM)
2.0 .2007
45272
12(16)
27. 12.2007
TOMER DAHAN AND YARON CHECHIK
Seat Cover
Class
Class
45294
11(02)
3. 1.2008
‫מתקן התקנה לכוח חשמלי‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
‫תומר דהן וירון צ'ציק‬
‫כיסוי מושב‬
‫סוג‬
‫עמי מוצרי נוי בע"מ‬
‫מתקן לגפרורים‬
AMY-ART WORK LTD.
Match stand
Class
45295
11(02)
3. 1.2008
‫סוג‬
‫עמי מוצרי נוי בע"מ‬
‫סט ליין‬
AMY-ART WORK LTD.
Wine set
Class
45297
11(02)
3. 1.2008
‫סוג‬
‫עמי מוצרי נוי בע"מ‬
‫מעמד לבקבוק יין‬
AMY-ART WORK LTD.
Wine bottle stand
Class
45298
11(02)
3. 1.2008
‫סוג‬
‫עמי מוצרי נוי בע"מ‬
‫מנורה‬
AMY-ART WORK LTD.
Candelabra
Class
45299
11(02)
3. 1.2008
‫סוג‬
‫עמי מוצרי נוי בע"מ‬
AMY-ART WORK LTD.
3337
December 29, 2008
– ‫ב' בטבת התשס"ט‬
‫מעמד לכלי כתיבה‬
Stand for writing stationery
Class
45303
11(02)
3. 1.2008
‫סוג‬
‫עמי מוצרי נוי בע"מ‬
‫מגש לפסח‬
AMY-ART WORK LTD.
Passover tray
Class
45303
11(02)
3. 1.2008
‫סוג‬
‫עמי מוצרי נוי בע"מ‬
‫מגש לפסח‬
AMY-ART WORK LTD.
Passover tray
Class
45304
11(02)
3. 1.2008
‫סוג‬
‫עמי מוצרי נוי בע"מ‬
‫מגש מצות‬
AMY-ART WORK LTD.
Matza tray
Class
45305
11(02)
3. 1.2008
‫סוג‬
‫עמי מוצרי נוי בע"מ‬
‫קערה ונטלה‬
AMY-ART WORK LTD.
Natla and base
Class
45306
11(02)
3. 1.2008
‫עמי מוצרי נוי בע"מ‬
‫יד לספר תורה על בסיס‬
AMY-ART WORK LTD.
Pointer
Class
‫סוג‬
45307
11(02)
3. 1.2008
‫סוג‬
‫עמי מוצרי נוי בע"מ‬
‫קישוט‬
AMY-ART WORK LTD.
Ornament
Class
December 29, 2008
– ‫ב' בטבת התשס"ט‬
45308
11(02)
3. 1.2008
‫סוג‬
3338
‫עמי מוצרי נוי בע"מ‬
‫מעמד לכרטיסי ביקור‬
AMY-ART WORK LTD.
Stand for visiting cards
Class
45329
11(01)
13. 1.2008
‫סוג‬
‫מיכאל יחיאלי‬
‫עגיל‬
MICHAEL YEHIELI
Earring
Class
45383
19(02)
21. 1.2008
‫סוג‬
SUN SAME ENTERPRISES CO., LTD.
‫חותמת דיו‬
Inking stamp
Class
45390, 45391
7(04)
23. 1.2008
‫סוג‬
KENWOOD LIMITED
Hand held kitchen appliance
Convention date (OHIM)
Class
01.1 .2007
45436
9(03)
4. 2.2008
‫כלי מטבח ידני‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
‫דרבוקס בע"מ‬
‫מיכל עם מכסה‬
DARBOX LTD.
Container with lid
Class
45459, 45460
7(06)
5. 2.2008
‫סוג‬
KENWOOD LIMITED
Stand for kitchen utensils
Convention date (OHIM)
Class
/1. 11.2007
45473, 45474, 45476
11(01)
7. 2.2008
‫מעמד לכלי מטבח‬
)‫הברית‬
)‫(אוהיים‬
‫אמנהנה(ארצות‬
‫תאריך האמ‬
‫סוג‬
‫מאיר דסה‬
‫תכשיט‬
MEIR DASA
Jewel
Class
3339
45479
9(05)
7. 2.2008
‫סוג‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
‫דניה פלסטיק פרטס בע"מ‬
‫ידית‬
DANIA PLASTIC PARTS LTD.
Handle
45496
29(02)
10. 2.2008
Class
‫סוג‬
‫יאיר דוד‬
‫מתאם לחגורת ביטחון‬
YAIR DAVID
Safety belt adapter
Class
45512, 45513
27(06)
13. 2.2008
‫סוג‬
‫) בע"מ‬0//4( ‫קיוסקאי שיווק‬
‫מארז לנייר סיגריות‬
KIOSKY MARKETING (2004) LTD.
Packing for cigarette paper
45531
10(05)
14. 2.2008
Class
‫סוג‬
TOMTOM INTERNATIONAL BV
Navigation device
Convention date (U.S.A.)
02. 8.2007
‫מתקן ניווט‬
)‫הברית‬
)‫(ארצותהברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
45556
2(04)
21. 2.2008
Class
‫סוג‬
LRC PRODUCTS LIMITED
Ball of foot cushion
Convention date (OHIM)
Class
00. 8.2007
45560, 45562
25(01)
24. 2.2008
‫כר לכרית כף הרגל‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
‫פלמט רילאיינס בע"מ‬
‫פרופיל‬
PALMAT RELIANCE LTD.
Profile
Class
45561
8(08)
24. 2.2008
‫פלמט רילאיינס בע"מ‬
‫יחידת הרכבה לשלב תריס‬
PALMAT RELIANCE LTD.
Assembly unit for slat shutter
Class
December 29, 2008
– ‫ב' בטבת התשס"ט‬
‫סוג‬
45563
8(05)
‫סוג‬
3340
24. 2.2008
‫פלמט רילאיינס בע"מ‬
‫חולית שרשרת הרמה‬
PALMAT RELIANCE LTD.
Lifting chain segment
45569
9(07)
24. 2.2008
I.M.A. 1990 – ITZUR MUTZAREI ARIZA
Lid
Class
Class
45580
25(02)
28. 2.2008
‫סוג‬
‫ – ייצור מוצרי אריזה‬066/ .‫א‬.‫מ‬.‫י‬
‫מכסה‬
‫סוג‬
‫נאור רן‬
‫מחסום המעטת הדף‬
RAN NAOR
Blast attenuation barrier
Class
45586
15(07)
28. 2.2008
‫סוג‬
SOCIETE DES PRODUITS NESTLE S.A.
Freezer
Convention date (Switzerland)
Class
00./ .2007
45587
14(03)
28. 2.2008
‫מקפיא‬
)‫(שוויץ)הברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
‫מאיר עמירם‬
‫מחזיק לטלפון סלולרי‬
MEIR AMIRAM
Cell phone holder
Class
45599, 45600, 45601
29(02)
3. 3.2008
‫סוג‬
‫יאיר דוד‬
‫מתאם לחגורת ביטחון‬
YAIR DAVID
Safety belt adapter
Class
45602
28(03)
3. 3.2008
‫סוג‬
JEMELLA GROUP LIMITED
Hair styler
Convention date (OHIM)
Class
3341
/./ .2007
45618, 45620
28(03)
5. 3.2008
‫מכשיר לעיצוב שיער‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
JEMELLA GROUP LIMITED
Hair styler
Convention date (OHIM)
0.01 .2007
45622
28(03)
5. 3.2008
Class
‫מכשיר לעיצוב שיער‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
JEMELLA GROUP LIMITED
‫מכשיר לעיצוב שיער‬
Hair styler
45673, 45674, 45675,
45676, 45677, 45678
Class
9(01)
11. 3.2008
NEVIOT-NATURE OF GALILEE LTD.
Bottle
45721
19(06)
20. 3.2008
Class
‫סוג‬
‫טבע הגליל בע"מ‬-‫נביעות‬
‫בקבוק‬
‫סוג‬
STILOLINEA S.R.L.
Writing instrument
Convention date (OHIM)
00./ .2007
45730
2(04)
25. 3.2008
Class
‫מכשיר כתיבה‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
‫אלינור גלעדי‬
‫גרב‬
ELINOR GILADI
Sock
45751
25(01)
27. 3.2008
Class
‫סוג‬
‫שוקת אלומיניום בע"מ‬
‫פרופיל‬
SHOKET ALUMINIUM LTD.
Profile
45752
9(03)
30. 3.2008
Class
‫סוג‬
‫גיא בוסקילה‬
‫פח אשפה‬
GUY BUSKILA
Trash container
Class
December 29, 2008
45779, 45780, 45781
8(06)
– ‫ב' בטבת התשס"ט‬
‫סוג‬
3342
1. 4.2008
‫יואב שעיה‬
‫ידית‬
YOAV SHAYA
Handle
45807, 45808
11(01)
8. 4.2008
Class
‫סוג‬
‫ עיצובים בע"מ‬.‫ק‬.‫ל‬
‫עגיל‬
L.K. DESIGNS LTD.
Earring
45814
7(05)
9. 4.2008
Class
‫סוג‬
KONINKLIJKE PHILIPS ELECTRONICS N.V.
Iron
Convention date (OHIM)
02.01 .2007
46301
7(04)
23. 1.2008
Class
‫מגהץ‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
KENWOOD LIMITED
Arm for a hand held kitchen appliance
Convention date (OHIM)
3343
01.1 .2007
‫זרוע לכלי מטבח ידני‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
‫מדגמים שחודשו‬
DESIGNS RENEWED
/1021
/1100
/000/
0/100
/1/02
/0/0/
/0011
December 29, 2008
/1/01
/0/02
/001/
/1002
/0/20
/0001
– ‫ב' בטבת התשס"ט‬
/1012
/0/01
/0011
/100/
/0/00
/0010
/10/1
/0011
/001/
/102/
/0000
/0200
3344
‫מדגמים שבוטלו‬
DESIGNS VOID
0000/
0001/
00/02
0/0//
0//00
/1010
/1000
/10/2
/1211
000/0
00001
0/011
0//11
0//0/
/1000
/1000
/10/1
/1210
000/0
00000
0/000
0//10
0//00
/10/0
/1002
/10/0
/121/
Dr. Meir Noam
Commissioner of Patents,
Designs and Trade Marks
3345
000/0
0000/
0/00/
0//10
0//02
/10/2
/1001
/10//
/1200
00001
00000
0/0/0
0//1/
0//10
/10/1
/1002
/1210
/1202
00000
00000
0/0/0
0//10
0//01
/10/0
/1001
/1210
/1201
00002
00002
0/0/2
0//0/
/10//
/10//
/10//
/1210
/1200
0001/
00001
0/0/1
0//00
/1011
/1001
/10/0
/1212
‫ד"ר מאיר נועם‬
‫ המדגמים‬,‫רשם הפטנטים‬
‫וסימני מסחר‬
December 29, 2008
– ‫ב' בטבת התשס"ט‬
‫מפתחות לבקשות שקובלו‬
‫‪INDICES OF APPLICATIONS ACCEPTED‬‬
‫מפתח שמי‬
‫‪NAME INDEX‬‬
‫אביב ציפר ‪0.9:09‬‬
‫אביב קרירי ‪0.//66‬‬
‫אלביט מערכות בע"מ ‪09.8.6‬‬
‫אליהו קנט ‪0.69//‬‬
‫אמיטק‪ -‬אדוואנס מולטילאייר אנטרקונקט‬
‫טכנולוג'יס בע"מ ‪0./970‬‬
‫אנטולי פלוטניקוב ‪09070/‬‬
‫ביופאק בע"מ ‪09/6./‬‬
‫ברנב בע"מ ‪0.6074‬‬
‫דיפבריז בע"מ ‪0906/0‬‬
‫דלתא גליל תעשיות בע"מ ‪09.006‬‬
‫המרכז הרפואי של אוניברסיטת ניו יורק‪,‬‬
‫‪0./4.7‬‬
‫האוניברסיטה העברית בירושלים ‪0.80./‬‬
‫ישי אורן ‪09::/:‬‬
‫מדינול בע"מ ‪0.7/0/‬‬
‫מדינת ישראל ‪ -‬משרד החקלאות ופיתוח‬
‫הכפר‪ ,‬מינהל המחקר החקלאי‪ ,‬מרכז‬
‫וולקני ‪09/6./‬‬
‫מדינת ישראל‪ ,‬משרד החקלאות ופיתוח‬
‫הכפר‪ ,‬מינהל המחקר החקלאי‪ ,‬מרכז‬
‫וולקני ‪00.40.‬‬
‫מישל דאדי ‪07:0/0‬‬
‫סטארבורד טכנולוגיות בע"מ ‪0906/4‬‬
‫סטרייקר ג'י אי בע"מ ‪0:80:7‬‬
‫סיגואליו טכנולוגיות בע"מ ‪0.4909‬‬
‫ערן צור ‪09::/:‬‬
‫וט‪-‬טק בע"מ ‪09948/‬‬
‫ולדימיר סחרוב ‪044::4 ,04/.6/‬‬
‫ולדימיר קלוגרמן ‪08/470‬‬
‫וסקולר ביוג'ניק בע"מ ‪0..64/‬‬
‫פאור פייפר בע"מ ‪04.6/4‬‬
‫פיטרקס בע"מ ‪09::00‬‬
‫פישר תעשיות פרמצבטיות בע"מ ‪096.0.‬‬
‫פלסאון בע"מ ‪0.4.78‬‬
‫חניתה מפעלי מתכת בע"מ ‪090.87‬‬
‫טראנספארמה מדיקל בע"מ ‪0.0.7.‬‬
‫ידע חברה למחקר ופיתוח בע"מ ‪0./4.7‬‬
‫יואב טיקוצ'ינסקי ‪09::/:‬‬
‫יוסי דנה ‪0960:0‬‬
‫יורם אלקון ‪0.69//‬‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים ‪048:4.‬‬
‫יישום חברה לפיתוח המחקר של‬
‫ב' בטבת התשס"ט –‬
‫‪December 29, 2008‬‬
‫רומן קלוגרמן ‪08/470‬‬
‫רפאל מערכות לחימה מתקדמות בע"מ‬
‫‪0.:780‬‬
‫תמנור יעוץ וניהול בע"מ ‪0.69//‬‬
‫‪i‬‬
ABBOTT LABORATORIES 136396
ACCENTUS PLC 164854
AIR PRODUCTS AND CHEMICALS,
INC. 156107
AKZO NOBEL N.V. 158905
ALKERMES CONTROLLED
THERAPEUTICS, INC. 152767
AMITEC- ADVANCED MULTILAYER
INTERCONNECT TECHNOLOGIES
LTD. 150672
ANATOLI PLOTNIKOV 161720
APPLETON PAPERS INC. 147579
APPLIED RESEARCH SYSTEMS ARS
HOLDING N.V. 136551
AQUANOVA GERMAN
SOLUBILISATE TECHNOLOGIES
(AGT) GMBH 158569
ARBITRON INC. 159375
ASK S.A. 161707
ASSA ABLOY AB 151630
ASTRAZENECA AB 120424, 143232,
152778, 153947, 163375
AURORA NETWORKS, INC. 156395
AVENT LIMITED 141606
AVIV KARIRI 150099
AVIV ZIFFER 156326
BARNEV LTD. 159174
BASELL POLIOLEFINE ITALIA S.P.A.
166300
BASF AKTIENGESELLSCHAFT
159072
BASF SE 132601, 174098
BAXTER INTERNATIONAL INC.
156310
BAYER BIOSCIENCE GMBH 113776
BAYER SCHERING PHARMA AG
154666
BIODERM, INC. 152592
BIOGEN IDEC MA INC. 148014
BIOPACK LTD. 160950
BIOSENSE, INC. 137946
BIOVEX LIMITED 150677, 150678
BRACCO IMAGING S.P.A. 156188,
156189
BRISTOL-MYERS SQUIBB
December 29, 2008
– ‫ב' בטבת התשס"ט‬
COMPANY 156990
BTG INTERNATIONAL LIMITED
163173
CADILA HEALTHCARE LIMITED
150821
CALGON CARBON CORPORATION
171015
CHEIL INDUSTRIES INC. 160184
CHIESI FARMACEUTICI S.P.A.
165306
CIBA SPECIALTY CHEMICALS
HOLDING INC. 149526
CITRIX SYSTEMS, INC. 161141,
184891
CYBERFONE TECHNOLOGIES, INC.
153300
CYRIL DESEVAUX 153654
DAIICHI SANKYO COMPANY
LIMITED 152018
DAIICHI SANKYO COMPANY,
LIMITED 151035
DEEPBREEZE LTD. 162901
DELAVAN INC. 167752
DELTA GALIL INDUSTRIES LTD.
165219
DONALDSON COMPANY, INC.
167798
DUKE UNIVERSITY 151065
EADS Astrium GmbH 156638
ELBIT SYSTEMS LTD. 165859
ELI LILLY AND COMPANY 145582
ELIYAHU KENT 159600
ELSIE VAN BOGAERT 153654
ERAN ZUR 163303
ESSILOR INTERNATIONAL
(COMPAGNIE GENERALE
D'OPTIQUE) 134305
ETEL SA 160102
F. HOFFMANN-LA ROCHE AG 154575
FABIO PERINI 167203
ii
FISCHER FARMACEUTICALS LTD.
169525
FITRACKS LTD. 163322
FRANCOIS CHOUINARD 153654
FUJIKIN INCORPORATED 161793
GE MEDICAL SYSTEMS GLOBAL
TECHNOLOGY COMPANY, LLC
161464
GENENTECH, INC. 137743, 138930,
155567, 158921
GEORGETOWN UNIVERSITY 152018
GILEAD SCIENCES, INC. 169243
GREENOVATION BIOTECH GMBH
148638
H. LUNDBECK A/S 150241
H.C. STARCK GMBH 166738
HANITA METAL WORKS LTD.
162587
HEIDELBERG PHARMA HOLDING
GMBH 113865
HITACHI HIGH-TECHNOLOGIES
CORPORATION 163568
IBM CORPORATION 169511
ILIGHT TECHNOLOGIES, INC. 157064
INDENA S.P.A. 161444
INGENEUS CORPORATION 153548
INGENEUS INC. 153548
INSCENTINEL LIMITED 162525
INTELLIMATS, LLC 157275
INTERDIGITAL TECHNOLOGY
CORPORATION 154074
IODINE TECHNOLOGIES
AUSTRALIA PTY LTD. 153900
ISHAI OREN 163303
ISIS INNOVATION LIMITED 149885
JAPAN TOBACCO INC. 162548
JENAPHARM GMBH & CO.KG 154666
JOHNSON & JOHNSON VISION
CARE, INC. 134305
JOMA INTERNATIONAL AS 162742
KCI LICENSING, INC. 149509
KCI MEDICAL LIMITED 149509
KONINKLIJKE PHILIPS
iii
ELECTRONICS N.V. 182994, 182995
KUREHA CORPORATION 154207
KVINNO CENTRE PTY LTD. 166942
LABORATOIRES SERONO SA 136551
LELY ENTERPRISES AG 164348
LITTON SYSTEMS, INC. 161532
LOCKHEED MARTIN CORPORATION
158714
LOOK DYNAMICS, INC. 151875
LOUGHBOROUGH UNIVERSITY
ENTERPRISES LTD. 163173
LTS LOHMANN THERAPIESYSTEME AG 146819
MEDICAL BIOSYSTEMS LTD. 148678
MEDINOL LTD. 157020
MERCK & CO., INC. 148891
MERCK PATENT GMBH 149974
MICHEL DADI 173202
MOTOROLA, INC. 157049, 159552
MOUNTAIN VIEW
PHARMACEUTICALS, INC. 151065
MOUNTAIN VIEW
PHARMACEUTICALS, INC. 151065
N.V. ORGANON 158905
NEUROSEARCH SWEDEN AB 150351
NEW YORK UNIVERSITY MEDICAL
CENTER 150457
NOVATEX GMBH 164227
NPS PHARMACEUTICALS, INC.
120424
NYCOMED GMBH 155601
OCEAN BRICK SYSTEM (O.B.S.) LTD.
159600
ONO PHARMACEUTICAL CO., LTD.
154231
PAPERLESS INTERACTIVE
NEWSPAPER, LLC 159363
PAUL STROOBANT 156446
PFIZER INC. 130306
PFIZER PRODUCTS, INC. 165746
PFLEIDERER
INFRASTRUKTURECHNIK GMBH &
CO. KG 169789
December 29, 2008
– ‫ב' בטבת התשס"ט‬
PHAT CUSHION LLC 157548
PIXMAN CORPORATION 164034
PLASSON LTD. 154578
POWER PAPER LTD. 145904
PRESIDENT AND FELLOWS OF
HARVARD COLLEGE 157073
PRE-TECH CO., LTD. 161793
PUMA AKTIENGESELLSCHAFT
RUDOLF DASSLER SPORT 163747
QUALCOMM INCORPORATED
154308, 155895, 157438, 162219, 162955
QUARK PHARMACEUTICALS, INC.
151360
QUELLAN, INC. 158211
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD. 153781
RAIL.ONE GMBH 169789
RAYTHEON COMPANY 153978
REINER HOPCKE 153654
RESEARCH IN MOTION LIMITED
169022
ROBERT J. MACDONALD 167205
ROHM GMBH & CO. KG 165130
ROLAND HERWIG FRIEDRICH BECK
153654
ROMAN KLUGERMAN 180472
RUAG AMMOTEC GMBH 153015
SAMSUNG ELECTRONICS CO., LTD.
160184
SANDVIK AB 162876
SANDVIK INTELLECTUAL
PROPERTY AB 162876
SANDVIK INTELLECTUAL
PROPERTY AB 162876
SANOCHEMIA PHARMAZEUTIKA
AG 145559
SANOFI-AVENTIS DEUTSCHLAND
GMBH 156314
SANOFI-AVENTIS DEUTSCHLAND
GMBH 155099
SCHERING-PLOUGH, LTD. 145518,
147242
SEB S.A. 153369
SHELL INTERNATIONALE
December 29, 2008
– ‫ב' בטבת התשס"ט‬
RESEARCH MAATSCHAPPIJ B.V.
152455
SHIONOGI & COMPANY LIMITED
163375
SHISHIAI-KABUSHIKIGAISHA
125467
SIGVALUE TECHNOLOGIES LTD.
154626
SILVERBROOK RESEARCH PTY.
LTD. 146716, 147355
SILVERBROOK RESEARCH PTY.
LTD. 156080
SOCIETE D'ETUDES ET DE
CONSTRUCTIONS AERO-NAVALES
154568
SOLVAY FLUOR GMBH 163262
STARBOARD TECHNOLOGIES LTD.
161904
STRYKER GI LTD. 138237
SWAGELOK COMPANY 168788
TADAHIRO OHMI 161793
TAMNOR MANAGEMENT &
CONSULTING LTD. 159600
TEENESS ASA 156860
TELEDIFFUSION DE FRANCE 153984
TEXMED GmbH 158042
THALES NEDERLAND B.V. 155168,
156293
THE BOEING COMPANY 164959
THE MOUNT SINAI SCHOOL OF
MEDICINE OF THE CITY
UNIVERSITY OF NEW YORK 105379
THE STATE OF ISRAEL- MINISTRY
OF AGRICULTURE & RURAL
DEVELOPMENT, AGRICULTURAL
RESEARCH ORGANIZATION
VOLCANI CENTER 160950
THE STATE OF ISRAEL, MINISTRY
OF AGRICULTURE AND RURAL
DEVELOPMENT, AGRICULTURAL
RESEARCH ORGANIZATION,
VOLCANI CENTER 125425
THE UNIVERSITY OF MELBOURNE
158963
THERAVANCE, INC. 149317
iv
TITAN PHARMACEUTICALS, INC.
145815
TRANSPHARMA MEDICAL LTD.
152575
TROMMSDORFF GMBH & CO. KG
ARZNEIMITTEL 160552
UMD, INC. 133431
UNIVERSITY OF DELAWARE 151948
UNIVERSITY OF TENNESSEE
RESEARCH FOUNDATION 138437
UNIVERSITY OF VIRGINIA PATENT
FOUNDATION 144188
VASCULAR BIOGENICS LTD. 155940
VET-TECH LTD. 166480
VIASAT, INC. 135783
VINCENT LENAERTS 153654
VLADIMIR KLUGERMAN 180472
VLADIMIR SAKHAROV 140590,
144334
WISCONSIN ALUMNI RESEARCH
FOUNDATION 132133
WYETH 149531
YEDA RESEARCH AND
DEVELOPMENT CO. LTD. 150457
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM 148345
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM 158150
YOAV TIKOCHINSKY 163303
YORAM ALKON 159600
YOSSI DANA 169132
ZYMOGENETICS INC. 129379
v
December 29, 2008
– ‫ב' בטבת התשס"ט‬
‫מפתח ענייני‬
SUBJECT MATTER INDEX
A01H – 125425, 149885
B21D – 154568
B23B – 156860
A01J – 164348
A01N – 160950, 174098
B23C – 162587
B23P – 162876
A23K – 145518
B29C – 164959, 165130, 169511
A43B – 163747
B32B – 165219
A47G – 157275, 167205
B41J – 156080
A47J – 153369, 161720
B42D – 161904
A61B – 138237, 158042, 159174,
162901, 163173
B65D – 163303
A61C – 173202
B65G – 167203
A61F – 133431, 146819, 166942
C07C – 130306, 149317, 149526,
149531, 152778, 154207,
155099, 156188, 156189
A61J – 164227
A61K – 132133, 138437, 145559,
145582, 145815, 147742,
147579, 148345, 150457,
151035, 152592, 152767,
153654, 155601, 156310,
158150, 158921, 158963,
160552, 165746, 169243
C07D – 136396, 143232, 148014,
148891, 149974, 150241,
150351, 150821, 153947,
154231, 156314, 158569,
158905, 161444, 162548,
163375
C07F – 159072
A61L – 169525
C07H – 113865, 144188
A61M – 141606, 149509, 152575,
157020, 165306
A61N – 137946
C07J – 154666
C07K – 129620, 136551, 154575,
157073
A63D – 163322
C08F – 166300
B01D – 167798
C08J – 157548, 163262
B01J – 162742, 164854, 171015
December 29, 2008
– ‫ב' בטבת התשס"ט‬
vi
C08L – 125467, 166738
C10L – 132601
G01P – 161532
G01S – 155168, 155895, 156293,
157438, 158714, 159552,
165859
G02C – 134305
C12N – 105379, 113776, 120424,
129379, 137743, 138930,
148638, 150677, 150678,
151065, 151948, 152018,
155567, 155940, 156446,
156990
G02F – 169132
G06F – 147355, 161141
G06K – 151 875, 161707
G06Q – 153300
C12Q – 148678, 151360, 153548
G06T – 166480
C25B – 153900
G09F – 164034
E01B – 169789
G11B – 182994, 182995
E03D – 150099
G21K – 161464
E04B – 159600
E05B – 151630
H01L – 140590, 156107, 160184,
161793
E21B – 152455
H01M – 145904
F02C – 167752
H01Q – 153978, 156638
F15B – 168788
H02K – 160102
F16H – 180472
H04B – 135783, 154074, 162955
F16L – 154578
H04H – 159375
F21L – 156326
H04L – 153984, 157049, 158211,
169022, 184891
F21V – 157064
H04M – 159363
F41H – 153781
H04Q – 154308, 154626, 162219
F42B – 153015
H05K – 150672, 156395
G01B – 163568
G01N – 162525
vii
December 29, 2008
– ‫ב' בטבת התשס"ט‬
‫ ירושלים‬,‫ משרד המשפטים‬,‫נערך ע"י רשות הפטנטים‬
‫ ירושלים‬,‫הופק והודפס במדפיס הממשלתי‬
EDITED BY THE PATENT OFFICE, MINISTRY OF JUSTICE, JERUSALEM
PRINTED AND PUBLISHED BY THE GOVERNMENT PRINTER